USPatent applicationPatented

Coding sequence polymorphisms in vascular pathology genes

Granted 17 Feb 2004 · 5 office actions

Application· this page
9054272
filed 1 Apr 1998
Publication
Not published
not published
Patent
US 6,692,909
granted 17 Feb 2004

Life of the application

13 dated events
⤢ drag to zoom19982000200220042006200820102012201420162018ProsecutionOwnershipTerm & fees
ProsecutionOwnershipTerm & feeshover for detail · click to open

Abstract

The invention provides nucleic acid segments of the human genome, particularly necleic acid segments from the coding region of a gene, including polymorphic sites. Allele-specific primers and probes hybridizing to regions flanking or containing these sites are also provided. The nucleic acids, primers and probes are used in applications such as phenotype correlations, forensics, paternity testing, medicine and genetic analysis.

Description

113 parts
›BACKGROUND OF THE INVENTION

The genomes of all organisms undergo spontaneous mutation in the course of their continuing evolution, generating variant forms of progenitor sequences (Gusella, Ann. Rev. Biochem. 55, 831-854 (1986)). The variant form may confer an evolutionary advantage or disadvantage relative to a progenitor form or may be neutral. In some instances, a variant form confers a lethal disadvantage and is not transmitted to subsequent generations of the organism. In other instances, a variant form confers an evolutionary advantage to the species and is eventually incorporated into the DNA of many or most members of the species and effectively becomes the progenitor form. In many instances, both progenitor and variant form(s) survive and co-exist in a species population. The coexistence of multiple forms of a sequence gives rise to polymorphisms.

Several different types of polymorphism have been reported. A restriction fragment length polymorphism (RFLP) Is a variation in DNA sequence that alters the length of a restriction fragment (Botstein et al., Am. J. Hum. Genet. 32, 314-331 (1980)). The restriction fragment length polymorphism may create or delete a restriction site, thus changing the length of the restriction fragment. RFLPs have been widely used in human and animal genetic analyses (see WO 90/13668; W090/11369; Donis-Keller, Cell 51, 319-337 (1987); Lander et al., Genetics 121, 85-99 (1989)). When a heritable trait can be linked to a particular RFLP, the presence of the RFLP in an individual can be used to predict the likelihood that the animal will also exhibit the trait.

Other polymorphisms take the form of short tandem repeats (STRs) that include tandem di-, tri- and tetra-nucleotide repeated motifs. These tandem repeats are also referred to as variable number tandem repeat (VNTR) polymorphisms. VNTRs have been used in identity and paternity analysis (U.S. Pat. No. 5,075,217; Armour et al., FEBS Lett. 307, 113-115 (1992); Horn et al., WO 91/14003; Jeffreys, EP 370,719), and in a large number of genetic mapping studies.

Other polymorphisms take the form of single nucleotide variations between individuals of the same species. Such polymorphisms are far more frequent than RFLPs, STRs and VNTRs. Some single nucleotide polymorphisms (SNP) occur in protein-coding sequences (coding sequence SNP (cSNP)), in which case, one of the polymorphic forms may give rise to the expression of a defective or otherwise variant protein and, potentially, a genetic disease. Examples of genes in which polymorphisms within coding sequences give rise to genetic disease include β-globin (sickle cell anemia), apoE4 (Alzheimer's Disease), Factor V Leiden (thrombosis), and CFTR (cystic fibrosis). cSNPs can alter the codon sequence of the gene and therefore specify an alternative amino acid. Such changes are called “missense” when another amino acid is substituted, and “nonsense” when the alternative codon specifies a stop signal in protein translation. When the cSNP does not alter the amino acid specified the cSNP is called “silent”.

Other single nucleotide polymorphisms occur in noncoding regions. Some of these polymorphisms may also result in defective protein expression (e.g., as a result of defective splicing). Other single nucleotide polymorphisms have no phenotypic effects.

Single nucleotide polymorphisms can be used in the same manner as RFLPs and VNTRs, but offer several advantages. Single nucleotide polymorphisms occur with greater frequency and are spaced more uniformly throughout the genome than other forms of polymorphism. The greater frequency and uniformity of single nucleotide polymorphisms means that there is a greater probability that such a polymorphism will be found in close proximity to a genetic locus of interest than would be the case for other polymorphisms. The different forms of characterized single nucleotide polymorphisms are often easier to distinguish than other types of polymorphism (e.g., by use of assays employing allele-specific hybridization probes or primers).

Only a small percentage of the total repository of polymorphisms in humans and other organisms has been identified. The limited number of polymorphisms identified to date is due to the large amount of work required for their detection by conventional methods. For example, a conventional approach to identifying polymorphisms might be to sequence the same stretch of DNA in a population of individuals by dideoxy sequencing. In this type of approach, the amount of work increases in proportion to both the length of sequence and the number of individuals in a population and becomes impractical for large stretches of DNA or large numbers of persons.

›SUMMARY OF THE INVENTION

Work described herein pertains to the identification of polymorphisms which can predispose individuals to disease, particularly vascular pathologies, by resequencing large numbers of genes in a large number of individuals. Eighteen genes in a minimum of 30 individuals have been resequenced as described herein, and 92 SNPs have been discovered (see the Table). Forty of these SNPs are cSNPs which specify a different amino acid sequence, while 49 of the SNPs are silent cSNPs. Three of the SNPs were located in non-coding regions.

The invention relates to a gene which comprises a single nucleotide polymorphism at a specific location. In a particular embodiment the invention relates to the variant allele of a gene having a single nucleotide polymorphism, which variant allele differs from a reference allele by one nucleotide at the site(s) identified in the Table. Complements of these nucleic acid segments are also included. The segments can be DNA or RNA, and can be double- or single-stranded. Segments can be, for example, 5-10, 5-15, 10-20, 5-25, 10-30, 10-50 or 10-100 bases long.

The invention further provides allele-specific oligonucleotides that hybridize to a gene comprising a single nucleotide polymorphism or to the complement of the gene. These oligonucleotides can be probes or primers.

The invention further provides a method of analyzing a nucleic acid from an individual. The method determines which base is present at any one of the polymorphic sites shown in the Table. Optionally, a set of bases occupying a set of the polymorphic sites shown in the Table is determined. This type of analysis can be performed on a number of individuals, who are tested for the presence of a disease phenotype. The presence or absence of disease phenotype is then correlated with a base or set of bases present at the polymorphic site or sites in the individuals tested.

›BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1A-1C are a table illustrating the locations of single nucleotide polymorphisms of various genes.

FIG. 2 is a listing of the genes from FIGS. 1A-C with their corresponding GenBank Accession numbers and the nucleotide position within that sequence at which the single nucleotide polymorphism is located.

FIGS. 3A-B are a listing of the nucleotide sequence and amino acid sequence corresponding to GenBank Accession number D10202 for the gene PTAFR SEQ ID NOS 1-2, respectively.

FIGS. 4A-B are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number D29832 for the gene AT3 SEQ ID NOS 3-4, respectively.

FIGS. 5A-C are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number D38081 for the gene TBXA2R SEQ ID NOS 5-6, respectively.

FIGS. 6A-C are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number J02703 for the gene ITGB3 SEQ ID NOS 7-8, respectively.

FIGS. 7A-C are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number J02764 for the gene ITGA2B SEQ ID NOS 9-10, respectively.

FIGS. 8A-F are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number J02846 for the gene F3 SEQ ID NOS 11-12, respectively.

FIGS. 9A-B are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number J02898 for the gene CETPA SEQ ID NOS 13-14, respectively.

FIGS. 10A-B are a listing of the nucleotide sequence and amin acid sequence corresponding to the GenBank Accession number J03225 for the gene TFPI SEQ ID NOS 15-16, respectively.

FIGS. 11A-B are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number K02059 for the gene PROC SEQ ID NOS 17-18, respectively.

FIG. 12 is a listing of the nucleotide sequence corresponding to the GenBank Accession number L00336 for the gene LDLR SEQ ID NO 19.

FIG. 13 is a listing of the nucleotide sequence corresponding to the GenBank Accession number L00338 SEQ ID NO 20.

FIG. 14 is a listing of the nucleotide sequence corresponding to the GenBank Accession number L00343 for the gene LDLR SEQ ID NO 21.

FIG. 15 is a listing of the nucleotide sequence corresponding to the GenBank Accession number L00344 for the gene LDLR SEQ ID NO 22.

FIG. 16 is a listing of the nucleotide sequence corresponding to the GenBank Accession number L00345 for the gene LDLR SEQ ID NO 23.

FIG. 17 is a listing of the nucleotide sequence corresponding to the GenBank Accession number L00347 for the gene LDLR SEQ ID NO 24.

FIG. 18 is a listing of the nucleotide sequence corresponding to the GenBank Accession number L00349 for the gene LDLR SEQ ID NO 25.

FIGS. 19A-B are a listing of the nucleotide sequence corresponding to the GenBank Accession number L00351 for the gene LDLR SEQ ID NO 26.

FIGS. 20A-B are a listing of the nucleotide sequence corresponding to the GenBank Accession number L29401 for the gene LDLR SEQ ID NO 27.

FIGS. 21A-B are a listing of the nucleotide sequence corresponding to the GenBank Accession number L32765 for the gene F5 SEQ ID NO 28.

FIGS. 22A-C are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number M11058 for the gene HMGCR SEQ ID NOS 29-30, respectively.

FIGS. 23A-F are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number M11228 for the gene PROC SEQ ID NOS 31-32, respectively.

FIGS. 24A-B are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number M12625 for the gene LCAT SEQ ID NOS 33-34, respectively.

FIGS. 25A-C are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number M12849 for the gene HCF2 SEQ ID NOS 35-36, respectively.

FIGS. 26A-E are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number M14335 for the gene F5 SEQ ID NOS 37-38, respectively.

FIGS. 27A-C are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number M15856 for the gene LPL SEQ ID NOS 39-40, respectively.

FIGS. 28A-N are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number M17262 for the gene F2 SEQ ID NOS 41-42, respectively.

FIGS. 29A-C are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number M20311 for the gene ITGB3 SEQ ID NOS 43-44, respectively.

FIG. 30 is a listing of the nucleotide sequence corresponding to the GenBank Accession number M21645 for the gene AT3 SEQ ID NO 45.

FIGS. 31A-B are a listing of the nucleotide sequence corresponding to the GenBank Accession number M22569 for the gene ITGA2B SEQ ID NO 46.

FIGS. 32A-B are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number M30185 for the gene CETP SEQ ID NOS 47-48, respectively.

FIGS. 33A-H are a listing of the nucleotide sequence corresponding to the GenBank Accession number M33320 for the gene ITGA2B SEQ ID NO 49.

FIGS. 34A-G are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number M58600 for the gene HCF2 SEQ ID NOS 50-51, respectively.

FIGS. 35A-B are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number M62424 for the gene F2R SEQ ID NOS 52-53, respectively.

FIGS. 36A-C are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number M76722 for the gene LPL SEQ ID NOS 54-55, respectively.

FIGS. 37A-B are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number U59436 for the gene LDLR SEQ ID NOS 56-57, respectively.

FIGS. 38A-B are a listing of the nucleotide sequence and amino acid sequence corresponding to the GenBank Accession number Z22555 for the gene CLanalog SEQ ID NOS 58-59, respectively.

›DETAILED DESCRIPTION OF THE INVENTION

The present invention relates to a gene which comprises a single nucleotide polymorphism (SNP) at a specific location. The gene which includes the SNP has at least two alleles, referred to herein as the reference allele and the variant allele. The reference allele (prototypical or wild type allele) has been designated arbitrarily and typically corresponds to the nucleotide sequence of the gene which has been deposited with GenBank under a given Accession number. The variant allele differs from the reference allele by one nucleotide at the site(s) identified in the Table. The present invention also relates to variant alleles of the described genes and to complements of the variant alleles. The invention further relates to portions of the variant alleles and portions of complements of the variant alleles which comprise (encompass) the site of the SNP and are at least 5 nucleotides in length. Portions can be, for example, 5-10, 5-15, 10-20, 5-25, 10-30, 10-50 or 10-100 bases long. For example, a portion of a variant allele which is 5 nucleotides in length includes the single nucleotide polymorphism (the nucleotide which differs from the reference allele at that site) and four additional nucleotides which flank the site in the variant allele. These nucleotides can be on one or both sides of the polymorphism. Polymorphisms which are the subject of this invention are defined in the Table with respect to the reference sequence deposited in GenBank under the Accession number indicated. For example, the invention relates to a portion of a gene (e.g., AT3) having a nucleotide sequence as deposited in GenBank (e.g., M21645) comprising a single nucleotide polymorphism at a specific position (e.g., nucleotide 100). The reference allele for AT3 is shown in column 15 and the variant allele is shown in column 17 of the Table. The nucleotide sequences of the invention can be double- or single-stranded.

The invention further provides allele-specific oligonucleotides that hybridize to a gene comprising a single nucleotide polymorphism or to the complement of the gene. These oligonucleotides can be probes or primers.

The invention further provides a method of analyzing a nucleic acid from an individual. The method determines which base is present at any one of the polymorphic sites shown in the Table. Optionally, a set of bases occupying a set of the polymorphic sites shown in the Table is determined. This type of analysis can be performed on a number of individuals, who are tested for the presence of a disease phenotype. The presence or absence of disease phenotype is then correlated with a base or set of bases present at the polymorphic site or sites in the individuals tested.

›DEFINITIONS · 1 of 7

An oligonucleotide can be DNA or RNA, and single- or double-stranded. Oligonucleotides can be naturally occurring or synthetic, but are typically prepared by synthetic means. Preferred oligonucleotides of the invention include segments of DNA, or their complements, which include any one of the polymorphic sites shown in the Table. The segments can be between 5 and 250 bases, and, in specific embodiments, are between 5-10, 5-20, 10-20, 10-50, 20-50 or 10-100 bases. The polymorphic site can occur within any position of the segment. The segments can be from any of the allelic forms of DNA shown in the Table.

As used herein, the terms “nucleotide” and “nucleic acid” are intended to be equivalent. The terms “nucleotide sequence”, “nucleic acid sequence” and “segment” are intended to be equivalent.

Hybridization probes are oligonucleotides which bind in a base-specific manner to a complementary strand of nucleic acid. Such probes include peptide nucleic acids, as described in Nielsen et al., Science 254, 1497-1500 (1991). Probes can be any length suitable for specific hybridization to the target nucleic acid sequence. The most appropriate length of the probe may vary depending upon the hybridization method in which it is being used; for example, particular lengths may be more appropriate for use in microfabricated arrays, while other lengths may be more suitable for use in classical hybridization methods. Suitable probes and primers can range from about 5 nucleotides to about 30 nucleotides in length. For example, probes and primers can be 5, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 25, 26, 28 or 30 nucleotides in length. The probe or primer preferably contains at least one polymorphic site occupied by any of the possible variant nucleotides. The nucleotide sequence can correspond to the coding sequence of the allele or to the complement of the coding sequence of the allele.

As used herein, the term “primer” refers to a single-stranded oligonucleotide which acts as a point of initiation of template-directed DNA synthesis under appropriate conditions (e.g., in the presence of four different nucleoside triphosphates and an agent for polymerization, such as, DNA or RNA polymerase or reverse transcriptase) in an appropriate buffer and at a suitable temperature. The appropriate length of a primer depends on the intended use of the primer, but typically ranges from 15 to 30 nucleotides. Short primer molecules generally require cooler temperatures to form sufficiently stable hybrid complexes with the template. A primer need not reflect the exact sequence of the template, but must be sufficiently complementary to hybridize with a template. The term primer site refers to the area of the target DNA to which a primer hybridizes. The term primer pair refers to a set of primers including a 5′ (upstream) primer that hybridizes with the 5′ end of the DNA sequence to be amplified and a 3′ (downstream) primer that hybridizes with the complement of the 3′ end of the sequence to be amplified.

As used herein, linkage describes the tendency of genes, alleles, loci or genetic markers to be inherited together as a result of their location on the same chromosome. It can be measured by percent recombination between the two genes, alleles, loci or genetic markers.

As used herein, polymorphism refers to the occurrence of two or more genetically determined alternative sequences or alleles in a population. A polymorphic marker or site is the locus at which divergence occurs. Preferred markers have at least two alleles, each occurring at frequency of greater than 1%, and more preferably greater than 10% or 20% of a selected population. A polymorphic locus may be as small as one base pair. Polymorphic markers include restriction fragment length polymorphisms, variable number of tandem repeats (VNTR's), hypervariable regions, minisatellites, dinucleotide repeats, trinucleotide repeats, tetranucleotide repeats, simple sequence repeats, and insertion elements such as Alu. The first identified allelic form is arbitrarily designated as the reference form and other allelic forms are designated as alternative or variant alleles. The allelic form occurring most frequently in a selected population is sometimes referred to as the wildtype form. Diploid organisms may be homozygous or heterozygous for allelic forms. A diallelic or biallelic polymorphism has two forms. A triallelic polymorphism has three forms.

Work described herein pertains to the resequencing of large numbers of genes in a large number of individuals to identify polymorphisms which can predispose individuals to disease, particularly vascular pathologies. Eighteen genes in a minimum of 30 individuals have been resequenced as described herein, and 92 SNPs have been discovered (see the Table). Forty of these SNPs are cSNPs which specify a different amino acid sequence, while 49 of the SNPs are silent cSNPs. Three of the SNPs were located in non-coding regions.

The 18 genes which were subjected to analysis encode proteins that are involved in biochemical pathways that regulate blood coagulation, lipid metabolism, and platelet and endothelial cell function. Polymorphisms in all 18 genes are candidates for genetic factors that influence the pathophysiology of the blood and blood vessels and thus can be relevant to the genetic risk of cardiovascular diseases. The identified polymorphisms can also be relevant to other disease categories.

By altering amino acid sequence, SNPs may alter the function of the encoded proteins. The discovery of the SNP facilitates biochemical analysis of the variants and the development of assays to characterize the variants and to screen for pharmaceutical that would interact directly with on or another form of the protein. SNPs (including silent SNPs) may also alter the regulation of the gene at the transcriptional or post-transcriptional level. SNPs (including silent SNPs) also enable the development of specific DNA, RNA, or protein-based diagnostics that detect the presence or absence of the polymorphism in particular conditions.

›DEFINITIONS · 2 of 7

A single nucleotide polymorphism occurs at a polymorphic site occupied by a single nucleotide, which is the site of variation between allelic sequences. The site is usually preceded by and followed by highly conserved sequences of the allele (e.g., sequences that vary in less than {fraction (1/100)} or {fraction (1/1000)} members of the populations).

A single nucleotide polymorphism usually arises due to substitution of one nucleotide for another at the polymorphic site. A transition is the replacement of one purine by another purine or one pyrimidine by another pyrimidine. A transversion is the replacement of a purine by a pyrimidine or vice versa. Single nucleotide polymorphisms can also arise from a deletion of a nucleotide or an insertion of a nucleotide relative to a reference allele. Typically the polymorphic site is occupied by a base other than the reference base. For example, where the reference allele contains the base “T” at the polymorphic site, the altered allele can contain a “C”, “G” or “A” at the polymorphic site.

Hybridizations are usually performed under stringent conditions, for example, at a salt concentration of no more than 1 M and a temperature of at least 25° C. For example, conditions of 5×SSPE (750 mM NaCl, 50 mM NaPhosphate, 5 mM EDTA, pH 7.4) and a temperature of 25-30° C., or equivalent conditions, are suitable for allele-specific probe hybridizations. Equivalent conditions can be determined by varying one or more of the parameters given as an example, as known in the art, while maintaining a similar degree of identity or similarity between the target nucleotide sequence and the primer or probe used.

The term “isolated” is used herein to indicate that the material in question exists in a physical milieu distinct from that in which it occurs in nature. For example, an isolated nucleic acid of the invention may be substantially isolated with respect to the complex cellular milieu in which it naturally occurs. In some instances, the isolated material will form part of a composition (for example, a crude extract containing other substances), buffer system or reagent mix. In other circumstance, the material may be purified to essential homogeneity, for example as determined by PAGE or column chromatography such as HPLC. Preferably, an isolated nucleic acid comprises at least about 50, 80 or 90 percent (on a molar basis) of all macromolecular species present.

I. Novel Polymorphisms of the Invention

The novel polymorphisms of the invention are shown in the Table.

II. Analysis of Polymorphisms

A. Preparation of Samples

Polymorphisms are detected in a target nucleic acid from an individual being analyzed. For assay of genomic DNA, virtually any biological sample (other than pure red blood cells) is suitable. For example, convenient tissue samples include whole blood, semen, saliva, tears, urine, fecal material, sweat, buccal, skin and hair. For assay of cDNA or mRNA, the tissue sample must be obtained from an organ in which the target nucleic acid is expressed. For example, if the target nucleic acid is a cytochrome P450, the liver is a suitable source.

Many of the methods described below require amplification of DNA from target samples. This can be accomplished by e.g., PCR. See generally PCR Technology: Principles and Applications for DNA Amplification (ed. H. A. Erlich, Freeman Press, NY, N.Y., 1992); PCR Protocols: A Guide to Methods and Applications (eds. Innis, et al., Academic Press, San Diego, Calif., 1990); Mattila et al., Nucleic Acids Res. 19, 4967 (1991); Eckert et al., PCR Methods and Applications 1, 17 (1991); PCR (eds. McPherson et al., IRL Press, Oxford); and U.S. Pat. No. 4,683,202.

Other suitable amplification methods include the ligase chain reaction (LCR) (see Wu and Wallace, Genomics 4, 560 (1989), Landegren et al., Science 241, 1077 (1988), transcription amplification (Kwoh et al., Proc. Natl. Acad. Sci. USA 86, 1173 (1989)), and self-sustained sequence replication (Guatelli et al., Proc. Nat. Acad. Sci. USA, 87, 1874 (1990)) and nucleic acid based sequence amplification (NASBA). The latter two amplification methods involve isothermal reactions based on isothermal transcription, which produce both single stranded RNA (ssRNA) and double stranded DNA (dsDNA) as the amplification products in a ratio of about 30 or 100 to 1, respectively.

B. Detection of Polymorphisms in Target DNA

There are two distinct types of analysis of target DNA for detecting polymorphisms. The first type of analysis, sometimes referred to as de novo characterization, is carried out to identify polymorphic sites not previously characterized (i.e., to identify new polymorphisms). This analysis compares target sequences in different individuals to identify points of variation, i.e., polymorphic sites. By analyzing groups of individuals representing the greatest ethnic diversity among humans and greatest breed and species variety in plants and animals, patterns characteristic of the most common alleles/haplotypes of the locus can be identified, and the frequencies of such alleles/haplotypes in the population can be determined. Additional allelic frequencies can be determined for subpopulations characterized by criteria such as geography, race, or gender. The de novo identification of polymorphisms of the invention is described in the Examples section. The second type of analysis determines which form(s) of a characterized (known) polymorphism are present in individuals under test. There are a variety of suitable procedures, which are discussed in turn.

1. Allele-Specific Probes

The design and use of allele-specific probes for analyzing polymorphisms is described by e.g., Saiki et al., Nature 324, 163-166 (1986); Dattagupta, EP 235,726, Saiki, WO 89/11548. Allele-specific probes can be designed that hybridize to a segment of target DNA from one individual but do not hybridize to the corresponding segment from another individual due to the presence of different polymorphic forms in the respective segments from the two individuals. Hybridization conditions should be sufficiently stringent that there is a significant difference in hybridization intensity between alleles, and preferably an essentially binary response, whereby a probe hybridizes to only one of the alleles. Some probes are designed to hybridize to a segment of target DNA such that the polymorphic site aligns with a central position (e.g., in a 15-mer at the 7 position; in a 16-mer, at either the 8 or 9 position) of the probe. This design of probe achieves good discrimination in hybridization between different allelic forms.

›DEFINITIONS · 3 of 7

Allele-specific probes are often used in pairs, one member of a pair showing a perfect match to a reference form of a target sequence and the other member showing a perfect match to a variant form. Several pairs of probes can then be immobilized on the same support for simultaneous analysis of multiple polymorphisms within the same target sequence.

2. Tiling Arrays

The polymorphisms can also be identified by hybridization to nucleic acid arrays, some examples of which are described in WO 95/11995. One form of such arrays is described in the Examples section in connection with de novo identification of polymorphisms. The same array or a different array can be used for analysis of characterized polymorphisms. WO 95/11995 also describes subarrays that are optimized for detection of a variant form of a precharacterized polymorphism. Such a subarray contains probes designed to be complementary to a second reference sequence, which is an allelic variant of the first reference sequence. The second group of probes is designed by the same principles as described in the Examples, except that the probes exhibit complementarity to the second reference sequence. The inclusion of a second group (or further groups) can be particularly useful for analyzing short subsequences of the primary reference sequence in which multiple mutations are expected to occur within a short distance commensurate with the length of the probes (e.g., two or more mutations within 9 to 21 bases).

3. Allele-Specific Primers

An allele-specific primer hybridizes to a site on target DNA overlapping a polymorphism and only primes amplification of an allelic form to which the primer exhibits perfect complementarity. See Gibbs, Nucleic Acid Res. 17, 2427-2448 (1989). This primer is used in conjunction with a second primer which hybridizes at a distal site. Amplification proceeds from the two primers, resulting in a detectable product which indicates the particular allelic form is present. A control is usually performed with a second pair of primers, one of which shows a single base mismatch at the polymorphic site and the other of which exhibits perfect complementarity to a distal site. The single-base mismatch prevents amplification and no detectable product is formed. The method works best when the mismatch is included in the 3′-most position of the oligonucleotide aligned with the polymorphism because this position is most destabilizing to elongation from the primer (see, e.g., WO 93/22456).

4. Direct-Sequencing

The direct analysis of the sequence of polymorphisms of the present invention can be accomplished using either the dideoxy chain termination method or the Maxam Gilbert method (see Sambrook et al., Molecular Cloning, A Laboratory Manual (2nd Ed., CSHP, New York 1989); Zyskind et al., Recombinant DNA Laboratory Manual, (Acad. Press, 1988)).

5. Denaturing Gradient Gel Electrophoresis

Amplification products generated using the polymerase chain reaction can be analyzed by the use of denaturing gradient gel electrophoresis. Different alleles can be identified based on the different sequence-dependent melting properties and electrophoretic migration of DNA in solution. Erlich, ed., PCR Technology, Principles and Applications for DNA Amplification, (W. H. Freeman and Co, New York, 1992), Chapter 7.

6. Single-Strand Conformation Polymorphism Analysis

Alleles of target sequences can be differentiated using single-strand conformation polymorphism analysis, which identifies base differences by alteration in electrophoretic migration of single stranded PCR products, as described in Orita et al., Proc. Nat. Acad. Sci. 86, 2766-2770 (1989). Amplified PCR products can be generated as described above, and heated or otherwise denatured, to form single stranded amplification products. Single-stranded nucleic acids may refold or form secondary structures which are partially dependent on the base sequence. The different electrophoretic mobilities of single-stranded amplification products can be related to base-sequence differences between alleles of target sequences.

III. Methods of Use

After determining polymorphic form(s) present in an individual at one or more polymorphic sites, this information can be used in a number of methods.

A. Forensics

Determination of which polymorphic forms occupy a set of polymorphic sites in an individual identifies a set of polymorphic forms that distinguishes the individual. See generally National Research Council, The Evaluation of Forensic DNA Evidence (Eds. Pollard et al., National Academy Press, DC, 1996). The more sites that are analyzed, the lower the probability that the set of polymorphic forms in one individual is the same as that in an unrelated individual. Preferably, if multiple sites are analyzed, the sites are unlinked. Thus, polymorphisms of the invention are often used in conjunction with polymorphisms in distal genes. Preferred polymorphisms for use in forensics are biallelic because the population frequencies of two polymorphic forms can usually be determined with greater accuracy than those of multiple polymorphic forms at multi-allelic loci.

The capacity to identify a distinguishing or unique set of forensic markers in an individual is useful for forensic analysis. For example, one can determine whether a blood sample from a suspect matches a blood or other tissue sample from a crime scene by determining whether the set of polymorphic forms occupying selected polymorphic sites is the same in the suspect and the sample. If the set of polymorphic markers does not match between a suspect and a sample, it can be concluded (barring experimental error) that the suspect was not the source of the sample. If the set of markers does match, one can conclude that the DNA from the suspect is consistent with that found at the crime scene. If frequencies of the polymorphic forms at the loci tested have been determined (e.g., by analysis of a suitable population of individuals), one can perform a statistical analysis to determine the probability that a match of suspect and crime scene sample would occur by chance.

›DEFINITIONS · 4 of 7

p(ID) is the probability that two random individuals have the same polymorphic or allelic form at a given polymorphic site. In biallelic loci, four genotypes are possible: AA, AB, BA, and BB. If alleles A and B occur in a haploid genome of the organism with frequencies x and y, the probability of each genotype in a diploid organism is (see WO 95/12607):

Homozygote: p ( AA )= x 2

Homozygote: p ( BB )= y 2 =(1 −x ) 2

Single Heterozygote: p ( AB )= p ( BA )= xy=x (1 −x )

Both Heterozygotes: p ( AB+BA )=2 xy =2 x (1 −x )

The probability of identity at one locus (i.e, the probability that two individuals, picked at random from a population will have identical polymorphic forms at a given locus) is given by the equation:

p ( ID )=( x 2 ) 2 +(2 xy ) 2 +( y 2 ) 2 .

These calculations can be extended for any number of polymorphic forms at a given locus. For example, the probability of identity p(ID) for a 3-allele system where the alleles have the frequencies in the population of x, y and z, respectively, is equal to the sum of the squares of the genotype frequencies:

p ( ID )= x 4 +(2 xy )+(2 yz ) 2 +(2 xz ) 2 +z 4 +y 4

In a locus of n alleles, the appropriate binomial expansion is used to calculate p(ID) and p(exc).

The cumulative probability of identity (cum p(ID)) for each of multiple unlinked loci is determined by multiplying the probabilities provided by each locus.

cum p ( ID )= p ( ID 1) p ( ID 2) p ( ID 3) . . . p ( ID n)

The cumulative probability of non-identity for n loci (i.e. the probability that two random individuals will be different at 1 or more loci) is given by the equation:

cum p (non ID )=1−cum p ( ID ).

If several polymorphic loci are tested, the cumulative probability of non-identity for random individuals becomes very high (e.g., one billion to one). Such probabilities can be taken into account together with other evidence in determining the guilt or innocence of the suspect.

B. Paternity Testing

The object of paternity testing is usually to determine whether a male is the father of a child. In most cases, the mother of the child is known and thus, the mother's contribution to the child's genotype can be traced. Paternity testing investigates whether the part of the child's genotype not attributable to the mother is consistent with that of the putative father. Paternity testing can be performed by analyzing sets of polymorphisms in the putative father and the child.

If the set of polymorphisms in the child attributable to the father does not match the set of polymorphisms of the putative father, it can be concluded, barring experimental error, that the putative father is not the real father. If the set of polymorphisms in the child attributable to the father does match the set of polymorphisms of the putative father, a statistical calculation can be performed to determine the probability of coincidental match.

The probability of parentage exclusion (representing the probability that a random male will have a polymorphic form at a given polymorphic site that makes him incompatible as the father) is given by the equation (see WO 95/12607):

p (exc)= xy (l− xy )

where x and y are the population frequencies of alleles A and B of a biallelic polymorphic site.

(At a triallelic site p(exc)=xy(1−xy)+yz(1−yz)+xz(l−xz)+3xyz(l−xyz))), where x, y and z and the respective population frequencies of alleles A, B and C).

The probability of non-exclusion is

p (non-exc)=1 −p (exc)

The cumulative probability of non-exclusion (representing the value obtained when n loci are used) is thus:

cum p (non-exc)= p (non-excl) p (non-exc2) p (non-exc3) . . . p (non-excn)

The cumulative probability of exclusion for n loci (representing the probability that a random male will be excluded)

cum p (exc)=1−cum p (non-exc).

If several polymorphic loci are included in the analysis, the cumulative probability of exclusion of a random male is very high. This probability can be taken into account in assessing the liability of a putative father whose polymorphic marker set matches the child's polymorphic marker set attributable to his/her father.

C. Correlation of Polymorphisms with Phenotypic Traits

The polymorphisms of the invention may contribute to the phenotype of an organism in different ways. Some polymorphisms occur within a protein coding sequence and contribute to phenotype by affecting protein structure. The effect may be neutral, beneficial or detrimental, or both beneficial and detrimental, depending on the circumstances. For example, a heterozygous sickle cell mutation confers resistance to malaria, but a homozygous sickle cell mutation is usually lethal. Other polymorphisms occur in noncoding regions but may exert phenotypic effects indirectly via influence on replication, transcription, and translation. A single polymorphism may affect more than one phenotypic trait. Likewise, a single phenotypic trait may be affected by polymorphisms in different genes. Further, some polymorphisms predispose an individual to a distinct mutation that is causally related to a certain phenotype.

Phenotypic traits include diseases that have known but hitherto unmapped genetic components (e.g., agammaglobulimenia, diabetes insipidus, Lesch-Nyhan syndrome, muscular dystrophy, Wiskott-Aldrich syndrome, Fabry's disease, familial hypercholesterolemia, polycystic kidney disease, hereditary spherocytosis, von Willebrand's disease, tuberous sclerosis, hereditary hemorrhagic telangiectasia, familial colonic polyposis, Ehlers-Danlos syndrome, osteogenesis imperfecta, and acute intermittent porphyria). Phenotypic traits also include symptoms of, or susceptibility to, multifactorial diseases of which a component is or may be genetic, such as autoimmune diseases, inflammation, cancer, diseases of the nervous system, and infection by pathogenic microorganisms. Some examples of autoimmune diseases include rheumatoid arthritis, multiple sclerosis, diabetes (insulin-dependent and non-independent), systemic lupus erythematosus and Graves disease. Some examples of cancers include cancers of the bladder, brain, breast, colon, esophagus, kidney, leukemia, liver, lung, oral cavity, ovary, pancreas, prostate, skin, stomach and uterus. Phenotypic traits also include characteristics such as longevity, appearance (e.g., baldness, obesity), strength, speed, endurance, fertility, and susceptibility or receptivity to particular drugs or therapeutic treatments.

›DEFINITIONS · 5 of 7

The correlation of one or more polymorphisms with phenotypic traits can be facilitated by knowledge of the gene product of the wild type (reference) gene. The genes in which cSNPs of the present invention have been identified are genes which have been previously sequenced and characterized in one of their allelic forms. For example, genes of the present invention in which cSNPs have been identified include genes encoding antithrombin III (Humphries, Semin Hematol 32:8-16 (1995); Mammen, Semin Hematol 32:2-6 (1995)), cholesterol ester transfer protein (Bruce and Tall, Curr Opin Lipidol 6:306-311 (1995)), CLanalog (HDL/scavenger receptor) (Freeman, Curr Opin Hematol 4:41-47 (1997); Knecht and Glass, Adv Genet 32:141-198 (1995); Rigotti et al., Curr Opin Lipidol 8:181-188 (1997)), thrombin receptor (Brass and Molino, Thromb Haemost 78:234-241 (1997); Jamieson, Thromb Haemost 78:242-246 (1997)), thrombin (Eisenberg, Coron Artery Dis 7:400-408 (1996); Jamieson, Thromb Haemost 78:242-246 (1997)), and heparin cofactor II (Bick and Pegram, Semin Thromb Hemost 20:109-132 (1994)). Also included are the genes encoding HMG coA-reductase (Bjelajac et al., Ann Pharmacother 30:1304-1315 (1996)), platelet glycoprotein IIB and IIIA (Jamieson, Thromb Haemost 78:242-246 (1997); Lefkovits et al., N Engl J Med 332:1553-1559 (1995); Nurden, Thromb Haemost 74:345-351 (1995)), lecithin:cholesterol acyltransferase (Kuivenhoven et al., J Lipid Res 38:191-205 (1997)), LDL receptor (Holvoet and Collen, Curr Opin Lipidol 8:320-328 (1997); Rigotti et al., Curr Opin Lipidol 8:181-188 (1997)), protein C (Bertina, Clin Chem 43:1678-1683 (1997); Bick and Pegram, Semin Thromb Hemost 20:109-132 (1994); Humphries, Semin Hematol 32:8-16 (1995); Koeleman et al., Semin Hematol 34:256-264 (1997)), platelet activating factor receptor (Feuerstein et al., J Lipid Mediat Cell Signal 15:255-284 (1997); Shimizu and Mutoh, Adv Exp Med Biol 407:197-204 (1997)), tissue factor (Abildgaard, Blood Coagul Fibrinolysis 6:S45-49(1995); Bick and Pegram, Semin Thromb Hemost 20:109-132 (1994); Harker et al., Haemostasis 1:76-82 (1996); Ruf and Edgington, Faseb J 8:385-390 (1994)), tissue factor pathway inhibitor (Shimizu and Mutoh, Adv Exp Med Biol 407:197-204 (1997); Feuerstein et al., J Lipid Mediat Cell Signal 15:255-284 (1997)), thromboxane A2 receptor (Feuerstein et al., J Lipid Mediat Cell Signal 15:255-284 (1997); Kinsella et al., Ann NY Acad Sci 714:270-278 (1994); Patrono and Renda, Am J Cardiol 80:17E-20E (1997)), lipoprotein lipase (Applebaum-Bowden, Curr Opin Lipidol 6:130-135 (1995)), and factor V (Bertina, Clin Chem 43:1678-1683 (1997); Harker et al., Haemostasis 1:76-82 (1996); Koeleman et al., Semin Hematol 34:256-264 (1997)).

Correlation is performed for a population of individuals who have been tested for the presence or absence of a phenotypic trait of interest and for polymorphic markers sets. To perform such analysis, the presence or absence of a set of polymorphisms (i.e. a polymorphic set) is determined for a set of the individuals, some of whom exhibit a particular trait, and some of which exhibit lack of the trait. The alleles of each polymorphism of the set are then reviewed to determine whether the presence or absence of a particular allele is associated with the trait of interest. Correlation can be performed by standard statistical methods such as a κ-squared test and statistically significant correlations between polymorphic form(s) and phenotypic characteristics are noted. For example, it might be found that the presence of allele A1 at polymorphism A correlates with heart disease. As a further example, it might be found that the combined presence of allele A1 at polymorphism A and allele B1 at polymorphism B correlates with increased milk production of a farm animal.

Such correlations can be exploited in several ways. In the case of a strong correlation between a set of one or more polymorphic forms and a disease for which treatment is available, detection of the polymorphic form set in a human or animal patient may justify immediate administration of treatment, or at least the institution of regular monitoring of the patient. Detection of a polymorphic form correlated with serious disease in a couple contemplating a family may also be valuable to the couple in their reproductive decisions. For example, the female partner might elect to undergo in vitro fertilization to avoid the possibility of transmitting such a polymorphism from her husband to her offspring. In the case of a weaker, but still statistically significant correlation between a polymorphic set and human disease, immediate therapeutic intervention or monitoring may not be justified. Nevertheless, the patient can be motivated to begin simple life-style changes (e.g., diet, exercise) that can be accomplished at little cost to the patient but confer potential benefits in reducing the risk of conditions to which the patient may have increased susceptibility by virtue of variant alleles. Identification of a polymorphic set in a patient correlated with enhanced receptiveness to one of several treatment regimes for a disease indicates that this treatment regime should be followed.

For animals and plants, correlations between characteristics and phenotype are useful for breeding for desired characteristics. For example, Beitz et al., U.S. Pat. No. 5,292,639 discuss use of bovine mitochondrial polymorphisms in a breeding program to improve milk production in cows. To evaluate the effect of mtDNA D-loop sequence polymorphism on milk production, each cow was assigned a value of 1 if variant or 0 if wildtype with respect to a prototypical mitochondrial DNA sequence at each of 17 locations considered. Each production trait was analyzed individually with the following animal model:

Y ijkpn =μ+YS i +P j +X k +β 1 + . . . β 17 +PE n +a n +e p

where Y ijknp is the milk, fat, fat percentage, SNF, SNF percentage, energy concentration, or lactation energy record; μ is an overall mean; YS i is the effect common to all cows calving in year-season; X k is the effect common to cows in either the high or average selection line; β 1 to β 17 are the binomial regressions of production record on mtDNA D-loop sequence polymorphisms; PE n is permanent environmental effect common to all records of cow n; a n is effect of animal n and is composed of the additive genetic contribution of sire and dam breeding values and a Mendelian sampling effect; and e p is a random residual. It was found that eleven of seventeen polymorphisms tested influenced at least one production trait. Bovines having the best polymorphic forms for milk production at these eleven loci are used as parents for breeding the next generation of the herd.

›DEFINITIONS · 6 of 7

D. Genetic Mapping of Phenotypic Traits

The previous section concerns identifying correlations between phenotypic traits and polymorphisms that directly or indirectly contribute to those traits. The present section describes identification of a physical linkage between a genetic locus associated with a trait of interest and polymorphic markers that are not associated with the trait, but are in physical proximity with the genetic locus responsible for the trait and co-segregate with it. Such analysis is useful for mapping a genetic locus associated with a phenotypic trait to a chromosomal position, and thereby cloning gene(s) responsible for the trait. See Lander et al., Proc. Natl. Acad. Sci. ( USA ) 83, 7353-7357 (1986); Lander et al., Proc. Natl. Acad. Sci. ( USA ) 84, 2363-2367 (1987); Donis-Keller et al., Cell 51, 319-337 (1987); Lander et al., Genetics 121, 185-199 (1989)). Genes localized by linkage can be cloned by a process known as directional cloning. See Wainwright, Med. J. Australia 159, 170-174 (1993); Collins, Nature Genetics 1, 3-6 (1992).

Linkage studies are typically performed on members of a family. Available members of the family are characterized for the presence or absence of a phenotypic trait and for a set of polymorphic markers. The distribution of polymorphic markers in an informative meiosis is then analyzed to determine which polymorphic markers co-segregate with a phenotypic trait. See, e.g., Kerem et al., Science 245, 1073-1080 (1989); Monaco et al., Nature 316, 842 (1985); Yamoka et al., Neurology 40, 222-226 (1990); Rossiter et al., FASEB Journal 5, 21-27 (1991).

Linkage is analyzed by calculation of LOD (log of the odds) values. A lod value is the relative likelihood of obtaining observed segregation data for a marker and a genetic locus when the two are located at a recombination fraction θ, versus the situation in which the two are not linked, and thus segregating independently (Thompson & Thompson, Genetics in Medicine (5th ed, W. B. Saunders Company, Philadelphia, 1991); Strachan,“Mapping the human genome” in The Human Genome (BIOS Scientific Publishers Ltd, Oxford), Chapter 4). A series of likelihood ratios are calculated at various recombination fractions (θ), ranging from θ=0.0 (coincident loci) to θ=0.50 (unlinked). Thus, the likelihood at a given value of θ is: probability of data if loci linked at θ to probability of data if loci unlinked. The computed likelihoods are usually expressed as the log 10 of this ratio (i.e., a lod score). For example, a lod score of 3 indicates 1000:1 odds against an apparent observed linkage being a coincidence. The use of logarithms allows data collected from different families to be combined by simple addition. Computer programs are available for the calculation of lod scores for differing values of θ (e.g., LIPED, MLINK (Lathrop, Proc. Nat. Acad. Sci. ( USA ) 81, 3443-3446 (1984)). For any particular lod score, a recombination fraction may be determined from mathematical tables. See Smith et al., Mathematical tables for research workers in human genetics (Churchill, London, 1961); Smith, Ann. Hum. Genet. 32, 127-150 (1968). The value of θ at which the lod score is the highest is considered to be the best estimate of the recombination fraction.

Positive lod score values suggest that the two loci are linked, whereas negative values suggest that linkage is less likely (at that value of θ) than the possibility that the two loci are unlinked. By convention, a combined lod score of +3 or greater (equivalent to greater than 1000:1 odds in favor of linkage) is considered definitive evidence that two loci are linked. Similarly, by convention, a negative lod score of −2 or less is taken as definitive evidence against linkage of the two loci being compared. Negative linkage data are useful in excluding a chromosome or a segment thereof from consideration. The search focuses on the remaining non-excluded chromosomal locations.

IV. Modified Polypeptides and Gene Sequences

The invention further provides variant forms of nucleic acids and corresponding proteins. The nucleic acids comprise one of the sequences described in the Table, column 8, in which the polymorphic position is occupied by one of the alternative bases for that position. Some nucleic acids encode full-length variant forms of proteins. Similarly, variant proteins have the prototypical amino acid sequences encoded by nucleic acid sequences shown in the Table, column 8, (read so as to be in-frame with the full-length coding sequence of which it is a component) except at an amino acid encoded by a codon including one of the polymorphic positions shown in the Table. That position is occupied by the amino acid coded by the corresponding codon in any of the alternative forms shown in the Table.

Variant genes can be expressed in an expression vector in which a variant gene is operably linked to a native or other promoter. Usually, the promoter is a eukaryotic promoter for expression in a mammalian cell. The transcription regulation sequences typically include a heterologous promoter and optionally an enhancer which is recognized by the host. The selection of an appropriate promoter, for example trp, lac, phage promoters, glycolytic enzyme promoters and tRNA promoters, depends on the host selected. Commercially available expression vectors can be used. Vectors can include host-recognized replication systems, amplifiable genes, selectable markers, host sequences useful for insertion into the host genome, and the like.

The means of introducing the expression construct into a host cell varies depending upon the particular construction and the target host. Suitable means include fusion, conjugation, transfection, transduction, electroporation or injection, as described in Sambrook, supra. A wide variety of host cells can be employed for expression of the variant gene, both prokaryotic and eukaryotic. Suitable host cells include bacteria such as E. coli, yeast, filamentous fungi, insect cells, mammalian cells, typically immortalized, e.g., mouse, CHO, human and monkey cell lines and derivatives thereof. Preferred host cells are able to process the variant gene product to produce an appropriate mature polypeptide. Processing includes glycosylation, ubiquitination, disulfide bond formation, general post-translational modification, and the like.

›DEFINITIONS · 7 of 7

The protein may be isolated by conventional means of protein biochemistry and purification to obtain a substantially pure product, i.e., 80, 95 or 99% free of cell component contaminants, as described in Jacoby, Methods in Enzymology Volume 104, Academic Press, New York (1984); Scopes, Protein Purification, Principles and Practice, 2nd Edition, Springer-Verlag, New York (1987); and Deutscher (ed), Guide to Protein Purification, Methods in Enzymology, Vol. 182 (1990). If the protein is secreted, it can be isolated from the supernatant in which the host cell is grown. If not secreted, the protein can be isolated from a lysate of the host cells.

The invention further provides transgenic nonhuman animals capable of expressing an exogenous variant gene and/or having one or both alleles of an endogenous variant gene inactivated. Expression of an exogenous variant gene is usually achieved by operably linking the gene to a promoter and optionally an enhancer, and microinjecting the construct into a zygote. See Hogan et al., “Manipulating the Mouse Embryo, A Laboratory Manual,” Cold Spring Harbor Laboratory. Inactivation of endogenous variant genes can be achieved by forming a transgene in which a cloned variant gene is inactivated by insertion of a positive selection marker. See Capecchi, Science 244, 1288-1292 (1989). The transgene is then introduced into an embryonic stem cell, where it undergoes homologous recombination with an endogenous variant gene. Mice and other rodents are preferred animals. Such animals provide useful drug screening systems.

In addition to substantially full-length polypeptides expressed by variant genes, the present invention includes biologically active fragments of the polypeptides, or analogs thereof, including organic molecules which simulate the interactions of the peptides. Biologically active fragments include any portion of the full-length polypeptide which confers a biological function on the variant gene product, including ligand binding, and antibody binding. Ligand binding includes binding by nucleic acids, proteins or polypeptides, small biologically active molecules, or large cellular structures.

Polyclonal and/or monoclonal antibodies that specifically bind to variant gene products but not to corresponding prototypical gene products are also provided. Antibodies can be made by injecting mice or other animals with the variant gene product or synthetic peptide fragments thereof. Monoclonal antibodies are screened as are described, for example, in Harlow & Lane, Antibodies, A Laboratory Manual, Cold Spring Harbor Press, New York (1988); Goding, Monoclonal antibodies, Principles and Practice (2d ed.) Academic Press, New York (1986). Monoclonal antibodies are tested for specific immunoreactivity with a variant gene product and lack of immunoreactivity to the corresponding prototypical gene product. These antibodies are useful in diagnostic assays for detection of the variant form, or as an active ingredient in a pharmaceutical composition.

V. Kits

The invention further provides kits comprising at least one allele-specific oligonucleotide as described above. Often, the kits contain one or more pairs of allele-specific oligonucleotides hybridizing to different forms of a polymorphism. In some kits, the allele-specific oligonucleotides are provided immobilized to a substrate. For example, the same substrate can comprise allele-specific oligonucleotide probes for detecting at least 10, 100 or all of the polymorphisms shown in the Table. Optional additional components of the kit include, for example, restriction enzymes, reverse-transcriptase or polymerase, the substrate nucleoside triphosphates, means used to label (for example, an avidin-enzyme conjugate and enzyme substrate and chromogen if the label is biotin), and the appropriate buffers for reverse transcription, PCR, or hybridization reactions. Usually, the kit also contains instructions for carrying out the methods.

The following Examples are offered for the purpose of illustrating the present invention and are not to be construed to limit the scope of this invention. The teachings of all references cited herein are hereby incorporated herein by reference.

›EXAMPLES · 1 of 2

The polymorphisms shown in the Table were identified by resequencing of target sequences from a minimum of 50 unrelated individuals of diverse ethnic and geographic backgrounds by hybridization to probes immobilized to microfabricated arrays. The strategy and principles for design and use of such arrays are generally described in WO 95/11995.

A typical probe array used in this analysis has two groups of four sets of probes that respectively tile both strands of a reference sequence. A first probe set comprises a plurality of probes exhibiting perfect complementarily with one of the reference sequences. Each probe in the first probe set has an interrogation position that corresponds to a nucleotide in the reference sequence. That is, the interrogation position is aligned with the corresponding nucleotide in the reference sequence, when the probe and reference sequence are aligned to maximize complementarily between the two. For each probe in the first set, there are three corresponding probes from three additional probe sets. Thus, there are four probes corresponding to each nucleotide in the reference sequence. The probes from the three additional probe sets are identical to the corresponding probe from the first probe set except at the interrogation position, which occurs in the same position in each of the four corresponding probes from the four probe sets, and is occupied by a different nucleotide in the four probe sets. In the present analysis, probes were 25 nucleotides long. Arrays tiled for multiple different references sequences were included on the same substrate.

Publicly available sequences for a given gene were assembled into Gap4 (http://www.biozentrum.unibas.ch/˜biocomp/staden/Overview.html). PCR primers covering each exon were designed using Primer 3 (http://www-genome.wi.mit.edu/cgibin/primer/primer3.cgi). Primers were not designed in regions where there were sequence discrepancies between reads. For CLA1, whose genomic sequence is not published, nested primers were designed from the cDNA. For all genes except CLA1, genomic DNA was amplified in at least 50 individuals using 2.5 pmol each primer, 1.5 mM MgCl 2 , 100 μM dNTPs, 0.75 μM AmpliTaq GOLD polymerase, and 19 ng DNA in a 15 μl reaction. Reactions were assembled using a PACKARD MultiPROBE robotic pipetting station and then put in MJ 96-well tetrad thermocyclers (96° C. for 10 minutes, followed by 35 cycles of 96° C. for 30 seconds, 59° C. for 2 minutes, and 72° C. for 2 minutes). A subset of the PCR assays for each individual were run on 3% NuSieve gels in 0.5×TBE to confirm that the reaction worked.

For CLA1, first strand cDNA was made using the Gibco BRL SuperScript Preamplification Kit (#18089-011) and following the manufacturers instructions except that 150 ng of random hexamers were used to primer 1 μg of total RNA. The cDNA was amplified using the outermost primer pairs and the above conditions; {fraction (1/20)} of the reaction was used as a template for the secondary PCR using the innermost primers. All RT-PCR products were run on 2% NuSieve gels in 1×TAE to confirm the presence of a product.

For a given DNA, 5 μl (about 50 ng) of each PCR or RT-PCR product were pooled (Final volume=150-200 μl). The products were purified using QiaQuick PCR purification from Qiagen. The samples were eluted once in 35 μl sterile water and 4 μl 10×One-Phor-All buffer (Pharmacia). The pooled samples were digested with 0.2μ DNaseI (Promega)for 10 minutes at 37° C. and then labeled with 0.5 nmols biotin-N6-ddATP and 15μ Terminal Transferase (GibcoBPL Life Technology) for 60 minutes at 37° C. Both fragmentation and labeling reactions were terminated by incubating the pooled sample for 15 minutes at 100° C.

Low-density DNA chips (Affymetrix, Calif.) were hybridized following the manufacturer's instructions. Briefly, the hybridization cocktail consisted of 3M TMACl, 10 mM Tris pH 7.8, 0.01% Triton X-100, 100 mg/ml herring sperm DNA (Gibco BPL), 200 pM control biotin-labeled oligo. The processed PCR products were denatured for 7 minutes at 100° C. and then added to prewarmed (37° C.) hybridization solution. The chips were hybridized overnight at 44° C. Chips were washed in 1×SSPET and 6×SSPET followed by staining with 2 μg/ml SARPE and 0.5 mg/ml acetylated BSA in 200 μl of 6×SSPET for 8 minutes at room temperature. Chips were scanned using a Molecular Dynamics scanner.

Chip image files were analyzed using Ulysses (Affymetrix, Calif.) which uses four algorithms to identify potential polymorphisms. Candidate polymorphisms were visually inspected and assigned a confidence value: high confidence candidates displayed all three genotypes, while likely candidates showed only two genotypes (homozygous for reference sequence and heterozygous for reference and variant). Some of the candidate polymorphisms were confirmed by ABI sequencing. Identified polymorphisms were compared to SwissProt and the Mutation Database to determine if they were novel. Results are shown in the Table.

In the Table, the genes listed in column 2 are as follows: antithrombin III (AT3); cholesterol ester transfer protein (CETP); CLanalog (HDL/scavenger receptor) (CLanalog); thrombin receptor (F2R); thrombin (F2); heparin Cofactor II (HCF2); HMG coA-reductase (HMGCR); platelet glycoprotein IIB (ITGA2B); platelet glycoprotein IIIA (ITGB3); lecithin:cholesterol acyltransferase (LCAT); LDL receptor (LDLR); protein C (PROC); platelet activating factor receptor (PTAFR); tissue factor pathway inhibitor (TFPI); thromboxane A2 receptor (TBXA2R); lipoprotein lipase (LPL); tissue factor (F3); and factor V (F5).

Column 1 of the Table shows the laboratory name for the particular gene. Column 3 shows the GenBank Accession number for the wild type (reference) allele. Column 4 shows the nucleotide number location of the polymorphism relative to the numbering of the sequence deposited with GenBank having the listed Accession number; the GenBank sequence is understood to be the nucleotide sequence present in the GenBank database on Apr. 1, 1998, which sequences are incorporated herein by reference in their entirety. These GenBank sequences are illustrated in FIGS. 3-38.

›EXAMPLES · 2 of 2

Column 5 shows the codon which is altered by the polymorphism. Columns 6, 7 and 8 show the reference codon, variant codon and amino acid change, resepctivley, for the silent polymorphisms. Columns 9, 10 and 11 show the reference codon, variant codon and amino acid change, resepctively, for the missense polymorphisms. Columns 12, 13 and 14 show the reference codon, variant codon and amino acid change, resepctively, for the nonsense polymorphisms. Columns 15 and 16 show the nucleotide of the reference allele and the frequency of that allele, resepctively. This base is arbitrarily designated the reference or prototypical form, but it is not necessarily the most frequently occurring form. Columns 17 and 18 show the nucleotide of the variant allele and the frequency of that allele, resepctively. It is noted that the genes with polymorphism IDs of F5u8, HCF2u1 and HMGCRu2 contained the indicated polymorphism at the indicated nucleotide position, but that these nucleotide positions are in the non-coding region of the gene.

From the foregoing, it is apparent that the invention includes a number of general uses that can be expressed concisely as follows. The invention provides for the use of any of the nucleic acid segments described above in the diagnosis or monitoring of diseases, such as cancer, inflammation, heart disease, diseases of the cardiovascular system, and infection by microorganisms. The invention further provides for the use of any of the nucleic acid segments in the manufacture of a medicament for the treatment or prophylaxis of such diseases. The invention further provides for the use of any of the DNA segments as a pharmaceutical.

All references cited above are incorporated by reference in their entirety for all purposes to the same extent as if each individual publication or patent application were specifically and individually indicated to be so incorporated by reference.

›EQUIVALENTS

While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. Those skilled in the art will recognize or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described specifically herein. Such equivalents are intended to be encompassed in the scope of the claims.

›SEQUENCE LISTING

(1) GENERAL INFORMATION:

(iii) NUMBER OF SEQUENCES: 59

(2) INFORMATION FOR SEQ ID NO:1:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 1780 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 113...1138

›(D) OTHER INFORMATION

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:

TTCACGAGGG CTGGGGCCAG GACCCAGACA GAGACACACG GTCACTGCAG CTGAAGCCGC 60

TGCCCCTGCT ACAGGCACCA CCAGGACCAG CTGATCATTC CAGCCCACAG CA ATG GAG 118

Met Glu

1

CCA CAT GAC TCC TCC CAC ATG GAC TCT GAG TTC CGA TAC ACT CTC TTC 166

Pro His Asp Ser Ser His Met Asp Ser Glu Phe Arg Tyr Thr Leu Phe

5 10 15

CCG ATT GTT TAC AGC ATC ATC TTT GTG CTC GGG GTC ATT GCT AAT GGC 214

Pro Ile Val Tyr Ser Ile Ile Phe Val Leu Gly Val Ile Ala Asn Gly

20 25 30

TAC GTG CTG TGG GTC TTT GCC CGC CTG TAC CCT TGC AAG AAA TTC AAT 262

Tyr Val Leu Trp Val Phe Ala Arg Leu Tyr Pro Cys Lys Lys Phe Asn

35 40 45 50

GAG ATA AAG ATC TTC ATG GTG AAC CTC ACC ATG GCG GAC ATG CTC TTC 310

Glu Ile Lys Ile Phe Met Val Asn Leu Thr Met Ala Asp Met Leu Phe

55 60 65

TTG ATC ACC CTG CCA CTT TGG ATT GTC TAC TAC CAA AAC CAG GGC AAC 358

Leu Ile Thr Leu Pro Leu Trp Ile Val Tyr Tyr Gln Asn Gln Gly Asn

70 75 80

TGG ATA CTC CCC AAA TTC CTG TGC AAC GTG GCT GGC TGC CTT TTC TTC 406

Trp Ile Leu Pro Lys Phe Leu Cys Asn Val Ala Gly Cys Leu Phe Phe

85 90 95

ATC AAC ACC TAC TGC TCT GTG GCC TTC CTG GGC GTC ATC ACT TAT AAC 454

Ile Asn Thr Tyr Cys Ser Val Ala Phe Leu Gly Val Ile Thr Tyr Asn

100 105 110

CGC TTC CAG GCA GTA ACT CGG CCC ATC AAG ACT GCT CAG GCC AAC ACC 502

Arg Phe Gln Ala Val Thr Arg Pro Ile Lys Thr Ala Gln Ala Asn Thr

115 120 125 130

CGC AAG CGT GGC ATC TCT TTG TCC TTG GTC ATC TGG GTG GCC ATT GTG 550

Arg Lys Arg Gly Ile Ser Leu Ser Leu Val Ile Trp Val Ala Ile Val

135 140 145

GGA GCT GCA TCC TAC TTC CTC ATC CTG GAC TCC ACC AAC ACA GTG CCC 598

Gly Ala Ala Ser Tyr Phe Leu Ile Leu Asp Ser Thr Asn Thr Val Pro

150 155 160

GAC AGT GCT GGC TCA GGC AAC GTC ACT CGC TGC TTT GAG CAT TAC GAG 646

Asp Ser Ala Gly Ser Gly Asn Val Thr Arg Cys Phe Glu His Tyr Glu

165 170 175

AAG GGC AGC GTG CCA GTC CTC ATC ATC CAC ATC TTC ATC GTG TTC AGC 694

Lys Gly Ser Val Pro Val Leu Ile Ile His Ile Phe Ile Val Phe Ser

180 185 190

TTC TTC CTG GTC TTC CTC ATC ATC CTC TTC TGC AAC CTG GTC ATC ATC 742

Phe Phe Leu Val Phe Leu Ile Ile Leu Phe Cys Asn Leu Val Ile Ile

195 200 205 210

CGT ACC TTG CTC ATG CAG CCG GTG CAG CAG CAG CGC AAC GCT GAA GTC 790

Arg Thr Leu Leu Met Gln Pro Val Gln Gln Gln Arg Asn Ala Glu Val

215 220 225

AAG CGC CGG GCG CTG TGG ATG GTG TGC ACG GTC TTG GCG GTG TTC ATC 838

Lys Arg Arg Ala Leu Trp Met Val Cys Thr Val Leu Ala Val Phe Ile

230 235 240

ATC TGC TTC GTG CCC CAC CAC GTG GTG CAG CTG CCC TGG ACC CTT GCT 886

Ile Cys Phe Val Pro His His Val Val Gln Leu Pro Trp Thr Leu Ala

245 250 255

GAG CTG GGC TTC CAG GAC AGC AAA TTC CAC CAG GCC ATT AAT GAT GCA 934

Glu Leu Gly Phe Gln Asp Ser Lys Phe His Gln Ala Ile Asn Asp Ala

260 265 270

CAT CAG GTC ACC CTC TGC CTC CTT AGC ACC AAC TGT GTC TTA GAC CCT 982

His Gln Val Thr Leu Cys Leu Leu Ser Thr Asn Cys Val Leu Asp Pro

275 280 285 290

GTT ATC TAC TGT TTC CTC ACC AAG AAG TTC CGC AAG CAC CTC ACC GAA 1030

Val Ile Tyr Cys Phe Leu Thr Lys Lys Phe Arg Lys His Leu Thr Glu

295 300 305

AAG TTC TAC AGC ATG CGC AGT AGC CGG AAA TGC TCC CGG GCC ACC ACG 1078

Lys Phe Tyr Ser Met Arg Ser Ser Arg Lys Cys Ser Arg Ala Thr Thr

310 315 320

GAT ACG GTC ACT GAA GTG GTT GTG CCA TTC AAC CAG ATC CCT GGC AAT 1126

Asp Thr Val Thr Glu Val Val Val Pro Phe Asn Gln Ile Pro Gly Asn

325 330 335

TCC CTC AAA AAT TAGTCCCTGC TTCCAGGCCT GAAGTCTTCT CCTCCATGAA 1178

Ser Leu Lys Asn

340

ACATCATGAC TGAGCTGGGG GAAGAAGGGA TATCTACTGT GGGTCTGGGC ACCACCTCTG 1238

TGGCACTGGT GGGCCATTAG ATTTGGAGGC TACCTCACCT GGGCAGGGAT GATGCAGAGC 1298

CAGGCTGTTG GAAAATCCAG AACTCAAATG AGCCCCTTCA TCCGCCTGTG GGCGCATACT 1358

ACAGTAACTG TGACTGATGA CTTTATCCTG AGTCCCTTAA TCTTATGGGG CCGGAAGGAA 1418

TGTCAGGGCC AGGTGCAGAC CTTGGGGGAA GACTTTAAAC CACCTAGTTC TCCCACTGGG 1478

GCATCGGTCT AAAGCTTTGG GGGAGTGGCC CCAGTGGCTC ACACCTGTAA TCCCAGCACT 1538

TTGGGAGGCC GAGGTGGGCA GATCATGGGT CAAGAGATCG AGACATCCTG GCCAACATTG 1598

TAAAACCCCA TCTCTACTAA AACATACAAA AATTAGCCGG GCATGGTGCA CACGCCTGTA 1658

GTCCCAGCTA CTCAGGAGGC TGAGGCAGGA GAATCGCTTG AACCTGGGAG GCAGAGGTTG 1718

CAGTGAACCT AGATTGCACC ATTGCACTCT AGCCTGGCAA CAGAGGCAGA TTCCCTCCTG 1778

CC 1780

(2) INFORMATION FOR SEQ ID NO:2:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 342 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:

Met Glu Pro His Asp Ser Ser His Met Asp Ser Glu Phe Arg Tyr Thr

1 5 10 15

Leu Phe Pro Ile Val Tyr Ser Ile Ile Phe Val Leu Gly Val Ile Ala

20 25 30

Asn Gly Tyr Val Leu Trp Val Phe Ala Arg Leu Tyr Pro Cys Lys Lys

35 40 45

Phe Asn Glu Ile Lys Ile Phe Met Val Asn Leu Thr Met Ala Asp Met

50 55 60

Leu Phe Leu Ile Thr Leu Pro Leu Trp Ile Val Tyr Tyr Gln Asn Gln

65 70 75 80

Gly Asn Trp Ile Leu Pro Lys Phe Leu Cys Asn Val Ala Gly Cys Leu

85 90 95

Phe Phe Ile Asn Thr Tyr Cys Ser Val Ala Phe Leu Gly Val Ile Thr

100 105 110

Tyr Asn Arg Phe Gln Ala Val Thr Arg Pro Ile Lys Thr Ala Gln Ala

115 120 125

Asn Thr Arg Lys Arg Gly Ile Ser Leu Ser Leu Val Ile Trp Val Ala

130 135 140

Ile Val Gly Ala Ala Ser Tyr Phe Leu Ile Leu Asp Ser Thr Asn Thr

145 150 155 160

Val Pro Asp Ser Ala Gly Ser Gly Asn Val Thr Arg Cys Phe Glu His

165 170 175

Tyr Glu Lys Gly Ser Val Pro Val Leu Ile Ile His Ile Phe Ile Val

180 185 190

Phe Ser Phe Phe Leu Val Phe Leu Ile Ile Leu Phe Cys Asn Leu Val

195 200 205

Ile Ile Arg Thr Leu Leu Met Gln Pro Val Gln Gln Gln Arg Asn Ala

210 215 220

Glu Val Lys Arg Arg Ala Leu Trp Met Val Cys Thr Val Leu Ala Val

225 230 235 240

Phe Ile Ile Cys Phe Val Pro His His Val Val Gln Leu Pro Trp Thr

245 250 255

Leu Ala Glu Leu Gly Phe Gln Asp Ser Lys Phe His Gln Ala Ile Asn

260 265 270

Asp Ala His Gln Val Thr Leu Cys Leu Leu Ser Thr Asn Cys Val Leu

275 280 285

Asp Pro Val Ile Tyr Cys Phe Leu Thr Lys Lys Phe Arg Lys His Leu

290 295 300

Thr Glu Lys Phe Tyr Ser Met Arg Ser Ser Arg Lys Cys Ser Arg Ala

305 310 315 320

Thr Thr Asp Thr Val Thr Glu Val Val Val Pro Phe Asn Gln Ile Pro

325 330 335

Gly Asn Ser Leu Lys Asn

340

(2) INFORMATION FOR SEQ ID NO:3:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 1467 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 22...1416

›(D) OTHER INFORMATION

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:

GAATTCGAGC TCGCCCCGGC C ATG TAT TCC AAT GTG ATA GGA ACT GTA ACC 51

Met Tyr Ser Asn Val Ile Gly Thr Val Thr

1 5 10

TCT GGA AAA AGG AAG GTT TAT CTC TTG TCC TTG CTG CTC ATT GGC TTC 99

Ser Gly Lys Arg Lys Val Tyr Leu Leu Ser Leu Leu Leu Ile Gly Phe

15 20 25

TGG GAC TGC GTG ACC TGT CAC GGG AGC CCT GTG GAC ATC TGC ACA GCC 147

Trp Asp Cys Val Thr Cys His Gly Ser Pro Val Asp Ile Cys Thr Ala

30 35 40

AAG CCG CGG GAC ATT CCC ATG AAT CCC ATG TGC ATT TAC CGC TCC CCG 195

Lys Pro Arg Asp Ile Pro Met Asn Pro Met Cys Ile Tyr Arg Ser Pro

45 50 55

GAG AAG AAG GCA ACT GAG GAT GAG GGC TCA GAA CAG AAG ATC CCG GAG 243

Glu Lys Lys Ala Thr Glu Asp Glu Gly Ser Glu Gln Lys Ile Pro Glu

60 65 70

GCC ACC AAC AAC CGG CGT GTC TGG GAA CTG TCC AAG GCC AAT TCC CGC 291

Ala Thr Asn Asn Arg Arg Val Trp Glu Leu Ser Lys Ala Asn Ser Arg

75 80 85 90

TTT GCT ACC ACT TTC TAT CAG CAC CTG GCA GAT TCC AAG AAT GAC AAT 339

Phe Ala Thr Thr Phe Tyr Gln His Leu Ala Asp Ser Lys Asn Asp Asn

95 100 105

GAT AAC ATT TTC CTG TCA CCC CTG AGT ATC TCT ACG GCT TTT GCT ATG 387

Asp Asn Ile Phe Leu Ser Pro Leu Ser Ile Ser Thr Ala Phe Ala Met

110 115 120

ACC AAG CTG GGT GCC TGT AAT GAC ACC CTC CAG CAA CTG ATG GAG GTA 435

Thr Lys Leu Gly Ala Cys Asn Asp Thr Leu Gln Gln Leu Met Glu Val

125 130 135

TTT AAG TTT GAC ACC ATA TCT GAG AAA ACA TCT GAT CAG ATC CAC TTC 483

Phe Lys Phe Asp Thr Ile Ser Glu Lys Thr Ser Asp Gln Ile His Phe

140 145 150

TTC TTT GCC AAA CTG AAC TGC CGA CTC TAT CGA AAA GCC AAC AAA TCC 531

Phe Phe Ala Lys Leu Asn Cys Arg Leu Tyr Arg Lys Ala Asn Lys Ser

155 160 165 170

TCC AAG TTA GTA TCA GCC AAT CGC CTT TTT GGA GAC AAA TCC CTT ACC 579

Ser Lys Leu Val Ser Ala Asn Arg Leu Phe Gly Asp Lys Ser Leu Thr

175 180 185

TTC AAT GAG ACC TAC CAG GAC ATC AGT GAG TTG GTA TAT GGA GCC AAG 627

Phe Asn Glu Thr Tyr Gln Asp Ile Ser Glu Leu Val Tyr Gly Ala Lys

190 195 200

CTC CAG CCC CTG GAC TTC AAG GAA AAT GCA GAG CAA TCC AGA GCG GCC 675

Leu Gln Pro Leu Asp Phe Lys Glu Asn Ala Glu Gln Ser Arg Ala Ala

205 210 215

ATC AAC AAA TGG GTG TCC AAT AAG ACC GAA GGC CGA ATC ACC GAT GTC 723

Ile Asn Lys Trp Val Ser Asn Lys Thr Glu Gly Arg Ile Thr Asp Val

220 225 230

ATT CCC TCG GAA GCC ATC AAT GAG CTC ACT GTT CTG GTG CTG GTT AAC 771

Ile Pro Ser Glu Ala Ile Asn Glu Leu Thr Val Leu Val Leu Val Asn

235 240 245 250

ACC ATT TAC TTC AAG GGC CTG TGG AAG TCA AAG TTC AGC CCT GAG AAC 819

Thr Ile Tyr Phe Lys Gly Leu Trp Lys Ser Lys Phe Ser Pro Glu Asn

255 260 265

ACA AGG AAG GAA CTG TTC TAC AAG GCT GAT GGA GAG TCG TGT TCA GCA 867

Thr Arg Lys Glu Leu Phe Tyr Lys Ala Asp Gly Glu Ser Cys Ser Ala

270 275 280

TCT ATG ATG TAC CAG GAA GGC AAG TTC CGT TAT CGG CGC GTG GCT GAA 915

Ser Met Met Tyr Gln Glu Gly Lys Phe Arg Tyr Arg Arg Val Ala Glu

285 290 295

GGC ACC CAG GTG CTT GAG TTG CCC TTC AAA GGT GAT GAC ATC ACC ATG 963

Gly Thr Gln Val Leu Glu Leu Pro Phe Lys Gly Asp Asp Ile Thr Met

300 305 310

GTC CTC ATC TTG CCC AAG CCT GAG AAG AGC CTG GCC AAG GTG GAG AAG 1011

Val Leu Ile Leu Pro Lys Pro Glu Lys Ser Leu Ala Lys Val Glu Lys

315 320 325 330

GAA CTC ACC CCA GAG GTG CTG CAG GAG TGG CTG GAT GAA TTG GAG GAG 1059

Glu Leu Thr Pro Glu Val Leu Gln Glu Trp Leu Asp Glu Leu Glu Glu

335 340 345

ATG ATG CTG GTG GTC CAC ATG CCC CGC TTC CGC ATT GAG GAC GGC TTC 1107

Met Met Leu Val Val His Met Pro Arg Phe Arg Ile Glu Asp Gly Phe

350 355 360

AGT TTG AAG GAG CAG CTG CAA GAC ATG GGC CTT GTC GAT CTG TTC AGC 1155

Ser Leu Lys Glu Gln Leu Gln Asp Met Gly Leu Val Asp Leu Phe Ser

365 370 375

CCT GAA AAG TCC AAA CTC CCA GGT ATT GTT GCA GAA GGC CGA GAT GAC 1203

Pro Glu Lys Ser Lys Leu Pro Gly Ile Val Ala Glu Gly Arg Asp Asp

380 385 390

CTC TAT GTC TCA GAT GCA TTC CAT AAG GCA TTT CTT GAG GTA AAT GAA 1251

Leu Tyr Val Ser Asp Ala Phe His Lys Ala Phe Leu Glu Val Asn Glu

395 400 405 410

GAA GGC AGT GAA GCA GCT GCA AGT ACC GCT GTT GTG ATT GCT GGC CGT 1299

Glu Gly Ser Glu Ala Ala Ala Ser Thr Ala Val Val Ile Ala Gly Arg

415 420 425

TCG CTA AAC CCC AAC AGG GTG ACT TTC AAG GCC AAC ATG CCT TTC CTG 1347

Ser Leu Asn Pro Asn Arg Val Thr Phe Lys Ala Asn Met Pro Phe Leu

430 435 440

GTT TTT ATA AGA GAA GTT CCT CTG AAC ACT ATT ATC TTC ATG GGC AGG 1395

Val Phe Ile Arg Glu Val Pro Leu Asn Thr Ile Ile Phe Met Gly Arg

445 450 455

GTA GCC AAC CCT TGT GTT AAG TAAAATGTTC TCTAGAGGAT CCCCCATCGA 1446

Val Ala Asn Pro Cys Val Lys

460 465

TGGGGTACCG AGCTCGAATT C 1467

(2) INFORMATION FOR SEQ ID NO:4:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 465 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:

Met Tyr Ser Asn Val Ile Gly Thr Val Thr Ser Gly Lys Arg Lys Val

1 5 10 15

Tyr Leu Leu Ser Leu Leu Leu Ile Gly Phe Trp Asp Cys Val Thr Cys

20 25 30

His Gly Ser Pro Val Asp Ile Cys Thr Ala Lys Pro Arg Asp Ile Pro

35 40 45

Met Asn Pro Met Cys Ile Tyr Arg Ser Pro Glu Lys Lys Ala Thr Glu

50 55 60

Asp Glu Gly Ser Glu Gln Lys Ile Pro Glu Ala Thr Asn Asn Arg Arg

65 70 75 80

Val Trp Glu Leu Ser Lys Ala Asn Ser Arg Phe Ala Thr Thr Phe Tyr

85 90 95

Gln His Leu Ala Asp Ser Lys Asn Asp Asn Asp Asn Ile Phe Leu Ser

100 105 110

Pro Leu Ser Ile Ser Thr Ala Phe Ala Met Thr Lys Leu Gly Ala Cys

115 120 125

Asn Asp Thr Leu Gln Gln Leu Met Glu Val Phe Lys Phe Asp Thr Ile

130 135 140

Ser Glu Lys Thr Ser Asp Gln Ile His Phe Phe Phe Ala Lys Leu Asn

145 150 155 160

Cys Arg Leu Tyr Arg Lys Ala Asn Lys Ser Ser Lys Leu Val Ser Ala

165 170 175

Asn Arg Leu Phe Gly Asp Lys Ser Leu Thr Phe Asn Glu Thr Tyr Gln

180 185 190

Asp Ile Ser Glu Leu Val Tyr Gly Ala Lys Leu Gln Pro Leu Asp Phe

195 200 205

Lys Glu Asn Ala Glu Gln Ser Arg Ala Ala Ile Asn Lys Trp Val Ser

210 215 220

Asn Lys Thr Glu Gly Arg Ile Thr Asp Val Ile Pro Ser Glu Ala Ile

225 230 235 240

Asn Glu Leu Thr Val Leu Val Leu Val Asn Thr Ile Tyr Phe Lys Gly

245 250 255

Leu Trp Lys Ser Lys Phe Ser Pro Glu Asn Thr Arg Lys Glu Leu Phe

260 265 270

Tyr Lys Ala Asp Gly Glu Ser Cys Ser Ala Ser Met Met Tyr Gln Glu

275 280 285

Gly Lys Phe Arg Tyr Arg Arg Val Ala Glu Gly Thr Gln Val Leu Glu

290 295 300

Leu Pro Phe Lys Gly Asp Asp Ile Thr Met Val Leu Ile Leu Pro Lys

305 310 315 320

Pro Glu Lys Ser Leu Ala Lys Val Glu Lys Glu Leu Thr Pro Glu Val

325 330 335

Leu Gln Glu Trp Leu Asp Glu Leu Glu Glu Met Met Leu Val Val His

340 345 350

Met Pro Arg Phe Arg Ile Glu Asp Gly Phe Ser Leu Lys Glu Gln Leu

355 360 365

Gln Asp Met Gly Leu Val Asp Leu Phe Ser Pro Glu Lys Ser Lys Leu

370 375 380

Pro Gly Ile Val Ala Glu Gly Arg Asp Asp Leu Tyr Val Ser Asp Ala

385 390 395 400

Phe His Lys Ala Phe Leu Glu Val Asn Glu Glu Gly Ser Glu Ala Ala

405 410 415

Ala Ser Thr Ala Val Val Ile Ala Gly Arg Ser Leu Asn Pro Asn Arg

420 425 430

Val Thr Phe Lys Ala Asn Met Pro Phe Leu Val Phe Ile Arg Glu Val

435 440 445

Pro Leu Asn Thr Ile Ile Phe Met Gly Arg Val Ala Asn Pro Cys Val

450 455 460

Lys

465

(2) INFORMATION FOR SEQ ID NO:5:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 2932 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 992...2020

›(D) OTHER INFORMATION

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:

GTAATGCAGA GATAATAAAA CTTCTTAGGT CCATAGGTCT TATAATAATT TAATAACCTA 60

AACATGGTAT ACAAATTCCT CCAAACCCAA TAACATAATT ATAGTTTCAA AAAGTTCCCC 120

AAACTTTCAA GTTAGATTTT ATTGCTTTGA TGAGTGGCTT TAAATATGAA AAGTCTTGCC 180

TGTGAAGGGC AATCCTTTTC CCGTGGACTG GGATCTATAG AAATACAGAA ATGTGCCCAG 240

GGGTTCATCT CCCTAATAAC CATCATTCAC ATTTCTCAAC CTCCCTAATA ACCAGCCACC 300

ATGTGAGAAG GATCCACAGT TACTGTTTAT GACTATAATT AACTAGTACC TGGGACTGGT 360

CAGTGGAGTT GGTTGCAACC TGATGCTAAG GATGTCAAAG TTGTCTCGGC CTCTGTTCCC 420

AGCCAGTAAG TAATTCCCTG GCCTCGGGCC ATACCCCCTA ATCTTGGTCA GCTGATTATG 480

ACAGGCAGAC AGCACAGTAA ATAACACTAT ATATTAAGAA AACCCAAAGC ATATGTATCA 540

ATGGTATATA CCCAACAGCA TCCTAGGAAT GGAGAGTCTG TAGCAAGGGC CTCCAATGTG 600

AAGGTCAACA CAGTCACTGT GATGCGTGTA TTTCCATTTT GTAAAGCATG ATCTCTGGTG 660

GTCATTTTTA TCTTCCTAAC TTATTGGAAA AGTCTCCTGT TTTGGGGGCC CGCCCCTGGT 720

CACAGCCAGA CTGACTCAGT TTCCCTGGGA GGTCCCGCTC GAGCCCGTCC TTCCCCTCCC 780

TCTGCCCGCC CCCAGCCCTC GCCCCACCCT CGGCGCCCGC ACATCTGCCT GCTCAGCTCC 840

AGACGGCGCC CGGACCCCCG GGCGCGGGAT CCAGCCAGGT GGGAGCCCCG CAGATGAGGT 900

CTCTGAAGGT GTGCCTGAAC CAGTGCCAGC CTGCCCTGTC TGCAGCATCG GCCTGATGGG 960

GTGGTGACTG ATCCCTCAGG GCTCCGGAGC C ATG TGG CCC AAC GGC AGT TCC 1012

Met Trp Pro Asn Gly Ser Ser

1 5

CTG GGG CCC TGT TTC CGG CCC ACA AAC ATT ACC CTG GAG GAG AGA CGG 1060

Leu Gly Pro Cys Phe Arg Pro Thr Asn Ile Thr Leu Glu Glu Arg Arg

10 15 20

CTG ATC GCC TCG CCC TGG TTC GCC GCC TCC TTC TGC GTG GTG GGC CTG 1108

Leu Ile Ala Ser Pro Trp Phe Ala Ala Ser Phe Cys Val Val Gly Leu

25 30 35

GCC TCC AAC CTG CTG GCC CTG AGC GTG CTG GCG GGC GCG CGG CAG GGG 1156

Ala Ser Asn Leu Leu Ala Leu Ser Val Leu Ala Gly Ala Arg Gln Gly

40 45 50 55

GGT TCG CAC ACG CGC TCC TCC TTC CTC ACC TTC CTC TGC GGC CTC GTC 1204

Gly Ser His Thr Arg Ser Ser Phe Leu Thr Phe Leu Cys Gly Leu Val

60 65 70

CTC ACC GAC TTC CTG GGG CTG CTG GTG ACC GGT ACC ATC GTG GTG TCC 1252

Leu Thr Asp Phe Leu Gly Leu Leu Val Thr Gly Thr Ile Val Val Ser

75 80 85

CAG CAC GCC GCG CTC TTC GAG TGG CAC GCC GTG GAC CCT GGC TGC CGT 1300

Gln His Ala Ala Leu Phe Glu Trp His Ala Val Asp Pro Gly Cys Arg

90 95 100

CTC TGT CGC TTC ATG GGC GTC GTC ATG ATC TTC TTC GGC CTG TCC CCG 1348

Leu Cys Arg Phe Met Gly Val Val Met Ile Phe Phe Gly Leu Ser Pro

105 110 115

CTG CTG CTG GGG GCC GCC ATG GCC TCA GAG CGC TAC CTG GGT ATC ACC 1396

Leu Leu Leu Gly Ala Ala Met Ala Ser Glu Arg Tyr Leu Gly Ile Thr

120 125 130 135

CGG CCC TTC TCG CGC CCG GCG GTC GCC TCG CAG CGC CGC GCC TGG GCC 1444

Arg Pro Phe Ser Arg Pro Ala Val Ala Ser Gln Arg Arg Ala Trp Ala

140 145 150

ACC GTG GGG CTG GTG TGG GCG GCC GCG CTG GCG CTG GGC CTG CTG CCC 1492

Thr Val Gly Leu Val Trp Ala Ala Ala Leu Ala Leu Gly Leu Leu Pro

155 160 165

CTG CTG GGC GTG GGT CGC TAC ACC GTG CAA TAC CCG GGG TCC TGG TGC 1540

Leu Leu Gly Val Gly Arg Tyr Thr Val Gln Tyr Pro Gly Ser Trp Cys

170 175 180

TTC CTG ACG CTG GGC GCC GAG TCC GGG GAC GTG GCC TTC GGG CTG CTC 1588

Phe Leu Thr Leu Gly Ala Glu Ser Gly Asp Val Ala Phe Gly Leu Leu

185 190 195

TTC TCC ATG CTG GGC GGC CTC TCG GTC GGG CTG TCC TTC CTG CTG AAC 1636

Phe Ser Met Leu Gly Gly Leu Ser Val Gly Leu Ser Phe Leu Leu Asn

200 205 210 215

ACG GTC AGC GTG GCC ACC CTG TGC CAC GTC TAC CAC GGG CAG GAG GCG 1684

Thr Val Ser Val Ala Thr Leu Cys His Val Tyr His Gly Gln Glu Ala

220 225 230

GCC CAG CAG CGT CCC CGG GAC TCC GAG GTG GAG ATG ATG GCT CAG CTC 1732

Ala Gln Gln Arg Pro Arg Asp Ser Glu Val Glu Met Met Ala Gln Leu

235 240 245

CTG GGG ATC ATG GTG GTG GCC AGC GTG TGT TGG CTG CCC CTT CTG GTC 1780

Leu Gly Ile Met Val Val Ala Ser Val Cys Trp Leu Pro Leu Leu Val

250 255 260

TTC ATT GCC CAG ACA GTG CTG CGA AAC CCG CCT GCC ATG AGC CCC GCC 1828

Phe Ile Ala Gln Thr Val Leu Arg Asn Pro Pro Ala Met Ser Pro Ala

265 270 275

GGG CAG CTG TCC CGC ACC ACG GAG AAG GAG CTG CTC ATC TAC TTG CGC 1876

Gly Gln Leu Ser Arg Thr Thr Glu Lys Glu Leu Leu Ile Tyr Leu Arg

280 285 290 295

GTG GCC ACC TGG AAC CAG ATC CTG GAC CCC TGG GTG TAT ATC CTG TTC 1924

Val Ala Thr Trp Asn Gln Ile Leu Asp Pro Trp Val Tyr Ile Leu Phe

300 305 310

CGC CGC GCC GTG CTC CGG CGT CTC CAG CCT CGC CTC AGC ACC CGG CCC 1972

Arg Arg Ala Val Leu Arg Arg Leu Gln Pro Arg Leu Ser Thr Arg Pro

315 320 325

AGG TCG CTG TCC CTC CAG CCC CAG CTC ACG CAG CGC TCC GGG CTG CAG 2020

Arg Ser Leu Ser Leu Gln Pro Gln Leu Thr Gln Arg Ser Gly Leu Gln

330 335 340

TAGGAAGTGG ACAGAGCGCC CCTCCCGCGC CTTTCCGCGG AGCCCTTGGC CCCTCGGACA 2080

GCCCATCTGC CTGTTCTGAG GATTCAGGGG CTGGGGGTGC TGGATGGACA GTGGGCATCA 2140

GCAGCAGGGT TTTGGGTTGA CCCCAATCCA ACCCGGGGAC CCCCAACTCC TCCCTGATCC 2200

TTTTACCAAG CACTCTCCCT TCCTCGGCCC CTTTTTCCCA TCCAGAGCTC CCACCCCTTC 2260

TCTGCGTCCC TCCCAACCCC AGGAAGGGCA TGCAGACATT GGAAGAGGGT CTTGCATTGC 2320

TATTTTTTTT TTTAGACGGA GTCTTGCTCT GTCCCCCAGG CTGGAGTGCA GTGGCGCAAT 2380

CTCAGCTCAC TGCAACCTCC ACCTCCCGGG TTCAAGCGAT TCTCCTGCCT CAGCCTCCTG 2440

AGTAGCTGGG ACTATAGGCG CGCGCCACCA CGCCCGGCTA ATTTTTGTAT TTTTAGTAGA 2500

GACGGGGTTT CACCGTGTTG GCCAGGCTGG TCTTGAACTC CTGACCTCAG GTGATTCACC 2560

AGCCTCAGCC TCCCAAAGTG CTGGGATCAC AGGCATGAAC CACCACACCT GGCCATTTTT 2620

TTTTTTTTTT TAGACGGAGT CTCACTCTGT GGCCCAGCCT GGAGTACAGT GGCACGATCT 2680

CGGCTCACTG CAACCTCCGC CTCCCGGGTT CAAGCGATTC TCGTGCCTCA GCCTCCCGAG 2740

CAGCTGGGAT TACAGGCGTA AGCCACTGCG CCCGGCCTTG CATGCTCTTT GACCCTGAAT 2800

TTGACCTACT TGCTGGGGTA CAGTTGCTTC CTTTTGAACC TCCAACAGGG AAGGCTCTGT 2860

CCAGAAAGGA TTGAATGTGA AACGGGGGCA CCCCCTTTTC TTGCCAAAAT ATATCTCTGC 2920

CTTTGGTTTT AT 2932

(2) INFORMATION FOR SEQ ID NO:6:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 343 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:

Met Trp Pro Asn Gly Ser Ser Leu Gly Pro Cys Phe Arg Pro Thr Asn

1 5 10 15

Ile Thr Leu Glu Glu Arg Arg Leu Ile Ala Ser Pro Trp Phe Ala Ala

20 25 30

Ser Phe Cys Val Val Gly Leu Ala Ser Asn Leu Leu Ala Leu Ser Val

35 40 45

Leu Ala Gly Ala Arg Gln Gly Gly Ser His Thr Arg Ser Ser Phe Leu

50 55 60

Thr Phe Leu Cys Gly Leu Val Leu Thr Asp Phe Leu Gly Leu Leu Val

65 70 75 80

Thr Gly Thr Ile Val Val Ser Gln His Ala Ala Leu Phe Glu Trp His

85 90 95

Ala Val Asp Pro Gly Cys Arg Leu Cys Arg Phe Met Gly Val Val Met

100 105 110

Ile Phe Phe Gly Leu Ser Pro Leu Leu Leu Gly Ala Ala Met Ala Ser

115 120 125

Glu Arg Tyr Leu Gly Ile Thr Arg Pro Phe Ser Arg Pro Ala Val Ala

130 135 140

Ser Gln Arg Arg Ala Trp Ala Thr Val Gly Leu Val Trp Ala Ala Ala

145 150 155 160

Leu Ala Leu Gly Leu Leu Pro Leu Leu Gly Val Gly Arg Tyr Thr Val

165 170 175

Gln Tyr Pro Gly Ser Trp Cys Phe Leu Thr Leu Gly Ala Glu Ser Gly

180 185 190

Asp Val Ala Phe Gly Leu Leu Phe Ser Met Leu Gly Gly Leu Ser Val

195 200 205

Gly Leu Ser Phe Leu Leu Asn Thr Val Ser Val Ala Thr Leu Cys His

210 215 220

Val Tyr His Gly Gln Glu Ala Ala Gln Gln Arg Pro Arg Asp Ser Glu

225 230 235 240

Val Glu Met Met Ala Gln Leu Leu Gly Ile Met Val Val Ala Ser Val

245 250 255

Cys Trp Leu Pro Leu Leu Val Phe Ile Ala Gln Thr Val Leu Arg Asn

260 265 270

Pro Pro Ala Met Ser Pro Ala Gly Gln Leu Ser Arg Thr Thr Glu Lys

275 280 285

Glu Leu Leu Ile Tyr Leu Arg Val Ala Thr Trp Asn Gln Ile Leu Asp

290 295 300

Pro Trp Val Tyr Ile Leu Phe Arg Arg Ala Val Leu Arg Arg Leu Gln

305 310 315 320

Pro Arg Leu Ser Thr Arg Pro Arg Ser Leu Ser Leu Gln Pro Gln Leu

325 330 335

Thr Gln Arg Ser Gly Leu Gln

340

(2) INFORMATION FOR SEQ ID NO:7:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 3170 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 21...2384

›(D) OTHER INFORMATION · 1 of 2

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:

CGCCGCGGGA GGCGGACGAG ATG CGA GCG CGG CCG CGG CCC CGG CCG CTC 50

Met Arg Ala Arg Pro Arg Pro Arg Pro Leu

1 5 10

TGG GTG ACT GTG CTG GCG CTG GGG GCG CTG GCG GGC GTT GGC GTA GGA 98

Trp Val Thr Val Leu Ala Leu Gly Ala Leu Ala Gly Val Gly Val Gly

15 20 25

GGG CCC AAC ATC TGT ACC ACG CGA GGT GTG AGC TCC TGC CAG CAG TGC 146

Gly Pro Asn Ile Cys Thr Thr Arg Gly Val Ser Ser Cys Gln Gln Cys

30 35 40

CTG GCT GTG AGC CCC ATG TGT GCC TGG TGC TCT GAT GAG GCC CTG CCT 194

Leu Ala Val Ser Pro Met Cys Ala Trp Cys Ser Asp Glu Ala Leu Pro

45 50 55

CTG GGC TCA CCT CGC TGT GAC CTG AAG GAG AAT CTG CTG AAG GAT AAC 242

Leu Gly Ser Pro Arg Cys Asp Leu Lys Glu Asn Leu Leu Lys Asp Asn

60 65 70

TGT GCC CCA GAA TCC ATC GAG TTC CCA GTG AGT GAG GCC CGA GTA CTA 290

Cys Ala Pro Glu Ser Ile Glu Phe Pro Val Ser Glu Ala Arg Val Leu

75 80 85 90

GAG GAC AGG CCC CTC AGC GAC AAG GGC TCT GGA GAC AGC TCC CAG GTC 338

Glu Asp Arg Pro Leu Ser Asp Lys Gly Ser Gly Asp Ser Ser Gln Val

95 100 105

ACT CAA GTC AGT CCC CAG AGG ATT GCA CTC CGG CTC CGG CCA GAT GAT 386

Thr Gln Val Ser Pro Gln Arg Ile Ala Leu Arg Leu Arg Pro Asp Asp

110 115 120

TCG AAG AAT TTC TCC ATC CAA GTG CGG CAG GTG GAG GAT TAC CCT GTG 434

Ser Lys Asn Phe Ser Ile Gln Val Arg Gln Val Glu Asp Tyr Pro Val

125 130 135

GAC ATC TAC TAC TTG ATG GAC CTG TCT TAC TCC ATG AAG GAT GAT CTG 482

Asp Ile Tyr Tyr Leu Met Asp Leu Ser Tyr Ser Met Lys Asp Asp Leu

140 145 150

TGG AGC ATC CAG AAC CTG GGT ACC AAG CTG GCC ACC CAG ATG CGA AAG 530

Trp Ser Ile Gln Asn Leu Gly Thr Lys Leu Ala Thr Gln Met Arg Lys

155 160 165 170

CTC ACC AGT AAC CTG CGG ATT GGC TTC GGG GCA TTT GTG GAC AAG CCT 578

Leu Thr Ser Asn Leu Arg Ile Gly Phe Gly Ala Phe Val Asp Lys Pro

175 180 185

GTG TCA CCA TAC ATG TAT ATC TCC CCA CCA GAG GCC CTC GAA AAC CCC 626

Val Ser Pro Tyr Met Tyr Ile Ser Pro Pro Glu Ala Leu Glu Asn Pro

190 195 200

TGC TAT GAT ATG AAG ACC ACC TGC TTG CCC ATG TTT GGC TAC AAA CAC 674

Cys Tyr Asp Met Lys Thr Thr Cys Leu Pro Met Phe Gly Tyr Lys His

205 210 215

GTG CTG ACG CTA ACT GAC CAG GTG ACC CGC TTC AAT GAG GAA GTG AAG 722

Val Leu Thr Leu Thr Asp Gln Val Thr Arg Phe Asn Glu Glu Val Lys

220 225 230

AAG CAG AGT GTG TCA CGG AAC CGA GAT GCC CCA GAG GGT GGC TTT GAT 770

Lys Gln Ser Val Ser Arg Asn Arg Asp Ala Pro Glu Gly Gly Phe Asp

235 240 245 250

GCC ATC ATG CAG GCT ACA GTC TGT GAT GAA AAG ATT GGC TGG AGG AAT 818

Ala Ile Met Gln Ala Thr Val Cys Asp Glu Lys Ile Gly Trp Arg Asn

255 260 265

GAT GCA TCC CAC TTG CTG GTG TTT ACC ACT GAT GCC AAG ACT CAT ATA 866

Asp Ala Ser His Leu Leu Val Phe Thr Thr Asp Ala Lys Thr His Ile

270 275 280

GCA TTG GAC GGA AGG CTG GCA GGC ATT GTC CAG CCT AAT GAC GGG CAG 914

Ala Leu Asp Gly Arg Leu Ala Gly Ile Val Gln Pro Asn Asp Gly Gln

285 290 295

TGT CAT GTT GGT AGT GAC AAT CAT TAC TCT GCC TCC ACT ACC ATG GAT 962

Cys His Val Gly Ser Asp Asn His Tyr Ser Ala Ser Thr Thr Met Asp

300 305 310

TAT CCC TCT TTG GGG CTG ATG ACT GAG AAG CTA TCC CAG AAA AAC ATC 1010

Tyr Pro Ser Leu Gly Leu Met Thr Glu Lys Leu Ser Gln Lys Asn Ile

315 320 325 330

AAT TTG ATC TTT GCA GTG ACT GAA AAT GTA GTC AAT CTC TAT CAG AAC 1058

Asn Leu Ile Phe Ala Val Thr Glu Asn Val Val Asn Leu Tyr Gln Asn

335 340 345

TAT AGT GAG CTC ATC CCA GGG ACC ACA GTT GGG GTT CTG TCC ATG GAT 1106

Tyr Ser Glu Leu Ile Pro Gly Thr Thr Val Gly Val Leu Ser Met Asp

350 355 360

TCC AGC AAT GTC CTC CAG CTC ATT GTT GAT GCT TAT GGG AAA ATC CGT 1154

Ser Ser Asn Val Leu Gln Leu Ile Val Asp Ala Tyr Gly Lys Ile Arg

365 370 375

TCT AAA GTC GAG CTG GAA GTG CGT GAC CTC CCT GAA GAG TTG TCT CTA 1202

Ser Lys Val Glu Leu Glu Val Arg Asp Leu Pro Glu Glu Leu Ser Leu

380 385 390

TCC TTC AAT GCC ACC TGC CTC AAC AAT GAG GTC ATC CCT GGC CTC AAG 1250

Ser Phe Asn Ala Thr Cys Leu Asn Asn Glu Val Ile Pro Gly Leu Lys

395 400 405 410

TCT TGT ATG GGA CTC AAG ATT GGA GAC ACG GTG AGC TTC AGC ATT GAG 1298

Ser Cys Met Gly Leu Lys Ile Gly Asp Thr Val Ser Phe Ser Ile Glu

415 420 425

GCC AAG GTG CGA GGC TGT CCC CAG GAG AAG GAG AAG TCC TTT ACC ATA 1346

Ala Lys Val Arg Gly Cys Pro Gln Glu Lys Glu Lys Ser Phe Thr Ile

430 435 440

AAG CCC GTG GGC TTC AAG GAC AGC CTG ATC GTC CAG GTC ACC TTT GAT 1394

Lys Pro Val Gly Phe Lys Asp Ser Leu Ile Val Gln Val Thr Phe Asp

445 450 455

TGT GAC TGT GCC TGC CAG GCC CAA GCT GAA CCT AAT AGC CAT CGC TGC 1442

Cys Asp Cys Ala Cys Gln Ala Gln Ala Glu Pro Asn Ser His Arg Cys

460 465 470

AAC AAT GGC AAT GGG ACC TTT GAG TGT GGG GTA TGC CGT TGT GGG CCT 1490

Asn Asn Gly Asn Gly Thr Phe Glu Cys Gly Val Cys Arg Cys Gly Pro

475 480 485 490

GGC TGG CTG GGA TCC CAG TGT GAG TGC TCA GAG GAG GAC TAT CGC CCT 1538

Gly Trp Leu Gly Ser Gln Cys Glu Cys Ser Glu Glu Asp Tyr Arg Pro

495 500 505

TCC CAG CAG GAC GAG TGC AGC CCC CGA GAG GGT CAG CCC GTC TGC AGC 1586

Ser Gln Gln Asp Glu Cys Ser Pro Arg Glu Gly Gln Pro Val Cys Ser

510 515 520

CAG CGG GGC GAG TGC CTC TGT GGT CAA TGT GTC TGC CAC AGC AGT GAC 1634

Gln Arg Gly Glu Cys Leu Cys Gly Gln Cys Val Cys His Ser Ser Asp

525 530 535

TTT GGC AAG ATC ACG GGC AAG TAC TGC GAG TGT GAC GAC TTC TCC TGT 1682

Phe Gly Lys Ile Thr Gly Lys Tyr Cys Glu Cys Asp Asp Phe Ser Cys

540 545 550

GTC CGC TAC AAG GGG GAG ATG TGC TCA GGC CAT GGC CAG TGC AGC TGT 1730

Val Arg Tyr Lys Gly Glu Met Cys Ser Gly His Gly Gln Cys Ser Cys

555 560 565 570

GGG GAC TGC CTG TGT GAC TCC GAC TGG ACC GGC TAC TAC TGC AAC TGT 1778

Gly Asp Cys Leu Cys Asp Ser Asp Trp Thr Gly Tyr Tyr Cys Asn Cys

575 580 585

ACC ACG CGT ACT GAC ACC TGC ATG TCC AGC AAT GGG CTG CTG TGC AGC 1826

Thr Thr Arg Thr Asp Thr Cys Met Ser Ser Asn Gly Leu Leu Cys Ser

590 595 600

GGC CGC GGC AAG TGT GAA TGT GGC AGC TGT GTC TGT ATC CAG CCG GGC 1874

Gly Arg Gly Lys Cys Glu Cys Gly Ser Cys Val Cys Ile Gln Pro Gly

605 610 615

TCC TAT GGG GAC ACC TGT GAG AAG TGC CCC ACC TGC CCA GAT GCC TGC 1922

Ser Tyr Gly Asp Thr Cys Glu Lys Cys Pro Thr Cys Pro Asp Ala Cys

620 625 630

ACC TTT AAG AAA GAA TGT GTG GAG TGT AAG AAG TTT GAC CGG GAG CCC 1970

Thr Phe Lys Lys Glu Cys Val Glu Cys Lys Lys Phe Asp Arg Glu Pro

635 640 645 650

TAC ATG ACC GAA AAT ACC TGC AAC CGT TAC TGC CGT GAC GAG ATT GAG 2018

Tyr Met Thr Glu Asn Thr Cys Asn Arg Tyr Cys Arg Asp Glu Ile Glu

655 660 665

TCA GTG AAA GAG CTT AAG GAC ACT GGC AAG GAT GCA GTG AAT TGT ACC 2066

›(D) OTHER INFORMATION · 2 of 2

Ser Val Lys Glu Leu Lys Asp Thr Gly Lys Asp Ala Val Asn Cys Thr

670 675 680

TAT AAG AAT GAG GAT GAC TGT GTC GTC AGA TTC CAG TAC TAT GAA GAT 2114

Tyr Lys Asn Glu Asp Asp Cys Val Val Arg Phe Gln Tyr Tyr Glu Asp

685 690 695

TCT AGT GGA AAG TCC ATC CTG TAT GTG GTA GAA GAG CCA GAG TGT CCC 2162

Ser Ser Gly Lys Ser Ile Leu Tyr Val Val Glu Glu Pro Glu Cys Pro

700 705 710

AAG GGC CCT GAC ATC CTG GTG GTC CTG CTC TCA GTG ATG GGG GCC ATT 2210

Lys Gly Pro Asp Ile Leu Val Val Leu Leu Ser Val Met Gly Ala Ile

715 720 725 730

CTG CTC ATT GGC CTT GCC GCC CTG CTC ATC TGG AAA CTC CTC ATC ACC 2258

Leu Leu Ile Gly Leu Ala Ala Leu Leu Ile Trp Lys Leu Leu Ile Thr

735 740 745

ATC CAC GAC CGA AAA GAA TTC GCT AAA TTT GAG GAA GAA CGC GCC AGA 2306

Ile His Asp Arg Lys Glu Phe Ala Lys Phe Glu Glu Glu Arg Ala Arg

750 755 760

GCA AAA TGG GAC ACA GCC AAC AAC CCA CTG TAT AAA GAG GCC ACG TCT 2354

Ala Lys Trp Asp Thr Ala Asn Asn Pro Leu Tyr Lys Glu Ala Thr Ser

765 770 775

ACC TTC ACC AAT ATC ACG TAC CGG GGC ACT TAATGATAAG CAGTCATCCT 2404

Thr Phe Thr Asn Ile Thr Tyr Arg Gly Thr

780 785

CAGATCATTA TCAGCCTGTG CCAGGATTGC AGGAGTCCCT GCCATCATGT TTACAGAGGA 2464

CAGTATTTGT GGGGAGGGAT TTCGGGGCTC AGAGTGGGGT AGGTTGGGAG AATGTCAGTA 2524

TGTGGAAGTG TGGGTCTGTG TGTGTGTATG TGGGGGTCTG TGTGTTTATG TGTGTGTGTT 2584

GTGTGTGGGA GTGTGTAATT TAAAATTGTG ATGTGTCCTG ATAAGCTGAG CTCCTTAGCC 2644

TTTGTCCCAG AATGCCTCCT GCAGGGATTC TTCCTGCTTA GCTTGAGGGT GACTATGGAG 2704

CTGAGCAGGT GTTCTTCATT ACCTCAGTGA GAAGCCAGCT TTCCTCATCA GGCCATTGTC 2764

CCTGAAGAGA AGGGCAGGGC TGAGGCCTCT CATTCCAGAG GAAGGGACAC CAAGCCTTGG 2824

CTCTACCCTG AGTTCATAAA TTTATGGTTC TCAGGCCTGA CTCTCAGCAG CTATGGTAGG 2884

AACTGCTGGC TTGGCAGCCC GGGTCATCTG TACCTCTGCC TCCTTTCCCC TCCCTCAGGC 2944

CGAAGGAGGA GTCAGGGAGA GCTGAACTAT TAGAGCTGCC TGTGCCTTTT GCCATCCCCT 3004

CAACCCAGCT ATGGTTCTCT CGCAAGGGAA GTCCTTGCAA GCTAATTCTT TGACCTGTTG 3064

GGAGTGAGGA TGTCTGGGCC ACTCAGGGGT CATTCATGGC CTGGGGGATG TACCAGCATC 3124

TCCCAGTTCA TAATCACAAC CCTTCAGATT TGCCTTATTG GCAGCG 3170

(2) INFORMATION FOR SEQ ID NO:8:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 788 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:

Met Arg Ala Arg Pro Arg Pro Arg Pro Leu Trp Val Thr Val Leu Ala

1 5 10 15

Leu Gly Ala Leu Ala Gly Val Gly Val Gly Gly Pro Asn Ile Cys Thr

20 25 30

Thr Arg Gly Val Ser Ser Cys Gln Gln Cys Leu Ala Val Ser Pro Met

35 40 45

Cys Ala Trp Cys Ser Asp Glu Ala Leu Pro Leu Gly Ser Pro Arg Cys

50 55 60

Asp Leu Lys Glu Asn Leu Leu Lys Asp Asn Cys Ala Pro Glu Ser Ile

65 70 75 80

Glu Phe Pro Val Ser Glu Ala Arg Val Leu Glu Asp Arg Pro Leu Ser

85 90 95

Asp Lys Gly Ser Gly Asp Ser Ser Gln Val Thr Gln Val Ser Pro Gln

100 105 110

Arg Ile Ala Leu Arg Leu Arg Pro Asp Asp Ser Lys Asn Phe Ser Ile

115 120 125

Gln Val Arg Gln Val Glu Asp Tyr Pro Val Asp Ile Tyr Tyr Leu Met

130 135 140

Asp Leu Ser Tyr Ser Met Lys Asp Asp Leu Trp Ser Ile Gln Asn Leu

145 150 155 160

Gly Thr Lys Leu Ala Thr Gln Met Arg Lys Leu Thr Ser Asn Leu Arg

165 170 175

Ile Gly Phe Gly Ala Phe Val Asp Lys Pro Val Ser Pro Tyr Met Tyr

180 185 190

Ile Ser Pro Pro Glu Ala Leu Glu Asn Pro Cys Tyr Asp Met Lys Thr

195 200 205

Thr Cys Leu Pro Met Phe Gly Tyr Lys His Val Leu Thr Leu Thr Asp

210 215 220

Gln Val Thr Arg Phe Asn Glu Glu Val Lys Lys Gln Ser Val Ser Arg

225 230 235 240

Asn Arg Asp Ala Pro Glu Gly Gly Phe Asp Ala Ile Met Gln Ala Thr

245 250 255

Val Cys Asp Glu Lys Ile Gly Trp Arg Asn Asp Ala Ser His Leu Leu

260 265 270

Val Phe Thr Thr Asp Ala Lys Thr His Ile Ala Leu Asp Gly Arg Leu

275 280 285

Ala Gly Ile Val Gln Pro Asn Asp Gly Gln Cys His Val Gly Ser Asp

290 295 300

Asn His Tyr Ser Ala Ser Thr Thr Met Asp Tyr Pro Ser Leu Gly Leu

305 310 315 320

Met Thr Glu Lys Leu Ser Gln Lys Asn Ile Asn Leu Ile Phe Ala Val

325 330 335

Thr Glu Asn Val Val Asn Leu Tyr Gln Asn Tyr Ser Glu Leu Ile Pro

340 345 350

Gly Thr Thr Val Gly Val Leu Ser Met Asp Ser Ser Asn Val Leu Gln

355 360 365

Leu Ile Val Asp Ala Tyr Gly Lys Ile Arg Ser Lys Val Glu Leu Glu

370 375 380

Val Arg Asp Leu Pro Glu Glu Leu Ser Leu Ser Phe Asn Ala Thr Cys

385 390 395 400

Leu Asn Asn Glu Val Ile Pro Gly Leu Lys Ser Cys Met Gly Leu Lys

405 410 415

Ile Gly Asp Thr Val Ser Phe Ser Ile Glu Ala Lys Val Arg Gly Cys

420 425 430

Pro Gln Glu Lys Glu Lys Ser Phe Thr Ile Lys Pro Val Gly Phe Lys

435 440 445

Asp Ser Leu Ile Val Gln Val Thr Phe Asp Cys Asp Cys Ala Cys Gln

450 455 460

Ala Gln Ala Glu Pro Asn Ser His Arg Cys Asn Asn Gly Asn Gly Thr

465 470 475 480

Phe Glu Cys Gly Val Cys Arg Cys Gly Pro Gly Trp Leu Gly Ser Gln

485 490 495

Cys Glu Cys Ser Glu Glu Asp Tyr Arg Pro Ser Gln Gln Asp Glu Cys

500 505 510

Ser Pro Arg Glu Gly Gln Pro Val Cys Ser Gln Arg Gly Glu Cys Leu

515 520 525

Cys Gly Gln Cys Val Cys His Ser Ser Asp Phe Gly Lys Ile Thr Gly

530 535 540

Lys Tyr Cys Glu Cys Asp Asp Phe Ser Cys Val Arg Tyr Lys Gly Glu

545 550 555 560

Met Cys Ser Gly His Gly Gln Cys Ser Cys Gly Asp Cys Leu Cys Asp

565 570 575

Ser Asp Trp Thr Gly Tyr Tyr Cys Asn Cys Thr Thr Arg Thr Asp Thr

580 585 590

Cys Met Ser Ser Asn Gly Leu Leu Cys Ser Gly Arg Gly Lys Cys Glu

595 600 605

Cys Gly Ser Cys Val Cys Ile Gln Pro Gly Ser Tyr Gly Asp Thr Cys

610 615 620

Glu Lys Cys Pro Thr Cys Pro Asp Ala Cys Thr Phe Lys Lys Glu Cys

625 630 635 640

Val Glu Cys Lys Lys Phe Asp Arg Glu Pro Tyr Met Thr Glu Asn Thr

645 650 655

Cys Asn Arg Tyr Cys Arg Asp Glu Ile Glu Ser Val Lys Glu Leu Lys

660 665 670

Asp Thr Gly Lys Asp Ala Val Asn Cys Thr Tyr Lys Asn Glu Asp Asp

675 680 685

Cys Val Val Arg Phe Gln Tyr Tyr Glu Asp Ser Ser Gly Lys Ser Ile

690 695 700

Leu Tyr Val Val Glu Glu Pro Glu Cys Pro Lys Gly Pro Asp Ile Leu

705 710 715 720

Val Val Leu Leu Ser Val Met Gly Ala Ile Leu Leu Ile Gly Leu Ala

725 730 735

Ala Leu Leu Ile Trp Lys Leu Leu Ile Thr Ile His Asp Arg Lys Glu

740 745 750

Phe Ala Lys Phe Glu Glu Glu Arg Ala Arg Ala Lys Trp Asp Thr Ala

755 760 765

Asn Asn Pro Leu Tyr Lys Glu Ala Thr Ser Thr Phe Thr Asn Ile Thr

770 775 780

Tyr Arg Gly Thr

785

(2) INFORMATION FOR SEQ ID NO:9:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 3303 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 2...3118

›(D) OTHER INFORMATION · 1 of 2

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:

G ATG GCC AGA GCT TTG TGT CCA CTG CAA GCC CTC TGG CTT CTG GAG TGG 49

Met Ala Arg Ala Leu Cys Pro Leu Gln Ala Leu Trp Leu Leu Glu Trp

1 5 10 15

GTG CTG CTG CTC TTG GGA CCT TGT GCT GCC CCT CCA GCC TGG GCC TTG 97

Val Leu Leu Leu Leu Gly Pro Cys Ala Ala Pro Pro Ala Trp Ala Leu

20 25 30

AAC CTG GAC CCA GTG CAG CTC ACC TTC TAT GCA GGC CCC AAT GGC AGC 145

Asn Leu Asp Pro Val Gln Leu Thr Phe Tyr Ala Gly Pro Asn Gly Ser

35 40 45

CAG TTT GGA TTT TCA CTG GAC TTC CAC AAG GAC AGC CAT GGG AGA GTG 193

Gln Phe Gly Phe Ser Leu Asp Phe His Lys Asp Ser His Gly Arg Val

50 55 60

GCC ATC GTG GTG GGC GCC CCG CGG ACC CTG GGC CCC AGC CAG GAG GAG 241

Ala Ile Val Val Gly Ala Pro Arg Thr Leu Gly Pro Ser Gln Glu Glu

65 70 75 80

ACG GGC GGC GTG TTC CTG TGC CCC TGG AGG GCC GAG GGC GGC CAG TGC 289

Thr Gly Gly Val Phe Leu Cys Pro Trp Arg Ala Glu Gly Gly Gln Cys

85 90 95

CCC TCG CTG CTC TTT GAC CTC CGT GAT GAG ACC CGA AAT GTA GGC TCC 337

Pro Ser Leu Leu Phe Asp Leu Arg Asp Glu Thr Arg Asn Val Gly Ser

100 105 110

CAA ACT TTA CAA ACC TTC AAG GCC CGC CAA GGA CTG GGG GCG TCG GTC 385

Gln Thr Leu Gln Thr Phe Lys Ala Arg Gln Gly Leu Gly Ala Ser Val

115 120 125

GTC AGC TGG AGC GAC GTC ATT GTG GCC TGC GCC CCC TGG CAG CAC TGG 433

Val Ser Trp Ser Asp Val Ile Val Ala Cys Ala Pro Trp Gln His Trp

130 135 140

AAC GTC CTA GAA AAG ACT GAG GAG GCT GAG AAG ACG CCC GTA GGT AGC 481

Asn Val Leu Glu Lys Thr Glu Glu Ala Glu Lys Thr Pro Val Gly Ser

145 150 155 160

TGC TTT TTG GCT CAG CCA GAG AGC GGC CGC CGC GCC GAG TAC TCC CCC 529

Cys Phe Leu Ala Gln Pro Glu Ser Gly Arg Arg Ala Glu Tyr Ser Pro

165 170 175

TGT CGC GGG AAC ACC CTG AGC CGC ATT TAC GTG GAA AAT GAT TTT AGC 577

Cys Arg Gly Asn Thr Leu Ser Arg Ile Tyr Val Glu Asn Asp Phe Ser

180 185 190

TGG GAC AAG CGT TAC TGT GAA GCG GGC TTC AGC TCC GTG GTC ACT CAG 625

Trp Asp Lys Arg Tyr Cys Glu Ala Gly Phe Ser Ser Val Val Thr Gln

195 200 205

GCC GGA GAG CTG GTG CTT GGG GCT CCT GGC GGC TAT TAT TTC TTA GGT 673

Ala Gly Glu Leu Val Leu Gly Ala Pro Gly Gly Tyr Tyr Phe Leu Gly

210 215 220

CTC CTG GCC CAG GCT CCA GTT GCG GAT ATT TTC TCG AGT TAC CGC CCA 721

Leu Leu Ala Gln Ala Pro Val Ala Asp Ile Phe Ser Ser Tyr Arg Pro

225 230 235 240

GGC ATC CTT TTG TGG CAC GTG TCC TCC CAG AGC CTC TCC TTT GAC TCC 769

Gly Ile Leu Leu Trp His Val Ser Ser Gln Ser Leu Ser Phe Asp Ser

245 250 255

AGC AAC CCA GAG TAC TTC GAC GGC TAC TGG GGG TAC TCG GTG GCC GTG 817

Ser Asn Pro Glu Tyr Phe Asp Gly Tyr Trp Gly Tyr Ser Val Ala Val

260 265 270

GGC GAG TTC GAC GGG GAT CTC AAC ACT ACA GAA TAT GTC GTC GGT GCC 865

Gly Glu Phe Asp Gly Asp Leu Asn Thr Thr Glu Tyr Val Val Gly Ala

275 280 285

CCC ACT TGG AGC TGG ACC CTG GGA GCG GTG GAA ATT TTG GAT TCC TAC 913

Pro Thr Trp Ser Trp Thr Leu Gly Ala Val Glu Ile Leu Asp Ser Tyr

290 295 300

TAC CAG AGG CTG CAT CGG CTG CGC GCA GAG CAG ATG GCG TCG TAT TTT 961

Tyr Gln Arg Leu His Arg Leu Arg Ala Glu Gln Met Ala Ser Tyr Phe

305 310 315 320

GGG CAT TCA GTG GCT GTC ACT GAC GTC AAC GGG GAT GGG AGG CAT GAT 1009

Gly His Ser Val Ala Val Thr Asp Val Asn Gly Asp Gly Arg His Asp

325 330 335

CTG CTG GTG GGC GCT CCA CTG TAT ATG GAG AGC CGG GCA GAC CGA AAA 1057

Leu Leu Val Gly Ala Pro Leu Tyr Met Glu Ser Arg Ala Asp Arg Lys

340 345 350

CTG GCC GAA GTG GGG CGT GTG TAT TTG TTC CTG CAG CCG CGA GGC CCC 1105

Leu Ala Glu Val Gly Arg Val Tyr Leu Phe Leu Gln Pro Arg Gly Pro

355 360 365

CAC GCG CTG GGT GCC CCC AGC CTC CTG CTG ACT GGC ACA CAG CTC TAT 1153

His Ala Leu Gly Ala Pro Ser Leu Leu Leu Thr Gly Thr Gln Leu Tyr

370 375 380

GGG CGA TTC GGC TCT GCC ATC GCA CCC CTG GGC GAC CTC GAC CGG GAT 1201

Gly Arg Phe Gly Ser Ala Ile Ala Pro Leu Gly Asp Leu Asp Arg Asp

385 390 395 400

GGC TAC AAT GAC ATT GCA GTG GCT GCC CCC TAC GGG GGT CCC AGT GGC 1249

Gly Tyr Asn Asp Ile Ala Val Ala Ala Pro Tyr Gly Gly Pro Ser Gly

405 410 415

CGG GGC CAA GTG CTG GTG TTC CTG GGT CAG AGT GAG GGG CTG AGG TCA 1297

Arg Gly Gln Val Leu Val Phe Leu Gly Gln Ser Glu Gly Leu Arg Ser

420 425 430

CGT CCC TCC CAG GTC CTG GAC AGC CCC TTC CCC ACA GGC TCT GCC TTT 1345

Arg Pro Ser Gln Val Leu Asp Ser Pro Phe Pro Thr Gly Ser Ala Phe

435 440 445

GGC TTC TCC CTT CGA GGT GCC GTA GAC ATC GAT GAC AAC GGA TAC CCA 1393

Gly Phe Ser Leu Arg Gly Ala Val Asp Ile Asp Asp Asn Gly Tyr Pro

450 455 460

GAC CTG ATC GTG GGA GCT TAC GGG GCC AAC CAG GTG GCT GTG TAC AGA 1441

Asp Leu Ile Val Gly Ala Tyr Gly Ala Asn Gln Val Ala Val Tyr Arg

465 470 475 480

GCT CAG CCA GTG GTG AAG GCC TCT GTC CAG CTA CTG GTG CAA GAT TCA 1489

Ala Gln Pro Val Val Lys Ala Ser Val Gln Leu Leu Val Gln Asp Ser

485 490 495

CTG AAT CCT GCT GTG AAG AGC TGT GTC CTA CCT CAG ACC AAG ACA CCC 1537

Leu Asn Pro Ala Val Lys Ser Cys Val Leu Pro Gln Thr Lys Thr Pro

500 505 510

GTG AGC TGC TTC AAC ATC CAG ATG TGT GTT GGA GCC ACT GGG CAC AAC 1585

Val Ser Cys Phe Asn Ile Gln Met Cys Val Gly Ala Thr Gly His Asn

515 520 525

ATT CCT CAG AAG CTA TCC CTA AAT GCC GAG CTG CAG CTG GAC CGG CAG 1633

Ile Pro Gln Lys Leu Ser Leu Asn Ala Glu Leu Gln Leu Asp Arg Gln

530 535 540

AAG CCC CGC CAG GGC CGG CGG GTG CTG CTG CTG GGC TCT CAA CAG GCA 1681

Lys Pro Arg Gln Gly Arg Arg Val Leu Leu Leu Gly Ser Gln Gln Ala

545 550 555 560

GGC ACC ACC CTG AAC CTG GAT CTG GGC GGA AAG CAC AGC CCC ATC TGC 1729

Gly Thr Thr Leu Asn Leu Asp Leu Gly Gly Lys His Ser Pro Ile Cys

565 570 575

CAC ACC ACC ATG GCC TTC CTT CGA GAT GAG GCA GAC TTC CGG GAC AAG 1777

His Thr Thr Met Ala Phe Leu Arg Asp Glu Ala Asp Phe Arg Asp Lys

580 585 590

CTG AGC CCC ATT GTG CTC AGC CTC AAT GTG TCC CTA CCG CCC ACG GAG 1825

Leu Ser Pro Ile Val Leu Ser Leu Asn Val Ser Leu Pro Pro Thr Glu

595 600 605

GCT GGA ATG GCC CCT GCT GTC GTG CTG CAT GGA GAC ACC CAT GTG CAG 1873

Ala Gly Met Ala Pro Ala Val Val Leu His Gly Asp Thr His Val Gln

610 615 620

GAG CAG ACA CGA ATC GTC CTG GAC TCT GGG GAA GAT GAC GTA TGT GTG 1921

Glu Gln Thr Arg Ile Val Leu Asp Ser Gly Glu Asp Asp Val Cys Val

625 630 635 640

CCC CAG CTT CAG CTC ACT GCC AGC GTG ACG GGC TCC CCG CTC CTA GTT 1969

Pro Gln Leu Gln Leu Thr Ala Ser Val Thr Gly Ser Pro Leu Leu Val

645 650 655

GGG GCA GAT AAT GTC CTG GAG CTG CAG ATG GAC GCA GCC AAC GAG GGC 2017

Gly Ala Asp Asn Val Leu Glu Leu Gln Met Asp Ala Ala Asn Glu Gly

660 665 670

GAG GGG GCC TAT GAA GCA GAG CTG GCC GTG CAC CTG CCC CAG GGC GCC 2065

›(D) OTHER INFORMATION · 2 of 2

Glu Gly Ala Tyr Glu Ala Glu Leu Ala Val His Leu Pro Gln Gly Ala

675 680 685

CAC TAC ATG CGG GCC CTA AGC AAT GTC GAG GGC TTT GAG AGA CTC ATC 2113

His Tyr Met Arg Ala Leu Ser Asn Val Glu Gly Phe Glu Arg Leu Ile

690 695 700

TGT AAT CAG AAG AAG GAG AAT GAG ACC AGG GTG GTG CTG TGT GAG CTG 2161

Cys Asn Gln Lys Lys Glu Asn Glu Thr Arg Val Val Leu Cys Glu Leu

705 710 715 720

GGC AAC CCC ATG AAG AAG AAC GCC CAG ATA GGA ATC GCG ATG TTG GTG 2209

Gly Asn Pro Met Lys Lys Asn Ala Gln Ile Gly Ile Ala Met Leu Val

725 730 735

AGC GTG GGG AAT CTG GAA GAG GCT GGG GAG TCT GTG TCC TTC CAG CTG 2257

Ser Val Gly Asn Leu Glu Glu Ala Gly Glu Ser Val Ser Phe Gln Leu

740 745 750

CAG ATA CGG AGC AAG AAC AGC CAG AAT CCA AAC AGC AAG ATT GTG CTG 2305

Gln Ile Arg Ser Lys Asn Ser Gln Asn Pro Asn Ser Lys Ile Val Leu

755 760 765

CTG GAC GTG CCG GTC CGG GCA GAG GCC CAA GTG GAG CTG CGA GGG AAC 2353

Leu Asp Val Pro Val Arg Ala Glu Ala Gln Val Glu Leu Arg Gly Asn

770 775 780

TCC TTT CCA GCC TCC CTG GTG GTG GCA GCA GAA GAA GGT GAG AGG GAG 2401

Ser Phe Pro Ala Ser Leu Val Val Ala Ala Glu Glu Gly Glu Arg Glu

785 790 795 800

CAG AAC AGC TTG GAC AGC TGG GGA CCC AAA GTG GAG CAC ACC TAT GAG 2449

Gln Asn Ser Leu Asp Ser Trp Gly Pro Lys Val Glu His Thr Tyr Glu

805 810 815

CTC CAC AAC AAT GGC CCT GGG ACT GTG AAT GGT CTT CAC CTC AGC ATC 2497

Leu His Asn Asn Gly Pro Gly Thr Val Asn Gly Leu His Leu Ser Ile

820 825 830

CAC CTT CCG GGA CAG TCC CAG CCC TCC GAC CTG CTC TAC ATC CTG GAT 2545

His Leu Pro Gly Gln Ser Gln Pro Ser Asp Leu Leu Tyr Ile Leu Asp

835 840 845

ATA CAG CCC CAG GGG GGC CTT CAG TGC TTC CCA CAG CCT CCT GTC AAC 2593

Ile Gln Pro Gln Gly Gly Leu Gln Cys Phe Pro Gln Pro Pro Val Asn

850 855 860

CCT CTC AAG GTG GAC TGG GGG CTG CCC ATC CCC AGC CCC TCC CCC ATT 2641

Pro Leu Lys Val Asp Trp Gly Leu Pro Ile Pro Ser Pro Ser Pro Ile

865 870 875 880

CAC CCG GCC CAT CAC AAG CGG GAT CGC AGA CAG ATC TTC CTG CCA GAG 2689

His Pro Ala His His Lys Arg Asp Arg Arg Gln Ile Phe Leu Pro Glu

885 890 895

CCC GAG CAG CCC TCG AGG CTT CAG GAT CCA GTT CTC GTA AGC TGC GAC 2737

Pro Glu Gln Pro Ser Arg Leu Gln Asp Pro Val Leu Val Ser Cys Asp

900 905 910

TCG GCG CCC TGT ACT GTG GTG CAG TGT GAC CTG CAG GAG ATG GCG CGC 2785

Ser Ala Pro Cys Thr Val Val Gln Cys Asp Leu Gln Glu Met Ala Arg

915 920 925

GGG CAG CGG GCC ATG GTC ACG GTG CTG GCC TTC CTG TGG CTG CCC AGC 2833

Gly Gln Arg Ala Met Val Thr Val Leu Ala Phe Leu Trp Leu Pro Ser

930 935 940

CTC TAC CAG AGG CCT CTG GAT CAG TTT GTG CTG CAG TCG CAC GCA TGG 2881

Leu Tyr Gln Arg Pro Leu Asp Gln Phe Val Leu Gln Ser His Ala Trp

945 950 955 960

TTC AAC GTG TCC TCC CTC CCC TAT GCG GTG CCC CCG CTC AGC CTG CCC 2929

Phe Asn Val Ser Ser Leu Pro Tyr Ala Val Pro Pro Leu Ser Leu Pro

965 970 975

CGA GGG GAA GCT CAG GTG TGG ACA CAG CTG CTC CGG GCC TTG GAG GAG 2977

Arg Gly Glu Ala Gln Val Trp Thr Gln Leu Leu Arg Ala Leu Glu Glu

980 985 990

AGG GCC ATT CCA ATC TGG TGG GTG CTG GTG GGT GTG CTG GGT GGC CTG 3025

Arg Ala Ile Pro Ile Trp Trp Val Leu Val Gly Val Leu Gly Gly Leu

995 1000 1005

CTG CTG CTC ACC ATC CTG GTC CTG GCC ATG TGG AAG GTC GGC TTC TTC 3073

Leu Leu Leu Thr Ile Leu Val Leu Ala Met Trp Lys Val Gly Phe Phe

1010 1015 1020

AAG CGG AAC CGG CCA CCC CTG GAA GAA GAT GAT GAA GAG GGG GAG 3118

Lys Arg Asn Arg Pro Pro Leu Glu Glu Asp Asp Glu Glu Gly Glu

1025 1030 1035

TGATGGTGCA GCCTACACTA TTCTAGCAGG AGGGTTGGGC GTGCTACCTG CACCGCCCCT 3178

TCTCCAACAA GTTGCCTCCA AGCTTTGGGT TGGAGCTGTT CCATTGGGTC CTCTTGGTGT 3238

CGTTTCCCTC CCAACAGAGC TGGGCTACCC CCCCTCCTGC TGCCTAATAA AGAGACTGAG 3298

CCCTG 3303

(2) INFORMATION FOR SEQ ID NO:10:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 1039 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:

Met Ala Arg Ala Leu Cys Pro Leu Gln Ala Leu Trp Leu Leu Glu Trp

1 5 10 15

Val Leu Leu Leu Leu Gly Pro Cys Ala Ala Pro Pro Ala Trp Ala Leu

20 25 30

Asn Leu Asp Pro Val Gln Leu Thr Phe Tyr Ala Gly Pro Asn Gly Ser

35 40 45

Gln Phe Gly Phe Ser Leu Asp Phe His Lys Asp Ser His Gly Arg Val

50 55 60

Ala Ile Val Val Gly Ala Pro Arg Thr Leu Gly Pro Ser Gln Glu Glu

65 70 75 80

Thr Gly Gly Val Phe Leu Cys Pro Trp Arg Ala Glu Gly Gly Gln Cys

85 90 95

Pro Ser Leu Leu Phe Asp Leu Arg Asp Glu Thr Arg Asn Val Gly Ser

100 105 110

Gln Thr Leu Gln Thr Phe Lys Ala Arg Gln Gly Leu Gly Ala Ser Val

115 120 125

Val Ser Trp Ser Asp Val Ile Val Ala Cys Ala Pro Trp Gln His Trp

130 135 140

Asn Val Leu Glu Lys Thr Glu Glu Ala Glu Lys Thr Pro Val Gly Ser

145 150 155 160

Cys Phe Leu Ala Gln Pro Glu Ser Gly Arg Arg Ala Glu Tyr Ser Pro

165 170 175

Cys Arg Gly Asn Thr Leu Ser Arg Ile Tyr Val Glu Asn Asp Phe Ser

180 185 190

Trp Asp Lys Arg Tyr Cys Glu Ala Gly Phe Ser Ser Val Val Thr Gln

195 200 205

Ala Gly Glu Leu Val Leu Gly Ala Pro Gly Gly Tyr Tyr Phe Leu Gly

210 215 220

Leu Leu Ala Gln Ala Pro Val Ala Asp Ile Phe Ser Ser Tyr Arg Pro

225 230 235 240

Gly Ile Leu Leu Trp His Val Ser Ser Gln Ser Leu Ser Phe Asp Ser

245 250 255

Ser Asn Pro Glu Tyr Phe Asp Gly Tyr Trp Gly Tyr Ser Val Ala Val

260 265 270

Gly Glu Phe Asp Gly Asp Leu Asn Thr Thr Glu Tyr Val Val Gly Ala

275 280 285

Pro Thr Trp Ser Trp Thr Leu Gly Ala Val Glu Ile Leu Asp Ser Tyr

290 295 300

Tyr Gln Arg Leu His Arg Leu Arg Ala Glu Gln Met Ala Ser Tyr Phe

305 310 315 320

Gly His Ser Val Ala Val Thr Asp Val Asn Gly Asp Gly Arg His Asp

325 330 335

Leu Leu Val Gly Ala Pro Leu Tyr Met Glu Ser Arg Ala Asp Arg Lys

340 345 350

Leu Ala Glu Val Gly Arg Val Tyr Leu Phe Leu Gln Pro Arg Gly Pro

355 360 365

His Ala Leu Gly Ala Pro Ser Leu Leu Leu Thr Gly Thr Gln Leu Tyr

370 375 380

Gly Arg Phe Gly Ser Ala Ile Ala Pro Leu Gly Asp Leu Asp Arg Asp

385 390 395 400

Gly Tyr Asn Asp Ile Ala Val Ala Ala Pro Tyr Gly Gly Pro Ser Gly

405 410 415

Arg Gly Gln Val Leu Val Phe Leu Gly Gln Ser Glu Gly Leu Arg Ser

420 425 430

Arg Pro Ser Gln Val Leu Asp Ser Pro Phe Pro Thr Gly Ser Ala Phe

435 440 445

Gly Phe Ser Leu Arg Gly Ala Val Asp Ile Asp Asp Asn Gly Tyr Pro

450 455 460

Asp Leu Ile Val Gly Ala Tyr Gly Ala Asn Gln Val Ala Val Tyr Arg

465 470 475 480

Ala Gln Pro Val Val Lys Ala Ser Val Gln Leu Leu Val Gln Asp Ser

485 490 495

Leu Asn Pro Ala Val Lys Ser Cys Val Leu Pro Gln Thr Lys Thr Pro

500 505 510

Val Ser Cys Phe Asn Ile Gln Met Cys Val Gly Ala Thr Gly His Asn

515 520 525

Ile Pro Gln Lys Leu Ser Leu Asn Ala Glu Leu Gln Leu Asp Arg Gln

530 535 540

Lys Pro Arg Gln Gly Arg Arg Val Leu Leu Leu Gly Ser Gln Gln Ala

545 550 555 560

Gly Thr Thr Leu Asn Leu Asp Leu Gly Gly Lys His Ser Pro Ile Cys

565 570 575

His Thr Thr Met Ala Phe Leu Arg Asp Glu Ala Asp Phe Arg Asp Lys

580 585 590

Leu Ser Pro Ile Val Leu Ser Leu Asn Val Ser Leu Pro Pro Thr Glu

595 600 605

Ala Gly Met Ala Pro Ala Val Val Leu His Gly Asp Thr His Val Gln

610 615 620

Glu Gln Thr Arg Ile Val Leu Asp Ser Gly Glu Asp Asp Val Cys Val

625 630 635 640

Pro Gln Leu Gln Leu Thr Ala Ser Val Thr Gly Ser Pro Leu Leu Val

645 650 655

Gly Ala Asp Asn Val Leu Glu Leu Gln Met Asp Ala Ala Asn Glu Gly

660 665 670

Glu Gly Ala Tyr Glu Ala Glu Leu Ala Val His Leu Pro Gln Gly Ala

675 680 685

His Tyr Met Arg Ala Leu Ser Asn Val Glu Gly Phe Glu Arg Leu Ile

690 695 700

Cys Asn Gln Lys Lys Glu Asn Glu Thr Arg Val Val Leu Cys Glu Leu

705 710 715 720

Gly Asn Pro Met Lys Lys Asn Ala Gln Ile Gly Ile Ala Met Leu Val

725 730 735

Ser Val Gly Asn Leu Glu Glu Ala Gly Glu Ser Val Ser Phe Gln Leu

740 745 750

Gln Ile Arg Ser Lys Asn Ser Gln Asn Pro Asn Ser Lys Ile Val Leu

755 760 765

Leu Asp Val Pro Val Arg Ala Glu Ala Gln Val Glu Leu Arg Gly Asn

770 775 780

Ser Phe Pro Ala Ser Leu Val Val Ala Ala Glu Glu Gly Glu Arg Glu

785 790 795 800

Gln Asn Ser Leu Asp Ser Trp Gly Pro Lys Val Glu His Thr Tyr Glu

805 810 815

Leu His Asn Asn Gly Pro Gly Thr Val Asn Gly Leu His Leu Ser Ile

820 825 830

His Leu Pro Gly Gln Ser Gln Pro Ser Asp Leu Leu Tyr Ile Leu Asp

835 840 845

Ile Gln Pro Gln Gly Gly Leu Gln Cys Phe Pro Gln Pro Pro Val Asn

850 855 860

Pro Leu Lys Val Asp Trp Gly Leu Pro Ile Pro Ser Pro Ser Pro Ile

865 870 875 880

His Pro Ala His His Lys Arg Asp Arg Arg Gln Ile Phe Leu Pro Glu

885 890 895

Pro Glu Gln Pro Ser Arg Leu Gln Asp Pro Val Leu Val Ser Cys Asp

900 905 910

Ser Ala Pro Cys Thr Val Val Gln Cys Asp Leu Gln Glu Met Ala Arg

915 920 925

Gly Gln Arg Ala Met Val Thr Val Leu Ala Phe Leu Trp Leu Pro Ser

930 935 940

Leu Tyr Gln Arg Pro Leu Asp Gln Phe Val Leu Gln Ser His Ala Trp

945 950 955 960

Phe Asn Val Ser Ser Leu Pro Tyr Ala Val Pro Pro Leu Ser Leu Pro

965 970 975

Arg Gly Glu Ala Gln Val Trp Thr Gln Leu Leu Arg Ala Leu Glu Glu

980 985 990

Arg Ala Ile Pro Ile Trp Trp Val Leu Val Gly Val Leu Gly Gly Leu

995 1000 1005

Leu Leu Leu Thr Ile Leu Val Leu Ala Met Trp Lys Val Gly Phe Phe

1010 1015 1020

Lys Arg Asn Arg Pro Pro Leu Glu Glu Asp Asp Glu Glu Gly Glu

1025 1030 1035

(2) INFORMATION FOR SEQ ID NO:11:

›(i) SEQUENCE CHARACTERISTICS · 1 of 3

(A) LENGTH: 13865 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:

GAATTCTCCC AGAGGCAAAC TGCCAGATGT GAGGCTGCTC TTCCTCAGTC ACTATCTCTG 60

GTCGTACCGG GCGATGCCTG AGCCAACTGA CCCTCAGACC TGTGAGCCGA GCCGGTCACA 120

CCGTGGCTGA CACCGGCATT CCCACCGCCT TTCTCCTGTG CGACCCGCTA AGGGCCCCGC 180

GAGGTGGGCA GGCCAAGTAT TCTTGACCTT CGTGGGGTAG AAGAAGCCAC CGTGGCTGGG 240

AGAGGGCCCT GCTCACAGCC ACACGTTTAC TTCGCTGCAG GTCCCGAGCT TCTGCCCCAG 300

GTGGGCAAAG CATCCGGGAA ATGCCCTCCG CTGCCCGAGG GGAGCCCAGA GCCCGTGCTT 360

TCTATTAAAT GTTGTAAATG CCGCCTCTCC CACTTTATCA CCAAATGGAA GGGAAGAATT 420

CTTCCAAGGC GCCCTCCCTT TCCTGCCATA GACCTGCAAC CCACCTAAGC TGCACGTCGG 480

AGTCGCGGGC CTGGGTGAAT CCGGGGGCCT TGGGGGACCC GGGCAACTAG ACCCGCCTGC 540

GTCCTCCAGG GCAGCTCCGC GCTCGGTGGC GCGGTTGAAT CACTGGGGTG AGTCATCCCT 600

TGCAGGGTCC CGGAGTTTCC TACCGGGAGG AGGCGGGGCA GGGGTGTGGA CTCGCCGGGG 660

GCCGCCCACC GCGACGGCAA GTGACCCGGG CCGGGGGCGG GGAGTCGGGA GGAGCGGCGG 720

GGGCGGGCGC CGGGGGCGGG CAGAGGCGCG GGAGAGCGCG CCGCCGGCCC TTTATAGCGC 780

GCGGGGCACC GGCTCCCCAA GACTGCGAGC TCCCCGCACC CCCTCGCACT CCCTCTGGCC 840

GGCCCAGGGC GCCTTCAGCC CAACCTCCCC AGCCCCACGG GCGCCACGGA ACCCGCTCGA 900

TCTCGCCGCC AACTGGTAGA CATGGAGACC CCTGCCTGGC CCCGGGTCCC GCGCCCCGAG 960

ACCGCCGTCG CTCGGACGCT CCTGCTCGGC TGGGTCTTCG CCCAGGTGGC CGGCGCTTCA 1020

GGTGAGTGGC ACCAGCCCCT GGAAGCCCGG GGCGCGCCAC ACGCAGGAGG GAGGCGACAG 1080

TCCTGGCTGG CAGCGGGCTC GCCCTGGTTC CCCGGGGCGC CCATGTTGTC CCCCGCGCCT 1140

ACGGGACTCG GCTGCGCTCA CCCAGCCCGG CTTGAATGAA CCGAGTCCGT CGGGCGCCGG 1200

CGGGAGTTGC AGGGAGGGAG TTGGCGCCCC AGACCCCGCT GCCCCTTCCG CTGGAGAGTT 1260

TTGCTCGGGG TGTCCGAGTA ATTGGACTGT TGTTGCATAA GCGGACTTTT AGCTCCCGCT 1320

TTAACTCTGG GGAAAGGGCT TCCCAGTGAG TTGCGACCTT CAATATGATA GGACTTGTGC 1380

CTGCGTCTGC ACGTGTTGGC GTGCAGAGGT TTGGATATTA TCTTTCATTA TATGTGCATC 1440

TTCCCTTAAT AAAGAGCGTC CCTGGTCTTT TCCTGGCCAT CTTTGTTCTA GGTTTGGGTA 1500

GAGGCAATCC AAAAGGGCTG GATTGCTGCT TAGATTGGAG CAGGTACAAC GTTGTGCATG 1560

CCCCGTATTT CTACGAGGTG TTCGGGACGG CGTAGAGACT GGGACCTGCT GCGTACTGGC 1620

AAAGCAGACC TTCATAAGAA ATAATCCTGA TCCAATACAG CCGACGGTGT GACAGGCCAC 1680

ACGTCCCCGT GGGTCTCTGT GGAAGTTTCA GTGTAGCGAC ATTTCAGATA AAAGTGGAAA 1740

AAGTGAAGTT TGGCTTTTTT CATTTGTATG CAGTCCTAAC TCTTGTCACA CGTGTGGGAT 1800

TTATCTTTTT CCATAACTTA CTGAAAACCC TTCCTGGCGG GCTGAACCTG ACTCTTCCTG 1860

AGCTGAGTCC TGGACTGGCA CACTGATGGC TCTGGGCTCT TCCCGGTCAA GTTATAACAA 1920

GGCTTTGCCC ATGAATAATT TCAAACGAAA ATGTCAAGAT CCTTGCCGGT GTCCTGGGAT 1980

TACAAGGTGA ATCTTGTCAT GAAGAAATTC TAGGTCTAGA AAAAATTTGA AGATTCTTTT 2040

TCTCTTGATA ATTCACTAAT GAAGCTTTTG TGGTTGAAAA ATAAAAAGTG AGGTTTATGG 2100

TGATGTCAGG TGGGAAGGTG TTTTATACAT CAATACATTC GAGTGCTCTG AAGTGCATGT 2160

AATAATAGCT GTTTCTCTGT TGTTTAAAGG CACTACAAAT ACTGTGGCAG CATATAATTT 2220

AACTTGGAAA TCAACTAATT TCAAGACAAT TTTGGAGTGG GAACCCAAAC CCGTCAATCA 2280

AGTCTACACT GTTCAAATAA GGTAAGCTGG GTACAGAAAA AGAAAATTAA GGTCTTTGAT 2340

GTTTCTACTG TCCTATGCTG AACAAGAATG TCTTTAAAGC TGATTACTGG ATGAAATTAT 2400

TTAACAGATG ACGAAGAAGA AGGGATTCTT GGCAATTCGC TGGCCGGTGT CATACTCTAT 2460

TAGGCCTGCA ACATTTCCAG ACCTTAAACT GATAGAACAT TTTAATTGTT TTAATTGTTT 2520

TTGGAAATGA TGGGAGAGTT CCTAAGTGGA GTATAAACTG TGGAGAGATG AACCATCTTG 2580

AGTAGGCACT GAAGTGTGCT TTGGGTCATG ATAGATTAAT TAATCTCATC TAAACATTGA 2640

TGTCTTTTTC CGTTGCTGTC TAGACTGTGA ACAATGTCTA ACACCTTAGG GAAGAGGTGG 2700

GGAGGAATCC CAATGTATAC ATTGCCCTTA AGCAGTGTTT GATTCATTCA TCTTTGGACT 2760

CCATGAATCG AAATCTGGTA GAATACATGA TCTTAGTGGA GGAGGCCAAA TGCGTGACTC 2820

ACTGAGCCTG GCAGAGCAGA AATACTCTGC TGTCTGCACC CTCTGGGTCT GGTGTGGCTC 2880

TGCTTCTTGG TGCTTCAACT CTGACTGGCA GCTGTCCCCA GGAGGCGATA ATTCAGCATG 2940

TTCAATCTAA AGGTTATGAC TTCCTTGATG GTTTTCACCA TATTCTTGGC AAGTTTTTGG 3000

TTTTTGAAAT GTTCTAGGAG GCTTGGTAGA GATCTTATGA AATAGAGAAT AGCTGCTGTG 3060

GAAATTATTT TAATGCTAAT TACATAAAAG TACAAAAGTA GCACTAGCTA AAACAAAAGG 3120

TATTTTGCTG TTCTGTTTTG TTTTAGCTTG TGCCAGGCCT TTTACAGCAT TAGGAATGCA 3180

ACTTCTAGAT AACGATGCAT CTTTTAAGTG AATGTTCTTG TTTTTCAAAA TGAACTTCAT 3240

GACAGTAGTT GCCAAACCAG CAAGGAGAAC TTGCATGCAT ACGTGCATGC ATGTGTGGAT 3300

ATGTATGGGG GTGGGGGGAG AGAAAGATGA AGGAATTTCA TAACATGAAA TAATGATTAC 3360

AGTTCTGGTC AAACTTGTCA ATTCAGATTT CACCAATTGA GAATTAGTAA GTAATTTCTC 3420

TGATACAGGC CTGAAGTTTA CCTTAGTAAA CACTTTACTT CCATATGGTA AAAATTAGAT 3480

TTTGGGAGGA ATGCTTACCT CCTAAATATA TTCAATCTAA TATTTGAGGA CACATGGGAA 3540

TATATTTATG ATTCATCTGC TTTTTAAACA TAAGCCTTTG TTAACTGTAA GTTCTTGAAC 3600

TTTATAAGGC TGCTGTTATT TAAATGAGCA CAGCTCCTGA TCTGCAAACA GCAGAGCGCA 3660

GGGCTACAGC TTGGGGGATG CCAGCCGACT CAGGGTGGTC CTGTGGACTG AACAATCTCT 3720

TGCTGCTGTA CTGGAGGGCC TGGGAGCTTT TCCATCAGCC TCGGCCTGAG GTGTGCACTC 3780

TTCTCCTGCC CACCCCAGGA ATAAATGAGA TTCCTGGTTA AAAAGGACCA GAGCAGTCAT 3840

TTTACAGTTG AGGAAACTGT TGCTCTGAGA AGTGAGGGAT TTATTCATGA CTACACTGAT 3900

GGTGAGTGCC CATGTCAGGT CTGGAACCAA AGTCTACCCA GTATCCACAC ACCACCATCC 3960

CTCAGGTGGC TCTGCCACAG TCTGATGGGA GGCTCCAAAG CGGGAGGAAG AAGGAAAGTC 4020

TTGCCCACTG CATCTCCTCA GTTGGCCTTC CTCTCTGCCT GTTTTCCCTC CCTACAGTTA 4080

GCATCTTAAG CAGCTGCCTC TCTTCCCTCC CGACTGCTCT CACTACTGCA GCCTGGCTCC 4140

AGCCGCAGGA CACTACTGCT GTGCAGAAGC CCCTACTTGG AACTCCAACT GCATTTTTCA 4200

CCTTTGCTAA CAGTTTTCAG TGGTGGTTGG GAAATGTTAT TGGCTTAAGC CTTAGCACAA 4260

ACCGTCACCG GTGATATTCA TTCCATGGAA ATGTTCTGAA TTCTAAAGCT GAATTTACAA 4320

AGCTTCTGGA AAACAACCTG CAACCAAATT AGTGACTGAA TTTTTTAGTT AACTCAAAAT 4380

TCCAAATCAG AGGGTTTTGC AATGCCTGGA GGAACCTTGG AGGCTTTTAA AGTGTTAATG 4440

CTATTAATGG CATTCAGAGG GATTTTCTAC AGAATTGTCC CTTCATTACC TGTTTATACA 4500

GTTTTACTAC TTACCAGGGT ACTGTATAAA TCCTTGTGCT AAATTTTGCT ATAGAGTATG 4560

TGGTCCCTGC TGTGAGCTGG GAGGAACCAA ATACTGTATC TCTATGTTAC ATAGAAAGCC 4620

CTAGGAGACT TTCTCCTGTT ATCTGAACAA CTATTTGCTG TACTGATAAA AAGGAAACAG 4680

CATAGTCTCA TTCACTTTTT GAAATGGAAA TGATAAAATA AAACACATTT TGGTCATTCG 4740

GGAACAAAAT ACCCTCTCTA CTTTTATCAC ATAAAATTAA ATAAATAGAA ACCAAAATAT 4800

TTCAGTATCA ATCTTAGTTT GTGCACTTTA GGATAAAGAA TGTGTTTACC CAAATCCTTT 4860

TGGCCTGGTT ACTTAGTTCA GATTTTGAAA GAAAATATAT TTGTGGCTTT TATGTGTGAA 4920

TTTAGACAAT GGAATCCATG TGGTGCCTCG TTTTCCCTGA GATTATGTAT TAATTCAACC 4980

TGTAAATGCA AACCATCTAA TAGTCAGCGA GACCCTATAG CCCTGCTGCT TAATGGGGGC 5040

›(i) SEQUENCE CHARACTERISTICS · 2 of 3

ACACAAGGGC ATGCAGCCCT CGTACCAGGC AGACTGTGTT CATATTAACA GCATCGTGGA 5100

GAAACTCATG CTGGGGGACA GGGGAGGGAG ATGTAAATGC TCAGCAGGGA GATCTGGAGA 5160

TTCCTGGAGC AGGTGGAGTT GGGACCTGGC CTTGAACGAT GGGTCTGGCT CTGGCAGTCA 5220

GTAATGCCAA AGGGAAGAGC AGCATAACTG TCACTTTCCA TGGGACAGAA GTGTGTGAAT 5280

CAAGTTGCAG TGACGCTTCA CCTATTTATT ATTTTGGTCA TTTAGAAGAA TTTCATTGTC 5340

AGTAGAAGTC CTTTAAATCA TTTCCCCTTC AGTGACGTCT CACAAAAAAA AGATCTGTCT 5400

TTAGCTTTTT AGTCTCAGAC TTTATTAGAC AGATACTACC TGTACTCTTA TTCTGTAATC 5460

TTTGTTGGGA TGGATTCACA TCTTGCAAAG GAAGGGAGGC ATGTAGTATA ATGGGGCAAA 5520

CAGACCCAGC TCTGCCACTC GTTAGATATG TGACCTTCTG CAAGTTGCTT AGTGCCTGTG 5580

AGCTTCAGTG TCCTCATGGA TAAGAAAGAT CCAACACCTT CTTGGAAGGA TTATATCAAA 5640

TGAAGTAACA TGAGTAAAGG GTCCAGCAGA ATACCTGGCA TATAGTGGAG TCAATGAATG 5700

ATTAATAATA TTATTAATAG TGGTCATGAG AGATATATGT ATAACATGTT ATTATGTAGA 5760

CTCACTATAT AGACTCTATT CTACATAGAA TATAGAACAT TATATAACAA ACAACTATAA 5820

TAAGTAGACT ATAGTAAACA ACCTCACTTT GTCTCAGTTG CCTCATCTTG ATGGAAAACT 5880

GCTCTTTCTC TCCTGTTACC CTGACAGAGA GCGTCTACAT TCTAAAAGAA AGATATTTAA 5940

CAAAATGGTT GAGTACAGAT CCAAGAGTCA AATAGCTGTC TGGTTCAAAG TCCAGCTGTG 6000

TGATTTTGAG CTAGTCACCC AATCTCACTT TGTCTCAGTA GCCTTATTTG TAAAAACAAG 6060

GCAAATTACA GAGCCATCCC CTGGGTTGCT ATGAGGACTC AAACATGCAT CCCAAGTGCT 6120

CGGTGTTGCT AGGTATGATG GCTCACACCT GTACATTCAG CACTTTGGGA GGCCGAAGCA 6180

GAAGGATCAG CCTGGGCAAC ATAGCAGGAC CCCATCTCTA CAAAACAATG TTTAAAAAAA 6240

AGCAAAGTGC TCAGCACAGT GACTGCATCA TTAGGATTGA TTGTAGGGCT CCTGATGTTA 6300

GCACAGAACA CCACAGCCAG GAAGCAGTCT ATCTTGTTGG GTGCAAATTG TAACATTCCA 6360

TTTATGTTTC TTCCTTCTTT TCTTTCTTTA GCACTAAGTC AGGAGATTGG AAAAGCAAAT 6420

GCTTTTACAC AACAGACACA GAGTGTGACC TCACCGACGA GATTGTGAAG GATGTGAAGC 6480

AGACGTACTT GGCACGGGTC TTCTCCTACC CGGCAGGGAA TGTGGAGAGC ACCGGTTCTG 6540

CTGGGGAGCC TCTGTATGAG AACTCCCCAG AGTTCACACC TTACCTGGAG AGTAAGTGGC 6600

TTGGGCTGTA ATACCGTTCA TTCTTGTTAG AAACGTCTGA ACATTCTCGT GATCTTGTGC 6660

CTTTAGGGGC TACAAAATTA AAAATATTTA TTCTTTTTTT CTCAGAAACT GGTATGTATC 6720

ACAGCCCTCT TCACACATTC CAGATGTGGT AGGAGGTTCA CAGAATGTGA ACTTTTGGAG 6780

CTGATGACAG TGTCATCAAG TAACTTTCTC CCCCAGTCTG TCCCCAGACC CTGTTACTGT 6840

CCTCAGTAAG CGGCTGAATG TGTGTTGGGA GAGGGCGGGC CAGGGAAGCG GGTAGGGATA 6900

GGAAATCCAC CAAGGCCGGG GTTTTAGCTT TTCCCTATAT ATATATCATG TATCCTGATT 6960

TTTCTGTCCC GTTATCACAC TAAAAATCCC AGTTGAGGAT TTTTCCCAAA CGGTCATAAA 7020

TCAATGAGGA AAGTCCATGG TTTCCCTCTG AGCCCATAAT TAGCCTAATT ATGCTGACCT 7080

TTTCTAATCA GTTGGCCATG ATTTGAGTTC CGTGATGTGC CAGCACCTGC CCAGCCATCT 7140

GCCTGTCACC CTCGTTCTGG TTTTGGAAAG GTGGAATACT TTCCTCCTCA GCCTTTGCCC 7200

CTGTAAGCTG GCCCTAGGAG CCAGTAAAAG AATGAAGAGA ATTCCTGTCA AGTAGGAGAT 7260

TTATTCTTTT GCCGCAACTG TGGCTCTGAG CTAGGCAATT TAGATAAATG CATGTAGCAC 7320

ATTGAGTAGA GTGAAATTAG CTTCTCTTGT AAGGCCAGCT GGTTAGAATG AAGGTGTTGT 7380

GTGAGTGTTA GGCCCAGCGA GAGAGAACAG TTTCTCAAGG TAGGAATGGT GAAAAGAAGG 7440

GGTGGACGGA CAACCAACCA ACCATCCTCC TCTGGTATCT ACTTTGAGGG TTGAAATAGG 7500

GGGCCTGACC CCAGGTGAAT GTGGCTGCCT TCCCAGAGCC CCCATTTGCA AGACCCTCCA 7560

GACCCCCAGG TGCTTCTGCT TGTGTCTTTT GTGGCACCAG GCAAGAATGT AGCAGCGTCA 7620

GCAGCCCCTC TGGTGACTGT GGCATGGTTG ACATTCATTT CCCCCCTAAT TAATGGCATC 7680

CTCATGATTC TCTTTTATAT TAATAGTTCT TGAGTTTTTT TGTAAGCTAC TTCAAATCCT 7740

TTGTTGGTGC AAGATAGAAG ATATTTTATG TGTTTGTTTT GCATGTGCAC ACACATATTT 7800

GGCCTGTGAA TTGATGTTTG TTTTCCTGTC ATTTAACCAA AGCACATGAG ATAATTGAGC 7860

CATTGCAGAG ACCCCGTGGT TAAATCCGGC TTCTCGAGGT ACCAAGGACA TTTCCTGGGC 7920

TTTCTCACAG CCCTACATAT TTTTGAACCT AAAATATCGT AGTTTATGCT ACCACCCTGT 7980

TCAGTATAGT AGCCACTAGC CACATGTGGC TGTTGACCAC TTGAAATATG GCTAATGCTC 8040

TAAGTATAAA GTACACACTG GAATTTAAGA AGTGTAGAAT ATCTCAAAAC TTTTTTATAT 8100

TGATTACACA TTAAAATGAT TATATTCCAG ATATATGCAG TTGACTCAAG CAATGCATGG 8160

CTGAGAGGCA CCGACTCCCT GTGCAGTTGA AAATCCGAGT ATAACTTGAC TCCCCAAAAA 8220

CTTAACTACT AATAGCCTAC CTATCGGTTG ACTGTTGACT GCAGCCTTAC CAATAAGATA 8280

AACAGTCAAT TAACACACAT TTTTCATGTT GCGTGTATTA TATACTGTAT TCTTACAATA 8340

AAGTAAGCTA GAGGAAAGAA AATGTTATTA AGAAAATTAT AAGGAAAAGA GGCTGGGCAT 8400

GGTGGCTCGT GCCTGTAATC TCAGAACTTT GGGATGCTAA GGCGGGTGGA TCACTTGAGG 8460

TCAGGAGTTC AAGACCAGCC TGGCCAACAT GGTGAAACCC CATCTCTACT AAAAATACAA 8520

AAATTAGCCA GGCGTGGTTG TGGGTGCCTG TAATCCCAGC TACTTGGGAG GCTGAGGCAG 8580

GAGAATCACT TCGACCCAGG TGGAGGAGGT TGCAGTGAAC TGAGATTGCG CCACTGCACT 8640

CCGGCCTGGG TGACAGAGCG AGACTCTGTC TAAAAAAGAA AGGGAAAGAA AGAAAAAAAA 8700

GAAAAGAAAA GAAAAGAAAG AAGGAAGGAA GAGAAAGAAT TATAAGGAAG AGAAAATATA 8760

TTTACTATTG ATAAAGTGGA AGTGGATCAT CATAAAGGTG TTCATCCTCG TCATCTTCAT 8820

GTTGAGTAGG CTGAGGAGGA GGAGGAGGAG GAAGAGCAGG GGCCACGGCA GGAGAAAAGA 8880

TGGAGGAAGT AGGAGGCGGC ACACTTGGTG TAACTTTTAT TTAAAAAAAT TTGCATACAA 8940

GTGGATCCAC AGAGTTCAAA CCCATGTTGT TCAGGGGTCA ACTGTCTTTG GTTAAATAAA 9000

ATATATTATT AAAATTAATT TCACCTGTTC CTTTTTACTT TTTCTAATGT GACTACTAGA 9060

AAACTTAAAA TGACATCTGA GGCTCCATTG TCTTCCCCTT GGGCCAGCAC TACCACAGAA 9120

TGTCTTAGGA TTCAGCTCCA GGCCGCCACG CCTGCTTCTT TCAGGGAGCT GGTTCTATGC 9180

ACATGTTTTA TATGAGAGAT AATTAAGTTG TCAATTGTGA TAACAAAACA GGATTTGACT 9240

TTGTACAGAA TTCTTTGGTT CCAACCAAGC TCATTTCCTT TGTTTCAGCA AACCTCGGAC 9300

AGCCAACAAT TCAGAGTTTT GAACAGGTGG GAACAAAAGT GAATGTGACC GTAGAAGATG 9360

AACGGACTTT AGTCAGAAGG AACAACACTT TCCTAAGCCT CCGGGATGTT TTTGGCAAGG 9420

ACTTAATTTA TACACTTTAT TATTGGAAAT CTTCAAGTTC AGGAAAGGTG AGCATTTTTT 9480

AATTTGTTTT TATGACCTGT TTTAAATTGT GAATACTTGG TTTTACAACC CATTTCTTCC 9540

CCAATTCAAA AATAGCAGAA CAGAGTTGTT GAGAAGGTGA TGGAGTAGAA GGGGGAGCGC 9600

GCACTGTGGG GAGGGGTGGA CAACAGGCCT GGTCCTACCT GTGACTCTGC ACTACCCTGT 9660

GACTCTGGCA GGGCCCCCTC GGAGACCCAG GTTCCTCAGC CAACCGGCTG GATCAGGTCA 9720

TCTCTAAAGG TCCCGCCACG CTCACATTTC TCCCTCTATT GAGGATCCCA GGCACAAAAT 9780

TTGTTTTTGG TTCAATGCAT AATACTCCCT TCCTTTTTCT TTTACTGCAG ATATCTTCTA 9840

AAGGGGCTCA ATAGGGTTCA ATATGCCTAA ATTGGATCTT CTCAGTCTTG GAAAAGGCAT 9900

TTTTAGCAGT GATCAAGGGA AACTGATTAG CGAAGTCACT TCTAATCCTT CACGTGTCAG 9960

CTGTGTTCTT GTAGGCTTTG CTTAGAACCT AGGTTTTTAC TTCCACAGTG ACTTAATAAA 10020

GGGGAAAGAA TTGACTCAGA GCCCAGATGA ATTAAGAACT CTATCTTTTT ACAGAAAACA 10080

GCCAAAACAA ACACTAATGA GTTTTTGATT GATGTGGATA AAGGAGAAAA CTACTGTTTC 10140

AGTGTTCAAG CAGTGATTCC CTCCCGAACA GTTAACCGGA AGAGTACAGA CAGCCCGGTA 10200

›(i) SEQUENCE CHARACTERISTICS · 3 of 3

GAGTGTATGG GCCAGGAGAA AGGGGAATTC AGAGGTGAGT GGCTCTGCCA GCCATTTGCC 10260

TGGGGGTATG GGTGCTGTGG GTGACTTCTG GAGGAGTAGC TCCACCCTCA GGGCTGGGAT 10320

ATACTTCCTT GGTTAAATAT TCAGGAAAAC AAACTGCCTG GAGGTTTTTT GTTGTTATTT 10380

GTTTGTTTTG GTTTTGATTT TGCTTTGGTA CAAAAAAGAT TTTGGACATT TAGAAATGTT 10440

TCTGTGTTGA TTGTGCCCTT GTATTAGCAG GTGTTTTCTT GAGCACCTGT CATGTGCTAA 10500

GCCCTCTGCT GAGCACTGGA TACACAAACT GTGTTTAGGA TTTAGCAACA AGTCACAGAT 10560

TTCCCTGGGC ATTTTTTCAT GCTTAAATTC TAATTCTGGG GGTGGCTTCT GGACCAGCTG 10620

CAACAGGACA CAGTAGACAT TCGTGAGTAC CCACTGTGGG CTGTTGCCAC AGAGGCTGTA 10680

GAGTCTAACC CATCAAGGGA AGGGATTGAG TATATCAAAT ATACCCACAT GCATGCATGT 10740

GTGTATATGG CGGACACGTG TGTGTACATG CATGTGCATA TGTTGGGAGC TCAGGCCCAT 10800

TGTGCGAGGA ACAGTCCCTA ACCGGAAGTG CTGTGGGCCT TCAGACTCTT GCAGGAAGCT 10860

GCAAGCCTGT GTGTCTCGAT CCATGCCTTA CAGGGAAAGT ATTCTGAGTA CTTTCAGTGA 10920

AGAAAAGAGT CAGGGGATAT AAACGATGGC TTACGCTGGG TGTGGTGGCT CACGCCTGTA 10980

GTCCCTGCAC TTTGGGAGGC CCAGACAGGC AAATCACTTG AGGTCAGGAG TTTGGGACCA 11040

GCCTGGCCAA CATGGTAAAA GCCCATCTCT ACTCAAAATA CAAAAAGTAG CTGGGTGTGG 11100

TTGCACGTGT CTGTAGTCCC AGCTACTCAG GAGGTTGAGG CAGGAGAATT GCTTGAACCT 11160

GGGAGGCGGA GGCTGAAGTG AGCTGAGATT GGACCACTGT ACTCCAGCCT GGGTGACAGA 11220

GCGAGATTCC ATCTCAAAAA AAAAAAAAAG AAACAACGAA AAAAGAAATG ATGGCTTAGC 11280

TCCATGTGAA GATGATATTT GAACATTTTA AAACACTTTA AATAAACTGT TCTCTCCTGT 11340

TTATTGCCAC TGACAGGAGA GGTTTCTCTT TACCTCTGGT CCTGCACCCC TCTGAGCCAT 11400

CCTACCCACA GCCTTCAGTC ATTGTCCTAA AGCCTAGCTC TAATTCCACT GCCTCTCCTT 11460

TTGTGCACAC ACACTTCTCT GCTTCCCTGG CCGTTCTCTA TCTTGGAGAG GCATTTCAAA 11520

CGCCACTTCC ACCAGAAGGC CTTGCTACTG CACCAACTAG TTACTATCTC TTCTTCACCC 11580

AAATCCTGGT AGCACTTTGG ATCTCCCACT TGCACTTAGG GTTCACCTTC CGTTATAATC 11640

ATTGCCATCA ATCTCAGCAT CGTTTTAGGC ACTTCTTTCC AGCCATTGTT CTTACCTCCA 11700

ACTACATATC TTTTCTGGAC TGTGCATTAT TCAGTTTATT AAATGCCCAT TAAATGTGTT 11760

TAGCCATTGT CAATTACTCT GAAACGTTCA GGTTTTGACA AATTCTTTCC TAATGTAAGT 11820

GTGGTGGAAA GAGTGAAAGA AAGTCAAATT GCACAAAAAT AGGATGGTGT AATTTGGGGT 11880

TATGCCGTCA ATTTTGTCCA CTGATAAATG GGATTTGAGC TCTCCAAGTT GACTAGATGC 11940

CCTTTATTTT TCAGAAATAT TCTACATCAT TGGAGCTGTG GTATTTGTGG TCATCATCCT 12000

TGTCATCATC CTGGCTATAT CTCTACACAA GTGTAGAAAG GCAGGAGTGG GGCAGAGCTG 12060

GAAGGAGAAC TCCCCACTGA ATGTTTCATA AAGGAAGCAC TGTTGGAGCT ACTGCAAATG 12120

CTATATTGCA CTGTGACCGA GAACTTTTAA GAGGATAGAA TACATGGAAA CGCAAATGAG 12180

TATTTCGGAG CATGAAGACC CTGGAGTTCA AAAAACTCTT GATATGACCT GTTATTACCA 12240

TTAGCATTCT GGTTTTGACA TCAGCATTAG TCACTTTGAA ATGTAACGAA TGGTACTACA 12300

ACCAATTCCA AGTTTTAATT TTTAACACCA TGGCACCTTT TGCACATAAC ATGCTTTAGA 12360

TCTTAAAAAA TCCTGGGTGG ACTTTTGAAA AGCTTTTTTT TTTTTTTTTT TTTTTGAGAC 12480

GGAGTCTTGC TCTGTTGCCC AGGCTGGAGT GCAGTAGCAC GATCTCGGCT CACTGCACCC 12540

TCCGTCTCTC GGGTTCAAGC AATTGTCTGC CTCAGCCTCC CGAGTAGCTG GGATTACAGG 12600

TGCGCACTAC CACGCCAAGC TAATTTTTGT ATTTTTTAGT AGAGATGGGG TTTCACCATC 12660

TTGGCCAGGC TGGTCTTGAA TTCCTGACCT CAGGTGATCC ACCCACCTTG GCCTCCCAAA 12720

GTGCTAGTAT TATGGGCGTG AACCACCATG CCCAGCCGAA AAGCTTTTGA GGGGCTGACT 12780

TCAATCCATG TAGGAAAGTA AAATGGAAGG AAATTGGGTG CATTTCTAGG ACTTTTCTAA 12840

CATATGTCTA TAATATAGTG TTTAGGTTCT TTTTTTTTTC AGGAATACAT TTGGAAATTC 12900

AAAACAATTG GCAAACTTTG TATTAATGTG TTAAGTGCAG GAGACATTGG TATTCTGGGC 12960

ACCTTCCTAA TATGCTTTAC AATCTGCACT TTAACTGACT TAAGTGGCAT TAAACATTTG 13020

AGAGCTAACT ATATTTTTAT AAGACTACTA TACAAACTAC AGAGTTTATG ATTTAAGGTA 13080

CTTAAAGCTT CTATGGTTGA CATTGTATAT ATAATTTTTT AAAAAGGTTT TCTATATGGG 13140

GATTTTCTAT TTATGTAGGT AATATTGTTC TATTTGTATA TATTGAGATA ATTTATTTAA 13200

TATACTTTAA ATAAAGGTGA CTGGGAATTG TTACTGTTGT ACTTATTCTA TCTTCCATTT 13260

ATTATTTATG TACAATTTGG TGTTTGTATT AGCTCTACTA CAGTAAATGA CTGTAAAATT 13320

GTCAGTGGCT TACAACAACG TATCTTTTTC GCTTATAATA CATTTTGGTG ACTGTAGGCT 13380

GACTGCACTT CTTCTCAATG TTTTCTCATT CTAGGATGCA AACCAATGGA GAAGCCCCTA 13440

ATTAGATCAG GGCAGAGGGA AAAACAAAAA ACTGGTAGAA ACCGGCAACC ACAGCTTCAA 13500

GCTTTAAGCC CATCTCCTAC ACTTCTGCTC TGTACGTGCC CATTGTCACT TCTGTTCACA 13560

TGCTACTGTC CCAAGCAAGT GACCAAGCCT GACAATACTT TGTCTACTGG AGTCACTGCA 13620

AGGCACATGA CGGGGCAGGG ATGTCGTCTT ACAGGGAAGA GAAAAGATAA TGCTCTCTAC 13680

TGCAGACTTG GAGAGATTTC TTCCCATTGG CAGTAGTTTG ACTAATTGGA GATGAGAAAA 13740

AAAGAAACAT TCTTGGGATG ATTGTATTGA AACAAAATTA GGTAAAAGGA CAATATAGGA 13800

TAGGGAGAGA TATAAGTGGA ATGAGATCTC TAGAGTCCAT TAAAAGCAAG CTAGATTGAG 13860

AGCTC 13865

(2) INFORMATION FOR SEQ ID NO:12:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 295 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:

Met Glu Thr Pro Ala Trp Pro Arg Val Pro Arg Pro Glu Thr Ala Val

1 5 10 15

Ala Arg Thr Leu Leu Leu Gly Trp Val Phe Ala Gln Val Ala Gly Ala

20 25 30

Ser Gly Thr Thr Asn Thr Val Ala Ala Tyr Asn Leu Thr Trp Lys Ser

35 40 45

Thr Asn Phe Lys Thr Ile Leu Glu Trp Glu Pro Lys Pro Val Asn Gln

50 55 60

Val Tyr Thr Val Gln Ile Ser Thr Lys Ser Gly Asp Trp Lys Ser Lys

65 70 75 80

Cys Phe Tyr Thr Thr Asp Thr Glu Cys Asp Leu Thr Asp Glu Ile Val

85 90 95

Lys Asp Val Lys Gln Thr Tyr Leu Ala Arg Val Phe Ser Tyr Pro Ala

100 105 110

Gly Asn Val Glu Ser Thr Gly Ser Ala Gly Glu Pro Leu Tyr Glu Asn

115 120 125

Ser Pro Glu Phe Thr Pro Tyr Leu Glu Thr Asn Leu Gly Gln Pro Thr

130 135 140

Ile Gln Ser Phe Glu Gln Val Gly Thr Lys Val Asn Val Thr Val Glu

145 150 155 160

Asp Glu Arg Thr Leu Val Arg Arg Asn Asn Thr Phe Leu Ser Leu Arg

165 170 175

Asp Val Phe Gly Lys Asp Leu Ile Tyr Thr Leu Tyr Tyr Trp Lys Ser

180 185 190

Ser Ser Ser Gly Lys Lys Thr Ala Lys Thr Asn Thr Asn Glu Phe Leu

195 200 205

Ile Asp Val Asp Lys Gly Glu Asn Tyr Cys Phe Ser Val Gln Ala Val

210 215 220

Ile Pro Ser Arg Thr Val Asn Arg Lys Ser Thr Asp Ser Pro Val Glu

225 230 235 240

Cys Met Gly Gln Glu Lys Gly Glu Phe Arg Glu Ile Phe Tyr Ile Ile

245 250 255

Gly Ala Val Val Phe Val Val Ile Ile Leu Val Ile Ile Leu Ala Ile

260 265 270

Ser Leu His Lys Cys Arg Lys Ala Gly Val Gly Gln Ser Trp Lys Glu

275 280 285

Asn Ser Pro Leu Asn Val Ser

290 295

(2) INFORMATION FOR SEQ ID NO:13:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 894 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:

GGATGGGTTG GGAGCTCAAG TTTTGGGGCA GAAGGGAATT TTTTTTGGCA GCAGAGTGCA 60

AGCCCTGCCG CCAGGCAAAC TCTGCTCTTC CTCATCCTCA GAAGCACTTG CTCACTCTGC 120

TAAATCAAAG TGAAACGCAT GTTTACAGAA TATTGGTCCA AAAGGGTCTC AGCATCTCCC 180

ACTACCCAGG GTGCAGAGCC TCGGGCCGGC CTTGCTCCCC AAGAAGGGCT GACTGGGGCT 240

CTGTCCCCTC GCCCAGGGCT CGAGGTAGTG TTTACAGCCC TCATGAACAG CAAAGGCGTG 300

AGCCTCTTCG ACATCATCAA CCCTGAGATT ATCACTCGAG ATGTGAGTAC AAAGCCCCCC 360

TCACCAGCCC CTGTTCCTGG GGAGAGAGGC CCAGACAGGA TTCCTGGGGT GACTGGGGGC 420

TGTTGGGGAG ACAGACAGAG GGGCCTCTAC CAGCTTGGCT CCCTCCTGGT GGCCTGGGAG 480

TCAGCCCAGC TCGCCCCTCT CTCCTACTGC CCCTCCCTTC AGGGCTTCCT GCTGCTGCAG 540

ATGGACTTTG GCTTCCCTGA GCACCTGCTG GTGGATTTCC TCCAGAGCTT GAGCTAGAAG 600

TCTCCAAGGA GGTCGGGATG GGGCTTGTAG CAGAAGGCAA GCACCAGGCT CACAGCTGGA 660

ACCCTGGTGT CTCCTCCAGC GTGGTGGAAG TTGGGTTAGG AGTACGGAGA TGGAGATTGG 720

CTCCCAACTC CTCCCTATCC TAAAGGCCCA CTGGCATTAA AGTGCTGTAT CCAAGAGCTG 780

CGGAGTCCTT CTTCTGTGGC TGGCGGGTAG AGGGGGGGGG AAGGGATTGT CTCACCAGTG 840

CCGTCCACCT CTTTTCAGCC CTTCCAAGCA GCTGCCCCCA AACCCTCCAA GCTT 894

(2) INFORMATION FOR SEQ ID NO:14:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 493 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:14:

Met Leu Ala Ala Thr Val Leu Thr Leu Ala Leu Leu Gly Asn Ala His

1 5 10 15

Ala Cys Ser Lys Gly Thr Ser His Glu Ala Gly Ile Val Cys Arg Ile

20 25 30

Thr Lys Pro Ala Leu Leu Val Leu Asn His Glu Thr Ala Lys Val Ile

35 40 45

Gln Thr Ala Phe Gln Arg Ala Ser Tyr Pro Asp Ile Thr Gly Glu Lys

50 55 60

Ala Met Met Leu Leu Gly Gln Val Lys Tyr Gly Leu His Asn Ile Gln

65 70 75 80

Ile Ser His Leu Ser Ile Ala Ser Ser Gln Val Glu Leu Val Glu Ala

85 90 95

Lys Ser Ile Asp Val Ser Ile Gln Asn Val Ser Val Val Phe Lys Gly

100 105 110

Thr Leu Lys Tyr Gly Tyr Thr Thr Ala Trp Trp Leu Gly Ile Asp Gln

115 120 125

Ser Ile Asp Phe Glu Ile Asp Ser Ala Ile Asp Leu Gln Ile Asn Thr

130 135 140

Gln Leu Thr Cys Asp Ser Gly Arg Val Arg Thr Asp Ala Pro Asp Cys

145 150 155 160

Tyr Leu Ser Phe His Lys Leu Leu Leu His Leu Gln Gly Glu Arg Glu

165 170 175

Pro Gly Trp Ile Lys Gln Leu Phe Thr Asn Phe Ile Ser Phe Thr Leu

180 185 190

Lys Leu Val Leu Lys Gly Gln Ile Cys Lys Glu Ile Asn Val Ile Ser

195 200 205

Asn Ile Met Ala Asp Phe Val Gln Thr Arg Ala Ala Ser Ile Leu Ser

210 215 220

Asp Gly Asp Ile Gly Val Asp Ile Ser Leu Thr Gly Asp Pro Val Ile

225 230 235 240

Thr Ala Ser Tyr Leu Glu Ser His His Lys Gly His Phe Ile Tyr Lys

245 250 255

Asn Val Ser Glu Asp Leu Pro Leu Pro Thr Phe Ser Pro Thr Leu Leu

260 265 270

Gly Asp Ser Arg Met Leu Tyr Phe Trp Phe Ser Glu Arg Val Phe His

275 280 285

Ser Leu Ala Lys Val Ala Phe Gln Asp Gly Arg Leu Met Leu Ser Leu

290 295 300

Met Gly Asp Glu Phe Lys Ala Val Leu Glu Thr Trp Gly Phe Asn Thr

305 310 315 320

Asn Gln Glu Ile Phe Gln Glu Val Val Gly Gly Phe Pro Ser Gln Ala

325 330 335

Gln Val Thr Val His Cys Leu Lys Met Pro Lys Ile Ser Cys Gln Asn

340 345 350

Lys Gly Val Val Val Asn Ser Ser Val Met Val Lys Phe Leu Phe Pro

355 360 365

Arg Pro Asp Gln Gln His Ser Val Ala Tyr Thr Phe Glu Glu Asp Ile

370 375 380

Val Thr Thr Val Gln Ala Ser Tyr Ser Lys Lys Lys Leu Phe Leu Ser

385 390 395 400

Leu Leu Asp Phe Gln Ile Thr Pro Lys Thr Val Ser Asn Leu Thr Glu

405 410 415

Ser Ser Ser Glu Ser Val Gln Ser Phe Leu Gln Ser Met Ile Thr Ala

420 425 430

Val Gly Ile Pro Glu Val Met Ser Arg Leu Glu Val Val Phe Thr Ala

435 440 445

Leu Met Asn Ser Lys Gly Val Ser Leu Phe Asp Ile Ile Asn Pro Glu

450 455 460

Ile Ile Thr Arg Asp Gly Phe Leu Leu Leu Gln Met Asp Phe Gly Phe

465 470 475 480

Pro Glu His Leu Leu Val Asp Phe Leu Gln Ser Leu Ser

485 490

(2) INFORMATION FOR SEQ ID NO:15:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 1431 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 133...1044

›(D) OTHER INFORMATION

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:15:

GGCGGGTCTG CTTCTAAAAG AAGAAGTAGA GAAGATAAAT CCTGTCTTCA ATACCTGGAA 60

GGAAAAACAA AATAACCTCA ACTCCGTTTT GAAAAAAACA TTCCAAGAAC TTTCATCAGA 120

GATTTTACTT AG ATG ATT TAC ACA ATG AAG AAA GTA CAT GCA CTT TGG GCT 171

Met Ile Tyr Thr Met Lys Lys Val His Ala Leu Trp Ala

1 5 10

TCT GTA TGC CTG CTG CTT AAT CTT GCC CCT GCC CCT CTT AAT GCT GAT 219

Ser Val Cys Leu Leu Leu Asn Leu Ala Pro Ala Pro Leu Asn Ala Asp

15 20 25

TCT GAG GAA GAT GAA GAA CAC ACA ATT ATC ACA GAT ACG GAG TTG CCA 267

Ser Glu Glu Asp Glu Glu His Thr Ile Ile Thr Asp Thr Glu Leu Pro

30 35 40 45

CCA CTG AAA CTT ATG CAT TCA TTT TGT GCA TTC AAG GCG GAT GAT GGC 315

Pro Leu Lys Leu Met His Ser Phe Cys Ala Phe Lys Ala Asp Asp Gly

50 55 60

CCA TGT AAA GCA ATC ATG AAA AGA TTT TTC TTC AAT ATT TTC ACT CGA 363

Pro Cys Lys Ala Ile Met Lys Arg Phe Phe Phe Asn Ile Phe Thr Arg

65 70 75

CAG TGC GAA GAA TTT ATA TAT GGG GGA TGT GAA GGA AAT CAG AAT CGA 411

Gln Cys Glu Glu Phe Ile Tyr Gly Gly Cys Glu Gly Asn Gln Asn Arg

80 85 90

TTT GAA AGT CTG GAA GAG TGC AAA AAA ATG TGT ACA AGA GAT AAT GCA 459

Phe Glu Ser Leu Glu Glu Cys Lys Lys Met Cys Thr Arg Asp Asn Ala

95 100 105

AAC AGG ATT ATA AAG ACA ACA TTG CAA CAA GAA AAG CCA GAT TTC TGC 507

Asn Arg Ile Ile Lys Thr Thr Leu Gln Gln Glu Lys Pro Asp Phe Cys

110 115 120 125

TTT TTG GAA GAA GAT CCT GGA ATA TGT CGA GGT TAT ATT ACC AGG TAT 555

Phe Leu Glu Glu Asp Pro Gly Ile Cys Arg Gly Tyr Ile Thr Arg Tyr

130 135 140

TTT TAT AAC AAT CAG ACA AAA CAG TGT GAA CGT TTC AAG TAT GGT GGA 603

Phe Tyr Asn Asn Gln Thr Lys Gln Cys Glu Arg Phe Lys Tyr Gly Gly

145 150 155

TGC CTG GGC AAT ATG AAC AAT TTT GAG ACA CTG GAA GAA TGC AAG AAC 651

Cys Leu Gly Asn Met Asn Asn Phe Glu Thr Leu Glu Glu Cys Lys Asn

160 165 170

ATT TGT GAA GAT GGT CCG AAT GGT TTC CAG GTG GAT AAT TAT GGA ACC 699

Ile Cys Glu Asp Gly Pro Asn Gly Phe Gln Val Asp Asn Tyr Gly Thr

175 180 185

CAG CTC AAT GCT GTG AAT AAC TCC CTG ACT CCG CAA TCA ACC AAG GTT 747

Gln Leu Asn Ala Val Asn Asn Ser Leu Thr Pro Gln Ser Thr Lys Val

190 195 200 205

CCC AGC CTT TTT GAA TTT CAC GGT CCC TCA TGG TGT CTC ACT CCA GCA 795

Pro Ser Leu Phe Glu Phe His Gly Pro Ser Trp Cys Leu Thr Pro Ala

210 215 220

GAC AGA GGA TTG TGT CGT GCC AAT GAG AAC AGA TTC TAC TAC AAT TCA 843

Asp Arg Gly Leu Cys Arg Ala Asn Glu Asn Arg Phe Tyr Tyr Asn Ser

225 230 235

GTC ATT GGG AAA TGC CGC CCA TTT AAG TAC AGT GGA TGT GGG GGA AAT 891

Val Ile Gly Lys Cys Arg Pro Phe Lys Tyr Ser Gly Cys Gly Gly Asn

240 245 250

GAA AAC AAT TTT ACT TCC AAA CAA GAA TGT CTG AGG GCA TGT AAA AAA 939

Glu Asn Asn Phe Thr Ser Lys Gln Glu Cys Leu Arg Ala Cys Lys Lys

255 260 265

GGT TTC ATC CAA AGA ATA TCA AAA GGA GGC CTA ATT AAA ACC AAA AGA 987

Gly Phe Ile Gln Arg Ile Ser Lys Gly Gly Leu Ile Lys Thr Lys Arg

270 275 280 285

AAA AGA AAG AAG CAG AGA GTG AAA ATA GCA TAT GAA GAA ATT TTT GTT 1035

Lys Arg Lys Lys Gln Arg Val Lys Ile Ala Tyr Glu Glu Ile Phe Val

290 295 300

AAA AAT ATG TGAATTTGTT ATAGCAATGT AACATTAATT CTACTAAATA 1084

Lys Asn Met

TTTTATATGA AATGTTTCAC TATGATTTTC TATTTTTCTT CTAAAATCGT TTTAATTAAT 1144

ATGTTCATTA AATTTTCTAT GCTTATTGTA CTTGTTATCA ACACGTTTGT ATCAGAGTTG 1204

CTTTTCTAAT CTTGTTAAAT TGCTTATTCT AGGTCTGTAA TTTATTAACT GGCTACTGGG 1264

AAATTACTTA TTTTCTGGAT CTATCTGTAT TTTCATTTAA CTACAAATTA TCATACTACC 1324

GGCTACATCA AATCAGTCCT TTGATTCCAT TTGGTGACCA TCTGTTTGAG AATATGATCA 1384

TGTAAATGAT TATCTCCTTT ATAGCCTGTA ACCAGATTAA GCCCCCC 1431

(2) INFORMATION FOR SEQ ID NO:16:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 304 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:

Met Ile Tyr Thr Met Lys Lys Val His Ala Leu Trp Ala Ser Val Cys

1 5 10 15

Leu Leu Leu Asn Leu Ala Pro Ala Pro Leu Asn Ala Asp Ser Glu Glu

20 25 30

Asp Glu Glu His Thr Ile Ile Thr Asp Thr Glu Leu Pro Pro Leu Lys

35 40 45

Leu Met His Ser Phe Cys Ala Phe Lys Ala Asp Asp Gly Pro Cys Lys

50 55 60

Ala Ile Met Lys Arg Phe Phe Phe Asn Ile Phe Thr Arg Gln Cys Glu

65 70 75 80

Glu Phe Ile Tyr Gly Gly Cys Glu Gly Asn Gln Asn Arg Phe Glu Ser

85 90 95

Leu Glu Glu Cys Lys Lys Met Cys Thr Arg Asp Asn Ala Asn Arg Ile

100 105 110

Ile Lys Thr Thr Leu Gln Gln Glu Lys Pro Asp Phe Cys Phe Leu Glu

115 120 125

Glu Asp Pro Gly Ile Cys Arg Gly Tyr Ile Thr Arg Tyr Phe Tyr Asn

130 135 140

Asn Gln Thr Lys Gln Cys Glu Arg Phe Lys Tyr Gly Gly Cys Leu Gly

145 150 155 160

Asn Met Asn Asn Phe Glu Thr Leu Glu Glu Cys Lys Asn Ile Cys Glu

165 170 175

Asp Gly Pro Asn Gly Phe Gln Val Asp Asn Tyr Gly Thr Gln Leu Asn

180 185 190

Ala Val Asn Asn Ser Leu Thr Pro Gln Ser Thr Lys Val Pro Ser Leu

195 200 205

Phe Glu Phe His Gly Pro Ser Trp Cys Leu Thr Pro Ala Asp Arg Gly

210 215 220

Leu Cys Arg Ala Asn Glu Asn Arg Phe Tyr Tyr Asn Ser Val Ile Gly

225 230 235 240

Lys Cys Arg Pro Phe Lys Tyr Ser Gly Cys Gly Gly Asn Glu Asn Asn

245 250 255

Phe Thr Ser Lys Gln Glu Cys Leu Arg Ala Cys Lys Lys Gly Phe Ile

260 265 270

Gln Arg Ile Ser Lys Gly Gly Leu Ile Lys Thr Lys Arg Lys Arg Lys

275 280 285

Lys Gln Arg Val Lys Ile Ala Tyr Glu Glu Ile Phe Val Lys Asn Met

290 295 300

(2) INFORMATION FOR SEQ ID NO:17:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 1366 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:17:

CCAAGGGCAC GGCACGTGCA TCGACGGCAT CGGCAGCTTC AGCTGCGACT GCCGCAGCGG 60

CTGGGAGGGC CGCTTCTGCC AGCGCGAGGT GAGCTTCCTC AATTGCTCTC TGGACAACGG 120

CGGCTGCACG CATTACTGCC TAGAGGAGGT GGGCTGGCGG CGCTGTAGCT GTGCGCCTGG 180

CTACAAGCTG GGGGACGACC TCCTGCAGTG TCACCCCGCA GTGAAGTTCC CTTGTGGGAG 240

GCCCTGGAAG CGGATGGAGA AGAAGCGCAG TCACCTGAAA CGAGACACAG AAGACCAAGA 300

AGACCAAGTA GATCCGCGGC TCATTGATGG GAAGATGACC AGGCGGGGAG ACAGCCCCTG 360

GCAGGTGGTC CTGCTGGACT CAAAGAAGAA GCTGGCCTGC GGGGCAGTGC TCATCCACCC 420

CTCCTGGGTG CTGACAGCGG CCCACTGCAT GGACGAGTCC AAGAAGCTCC TTGTCAGGCT 480

TGGAGAGTAT GACCTGCGGC GCTGGGAGAA GTGGGAGCTG GACCTGGACA TCAAGGAGGT 540

CTTCGTCCAC CCCAACTACA GCAAGAGCAC CACCGACAAT GACATCGCAC TGCTGCACCT 600

GGCCCAGCCC GCCACCCTCT CGCAGACCAT AGTGCCCATC TGCCTCCCGG ACAGCGGCCT 660

TGCAGAGCGC GAGCTCAATC AGGCCGGCCA GGAGACCCTC GTGACGGGCT GGGGCTACCA 720

CAGCAGCCGA GAGAAGGAGG CCAAGAGAAA CCGCACCTTC GTCCTCAACT TCATCAAGAT 780

TCCCGTGGTC CCGCACAATG AGTGCAGCGA GGTCATGAGC AACATGGTGT CTGAGAACAT 840

GCTGTGTGCG GGCATCCTCG GGGACCGGCA GGATGCCTGC GAGGGCGACA GTGGGGGGCC 900

CATGGTCGCC TCCTTCCACG GCACCTGGTT CCTGGTGGGC CTGGTGAGCT GGGGTGAGGG 960

CTGTGGGCTC CTTCACAACT ACGGCGTTTA CACCAAAGTC AGCCGCTACC TCGACTGGAT 1020

CCATGGGCAC ATCAGAGACA AGGAAGCCCC CCAGAAGAGC TGGGCACCTT AGCGACCCTC 1080

CCTGCAGGGC TGGGCTTTTG CATGGCAATG GATGGGACAT TAAAGGGACA TGTAACAAGC 1140

ACACCGGCCT GCTGTTCTGT CCTTCCATCC CTCTTTTGGG CTCTTCTGGA GGGAAGTAAC 1200

ATTTACTGAG CACCTGTTGT ATGTCACATG CCTTATGAAT AGAATCTTAA CTCCTAGAGC 1260

AACTCTGTCG GGTGGGGAGG AGCAGATCCA AGTTTTGCGG GGTCTAAAGC TGTGTGTGTT 1320

GAGGGGGATA CTCTGTTTAT GAAAAAGAAT AAAAAACACA ACCACG 1366

(2) INFORMATION FOR SEQ ID NO:18:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 356 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:18:

Gln Gly His Gly Thr Cys Ile Asp Gly Ile Gly Ser Phe Ser Cys Asp

1 5 10 15

Cys Arg Ser Gly Trp Glu Gly Arg Phe Cys Gln Arg Glu Val Ser Phe

20 25 30

Leu Asn Cys Ser Leu Asp Asn Gly Gly Cys Thr His Tyr Cys Leu Glu

35 40 45

Glu Val Gly Trp Arg Arg Cys Ser Cys Ala Pro Gly Tyr Lys Leu Gly

50 55 60

Asp Asp Leu Leu Gln Cys His Pro Ala Val Lys Phe Pro Cys Gly Arg

65 70 75 80

Pro Trp Lys Arg Met Glu Lys Lys Arg Ser His Leu Lys Arg Asp Thr

85 90 95

Glu Asp Gln Glu Asp Gln Val Asp Pro Arg Leu Ile Asp Gly Lys Met

100 105 110

Thr Arg Arg Gly Asp Ser Pro Trp Gln Val Val Leu Leu Asp Ser Lys

115 120 125

Lys Lys Leu Ala Cys Gly Ala Val Leu Ile His Pro Ser Trp Val Leu

130 135 140

Thr Ala Ala His Cys Met Asp Glu Ser Lys Lys Leu Leu Val Arg Leu

145 150 155 160

Gly Glu Tyr Asp Leu Arg Arg Trp Glu Lys Trp Glu Leu Asp Leu Asp

165 170 175

Ile Lys Glu Val Phe Val His Pro Asn Tyr Ser Lys Ser Thr Thr Asp

180 185 190

Asn Asp Ile Ala Leu Leu His Leu Ala Gln Pro Ala Thr Leu Ser Gln

195 200 205

Thr Ile Val Pro Ile Cys Leu Pro Asp Ser Gly Leu Ala Glu Arg Glu

210 215 220

Leu Asn Gln Ala Gly Gln Glu Thr Leu Val Thr Gly Trp Gly Tyr His

225 230 235 240

Ser Ser Arg Glu Lys Glu Ala Lys Arg Asn Arg Thr Phe Val Leu Asn

245 250 255

Phe Ile Lys Ile Pro Val Val Pro His Asn Glu Cys Ser Glu Val Met

260 265 270

Ser Asn Met Val Ser Glu Asn Met Leu Cys Ala Gly Ile Leu Gly Asp

275 280 285

Arg Gln Asp Ala Cys Glu Gly Asp Ser Gly Gly Pro Met Val Ala Ser

290 295 300

Phe His Gly Thr Trp Phe Leu Val Gly Leu Val Ser Trp Gly Glu Gly

305 310 315 320

Cys Gly Leu Leu His Asn Tyr Gly Val Tyr Thr Lys Val Ser Arg Tyr

325 330 335

Leu Asp Trp Ile His Gly His Ile Arg Asp Lys Glu Ala Pro Gln Lys

340 345 350

Ser Trp Ala Pro

355

(2) INFORMATION FOR SEQ ID NO:19:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 144 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:19:

TTTCCTCTCT CTCAGTGGGC GACAGATGTG AAAGAAACGA GTTCCAGTGC CAAGACGGGA 60

AATGCATCTC CTACAAGTGG GTCTGCGATG GCAGCGCTGA GTGCCAGGAT GGCTCTGATG 120

AGTCCCAGGA GACGTGCTGT GAGT 144

(2) INFORMATION FOR SEQ ID NO:20:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 402 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:20:

CATCCATCCC TGCAGCCCCC AAGACGTGCT CCCAGGACGA GTTTCGCTGC CACGATGGGA 60

AGTGCATCTC TCGGCAGTTC GTCTGTGACT CAGACCGGGA CTGCTTGGAC GGCTCAGACG 120

AGGCCTCCTG CCCGGTGCTC ACCTGTGGTC CCGCCAGCTT CCAGTGCAAC AGCTCCACCT 180

GCATCCCCCA GCTGTGGGCC TGCGACAACG ACCCCGACTG CGAAGATGGC TCGGATGAGT 240

GGCCGCAGCG CTGTAGGGGT CTTTACGTGT TCCAAGGGGA CAGTAGCCCC TGCTCGGCCT 300

TCGAGTTCCA CTGCCTAAGT GGCGAGTGCA TCCACTCCAG CTGGCGCTGT GATGGTGGCC 360

CCGACTGCAA GGACAAATCT GACGAGGAAA ACTGCGGTAT GG 402

(2) INFORMATION FOR SEQ ID NO:21:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 193 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:21:

TCCCCGGACC CCCAGGCTCC ATCGCCTACC TCTTCTTCAC CAACCGGCAC GAGGTCAGGA 60

AGATGACGCT GGACCGGAGC GAGTACACCA GCCTCATCCC CAACCTGAGG AACGTGGTCG 120

CTCTGGACAC GGAGGTGGCC AGCAATAGAA TCTACTGGTC TGACCTGTCC CAGAGAATGA 180

TCTGCAGGTG AGC 193

(2) INFORMATION FOR SEQ ID NO:22:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 249 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:22:

CTCCTCCTGC CTCAGCACCC AGCTTGACAG AGCCCACGGC GTCTCTTCCT ATGACACCGT 60

CATCAGCAGG GACATCCAGG CCCCCGACGG GCTGGCTGTG GACTGGATCC ACAGCAACAT 120

CTACTGGACC GACTCTGTCC TGGGCACTGT CTCTGTTGCG GATACCAAGG GCGTGAAGAG 180

GAAAACGTTA TTCAGGGAGA ACGGCTCCAA GCCAAGGGCC ATCGTGGTGG ATCCTGTTCA 240

TGGGTGCGT 249

(2) INFORMATION FOR SEQ ID NO:23:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 140 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:23:

CTGTCCTCCC ACCAGCTTCA TGTACTGGAC TGACTGGGGA ACTCCCGCCA AGATCAAGAA 60

AGGGGGCCTG AATGGTGTGG ACATCTACTC GCTGGTGACT GAAAACATTC AGTGGCCCAA 120

TGGCATCACC CTAGGTATGT 140

(2) INFORMATION FOR SEQ ID NO:24:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 163 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:24:

TTGCTGCCTG TTTAGGACAA AGTATTTTGG ACAGATATCA TCAACGAAGC CATTTTCAGT 60

GCCAACCGCC TCACAGGTTC CGATGTCAAC TTGTTGGCTG AAAACCTACT GTCCCCAGAG 120

GATATGGTCC TCTTCCACAA CCTCACCCAG CCAAGAGGTA AGG 163

(2) INFORMATION FOR SEQ ID NO:25:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 192 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:25:

TATTTATTCT TTCAGAGGCT GAGGCTGCAG TGGCCACCCA GGAGACATCC ACCGTCAGGC 60

TAAAGGTCAG CTCCACAGCC GTAAGGACAC AGCACACAAC CACCCGGCCT GTTCCCGACA 120

CCTCCCGGCT GCCTGGGGCC ACCCCTGGGC TCACCACGGT GGAGATAGTG ACAATGTCTC 180

ACCAAGGTAA AG 192

(2) INFORMATION FOR SEQ ID NO:26:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 179 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:26:

TGCCTCTCCC TACAGTGCTC CTCGTCTTCC TTTGCCTGGG GGTCTTCCTT CTATGGAAGA 60

ACTGGCGGCT TAAGAACATC AACAGCATCA ACTTTGACAA CCCCGTCTAT CAGAAGACCA 120

CAGAGGATGA GGTCCACATT TGCCACAACC AGGACGGCTA CAGCTACCCC TCGGTGAGT 179

(2) INFORMATION FOR SEQ ID NO:27:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 769 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:27:

GGATCCCACA AAACAAAAAA TATTTTTTTG GCTGTACTTT TGTGAAGATT TTATTTAAAT 60

TCCTGATTGA TCAGTGTCTA TTAGGTGATT TGGAATAACA ATGTAAAAAC AATATACAAC 120

GAAAGGAAGC TAAAAATCTA TACACAATTC CTAGAAAGGA AAAGGCAAAT ATAGAAAGTG 180

GCGGAAGTTC CCAACATTTT TAGTGTTTTC CTTTTGAGGC AGAGAGGACA ATGGCATTAG 240

GCTATTGGAG GATCTTGAAA GGCTGTTGTT ATCCTTCTGT GGACAACAAC AGCAAAATGT 300

TAACAGTTAA ACATCGAGAA ATTTCAGGAG GATCTTTCAG AAGATGCGTT TCCAATTTTG 360

AGGGGGCGTC AGCTCTTCAC CGGAGACCCA AATACAACAA ATCAAGTCGC CTGCCCTGGC 420

GACACTTTCG AAGGACTGGA GTGGGAATCA GAGCTTCACG GGTTAAAAGC CGATGTCACA 480

TCGGCCGTTC GAAACTCCTC CTCTTGCAGT GAGGTGAAGA CATTTGAAAA TCACCCCACT 540

GCAAACTCCT CCCCCTGCTA GAAACCTCAC ATTGAAATGC TGTAAATGAC GTGGGCCCCG 600

AGTGCAATCG CGGGAAGCCA GGGTTTCCAG CTAGGACACA GCAGGTCGTG ATCCGGGTCG 660

GGACACTGCC TGGCAGAGGC TGCGAGCATG GGGCCCTGGG GCTGGAAATT GCGCTGGACC 720

GTCGCCTTGC TCCTCGCCGC GGCGGGGACT GCAGGTAAGG CTTGCTCCA 769

(2) INFORMATION FOR SEQ ID NO:28:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 279 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:28:

TCTGAGTTCT CTATTCTGTT CCATTGGTCT ATGCGTCTGT TCTTGTACCA GTACTATACT 60

GTTTTGTCCT CCAGAGGGCA GCAGACATCG AACAGCAGGC TGTGTTTGCT GTGTTTGATG 120

AGAACAAAAG CTGGTACCTT GAGGACAACA TCAACAAGTT TTGTGAAAAT CCTGATGAGG 180

TGAAACGTGA TGACCCCAAG TTTTATGAAT CAAACATCAT GAGCAGTAAG TCAGAGTACT 240

ATTTTTGTTC ATCAGTTTTT CATTCCTGTG GTTGAAATA 279

(2) INFORMATION FOR SEQ ID NO:29:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 2904 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 51...2714

›(D) OTHER INFORMATION · 1 of 2

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:29:

TTCGGTGGCC TCTAGTGAGA TCTGGAGGAT CCAAGGATTC TGTAGCTACA ATG TTG 56

Met Leu

1

TCA AGA CTT TTT CGA ATG CAT GGC CTC TTT GTG GCC TCC CAT CCC TGG 104

Ser Arg Leu Phe Arg Met His Gly Leu Phe Val Ala Ser His Pro Trp

5 10 15

GAA GTC ATA GTG GGG ACA GTG ACA CTG ACC ATC TGC ATG ATG TCC ATG 152

Glu Val Ile Val Gly Thr Val Thr Leu Thr Ile Cys Met Met Ser Met

20 25 30

AAC ATG TTT ACT GGT AAC AAT AAG ATC TGT GGT TGG AAT TAT GAA TGT 200

Asn Met Phe Thr Gly Asn Asn Lys Ile Cys Gly Trp Asn Tyr Glu Cys

35 40 45 50

CCA AAG TTT GAA GAG GAT GTT TTG AGC AGT GAC ATT ATA ATT CTG ACA 248

Pro Lys Phe Glu Glu Asp Val Leu Ser Ser Asp Ile Ile Ile Leu Thr

55 60 65

ATA ACA CGA TGC ATA GCC ATC CTG TAT ATT TAC TTC CAG TTC CAG AAT 296

Ile Thr Arg Cys Ile Ala Ile Leu Tyr Ile Tyr Phe Gln Phe Gln Asn

70 75 80

TTA CGT CAA CTT GGA TCA AAA TAT ATT TTG GGT ATT GCT GGC CTT TTC 344

Leu Arg Gln Leu Gly Ser Lys Tyr Ile Leu Gly Ile Ala Gly Leu Phe

85 90 95

ACA ATT TTC TCA AGT TTT GTA TTC AGT ACA GTT GTC ATT CAC TTC TTA 392

Thr Ile Phe Ser Ser Phe Val Phe Ser Thr Val Val Ile His Phe Leu

100 105 110

GAC AAA GAA TTG ACA GGC TTG AAT GAA GCT TTG CCC TTT TTC CTA CTT 440

Asp Lys Glu Leu Thr Gly Leu Asn Glu Ala Leu Pro Phe Phe Leu Leu

115 120 125 130

TTG ATT GAC CTT TCC AGA GCA AGC ACA TTA GCA AAG TTT GCC CTC AGT 488

Leu Ile Asp Leu Ser Arg Ala Ser Thr Leu Ala Lys Phe Ala Leu Ser

135 140 145

TCC AAC TCA CAG GAT GAA GTA AGG GAA AAT ATT GCT CGT GGA ATG GCA 536

Ser Asn Ser Gln Asp Glu Val Arg Glu Asn Ile Ala Arg Gly Met Ala

150 155 160

ATT TTA GGT CCT ACG TTT ACC CTC GAT GCT CTT GTT GAA TGT CTT GTG 584

Ile Leu Gly Pro Thr Phe Thr Leu Asp Ala Leu Val Glu Cys Leu Val

165 170 175

ATT GGA GTT GGT ACC ATG TCA GGG GTA CGT CAG CTT GAA ATT ATG TGC 632

Ile Gly Val Gly Thr Met Ser Gly Val Arg Gln Leu Glu Ile Met Cys

180 185 190

TGC TTT GGC TGC ATG TCA GTT CTT GCC AAC TAC TTC GTG TTC ATG ACT 680

Cys Phe Gly Cys Met Ser Val Leu Ala Asn Tyr Phe Val Phe Met Thr

195 200 205 210

TTC TTC CCA GCT TGT GTG TCC TTG GTA TTA GAG CTT TCT CGG GAA AGC 728

Phe Phe Pro Ala Cys Val Ser Leu Val Leu Glu Leu Ser Arg Glu Ser

215 220 225

CGC GAG GGT CGT CCA ATT TGG CAG CTC AGC CAT TTT GCC CGA GTT TTA 776

Arg Glu Gly Arg Pro Ile Trp Gln Leu Ser His Phe Ala Arg Val Leu

230 235 240

GAA GAA GAA GAA AAT AAG CCG AAT CCT GTA ACT CAG AGG GTC AAG ATG 824

Glu Glu Glu Glu Asn Lys Pro Asn Pro Val Thr Gln Arg Val Lys Met

245 250 255

ATT ATG TCT CTA GGC TTG GTT CTT GTT CAT GCT CAC AGT CGC TGG ATA 872

Ile Met Ser Leu Gly Leu Val Leu Val His Ala His Ser Arg Trp Ile

260 265 270

GCT GAT CCT TCT CCT CAA AAC AGT ACA GCA GAT ACT TCT AAG GTT TCA 920

Ala Asp Pro Ser Pro Gln Asn Ser Thr Ala Asp Thr Ser Lys Val Ser

275 280 285 290

TTA GGA CTG GAT GAA AAT GTG TCC AAG AGA ATT GAA CCA AGT GTT TCC 968

Leu Gly Leu Asp Glu Asn Val Ser Lys Arg Ile Glu Pro Ser Val Ser

295 300 305

CTC TGG CAG TTT TAT CTC TCT AAA ATG ATC AGC ATG GAT ATT GAA CAA 1016

Leu Trp Gln Phe Tyr Leu Ser Lys Met Ile Ser Met Asp Ile Glu Gln

310 315 320

GTT ATT ACC CTA AGT TTA GCT CTC CTT CTG GCT GTC AAG TAC ATC TTC 1064

Val Ile Thr Leu Ser Leu Ala Leu Leu Leu Ala Val Lys Tyr Ile Phe

325 330 335

TTT GAA CAA ACA GAG ACA GAA TCT ACA CTC TCA TTA AAA AAC CCT ATC 1112

Phe Glu Gln Thr Glu Thr Glu Ser Thr Leu Ser Leu Lys Asn Pro Ile

340 345 350

ACA TCT CCT GTA GTG ACA CAA AAG AAA GTC CCA GAC AAT TGT TGT AGA 1160

Thr Ser Pro Val Val Thr Gln Lys Lys Val Pro Asp Asn Cys Cys Arg

355 360 365 370

CGT GAA CCT ATG CTG GTC AGA AAT AAC CAG AAA TGT GAT TCA GTA GAG 1208

Arg Glu Pro Met Leu Val Arg Asn Asn Gln Lys Cys Asp Ser Val Glu

375 380 385

GAA GAG ACA GGG ATA AAC CGA GAA AGA AAA GTT GAG GTT ATA AAA CCC 1256

Glu Glu Thr Gly Ile Asn Arg Glu Arg Lys Val Glu Val Ile Lys Pro

390 395 400

TTA GTG GCT GAA ACA GAT ACC CCA AAC AGA GCT ACA TTT GTG GTT GGT 1304

Leu Val Ala Glu Thr Asp Thr Pro Asn Arg Ala Thr Phe Val Val Gly

405 410 415

AAC TCC TCC TTA CTC GAT ACT TCA TCA GTA CTG GTG ACA CAG GAA CCT 1352

Asn Ser Ser Leu Leu Asp Thr Ser Ser Val Leu Val Thr Gln Glu Pro

420 425 430

GAA ATT GAA CTT CCC AGG GAA CCT CGG CCT AAT GAA GAA TGT CTA CAG 1400

Glu Ile Glu Leu Pro Arg Glu Pro Arg Pro Asn Glu Glu Cys Leu Gln

435 440 445 450

ATA CTT GGG AAT GCA GAG AAA GGT GCA AAA TTC CTT AGT GAT GCT GAG 1448

Ile Leu Gly Asn Ala Glu Lys Gly Ala Lys Phe Leu Ser Asp Ala Glu

455 460 465

ATC ATC CAG TTA GTC AAT GCT AAG CAT ATC CCA GCC TAC AAG TTG GAA 1496

Ile Ile Gln Leu Val Asn Ala Lys His Ile Pro Ala Tyr Lys Leu Glu

470 475 480

ACT CTG ATG GAA ACT CAT GAG CGT GGT GTA TCT ATT CGC CGA CAG TTA 1544

Thr Leu Met Glu Thr His Glu Arg Gly Val Ser Ile Arg Arg Gln Leu

485 490 495

CTT TCC AAG AAG CTT TCA GAA CCT TCT TCT CTC CAG TAC CTA CCT TAC 1592

Leu Ser Lys Lys Leu Ser Glu Pro Ser Ser Leu Gln Tyr Leu Pro Tyr

500 505 510

AGG GAT TAT AAT TAC TCC TTG GTG ATG GGA GCT TGT TGT GAG AAT GTT 1640

Arg Asp Tyr Asn Tyr Ser Leu Val Met Gly Ala Cys Cys Glu Asn Val

515 520 525 530

ATT GGA TAT ATG CCC ATC CCT GTT GGA GTG GCA GGA CCC CTT TGC TTA 1688

Ile Gly Tyr Met Pro Ile Pro Val Gly Val Ala Gly Pro Leu Cys Leu

535 540 545

GAT GAA AAA GAA TTT CAG GTT CCA ATG GCA ACA ACA GAA GGT TGT CTT 1736

Asp Glu Lys Glu Phe Gln Val Pro Met Ala Thr Thr Glu Gly Cys Leu

550 555 560

GTG GCC AGC ACC AAT AGA GGC TGC AGA GCA ATA GGT CTT GGT GGA GGT 1784

Val Ala Ser Thr Asn Arg Gly Cys Arg Ala Ile Gly Leu Gly Gly Gly

565 570 575

GCC AGC AGC CGA GTC CTT GCA GAT GGG ATG ACT CGT GGC CCA GTT GTG 1832

Ala Ser Ser Arg Val Leu Ala Asp Gly Met Thr Arg Gly Pro Val Val

580 585 590

CGT CTT CCA CGT GCT TGT GAC TCT GCA GAA GTG AAA GCC TGG CTC GAA 1880

Arg Leu Pro Arg Ala Cys Asp Ser Ala Glu Val Lys Ala Trp Leu Glu

595 600 605 610

ACA TCT GAA GGG TTC GCA GTG ATA AAG GAG GCA TTT GAC AGC ACT AGC 1928

Thr Ser Glu Gly Phe Ala Val Ile Lys Glu Ala Phe Asp Ser Thr Ser

615 620 625

AGA TTT GCA CGT CTA CAG AAA CTT CAT ACA AGT ATA GCT GGA CGC AAC 1976

Arg Phe Ala Arg Leu Gln Lys Leu His Thr Ser Ile Ala Gly Arg Asn

630 635 640

CTT TAT ATC CGT TTC CAG TCC AGG TCA GGG GAT GCC ATG GGG ATG AAC 2024

Leu Tyr Ile Arg Phe Gln Ser Arg Ser Gly Asp Ala Met Gly Met Asn

645 650 655

ATG ATT TCA AAG GGT ACA GAG AAA GCA CTT TCA AAA CTT CAC GAG TAT 2072

Met Ile Ser Lys Gly Thr Glu Lys Ala Leu Ser Lys Leu His Glu Tyr

›(D) OTHER INFORMATION · 2 of 2

660 665 670

TTC CCT GAA ATG CAG ATT CTA GCC GTT AGT GGT AAC TAT TGT ACT GAC 2120

Phe Pro Glu Met Gln Ile Leu Ala Val Ser Gly Asn Tyr Cys Thr Asp

675 680 685 690

AAG AAA CCT GCT GCT ATA AAT TGG ATA GAG GGA AGA GGA AAA TCT GTT 2168

Lys Lys Pro Ala Ala Ile Asn Trp Ile Glu Gly Arg Gly Lys Ser Val

695 700 705

GTT TGT GAA GCT GTC ATT CCA GCC AAG GTT GTC AGA GAA GTA TTA AAG 2216

Val Cys Glu Ala Val Ile Pro Ala Lys Val Val Arg Glu Val Leu Lys

710 715 720

ACT ACC ACA GAG GCT ATG ATT GAG GTC AAC ATT AAC AAG AAT TTA GTG 2264

Thr Thr Thr Glu Ala Met Ile Glu Val Asn Ile Asn Lys Asn Leu Val

725 730 735

GGC TCT GCC ATG GCT GGG AGC ATA GGA GGC TAC AAC GCC CAT GCA GCA 2312

Gly Ser Ala Met Ala Gly Ser Ile Gly Gly Tyr Asn Ala His Ala Ala

740 745 750

AAC ATT GTC ACC GCC ATC TAC ATT GCC TGT GGA CAG GAT GCA GCA CAG 2360

Asn Ile Val Thr Ala Ile Tyr Ile Ala Cys Gly Gln Asp Ala Ala Gln

755 760 765 770

AAT GTT GGT AGT TCA AAC TGT ATT ACT TTA ATG GAA GCA AGT GGT CCC 2408

Asn Val Gly Ser Ser Asn Cys Ile Thr Leu Met Glu Ala Ser Gly Pro

775 780 785

ACA AAT GAA GAT TTA TAT ATC AGC TGC ACC ATG CCA TCT ATA GAG ATA 2456

Thr Asn Glu Asp Leu Tyr Ile Ser Cys Thr Met Pro Ser Ile Glu Ile

790 795 800

GGA ACG GTG GGT GGT GGG ACC AAC CTA CTA CCT CAG CAA GCC TGT TTG 2504

Gly Thr Val Gly Gly Gly Thr Asn Leu Leu Pro Gln Gln Ala Cys Leu

805 810 815

CAG ATG CTA GGT GTT CAA GGA GCA TGC AAA GAT AAT CCT GGG GAA AAT 2552

Gln Met Leu Gly Val Gln Gly Ala Cys Lys Asp Asn Pro Gly Glu Asn

820 825 830

GCC CGG CAG CTT GCC CGA ATT GTG TGT GGG ACC GTA ATG GCT GGG GAA 2600

Ala Arg Gln Leu Ala Arg Ile Val Cys Gly Thr Val Met Ala Gly Glu

835 840 845 850

TTG TCA CTT ATG GCA GCA TTG GCA GCA GGA CAT CTT GTC AAA AGT CAC 2648

Leu Ser Leu Met Ala Ala Leu Ala Ala Gly His Leu Val Lys Ser His

855 860 865

ATG ATT CAC AAC AGG TCG AAG ATC AAT TTA CAA GAC CTC CAA GGA GCT 2696

Met Ile His Asn Arg Ser Lys Ile Asn Leu Gln Asp Leu Gln Gly Ala

870 875 880

TGC ACC AAG AAG ACA GCC TGAATAGCCC GACAGTTCTG AACTGGAACA 2744

Cys Thr Lys Lys Thr Ala

885

TGGGCATTGG GTTCTAAAGG ACTAACATAA AATCTGTGAA TTAAAAAAGC TCAATGCATT 2804

GTCTTGTGGA GGATGAATAA ATGTGATCAC TGAGACAGCC ACTTGGTTTT TGGCTCTTTC 2864

AGAGAGGTCT CAGGTTCTTT CCATGCAGAC TCCTCAGATC 2904

(2) INFORMATION FOR SEQ ID NO:30:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 888 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:30:

Met Leu Ser Arg Leu Phe Arg Met His Gly Leu Phe Val Ala Ser His

1 5 10 15

Pro Trp Glu Val Ile Val Gly Thr Val Thr Leu Thr Ile Cys Met Met

20 25 30

Ser Met Asn Met Phe Thr Gly Asn Asn Lys Ile Cys Gly Trp Asn Tyr

35 40 45

Glu Cys Pro Lys Phe Glu Glu Asp Val Leu Ser Ser Asp Ile Ile Ile

50 55 60

Leu Thr Ile Thr Arg Cys Ile Ala Ile Leu Tyr Ile Tyr Phe Gln Phe

65 70 75 80

Gln Asn Leu Arg Gln Leu Gly Ser Lys Tyr Ile Leu Gly Ile Ala Gly

85 90 95

Leu Phe Thr Ile Phe Ser Ser Phe Val Phe Ser Thr Val Val Ile His

100 105 110

Phe Leu Asp Lys Glu Leu Thr Gly Leu Asn Glu Ala Leu Pro Phe Phe

115 120 125

Leu Leu Leu Ile Asp Leu Ser Arg Ala Ser Thr Leu Ala Lys Phe Ala

130 135 140

Leu Ser Ser Asn Ser Gln Asp Glu Val Arg Glu Asn Ile Ala Arg Gly

145 150 155 160

Met Ala Ile Leu Gly Pro Thr Phe Thr Leu Asp Ala Leu Val Glu Cys

165 170 175

Leu Val Ile Gly Val Gly Thr Met Ser Gly Val Arg Gln Leu Glu Ile

180 185 190

Met Cys Cys Phe Gly Cys Met Ser Val Leu Ala Asn Tyr Phe Val Phe

195 200 205

Met Thr Phe Phe Pro Ala Cys Val Ser Leu Val Leu Glu Leu Ser Arg

210 215 220

Glu Ser Arg Glu Gly Arg Pro Ile Trp Gln Leu Ser His Phe Ala Arg

225 230 235 240

Val Leu Glu Glu Glu Glu Asn Lys Pro Asn Pro Val Thr Gln Arg Val

245 250 255

Lys Met Ile Met Ser Leu Gly Leu Val Leu Val His Ala His Ser Arg

260 265 270

Trp Ile Ala Asp Pro Ser Pro Gln Asn Ser Thr Ala Asp Thr Ser Lys

275 280 285

Val Ser Leu Gly Leu Asp Glu Asn Val Ser Lys Arg Ile Glu Pro Ser

290 295 300

Val Ser Leu Trp Gln Phe Tyr Leu Ser Lys Met Ile Ser Met Asp Ile

305 310 315 320

Glu Gln Val Ile Thr Leu Ser Leu Ala Leu Leu Leu Ala Val Lys Tyr

325 330 335

Ile Phe Phe Glu Gln Thr Glu Thr Glu Ser Thr Leu Ser Leu Lys Asn

340 345 350

Pro Ile Thr Ser Pro Val Val Thr Gln Lys Lys Val Pro Asp Asn Cys

355 360 365

Cys Arg Arg Glu Pro Met Leu Val Arg Asn Asn Gln Lys Cys Asp Ser

370 375 380

Val Glu Glu Glu Thr Gly Ile Asn Arg Glu Arg Lys Val Glu Val Ile

385 390 395 400

Lys Pro Leu Val Ala Glu Thr Asp Thr Pro Asn Arg Ala Thr Phe Val

405 410 415

Val Gly Asn Ser Ser Leu Leu Asp Thr Ser Ser Val Leu Val Thr Gln

420 425 430

Glu Pro Glu Ile Glu Leu Pro Arg Glu Pro Arg Pro Asn Glu Glu Cys

435 440 445

Leu Gln Ile Leu Gly Asn Ala Glu Lys Gly Ala Lys Phe Leu Ser Asp

450 455 460

Ala Glu Ile Ile Gln Leu Val Asn Ala Lys His Ile Pro Ala Tyr Lys

465 470 475 480

Leu Glu Thr Leu Met Glu Thr His Glu Arg Gly Val Ser Ile Arg Arg

485 490 495

Gln Leu Leu Ser Lys Lys Leu Ser Glu Pro Ser Ser Leu Gln Tyr Leu

500 505 510

Pro Tyr Arg Asp Tyr Asn Tyr Ser Leu Val Met Gly Ala Cys Cys Glu

515 520 525

Asn Val Ile Gly Tyr Met Pro Ile Pro Val Gly Val Ala Gly Pro Leu

530 535 540

Cys Leu Asp Glu Lys Glu Phe Gln Val Pro Met Ala Thr Thr Glu Gly

545 550 555 560

Cys Leu Val Ala Ser Thr Asn Arg Gly Cys Arg Ala Ile Gly Leu Gly

565 570 575

Gly Gly Ala Ser Ser Arg Val Leu Ala Asp Gly Met Thr Arg Gly Pro

580 585 590

Val Val Arg Leu Pro Arg Ala Cys Asp Ser Ala Glu Val Lys Ala Trp

595 600 605

Leu Glu Thr Ser Glu Gly Phe Ala Val Ile Lys Glu Ala Phe Asp Ser

610 615 620

Thr Ser Arg Phe Ala Arg Leu Gln Lys Leu His Thr Ser Ile Ala Gly

625 630 635 640

Arg Asn Leu Tyr Ile Arg Phe Gln Ser Arg Ser Gly Asp Ala Met Gly

645 650 655

Met Asn Met Ile Ser Lys Gly Thr Glu Lys Ala Leu Ser Lys Leu His

660 665 670

Glu Tyr Phe Pro Glu Met Gln Ile Leu Ala Val Ser Gly Asn Tyr Cys

675 680 685

Thr Asp Lys Lys Pro Ala Ala Ile Asn Trp Ile Glu Gly Arg Gly Lys

690 695 700

Ser Val Val Cys Glu Ala Val Ile Pro Ala Lys Val Val Arg Glu Val

705 710 715 720

Leu Lys Thr Thr Thr Glu Ala Met Ile Glu Val Asn Ile Asn Lys Asn

725 730 735

Leu Val Gly Ser Ala Met Ala Gly Ser Ile Gly Gly Tyr Asn Ala His

740 745 750

Ala Ala Asn Ile Val Thr Ala Ile Tyr Ile Ala Cys Gly Gln Asp Ala

755 760 765

Ala Gln Asn Val Gly Ser Ser Asn Cys Ile Thr Leu Met Glu Ala Ser

770 775 780

Gly Pro Thr Asn Glu Asp Leu Tyr Ile Ser Cys Thr Met Pro Ser Ile

785 790 795 800

Glu Ile Gly Thr Val Gly Gly Gly Thr Asn Leu Leu Pro Gln Gln Ala

805 810 815

Cys Leu Gln Met Leu Gly Val Gln Gly Ala Cys Lys Asp Asn Pro Gly

820 825 830

Glu Asn Ala Arg Gln Leu Ala Arg Ile Val Cys Gly Thr Val Met Ala

835 840 845

Gly Glu Leu Ser Leu Met Ala Ala Leu Ala Ala Gly His Leu Val Lys

850 855 860

Ser His Met Ile His Asn Arg Ser Lys Ile Asn Leu Gln Asp Leu Gln

865 870 875 880

Gly Ala Cys Thr Lys Lys Thr Ala

885

(2) INFORMATION FOR SEQ ID NO:31:

›(i) SEQUENCE CHARACTERISTICS · 1 of 3

(A) LENGTH: 11725 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:31:

AGTGAATCTG GGCGAGTAAC ACAAAACTTG AGTGTCCTTA CCTGAAAAAT AGAGGTTAGA 60

GGGATGCTAT GTGCCATTGT GTGTGTGTGT TGGGGGTGGG GATTGGGGGT GATTTGTGAG 120

CAATTGGAGG TGAGGGTGGA GCCCAGTGCC CAGCACCTAT GCACTGGGGA CCCAAAAAGG 180

AGCATCTTCT CATGATTTTA TGTATCAGAA ATTGGGATGG CATGTCATTG GGACAGCGTC 240

TTTTTTCTTG TATGGTGGCA CATAAATACA TGTGTCTTAT AATTAATGGT ATTTTAGATT 300

TGACGAAATA TGGAATATTA CCTGTTGTGC TGATCTTGGG CAAACTATAA TATCTCTGGG 360

CAAAAATGTC CCCATCTGAA AAACAGGGAC AACGTTCCTC CCTCAGCCAG CCACTATGGG 420

GCTAAAATGA GACCACATCT GTCAAGGGTT TTGCCCTCAC CTCCCTCCCT GCTGGATGGC 480

ATCCTTGGTA GGCAGAGGTG GGCTTCGGGC AGAACAAGCC GTGCTGAGCT AGGACCAGGA 540

GTGCTAGTGC CACTGTTTGT CTATGGAGAG GGAGGCCTCA GTGCTGAGGG CCAAGCAAAT 600

ATTTGTGGTT ATGGATTAAC TCGAACTCCA GGCTGTCATG GCGGCAGGAC GGCGAACTTG 660

CAGTATCTCC ACGACCCGCC CCTGTGAGTC CCCCTCCAGG CAGGTCTATG AGGGGTGTGG 720

AGGGAGGGCT GCCCCCGGGA GAAGAGAGCT AGGTGGTGAT GAGGGCTGAA TCCTCCAGCC 780

AGGGTGCTCA ACAAGCCTGA GCTTGGGGTA AAAGGACACA AGGCCCTCCA CAGGCCAGGC 840

CTGGCAGCCA CAGTCTCAGG TCCCTTTGCC ATGCGCCTCC CTCTTTCCAG GCCAAGGGTC 900

CCCAGGCCCA GGGCCATTCC AACAGACAGT TTGGAGCCCA GGACCCTCCA TTCTCCCCAC 960

CCCACTTCCA CCTTTGGGGG TGTCGGATTT GAACAAATCT CAGAAGCGGC CTCAGAGGGA 1020

GTCGGCAAGA ATGGAGAGCA GGGTCCGGTA GGGTGTGCAG AGGCCACGTG GCCTATCCAC 1080

TGGGGAGGGT TCCTTGATCT CTGGCCACCA GGGCTATCTC TGTGGCCTTT TGGAGCAACC 1140

TGGTGGTTTG GGGCAGGGGT TGAATTTCCA GGCCTAAAAC CACACAGGCC TGGCCTTGAG 1200

TCCTGGCTCT GCGAGTAATG CATGGATGTA AACATGGAGA CCCAGGACCT TGCCTCAGTC 1260

TTCCGAGTCT GGTGCCTGCA GTGTACTGAT GGTGTGAGAC CCTACTCCTG GAGGATGGGG 1320

GACAGAATCT GATCGATCCC CTGGGTTGGT GACTTCCCTG TGCAATCAAC GGAGACCAGC 1380

AAGGGTTGGA TTTTTAATAA ACCACTTAAC TCCTCCGAGT CTCAGTTTCC CCCTCTATGA 1440

AATGGGGTTG ACAGCATTAA TAACTACCTC TTGGGTGGTT GTGAGCCTTA ACTGAAGTCA 1500

TAATATCTCA TGTTTACTGA GCATGAGCTA TGTGCAAAGC CTGTTTTGAG AGCTTTATGT 1560

GGACTAACTC CTTTAATTCT CACAACACCC TTTAAGGCAC AGATACACCA CGTTATTCCA 1620

TCCATTTTAC AAATGAGGAA ACTGAGGCAT GGAGCAGTTA AGCATCTTGC CCAACATTGC 1680

CCTCCAGTAA GTGCTGGAGC TGGAATTTGC ACCGTGCAGT CTGGCTTCAT GGCCTGCCCT 1740

GTGAATCCTG TAAAAATTGT TTGAAAGACA CCATGAGTGT CCAATCAACG TTAGCTAATA 1800

TTCTCAGCCC AGTCATCAGA CCGGCAGAGG CAGCCACCCC ACTGTCCCCA GGGAGGACAC 1860

AAACATCCTG GCACCCTCTC CACTGCATTC TGGAGCTGCT TTCTAGGCAG GCAGTGTGAG 1920

CTCAGCCCCA CGTAGAGCGG GCAGCCGAGG CCTTCTGAGG CTATGTCTCT AGCGAACAAG 1980

GACCCTCAAT TCCAGCTTCC GCCTGACGGC CAGCACACAG GGACAGCCCT TTCATTCCGC 2040

TTCCACCTGG GGGTGCAGGC AGAGCAGCAG CGGGGGTAGC ACTGCCCGGA GCTCAGAAGT 2100

CCTCCTCAGA CAGGTGCCAG TGCCTCCAGA ATGTGGCAGC TCACAAGCCT CCTGCTGTTC 2160

GTGGCCACCT GGGGAATTTC CGGCACACCA GCTCCTCTTG GTAAGGCCAC CCCACCCCTA 2220

CCCCGGGACC CTTGTGGCCT CTACAAGGCC CTGGTGGCAT CTGCCCAGGC CTTCACAGCT 2280

TCCACCATCT CTCTGAGCCC TGGGTGAGGT GAGGGGCAGA TGGGAATGGC AGGAATCAAC 2340

TGACAAGTCC CAGGTAGGCC AGCTGCCAGA GTGCCACACA GGGGCTGCCA GGGCAGGCAT 2400

GCGTGATGGC AGGGAGCCCC GCGATGACCT CCTAAAGCTC CCTCCTCCAC ACGGGGATGG 2460

TCACAGAGTC CCCTGGGCCT TCCCTCTCCA CCCACTCACT CCCTCAACTG TGAAGACCCC 2520

AGGCCCAGGC TACCGTCCAC ACTATCCAGC ACAGCCTCCC CTACTCAAAT GCACACTGGC 2580

CTCATGGCTG CCCTGCCCCA ACCCCTTTCC TGGTCTCCAC AGCCAACGGG AGGAGGCCAT 2640

GATTCTTGGG GAGGTCCGCA GGCACATGGG CCCCTAAAGC CACACCAGGC TGTTGGTTTC 2700

ATTTGTGCCT TTATAGAGCT GTTTATCTGC TTGGGACCTG CACCTCCACC CTTTCCCAAG 2760

GTGCCCTCAG CTCAGGCATA CCCTCCTCTA GGATGCCTTT TCCCCCATCC CTTCTTGCTC 2820

ACACCCCCAA CTTGATCTCT CCCTCCTAAC TGTGCCCTGC ACCAAGACAG ACACTTCACA 2880

GAGCCCAGGA CACACCTGGG GACCCTTCCT GGGTGATAGG TCTGTCTATC CTCCAGGTGT 2940

CCCTGCCCAA GGGGAGAAGC ATGGGGAATA CTTGGTTGGG GGAGGAAAGG AAGACTGGGG 3000

GGATGTGTCA AGATGGGGCT GCATGTGGTG TACTGGCAGA AGAGTGAGAG GATTTAACTT 3060

GGCAGCCTTT ACAGCAGCAG CCAGGGCTTG AGTACTTATC TCTGGGCCAG GCTGTATTGG 3120

ATGTTTTACA TGACGGTCTC ATCCCCATGT TTTTGGATGA GTAAATTGAA CCTTAGAAAG 3180

GTAAAGACAC TGGCTCAAGG TCACACAGAG ATCGGGGTGG GGTTCACAGG GAGGCCTGTC 3240

CATCTCAGAG CAAGGCTTCG TCCTCCAACT GCCATCTGCT TCCTGGGGAG GAAAAGAGCA 3300

GAGGACCCCT GCGCCAAGCC ATGACCTAGA ATTAGAATGA GTCTTGAGGG GGCGGAGACA 3360

AGACCTTCCC AGGCTCTCCC AGCTCTGCTT CCTCAGACCC CCTCATGGCC CCAGCCCCTC 3420

TTAGGCCCCT CACCAAGGTG AGCTCCCCTC CCTCCAAAAC CAGACTCAGT GTTCTCCAGC 3480

AGCGAGCGTG CCCACCAGGT GCTGCGGATC CGCAAACGTG CCAACTCCTT CCTGGAGGAG 3540

CTCCGTCACA GCAGCCTGGA GCGGGAGTGC ATAGAGGAGA TCTGTGACTT CGAGGAGGCC 3600

AAGGAAATTT TCCAAAATGT GGATGACACA GTAAGGCCAC CATGGGTCCA GAGGATGAGG 3660

CTCAGGGGCG AGCTGGTAAC CAGCAGGGGC CTCGAGGAGC AGGTGGGGAC TCAATGCTGA 3720

GGCCCTCTTA GGAGTTGTGG GGGTGGCTGA GTGGAGCGAT TAGGATGCTG GCCCTATGAT 3780

GTCGGCCAGG CACATGTGAC TGCAAGAAAC AGAATTCAGG AAGAAGCTCC AGGAAAGAGT 3840

GTGGGGTGAC CCTAGGTGGG GACTCCCACA GCCACAGTGT AGGTGGTTCA GTCCACCCTC 3900

CAGCCACTGC TGAGCACCAC TGCCTCCCCG TCCCACCTCA CAAAGAGGGG ACCTAAAGAC 3960

CACCCTGCTT CCACCCATGC CTCTGCTGAT CAGGGTGTGT GTGTGACCGA AACTCACTTC 4020

TGTCCACATA AAATCGCTCA CTCTGTGCCT CACATCAAAG GGAGAAAATC TGATTGTTCA 4080

GGGGGTCGGA AGACAGGGTC TGTGTCCTAT TTGTCTAAGG GTCAGAGTCC TTTGGAGCCC 4140

CCAGAGTCCT GTGGACGTGG CCCTAGGTAG TAGGGTGAGC TTGGTAACGG GGCTGGCTTC 4200

CTGAGACAAG GCTCAGACCC GCTCTGTCCC TGGGGATCGC TTCAGCCACC AGGACCTGAA 4260

AATTGTGCAC GCCTGGGCCC CCTTCCAAGG CATCCAGGGA TGCTTTCCAG TGGAGGCTTT 4320

CAGGGCAGGA GACCCTCTGG CCTGCACCCT CTCTTGCCCT CAGCCTCCAC CTCCTTGACT 4380

GGACCCCCAT CTGGACCTCC ATCCCCACCA CCTCTTTCCC CAGTGGCCTC CCTGGCAGAC 4440

ACCACAGTGA CTTTCTGCAG GCACATATCT GATCACATCA AGTCCCCACC GTGCTCCCAC 4500

CTCACCCATG GTCTCTCAGC CCCAGCAGCC TTGGCTGGCC TCTCTGATGG AGCAGGCATC 4560

AGGCACAGGC CGTGGGTCTC AACGTGGGCT GGGTGGTCCT GGACCAGCAG CAGCCGCCGC 4620

AGCAGCAACC CTGGTACCTG GTTAGGAACG CAGACCCTCT GCCCCCATCC TCCCAACTCT 4680

GAAAAACACT GGCTTAGGGA AAGGCGCGAT GCTCAGGGGT CCCCCAAAGC CCGCAGGCAG 4740

AGGGAGTGAT GGGACTGGAA GGAGGCCGAG TGACTTGGTG AGGGATTCGG GTCCCTTGCA 4800

TGCAGAGGCT GCTGTGGGAG CGGACAGTCG CGAGAGCAGC ACTGCAGCTG CATGGGGAGA 4860

GGGTGTTGCT CCAGGGACGT GGGATGGAGG CTGGGCGCGG GCGGGTGGCG CTGGAGGGCG 4920

GGGGAGGGGC AGGGAGCACC AGCTCCTAGC AGCCAACGAC CATCGGGCGT CGATCCCTGT 4980

TTGTCTGGAA GCCCTCCCCT CCCCTGCCCG CTCACCCGCT GCCCTGCCCC ACCCGGGCGC 5040

›(i) SEQUENCE CHARACTERISTICS · 2 of 3

GCCCCTCCGC ACACCGGCTG CAGGAGCCTG ACGCTGCCCG CTCTCTCCGC AGCTGGCCTT 5100

CTGGTCCAAG CACGTCGGTG AGTGCGTTCT AGATCCCCGG CTGGACTACC GGCGCCCGCG 5160

CCCCTCGGGA TCTCTGGCCG CTGACCCCCT ACCCCGCCTT GTGTCGCAGA CGGTGACCAG 5220

TGCTTGGTCT TGCCCTTGGA GCACCCGTGC GCCAGCCTGT GCTGCGGGCA CGGCACGTGC 5280

ATCGACGGCA TCGGCAGCTT CAGCTGCGAC TGCCGCAGCG GCTGGGAGGG CCGCTTCTGC 5340

CAGCGCGGTG AGGGGGAGAG GTGGATGCTG GCGGGCGGCG GGGCGGGGCT GGGGCCGGGT 5400

TGGGGGCGCG GCACCAGCAC CAGCTGCCCG CGCCCTCCCC TGCCCGCAGA GGTGAGCTTC 5460

CTCAATTGCT CTCTGGACAA CGGCGGCTGC ACGCATTACT GCCTAGAGGA GGTGGGCTGG 5520

CGGCGCTGTA GCTGTGCGCC TGGCTACAAG CTGGGGGACG ACCTCCTGCA GTGTCACCCC 5580

GCAGGTGAGA AGCCCCCAAT ACATCGCCCA GGAATCACGC TGGGTGCGGG GTGGGCAGGC 5640

CCCTGACGGG CGCGGCGCGG GGGGCTCAGG AGGGTTTCTA GGGAGGGAGC GAGGAACAGA 5700

GTTGAGCCTT GGGGCAGCGG CAGACGCGCC CAACACCGGG GCCACTGTTA GCGCAATCAG 5760

CCCGGGAGCT GGGCGCGCCC TCCGCTTTCC CTGCTTCCTT TCTTCCTGGC GTCCCCGCTT 5820

CCTCCGGGCG CCCCTGCGAC CTGGGGCCAC CTCCTGGAGC GCAAGCCCAG TGGTGGCTCC 5880

GCTCCCCAGT CTGAGCGTAT CTGGGGCGAG GCGTGCAGCG TCCTCCTCCA TGTAGCCTGG 5940

CTGCGTTTTT CTCTGACGTT GTCCGGCGTG CATCGCATTT CCCTCTTTAC CCCCTTGCTT 6000

CCTTGAGGAG AGAACAGAAT CCCGATTCTG CCTTCTTCTA TATTTTCCTT TTTATGCATT 6060

TTAATCAAAT TTATATATGT ATGAAACTTT AAAAATCAGA GTTTTACAAC TCTTACACTT 6120

TCAGCATGCT GTTCCTTGGC ATGGGTCCTT TTTTCATTCA TTTTCATAAA AGGTGGACCC 6180

TTTTAATGTG GAAATTCCTA TCTTCTGCCT CTAGGGCATT TATCACTTAT TTCTTCTACA 6240

ATCTCCCCTT TACTTCCTCT ATTTTCTCTT TCTGGACCTC CCATTATTCA GACCTCTTTC 6300

CTCTAGTTTT ATTGTCTCTT CTATTTCCCA TCTCTTTGAC TTTGTGTTTT CTTTCAGGGA 6360

ACTTTCTTTT TTTTCTTTTT TTTTGAGATG GAGTTTCACT CTTGTTGTCC CAGGCTGGAG 6420

TGCAATGACG TGATCTCAGC TCACCACAAC CTCCGCCTCC TGGATTCAAG CGATTCTCCT 6480

GCCGCAGCCT CCCGAGTAGC TGGGATTACA GGCATGCGCC ACCACGCCCA GCTAATTTTG 6540

TGTTTTTAGT AGAGAAGGGG TTTCTCCGTG TTGGTCAAGC TGGTCTTGAA CTCCTGACCT 6600

CAGGTGATCC ACCTGCCTTG GCCTCCTAAA GTGCTGGGAT TACAGGCGTG AGCCACCGCG 6660

CCCAGCCTCT TTCAGGGAAC TTTCTACAAC TTTATAATTC AATTCTTCTG CAGAAAAAAA 6720

TTTTTGGCCA GGCTCAGTAG CTCAGACCAA TAATTCCAGC ACTTTGAGAG GCTGAGGTGG 6780

GAGGATTGCT TGAGCTTGGG AGTTTGAGAC TAGCCTGGGC AACACAGTGA GACCCTGTCT 6840

CTATTTTTAA AAAAAGTAAA AAAAGATCTA AAAATTTAAC TTTTTATTTT GAAATAATTA 6900

GATATTTCCA GGAAGCTGCA AAGAAATGCC TGGTGGGCCT GTTGGCTGTG GGTTTCCTGC 6960

AAGGCCGTGG GAAGGCCCTG TCATTGGCAG AACCCCAGAT CGTGAGGGCT TTCCTTTTAG 7020

GCTGCTTTCT AAGAGGACTC CTCCAAGCTC TTGGAGGATG GAAGACGCTC ACCCATGGTG 7080

TTCGGCCCCT CAGAGCAGGG TGGGGCAGGG GAGCTGGTGC CTGTGCAGGC TGTGGACATT 7140

TGCATGACTC CCTGTGGTCA GCTAAGAGCA CCACTCCTTC CTGAAGCGGG GCCTGAAGTC 7200

CCTAGTCAGA GCCTCTGGTT CACCTTCTGC AGGCAGGGAG AGGGGAGTCA AGTCAGTGAG 7260

GAGGGCTTTC GCAGTTTCTC TTACAAACTC TCAACATGCC CTCCCACCTG CACTGCCTTC 7320

CTGGAAGCCC CACAGCCTCC TATGGTTCCG TGGTCCAGTC CTTCAGCTTC TGGGCGCCCC 7380

CATCACGGGC TGAGATTTTT GCTTTCCAGT CTGCCAAGTC AGTTACTGTG TCCATCCATC 7440

TGCTGTCAGC TTCTGGAATT GTTGCTGTTG TGCCCTTTCC ATTCTTTTGT TATGATGCAG 7500

CTCCCCTGCT GACGACGTCC CATTGCTCTT TTAAGTCTAG ATATCTGGAC TGGGCATTCA 7560

AGGCCCATTT TGAGCAGAGT CGGGCTGACC TTTCAGCCCT CAGTTCTCCA TGGAGTATGC 7620

GCTCTCTTCT TGGCAGGGAG GCCTCACAAA CATGCCATGC CTATTGTAGC AGCTCTCCAA 7680

GAATGCTCAC CTCCTTCTCC CTGTAATTCC TTTCCTCTGT GAGGAGCTCA GCAGCATCCC 7740

ATTATGAGAC CTTACTAATC CCAGGGATCA CCCCCAACAG CCCTGGGGTA CAATGAGCTT 7800

TTAAGAAGTT TAACCACCTA TGTAAGGAGA CACAGGCAGT GGGCGATGCT GCCTGGCCTG 7860

ACTCTTGCCA TTGGGTGGTA CTGTTTGTTG ACTGACTGAC TGACTGACTG GAGGGGGTTT 7920

GTAATTTGTA TCTCAGGGAT TACCCCCAAC AGCCCTGGGG TACAATGAGC CTTCAAGAAG 7980

TTTAACAACC TATGTAAGGA CACACAGCCA GTGGGTGATG CTGCCTGGTC TGACTCTTGC 8040

CATTCAGTGG CACTGTTTGT TGACTGACTG ACTGACTGAC TGGCTGACTG GAGGGGGTTC 8100

ATAGCTAATA TTAATGGAGT GGTCTAAGTA TCATTGGTTC CTTGAACCCT GCACTGTGGC 8160

AAAGTGGCCC ACAGGCTGGA GGAGGACCAA GACAGGAGGG CAGTCTCGGG AGGAGTGCCT 8220

GGCAGGCCCC TCACCACCTC TGCCTACCTC AGTGAAGTTC CCTTGTGGGA GGCCCTGGAA 8280

GCGGATGGAG AAGAAGCGCA GTCACCTGAA ACGAGACACA GAAGACCAAG AAGACCAAGT 8340

AGATCCGCGG CTCATTGATG GGAAGATGAC CAGGCGGGGA GACAGCCCCT GGCAGGTGGG 8400

AGGCGAGGCA GCACCGGCTC GTCACGTGCT GGGTCCGGGA TCACTGAGTC CATCCTGGCA 8460

GCTATGCTCA GGGTGCAGAA ACCGAGAGGG AAGCGCTGCC ATTGCGTTTG GGGGATGATG 8520

AAGGTGGGGG ATGCTTCAGG GAAAGATGGA CGCAACCTGA GGGGAGAGGA GCAGCCAGGG 8580

TGGGTGAGGG GAGGGGCATG GGGGCATGGA GGGGTCTGCA GGAGGGAGGG TTACAGTTTC 8640

TAAAAAGAGC TGGAAAGACA CTGCTCTGCT GGCGGGATTT TAGGCAGAAG CCCTGCTGAT 8700

GGGAGAGGGC TAGGAGGGAG GGCCGGGCCT GAGTACCCCT CCAGCCTCCA CATGGGAACT 8760

GACACTTACT GGGTTCCCCT CTCTGCCAGG CATGGGGGAG ATAGGAACCA ACAAGTGGGA 8820

GTATTTGCCC TGGGGACTCA GACTCTGCAA GGGTCAGGAC CCCAAAGACC CGGCAGCCCA 8880

GTGGGACCAC AGCCAGGACG GCCCTTCAAG ATAGGGGCTG AGGGAGGCCA AGGGGAACAT 8940

CCAGGCAGCC TGGGGGCCAC AAAGTCTTCC TGGAAGACAC AAGGCCTGCC AAGCCTCTAA 9000

GGATGAGAGG AGCTCGCTGG GCGATGTTGG TGTGGCTGAG GGTGACTGAA ACAGTATGAA 9060

CAGTGCAGGA ACAGCATGGG CAAAGGCAGG AAGACACCCT GGGACAGGCT GACACTGTAA 9120

AATGGGCAAA AATAGAAAAC GCCAGAAAGG CCTAAGCCTA TGCCCATATG ACCAGGGAAC 9180

CCAGGAAAGT GCATATGAAA CCCAGGTGCC CTGGACTGGA GGCTGTCAGG AGGCAGCCCT 9240

GTGATGTCAT CATCCCACCC CATTCCAGGT GGTCCTGCTG GACTCAAAGA AGAAGCTGGC 9300

CTGCGGGGCA GTGCTCATCC ACCCCTCCTG GGTGCTGACA GCGGCCCACT GCATGGATGA 9360

GTCCAAGAAG CTCCTTGTCA GGCTTGGTAT GGGCTGGAGC CAGGCAGAAG GGGGCTGCCA 9420

GAGGCCTGGG TAGGGGGACC AGGCAGGCTG TTCAGGTTTG GGGGACCCCG CTCCCCAGGT 9480

GCTTAAGCAA GAGGCTTCTT GAGCTCCACA GAAGGTGTTT GGGGGGAAGA GGCCTATGTG 9540

CCCCCACCCT GCCCACCCAT GTACACCCAG TATTTTGCAG TAGGGGGTTC TCTGGTGCCC 9600

TCTTCGAATC TGGGCACAGG TACCTGCACA CACATGTTTG TGAGGGGCTA CACAGACCTT 9660

CACCTCTCCA CTCCCACTCA TGAGGAGCAG GCTGTGTGGG CCTCAGCACC CTTGGGTGCA 9720

GAGACCAGCA AGGCCTGGCC TCAGGGCTGT GCCTCCCACA GACTGACAGG GATGGAGCTG 9780

TACAGAGGGA GCCCTAGCAT CTGCCAAAGC CACAAGCTGC TTCCCTAGCA GGCTGGGGGC 9840

TCCTATGCAT TGGCCCCGAT CTATGGCAAT TTCTGGAGGG GGGGTCTGGC TCAACTCTTT 9900

ATGCCAAAAA GAAGGCAAAG CATATTGAGA AAGGCCAAAT TCACATTTCC TACAGCATAA 9960

TCTATGCCAG TGGCCCCGTG GGGCTTGGCT TAGAATTCCC AGGTGCTCTT CCCAGGGAAC 10020

CATCAGTCTG GACTGAGAGG ACCTTCTCTC TCAGGTGGGA CCCGGCCCTG TCCTCCCTGG 10080

CAGTGCCGTG TTCTGGGGGT CCTCCTCTCT GGGTCTCACT GCCCCTGGGG TCTCTCCAGC 10140

TACCTTTGCT CCATGTTCCT TTGTGGCTCT GGTCTGTGTC TGGGGTTTCC AGGGGTCTCG 10200

›(i) SEQUENCE CHARACTERISTICS · 3 of 3

GGCTTCCCTG CTGCCCATTC CTTCTCTGGT CTCACGGCTC CGTGACTCCT GAAAACCAAC 10260

CAGCATCCTA CCCCTTTGGA TTGACACCTG TTGGCCACTC CTTCTGGCAG GAAAAGTCAC 10320

CGTTGATAGG GTTCCACGGC ATAGACAGGT GGCTCCGCGC CAGTGCCTGG GACGTGTGGG 10380

TGCACAGTCT CCGGGTGAAC CTTCTTCAGG CCCTCTCCCA GGCCTGCAGG GGCACAGCAG 10440

TGGGTGGGCC TCAGGAAAGT GCCACTGGGG AGAGGCTCCC CGCAGCCCAC TCTGACTGTG 10500

CCCTCTGCCC TGCAGGAGAG TATGACCTGC GGCGCTGGGA GAAGTGGGAG CTGGACCTGG 10560

ACATCAAGGA GGTCTTCGTC CACCCCAACT ACAGCAAGAG CACCACCGAC AATGACATCG 10620

CACTGCTGCA CCTGGCCCAG CCCGCCACCC TCTCGCAGAC CATAGTGCCC ATCTGCCTCC 10680

CGGACAGCGG CCTTGCAGAG CGCGAGCTCA ATCAGGCCGG CCAGGAGACC CTCGTGACGG 10740

GCTGGGGCTA CCACAGCAGC CGAGAGAAGG AGGCCAAGAG AAACCGCACC TTCGTCCTCA 10800

ACTTCATCAA GATTCCCGTG GTCCCGCACA ATGAGTGCAG CGAGGTCATG AGCAACATGG 10860

TGTCTGAGAA CATGCTGTGT GCGGGCATCC TCGGGGACCG GCAGGATGCC TGCGAGGGCG 10920

ACAGTGGGGG GCCCATGGTC GCCTCCTTCC ACGGCACCTG GTTCCTGGTG GGCCTGGTGA 10980

GCTGGGGTGA GGGCTGTGGG CTCCTTCACA ACTACGGCGT TTACACCAAA GTCAGCCGCT 11040

ACCTCGACTG GATCCATGGG CACATCAGAG ACAAGGAAGC CCCCCAGAAG AGCTGGGCAC 11100

CTTAGCGACC CTCCCTGCAG GGCTGGGCTT TTGCATGGCA ATGGATGGGA CATTAAAGGG 11160

ACATGTAACA AGCACACCGG CCTGCTGTTC TGTCCTTCCA TCCCTCTTTT GGGCTCTTCT 11220

GGAGGGAAGT AACATTTACT GAGCACCTGT TGTATGTCAC ATGCCTTATG AATAGAATCT 11280

TAACTCCTAG AGCAACTCTG TGGGGTGGGG AGGAGCAGAT CCAAGTTTTG CGGGGTCTAA 11340

AGCTGTGTGT GTTGAGGGGG ATACTCTGTT TATGAAAAAG AATAAAAAAC ACAACCACGA 11400

AGCCACTAGA GCCTTTTCCA GGGCTTTGGG AAGAGCCTGT GCAAGCCGGG GATGCTGAAG 11460

GTGAGGCTTG ACCAGCTTTC CAGCTAGCCC AGCTATGAGG TAGACATGTT TAGCTCATAT 11520

CACAGAGGAG GAAACTGAGG GGTCTGAAAG GTTTACATGG TGGAGCCAGG ATTCAAATCT 11580

AGGTCTGACT CCAAAACCCA GGTGCTTTTT TCTGTTCTCC ACTGTCCTGG AGGACAGCTG 11640

TTTCGACGGT GCTCAGTGTG GAGGCCACTA TTAGCTCTGT AGGGAAGCAG CCAGAGACCC 11700

AGAAAGTGTT GGTTCAGCCC AGAAT 11725

(2) INFORMATION FOR SEQ ID NO:32:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 461 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:32:

Met Trp Gln Leu Thr Ser Leu Leu Leu Phe Val Ala Thr Trp Gly Ile

1 5 10 15

Ser Gly Thr Pro Ala Pro Leu Asp Ser Val Phe Ser Ser Ser Glu Arg

20 25 30

Ala His Gln Val Leu Arg Ile Arg Lys Arg Ala Asn Ser Phe Leu Glu

35 40 45

Glu Leu Arg His Ser Ser Leu Glu Arg Glu Cys Ile Glu Glu Ile Cys

50 55 60

Asp Phe Glu Glu Ala Lys Glu Ile Phe Gln Asn Val Asp Asp Thr Leu

65 70 75 80

Ala Phe Trp Ser Lys His Val Asp Gly Asp Gln Cys Leu Val Leu Pro

85 90 95

Leu Glu His Pro Cys Ala Ser Leu Cys Cys Gly His Gly Thr Cys Ile

100 105 110

Asp Gly Ile Gly Ser Phe Ser Cys Asp Cys Arg Ser Gly Trp Glu Gly

115 120 125

Arg Phe Cys Gln Arg Glu Val Ser Phe Leu Asn Cys Ser Leu Asp Asn

130 135 140

Gly Gly Cys Thr His Tyr Cys Leu Glu Glu Val Gly Trp Arg Arg Cys

145 150 155 160

Ser Cys Ala Pro Gly Tyr Lys Leu Gly Asp Asp Leu Leu Gln Cys His

165 170 175

Pro Ala Val Lys Phe Pro Cys Gly Arg Pro Trp Lys Arg Met Glu Lys

180 185 190

Lys Arg Ser His Leu Lys Arg Asp Thr Glu Asp Gln Glu Asp Gln Val

195 200 205

Asp Pro Arg Leu Ile Asp Gly Lys Met Thr Arg Arg Gly Asp Ser Pro

210 215 220

Trp Gln Val Val Leu Leu Asp Ser Lys Lys Lys Leu Ala Cys Gly Ala

225 230 235 240

Val Leu Ile His Pro Ser Trp Val Leu Thr Ala Ala His Cys Met Asp

245 250 255

Glu Ser Lys Lys Leu Leu Val Arg Leu Gly Glu Tyr Asp Leu Arg Arg

260 265 270

Trp Glu Lys Trp Glu Leu Asp Leu Asp Ile Lys Glu Val Phe Val His

275 280 285

Pro Asn Tyr Ser Lys Ser Thr Thr Asp Asn Asp Ile Ala Leu Leu His

290 295 300

Leu Ala Gln Pro Ala Thr Leu Ser Gln Thr Ile Val Pro Ile Cys Leu

305 310 315 320

Pro Asp Ser Gly Leu Ala Glu Arg Glu Leu Asn Gln Ala Gly Gln Glu

325 330 335

Thr Leu Val Thr Gly Trp Gly Tyr His Ser Ser Arg Glu Lys Glu Ala

340 345 350

Lys Arg Asn Arg Thr Phe Val Leu Asn Phe Ile Lys Ile Pro Val Val

355 360 365

Pro His Asn Glu Cys Ser Glu Val Met Ser Asn Met Val Ser Glu Asn

370 375 380

Met Leu Cys Ala Gly Ile Leu Gly Asp Arg Gln Asp Ala Cys Glu Gly

385 390 395 400

Asp Ser Gly Gly Pro Met Val Ala Ser Phe His Gly Thr Trp Phe Leu

405 410 415

Val Gly Leu Val Ser Trp Gly Glu Gly Cys Gly Leu Leu His Asn Tyr

420 425 430

Gly Val Tyr Thr Lys Val Ser Arg Tyr Leu Asp Trp Ile His Gly His

435 440 445

Ile Arg Asp Lys Glu Ala Pro Gln Lys Ser Trp Ala Pro

450 455 460

(2) INFORMATION FOR SEQ ID NO:33:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 1744 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 268...1587

›(D) OTHER INFORMATION

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:33:

TGAGGCCTGA CTTTTTCAAT AAAACATTGT GTAGTTCTGG GCCTCCTGCT GCCCCGGCTC 60

TGTTTCCCCT GGCGCCAAGA GAAGAAGGCG GAACTGAACC CAGGCCCAGA GCCGGCTCCC 120

TGAGGCTGTG CCCCTTTCCG GCAATCTCTG GCCACAACCC CCACTGGCCA GGCCGTCCCT 180

CCCACTGGCC CTAGGGCCCC TCCCACTCCC ACACCAGATA AGGACAGCCC AGTGCCGCTT 240

TCTCTGGCAG TAGGCACCAG GGCTGGA ATG GGG CCG CCC GGC TCC CCA TGG CAG 294

Met Gly Pro Pro Gly Ser Pro Trp Gln

1 5

TGG GTG ACG CTG CTG CTG GGG CTG CTG CTC CCT CCT GCC GCC CCC TTC 342

Trp Val Thr Leu Leu Leu Gly Leu Leu Leu Pro Pro Ala Ala Pro Phe

10 15 20 25

TGG CTC CTC AAT GTG CTC TTC CCC CCG CAC ACC ACG CCC AAG GCT GAG 390

Trp Leu Leu Asn Val Leu Phe Pro Pro His Thr Thr Pro Lys Ala Glu

30 35 40

CTC AGT AAC CAC ACA CGG CCC GTC ATC CTC GTG CCC GGC TGC CTG GGG 438

Leu Ser Asn His Thr Arg Pro Val Ile Leu Val Pro Gly Cys Leu Gly

45 50 55

AAT CAG CTA GAA GCC AAG CTG GAC AAA CCA GAT GTG GTG AAC TGG ATG 486

Asn Gln Leu Glu Ala Lys Leu Asp Lys Pro Asp Val Val Asn Trp Met

60 65 70

TGC TAC CGC AAG ACA GAG GAC TTC TTC ACC ATC TGG CTG GAT CTC AAC 534

Cys Tyr Arg Lys Thr Glu Asp Phe Phe Thr Ile Trp Leu Asp Leu Asn

75 80 85

ATG TTC CTA CCC CTT GGG GTA GAC TGC TGG ATC GAT AAC ACC AGG GTT 582

Met Phe Leu Pro Leu Gly Val Asp Cys Trp Ile Asp Asn Thr Arg Val

90 95 100 105

GTC TAC AAC CGG AGC TCT GGG CTC GTG TCC AAC GCC CCT GGT GTC CAG 630

Val Tyr Asn Arg Ser Ser Gly Leu Val Ser Asn Ala Pro Gly Val Gln

110 115 120

ATC CGC GTC CCT GGC TTT GGC AAG ACC TAC TCT GTG GAG TAC CTG GAC 678

Ile Arg Val Pro Gly Phe Gly Lys Thr Tyr Ser Val Glu Tyr Leu Asp

125 130 135

AGC AGC AAG CTG GCA GGG TAC CTG CAC ACA CTG GTG CAG AAC CTG GTC 726

Ser Ser Lys Leu Ala Gly Tyr Leu His Thr Leu Val Gln Asn Leu Val

140 145 150

AAC AAT GGC TAC GTG CGG GAC GAG ACT GTG CGC GCC GCC CCC TAT GAC 774

Asn Asn Gly Tyr Val Arg Asp Glu Thr Val Arg Ala Ala Pro Tyr Asp

155 160 165

TGG CGG CTG GAG CCC GGC CAG CAG GAG GAG TAC TAC CGC AAG CTC GCA 822

Trp Arg Leu Glu Pro Gly Gln Gln Glu Glu Tyr Tyr Arg Lys Leu Ala

170 175 180 185

GGG CTG GTG GAG GAG ATG CAC GCT GCC TAT GGG AAG CCT GTC TTC CTC 870

Gly Leu Val Glu Glu Met His Ala Ala Tyr Gly Lys Pro Val Phe Leu

190 195 200

ATT GGC CAC AGC CTC GGC TGT CTA CAC TTG CTC TAT TTC CTG CTG CGC 918

Ile Gly His Ser Leu Gly Cys Leu His Leu Leu Tyr Phe Leu Leu Arg

205 210 215

CAG CCC CAG GCC TGG AAG GAC CGC TTT ATT GAT GGC TTC ATC TCT CTT 966

Gln Pro Gln Ala Trp Lys Asp Arg Phe Ile Asp Gly Phe Ile Ser Leu

220 225 230

GGG GCT CCC TGG GGT GGC TCC ATC AAG CCC ATG CTG GTC TTG GCC TCA 1014

Gly Ala Pro Trp Gly Gly Ser Ile Lys Pro Met Leu Val Leu Ala Ser

235 240 245

GGT GAC AAC CAG GGC ATC CCC ATC ATG TCC AGC ATC AAG CTG AAA GAG 1062

Gly Asp Asn Gln Gly Ile Pro Ile Met Ser Ser Ile Lys Leu Lys Glu

250 255 260 265

GAG CAG CGC ATA ACC ACC ACC TCC CCC TGG ATG TTT CCC TCT CGC ATG 1110

Glu Gln Arg Ile Thr Thr Thr Ser Pro Trp Met Phe Pro Ser Arg Met

270 275 280

GCG TGG CCT GAG GAC CAC GTG TTC ATT TCC ACA CCC AGC TTC AAC TAC 1158

Ala Trp Pro Glu Asp His Val Phe Ile Ser Thr Pro Ser Phe Asn Tyr

285 290 295

ACA GGC CGT GAC TTC CAA CGC TTC TTT GCA GAC CTG CAC TTT GAG GAA 1206

Thr Gly Arg Asp Phe Gln Arg Phe Phe Ala Asp Leu His Phe Glu Glu

300 305 310

GGC TGG TAC ATG TGG CTG CAG TCA CGT GAC CTC CTG GCA GGA CTC CCA 1254

Gly Trp Tyr Met Trp Leu Gln Ser Arg Asp Leu Leu Ala Gly Leu Pro

315 320 325

GCA CCT GGT GTG GAA GTA TAC TGT CTT TAC GGC GTG GGC CTG CCC ACG 1302

Ala Pro Gly Val Glu Val Tyr Cys Leu Tyr Gly Val Gly Leu Pro Thr

330 335 340 345

CCC CGC ACC TAC ATC TAC GAC CAC GGC TTC CCC TAC ACG GAC CCT GTG 1350

Pro Arg Thr Tyr Ile Tyr Asp His Gly Phe Pro Tyr Thr Asp Pro Val

350 355 360

GGT GTG CTC TAT GAG GAT GGT GAT GAC ACG GTG GCG ACC CGC AGC ACC 1398

Gly Val Leu Tyr Glu Asp Gly Asp Asp Thr Val Ala Thr Arg Ser Thr

365 370 375

GAG CTC TGT GGC CTG TGG CAG GGC CGC CAG CCA CAG CCT GTG CAC CTG 1446

Glu Leu Cys Gly Leu Trp Gln Gly Arg Gln Pro Gln Pro Val His Leu

380 385 390

CTG CCC CTG CAC GGG ATA CAG CAT CTC AAC ATG GTC TTC AGC AAC CTG 1494

Leu Pro Leu His Gly Ile Gln His Leu Asn Met Val Phe Ser Asn Leu

395 400 405

ACC CTG GAG CAC ATC AAT GCC ATC CTG CTG GGT GCC TAC CGC CAG GGT 1542

Thr Leu Glu His Ile Asn Ala Ile Leu Leu Gly Ala Tyr Arg Gln Gly

410 415 420 425

CCC CCT GCA TCC CCG ACT GCC AGC CCA GAG CCC CCG CCT CCT GAA 1587

Pro Pro Ala Ser Pro Thr Ala Ser Pro Glu Pro Pro Pro Pro Glu

430 435 440

TAAAGACCTT CCTTTGCTAC CGTAAGCCCT GATGGCTATG TTTCAGGTTG AAGGGAGGCA 1647

CTAGAGTCCC ACACTAGGTT TCACTCCTCA CCAGCCACAG GCTCAGTGCT GTGTGCAGTG 1707

AGGCAAGATG GGCTCTGCTG AGGCCTGGGA CTGAGCT 1744

(2) INFORMATION FOR SEQ ID NO:34:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 440 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:34:

Met Gly Pro Pro Gly Ser Pro Trp Gln Trp Val Thr Leu Leu Leu Gly

1 5 10 15

Leu Leu Leu Pro Pro Ala Ala Pro Phe Trp Leu Leu Asn Val Leu Phe

20 25 30

Pro Pro His Thr Thr Pro Lys Ala Glu Leu Ser Asn His Thr Arg Pro

35 40 45

Val Ile Leu Val Pro Gly Cys Leu Gly Asn Gln Leu Glu Ala Lys Leu

50 55 60

Asp Lys Pro Asp Val Val Asn Trp Met Cys Tyr Arg Lys Thr Glu Asp

65 70 75 80

Phe Phe Thr Ile Trp Leu Asp Leu Asn Met Phe Leu Pro Leu Gly Val

85 90 95

Asp Cys Trp Ile Asp Asn Thr Arg Val Val Tyr Asn Arg Ser Ser Gly

100 105 110

Leu Val Ser Asn Ala Pro Gly Val Gln Ile Arg Val Pro Gly Phe Gly

115 120 125

Lys Thr Tyr Ser Val Glu Tyr Leu Asp Ser Ser Lys Leu Ala Gly Tyr

130 135 140

Leu His Thr Leu Val Gln Asn Leu Val Asn Asn Gly Tyr Val Arg Asp

145 150 155 160

Glu Thr Val Arg Ala Ala Pro Tyr Asp Trp Arg Leu Glu Pro Gly Gln

165 170 175

Gln Glu Glu Tyr Tyr Arg Lys Leu Ala Gly Leu Val Glu Glu Met His

180 185 190

Ala Ala Tyr Gly Lys Pro Val Phe Leu Ile Gly His Ser Leu Gly Cys

195 200 205

Leu His Leu Leu Tyr Phe Leu Leu Arg Gln Pro Gln Ala Trp Lys Asp

210 215 220

Arg Phe Ile Asp Gly Phe Ile Ser Leu Gly Ala Pro Trp Gly Gly Ser

225 230 235 240

Ile Lys Pro Met Leu Val Leu Ala Ser Gly Asp Asn Gln Gly Ile Pro

245 250 255

Ile Met Ser Ser Ile Lys Leu Lys Glu Glu Gln Arg Ile Thr Thr Thr

260 265 270

Ser Pro Trp Met Phe Pro Ser Arg Met Ala Trp Pro Glu Asp His Val

275 280 285

Phe Ile Ser Thr Pro Ser Phe Asn Tyr Thr Gly Arg Asp Phe Gln Arg

290 295 300

Phe Phe Ala Asp Leu His Phe Glu Glu Gly Trp Tyr Met Trp Leu Gln

305 310 315 320

Ser Arg Asp Leu Leu Ala Gly Leu Pro Ala Pro Gly Val Glu Val Tyr

325 330 335

Cys Leu Tyr Gly Val Gly Leu Pro Thr Pro Arg Thr Tyr Ile Tyr Asp

340 345 350

His Gly Phe Pro Tyr Thr Asp Pro Val Gly Val Leu Tyr Glu Asp Gly

355 360 365

Asp Asp Thr Val Ala Thr Arg Ser Thr Glu Leu Cys Gly Leu Trp Gln

370 375 380

Gly Arg Gln Pro Gln Pro Val His Leu Leu Pro Leu His Gly Ile Gln

385 390 395 400

His Leu Asn Met Val Phe Ser Asn Leu Thr Leu Glu His Ile Asn Ala

405 410 415

Ile Leu Leu Gly Ala Tyr Arg Gln Gly Pro Pro Ala Ser Pro Thr Ala

420 425 430

Ser Pro Glu Pro Pro Pro Pro Glu

435 440

(2) INFORMATION FOR SEQ ID NO:35:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 2182 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 29...1525

›(D) OTHER INFORMATION

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:35:

CGAAACACAG AGCTTTAGCT CCGCCAAA ATG AAA CAC TCA TTA AAC GCA CTT 52

Met Lys His Ser Leu Asn Ala Leu

1 5

CTC ATT TTC CTC ATC ATA ACA TCT GCG TGG GGT GGG AGC AAA GGC CCG 100

Leu Ile Phe Leu Ile Ile Thr Ser Ala Trp Gly Gly Ser Lys Gly Pro

10 15 20

CTG GAT CAG CTA GAG AAA GGA GGG GAA ACT GCT CAG TCT GCA GAT CCC 148

Leu Asp Gln Leu Glu Lys Gly Gly Glu Thr Ala Gln Ser Ala Asp Pro

25 30 35 40

CAG TGG GAG CAG TTA AAT AAC AAA AAC CTG AGC ATG CCT CTT CTC CCT 196

Gln Trp Glu Gln Leu Asn Asn Lys Asn Leu Ser Met Pro Leu Leu Pro

45 50 55

GCC GAC TTC CAC AAG GAA AAC ACC GTC ACC AAC GAC TGG ATT CCA GAG 244

Ala Asp Phe His Lys Glu Asn Thr Val Thr Asn Asp Trp Ile Pro Glu

60 65 70

GGG GAG GAG GAC GAC GAC TAT CTG GAC CTG GAG AAG ATA TTC AGT GAA 292

Gly Glu Glu Asp Asp Asp Tyr Leu Asp Leu Glu Lys Ile Phe Ser Glu

75 80 85

GAC GAC GAC TAC ATC GAC ATC GTC GAC AGT CTG TCA GTT TCC CCG ACA 340

Asp Asp Asp Tyr Ile Asp Ile Val Asp Ser Leu Ser Val Ser Pro Thr

90 95 100

GAC TCT GAT GTG AGT GCT GGG AAC ATC CTC CAG CTT TTT CAT GGC AAG 388

Asp Ser Asp Val Ser Ala Gly Asn Ile Leu Gln Leu Phe His Gly Lys

105 110 115 120

AGC CGG ATC CAG CGT CTT AAC ATC CTC AAC GCC AAG TTC GCT TTC AAC 436

Ser Arg Ile Gln Arg Leu Asn Ile Leu Asn Ala Lys Phe Ala Phe Asn

125 130 135

CTC TAC CGA GTG CTG AAA GAC CAG GTC AAC ACT TTC GAT AAC ATC TTC 484

Leu Tyr Arg Val Leu Lys Asp Gln Val Asn Thr Phe Asp Asn Ile Phe

140 145 150

ATA GCA CCC GTT GGC ATT TCT ACT GCG ATG GGT ATG ATT TCC TTA GGT 532

Ile Ala Pro Val Gly Ile Ser Thr Ala Met Gly Met Ile Ser Leu Gly

155 160 165

CTG AAG GGA GAG ACC CAT GAA CAA GTG CAC TCG ATT TTG CAT TTT AAA 580

Leu Lys Gly Glu Thr His Glu Gln Val His Ser Ile Leu His Phe Lys

170 175 180

GAC TTT GTT AAT GCC AGC AGC AAG TAT GAA ATC ACG ACC ATT CAT AAT 628

Asp Phe Val Asn Ala Ser Ser Lys Tyr Glu Ile Thr Thr Ile His Asn

185 190 195 200

CTC TTC CGT AAG CTG ACT CAT CGC CTC TTC AGG AGG AAT TTT GGG TAC 676

Leu Phe Arg Lys Leu Thr His Arg Leu Phe Arg Arg Asn Phe Gly Tyr

205 210 215

ACA CTG CGG TCA GTC AAT GAC CTT TAT ATC CAG AAG CAG TTT CCA ATC 724

Thr Leu Arg Ser Val Asn Asp Leu Tyr Ile Gln Lys Gln Phe Pro Ile

220 225 230

CTG CTT GAC TTC AGA ACT AAA GTA AGA GAG TAT TAC TTT GCT GAG GCC 772

Leu Leu Asp Phe Arg Thr Lys Val Arg Glu Tyr Tyr Phe Ala Glu Ala

235 240 245

CAG ATA GCT GAC TTC TCA GAC CCT GCC TTC ATA TCA AAA ACC AAC AAC 820

Gln Ile Ala Asp Phe Ser Asp Pro Ala Phe Ile Ser Lys Thr Asn Asn

250 255 260

CAC ATC ATG AAG CTC ACC AAG GGC CTC ATA AAA GAT GCT CTG GAG AAT 868

His Ile Met Lys Leu Thr Lys Gly Leu Ile Lys Asp Ala Leu Glu Asn

265 270 275 280

ATA GAC CCT GCT ACC CAG ATG ATG ATT CTC AAC TGC ATC TAC TTC AAA 916

Ile Asp Pro Ala Thr Gln Met Met Ile Leu Asn Cys Ile Tyr Phe Lys

285 290 295

GGA TCC TGG GTG AAT AAA TTC CCA GTG GAA ATG ACA CAC AAC CAC AAC 964

Gly Ser Trp Val Asn Lys Phe Pro Val Glu Met Thr His Asn His Asn

300 305 310

TTC CGG CTG AAT GAG AGA GAG GTA GTT AAG GTT TCC ATG ATG CAG ACC 1012

Phe Arg Leu Asn Glu Arg Glu Val Val Lys Val Ser Met Met Gln Thr

315 320 325

AAG GGG AAC TTC CTC GCA GCA AAT GAC CAG GAG CTG GAC TGC GAC ATC 1060

Lys Gly Asn Phe Leu Ala Ala Asn Asp Gln Glu Leu Asp Cys Asp Ile

330 335 340

CTC CAG CTG GAA TAC GTG GGG GGC ATC AGC ATG CTA ATT GTG GTC CCA 1108

Leu Gln Leu Glu Tyr Val Gly Gly Ile Ser Met Leu Ile Val Val Pro

345 350 355 360

CAC AAG ATG TCT GGG ATG AAG ACC CTC GAA GCG CAA CTG ACA CCC CGG 1156

His Lys Met Ser Gly Met Lys Thr Leu Glu Ala Gln Leu Thr Pro Arg

365 370 375

GTG GTG GAG AGA TGG CAA AAA AGC ATG ACA AAC AGA ACT CGA GAA GTG 1204

Val Val Glu Arg Trp Gln Lys Ser Met Thr Asn Arg Thr Arg Glu Val

380 385 390

CTT CTG CCG AAA TTC AAG CTG GAG AAG AAC TAC AAT CTA GTG GAG TCC 1252

Leu Leu Pro Lys Phe Lys Leu Glu Lys Asn Tyr Asn Leu Val Glu Ser

395 400 405

CTG AAG TTG ATG GGG ATC AGG ATG CTG TTT GAC AAA AAT GGC AAC ATG 1300

Leu Lys Leu Met Gly Ile Arg Met Leu Phe Asp Lys Asn Gly Asn Met

410 415 420

GCA GGC ATC TCA GAC CAA AGG ATC GCC ATC GAC CTG TTC AAG CAC CAA 1348

Ala Gly Ile Ser Asp Gln Arg Ile Ala Ile Asp Leu Phe Lys His Gln

425 430 435 440

GGC ACG ATC ACA GTG AAC GAG GAA GGC ACC CAA GCC ACC ACT GTG ACC 1396

Gly Thr Ile Thr Val Asn Glu Glu Gly Thr Gln Ala Thr Thr Val Thr

445 450 455

ACG GTG GGG TTC ATG CCG CTG TCC ACC CAA GTC CGC TTC ACT GTC GAC 1444

Thr Val Gly Phe Met Pro Leu Ser Thr Gln Val Arg Phe Thr Val Asp

460 465 470

CGC CCC TTT CTT TTC CTC ATC TAC GAG CAC CGC ACC AGC TGC CTG CTC 1492

Arg Pro Phe Leu Phe Leu Ile Tyr Glu His Arg Thr Ser Cys Leu Leu

475 480 485

TTC ATG GGA AGA GTG GCC AAC CCC AGC AGG TCC TAGAGGTGGA GGTCTAGGTG 1545

Phe Met Gly Arg Val Ala Asn Pro Ser Arg Ser

490 495

TCTGAAGTGC CTTGGGGGCA CCCTCATTTT GTTTCCATTC CAACAACGAG AACAGAGATG 1605

TTCTGGCATC ATTTACGTAG TTTACGCTAC CAATCTGAAT TCGAGGCCCA TATGAGAGGA 1665

GCTTAGAAAC GACCAAGAAG AGAGGCTTGT TGGAATCAAT TCTGCACAAT AGCCCATGCT 1725

GTAAGCTCAT AGAAGTCACT GTAACTGTAG TGTGTCTGCT GTTACCTAGA GGGTCTCACC 1785

TCCCCACTCT TCACAGCAAA CCTGAGCAGC GCGTCCTAAG CACCTCCCGC TCCGGTGACC 1845

CCATCCTTGC ACACCTGACT CTGTCACTCA AGCCTTTCTC CACCAGGCCC CTCATCTGAA 1905

TACCAAGCAC AGAAATGAGT GGTGTGACTA ATTCCTTACC TCTCCCAAGG AGGGTACACA 1965

ACTAGCACCA TTCTTGATGT CCAGGGAAGA AGCCACCTCA AGACATATGA GGGGTGCCCT 2025

GGGCTAATGT TAGGGCTTAA TTTTCTCAAA GCCTGACCTT TCAAATCCAT GATGAATGCC 2085

ATCAGTCCCT CCTGCTGTTG CCTCCCTGTG ACCTGGAGGA CAGTGTGTGC CATGTCTCCC 2145

ATACTAGAGA TAAATAAATG TAGCCACATT TACTGTG 2182

(2) INFORMATION FOR SEQ ID NO:36:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 499 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:36:

Met Lys His Ser Leu Asn Ala Leu Leu Ile Phe Leu Ile Ile Thr Ser

1 5 10 15

Ala Trp Gly Gly Ser Lys Gly Pro Leu Asp Gln Leu Glu Lys Gly Gly

20 25 30

Glu Thr Ala Gln Ser Ala Asp Pro Gln Trp Glu Gln Leu Asn Asn Lys

35 40 45

Asn Leu Ser Met Pro Leu Leu Pro Ala Asp Phe His Lys Glu Asn Thr

50 55 60

Val Thr Asn Asp Trp Ile Pro Glu Gly Glu Glu Asp Asp Asp Tyr Leu

65 70 75 80

Asp Leu Glu Lys Ile Phe Ser Glu Asp Asp Asp Tyr Ile Asp Ile Val

85 90 95

Asp Ser Leu Ser Val Ser Pro Thr Asp Ser Asp Val Ser Ala Gly Asn

100 105 110

Ile Leu Gln Leu Phe His Gly Lys Ser Arg Ile Gln Arg Leu Asn Ile

115 120 125

Leu Asn Ala Lys Phe Ala Phe Asn Leu Tyr Arg Val Leu Lys Asp Gln

130 135 140

Val Asn Thr Phe Asp Asn Ile Phe Ile Ala Pro Val Gly Ile Ser Thr

145 150 155 160

Ala Met Gly Met Ile Ser Leu Gly Leu Lys Gly Glu Thr His Glu Gln

165 170 175

Val His Ser Ile Leu His Phe Lys Asp Phe Val Asn Ala Ser Ser Lys

180 185 190

Tyr Glu Ile Thr Thr Ile His Asn Leu Phe Arg Lys Leu Thr His Arg

195 200 205

Leu Phe Arg Arg Asn Phe Gly Tyr Thr Leu Arg Ser Val Asn Asp Leu

210 215 220

Tyr Ile Gln Lys Gln Phe Pro Ile Leu Leu Asp Phe Arg Thr Lys Val

225 230 235 240

Arg Glu Tyr Tyr Phe Ala Glu Ala Gln Ile Ala Asp Phe Ser Asp Pro

245 250 255

Ala Phe Ile Ser Lys Thr Asn Asn His Ile Met Lys Leu Thr Lys Gly

260 265 270

Leu Ile Lys Asp Ala Leu Glu Asn Ile Asp Pro Ala Thr Gln Met Met

275 280 285

Ile Leu Asn Cys Ile Tyr Phe Lys Gly Ser Trp Val Asn Lys Phe Pro

290 295 300

Val Glu Met Thr His Asn His Asn Phe Arg Leu Asn Glu Arg Glu Val

305 310 315 320

Val Lys Val Ser Met Met Gln Thr Lys Gly Asn Phe Leu Ala Ala Asn

325 330 335

Asp Gln Glu Leu Asp Cys Asp Ile Leu Gln Leu Glu Tyr Val Gly Gly

340 345 350

Ile Ser Met Leu Ile Val Val Pro His Lys Met Ser Gly Met Lys Thr

355 360 365

Leu Glu Ala Gln Leu Thr Pro Arg Val Val Glu Arg Trp Gln Lys Ser

370 375 380

Met Thr Asn Arg Thr Arg Glu Val Leu Leu Pro Lys Phe Lys Leu Glu

385 390 395 400

Lys Asn Tyr Asn Leu Val Glu Ser Leu Lys Leu Met Gly Ile Arg Met

405 410 415

Leu Phe Asp Lys Asn Gly Asn Met Ala Gly Ile Ser Asp Gln Arg Ile

420 425 430

Ala Ile Asp Leu Phe Lys His Gln Gly Thr Ile Thr Val Asn Glu Glu

435 440 445

Gly Thr Gln Ala Thr Thr Val Thr Thr Val Gly Phe Met Pro Leu Ser

450 455 460

Thr Gln Val Arg Phe Thr Val Asp Arg Pro Phe Leu Phe Leu Ile Tyr

465 470 475 480

Glu His Arg Thr Ser Cys Leu Leu Phe Met Gly Arg Val Ala Asn Pro

485 490 495

Ser Arg Ser

(2) INFORMATION FOR SEQ ID NO:37:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 6893 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 77...6748

›(D) OTHER INFORMATION · 1 of 4

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:37:

CTCCGGGCTG TCCCAGCTCG GCAAGCGCTG CCCAGGTCCT GGGGTGGTGG CAGCCAGCGG 60

GAGCAGGAAA GGAAGC ATG TTC CCA GGC TGC CCA CGC CTC TGG GTC CTG GTG 112

Met Phe Pro Gly Cys Pro Arg Leu Trp Val Leu Val

1 5 10

GTC TTG GGC ACC AGC TGG GTA GGC TGG GGG AGC CAA GGG ACA GAA GCG 160

Val Leu Gly Thr Ser Trp Val Gly Trp Gly Ser Gln Gly Thr Glu Ala

15 20 25

GCA CAG CTA AGG CAG TTC TAC GTG GCT GCT CAG GGC ATC AGT TGG AGC 208

Ala Gln Leu Arg Gln Phe Tyr Val Ala Ala Gln Gly Ile Ser Trp Ser

30 35 40

TAC CGA CCT GAG CCC ACA AAC TCA AGT TTG AAT CTT TCT GTA ACT TCC 256

Tyr Arg Pro Glu Pro Thr Asn Ser Ser Leu Asn Leu Ser Val Thr Ser

45 50 55 60

TTT AAG AAA ATT GTC TAC AGA GAG TAT GAA CCA TAT TTT AAG AAA GAA 304

Phe Lys Lys Ile Val Tyr Arg Glu Tyr Glu Pro Tyr Phe Lys Lys Glu

65 70 75

AAA CCA CAA TCT ACC ATT TCA GGA CTT CTT GGG CCT ACT TTA TAT GCT 352

Lys Pro Gln Ser Thr Ile Ser Gly Leu Leu Gly Pro Thr Leu Tyr Ala

80 85 90

GAA GTC GGA GAC ATC ATA AAA GTT CAC TTT AAA AAT AAG GCA GAT AAG 400

Glu Val Gly Asp Ile Ile Lys Val His Phe Lys Asn Lys Ala Asp Lys

95 100 105

CCC TTG AGC ATC CAT CCT CAA GGA ATT AGG TAC AGT AAA TTA TCA GAA 448

Pro Leu Ser Ile His Pro Gln Gly Ile Arg Tyr Ser Lys Leu Ser Glu

110 115 120

GGT GCT TCT TAC CTT GAC CAC ACA TTC CCT GCA GAG AAG ATG GAC GAC 496

Gly Ala Ser Tyr Leu Asp His Thr Phe Pro Ala Glu Lys Met Asp Asp

125 130 135 140

GCT GTG GCT CCA GGC CGA GAA TAC ACC TAT GAA TGG AGT ATC AGT GAG 544

Ala Val Ala Pro Gly Arg Glu Tyr Thr Tyr Glu Trp Ser Ile Ser Glu

145 150 155

GAC AGT GGA CCC ACC CAT GAT GAC CCT CCA TGC CTC ACA CAC ATC TAT 592

Asp Ser Gly Pro Thr His Asp Asp Pro Pro Cys Leu Thr His Ile Tyr

160 165 170

TAC TCC CAT GAA AAT CTG ATC GAG GAT TTC AAC TCT GGG CTG ATT GGG 640

Tyr Ser His Glu Asn Leu Ile Glu Asp Phe Asn Ser Gly Leu Ile Gly

175 180 185

CCC CTG CTT ATC TGT AAA AAA GGG ACC CTA ACT GAG GGT GGG ACA CAG 688

Pro Leu Leu Ile Cys Lys Lys Gly Thr Leu Thr Glu Gly Gly Thr Gln

190 195 200

AAG ACG TTT GAC AAG CAA ATC GTG CTA CTA TTT GCT GTG TTT GAT GAA 736

Lys Thr Phe Asp Lys Gln Ile Val Leu Leu Phe Ala Val Phe Asp Glu

205 210 215 220

AGC AAG AGC TGG AGC CAG TCA TCA TCC CTA ATG TAC ACA GTC AAT GGA 784

Ser Lys Ser Trp Ser Gln Ser Ser Ser Leu Met Tyr Thr Val Asn Gly

225 230 235

TAT GTG AAT GGG ACA ATG CCA GAT ATA ACA GTT TGT GCC CAT GAC CAC 832

Tyr Val Asn Gly Thr Met Pro Asp Ile Thr Val Cys Ala His Asp His

240 245 250

ATC AGC TGG CAT CTG CTG GGA ATG AGC TCG GGG CCA GAA TTA TTC TCC 880

Ile Ser Trp His Leu Leu Gly Met Ser Ser Gly Pro Glu Leu Phe Ser

255 260 265

ATT CAT TTC AAC GGC CAG GTC CTG GAG CAG AAC CAT CAT AAG GTC TCA 928

Ile His Phe Asn Gly Gln Val Leu Glu Gln Asn His His Lys Val Ser

270 275 280

GCC ATC ACC CTT GTC AGT GCT ACA TCC ACT ACC GCA AAT ATG ACT GTG 976

Ala Ile Thr Leu Val Ser Ala Thr Ser Thr Thr Ala Asn Met Thr Val

285 290 295 300

GGC CCA GAG GGA AAG TGG ATC ATA TCT TCT CTC ACC CCA AAA CAT TTG 1024

Gly Pro Glu Gly Lys Trp Ile Ile Ser Ser Leu Thr Pro Lys His Leu

305 310 315

CAA GCT GGG ATG CAG GCT TAC ATT GAC ATT AAA AAC TGC CCA AAG AAA 1072

Gln Ala Gly Met Gln Ala Tyr Ile Asp Ile Lys Asn Cys Pro Lys Lys

320 325 330

ACC AGG AAT CTT AAG AAA ATA ACT CGT GAG CAG AGG CGG CAC ATG AAG 1120

Thr Arg Asn Leu Lys Lys Ile Thr Arg Glu Gln Arg Arg His Met Lys

335 340 345

AGG TGG GAA TAC TTC ATT GCT GCA GAG GAA GTC ATT TGG GAC TAT GCA 1168

Arg Trp Glu Tyr Phe Ile Ala Ala Glu Glu Val Ile Trp Asp Tyr Ala

350 355 360

CCT GTA ATA CCA GCG AAT ATG GAC AAA AAA TAC AGG TCT CAG CAT TTG 1216

Pro Val Ile Pro Ala Asn Met Asp Lys Lys Tyr Arg Ser Gln His Leu

365 370 375 380

GAT AAT TTC TCA AAC CAA ATT GGA AAA CAT TAT AAG AAA GTT ATG TAC 1264

Asp Asn Phe Ser Asn Gln Ile Gly Lys His Tyr Lys Lys Val Met Tyr

385 390 395

ACA CAG TAC GAA GAT GAG TCC TTC ACC AAA CAT ACA GTG AAT CCC AAT 1312

Thr Gln Tyr Glu Asp Glu Ser Phe Thr Lys His Thr Val Asn Pro Asn

400 405 410

ATG AAA GAA GAT GGG ATT TTG GGT CCT ATT ATC AGA GCC CAG GTC AGA 1360

Met Lys Glu Asp Gly Ile Leu Gly Pro Ile Ile Arg Ala Gln Val Arg

415 420 425

GAC ACA CTC AAA ATC GTG TTC AAA AAT ATG GCC AGC CGC CCC TAT AGC 1408

Asp Thr Leu Lys Ile Val Phe Lys Asn Met Ala Ser Arg Pro Tyr Ser

430 435 440

ATT TAC CCT CAT GGA GTG ACC TTC TCG CCT TAT GAA GAT GAA GTC AAC 1456

Ile Tyr Pro His Gly Val Thr Phe Ser Pro Tyr Glu Asp Glu Val Asn

445 450 455 460

TCT TCT TTC ACC TCA GGC AGG AAC AAC ACC ATG ATC AGA GCA GTT CAA 1504

Ser Ser Phe Thr Ser Gly Arg Asn Asn Thr Met Ile Arg Ala Val Gln

465 470 475

CCA GGG GAA ACC TAT ACT TAT AAG TGG AAC ATC TTA GAG TTT GAT GAA 1552

Pro Gly Glu Thr Tyr Thr Tyr Lys Trp Asn Ile Leu Glu Phe Asp Glu

480 485 490

CCC ACA GAA AAT GAT GCC CAG TGC TTA ACA AGA CCA TAC TAC AGT GAC 1600

Pro Thr Glu Asn Asp Ala Gln Cys Leu Thr Arg Pro Tyr Tyr Ser Asp

495 500 505

GTG GAC ATC ATG AGA GAC ATC GCC TCT GGG CTA ATA GGA CTA CTT CTA 1648

Val Asp Ile Met Arg Asp Ile Ala Ser Gly Leu Ile Gly Leu Leu Leu

510 515 520

ATC TGT AAG AGC AGA TCC CTG GAC AGG CGA GGA ATA CAG AGG GCA GCA 1696

Ile Cys Lys Ser Arg Ser Leu Asp Arg Arg Gly Ile Gln Arg Ala Ala

525 530 535 540

GAC ATC GAA CAG CAG GCT GTG TTT GCT GTG TTT GAT GAG AAC AAA AGC 1744

Asp Ile Glu Gln Gln Ala Val Phe Ala Val Phe Asp Glu Asn Lys Ser

545 550 555

TGG TAC CTT GAG GAC AAC ATC AAC AAG TTT TGT GAA AAT CCT GAT GAG 1792

Trp Tyr Leu Glu Asp Asn Ile Asn Lys Phe Cys Glu Asn Pro Asp Glu

560 565 570

GTG AAA CGT GAT GAC CCC AAG TTT TAT GAA TCA AAC ATC ATG AGC ACT 1840

Val Lys Arg Asp Asp Pro Lys Phe Tyr Glu Ser Asn Ile Met Ser Thr

575 580 585

ATC AAT GGC TAT GTG CCT GAG AGC ATA ACT ACT CTT GGA TTC TGC TTT 1888

Ile Asn Gly Tyr Val Pro Glu Ser Ile Thr Thr Leu Gly Phe Cys Phe

590 595 600

GAT GAC ACT GTC CAG TGG CAC TTC TGT AGT GTG GGG ACC CAG AAT GAA 1936

Asp Asp Thr Val Gln Trp His Phe Cys Ser Val Gly Thr Gln Asn Glu

605 610 615 620

ATT TTG ACC ATC CAC TTC ACT GGG CAC TCA TTC ATC TAT GGA AAG AGG 1984

Ile Leu Thr Ile His Phe Thr Gly His Ser Phe Ile Tyr Gly Lys Arg

625 630 635

CAT GAG GAC ACC TTG ACC CTC TTC CCC ATG CGT GGA GAA TCT GTG ACG 2032

His Glu Asp Thr Leu Thr Leu Phe Pro Met Arg Gly Glu Ser Val Thr

640 645 650

GTC ACA ATG GAT AAT GTT GGA ACT TGG ATG TTA ACT TCC ATG AAT TCT 2080

Val Thr Met Asp Asn Val Gly Thr Trp Met Leu Thr Ser Met Asn Ser

›(D) OTHER INFORMATION · 2 of 4

655 660 665

AGT CCA AGA AGC AAA AAG CTG AGG CTG AAA TTC AGG GAT GTT AAA TGT 2128

Ser Pro Arg Ser Lys Lys Leu Arg Leu Lys Phe Arg Asp Val Lys Cys

670 675 680

ATC CCA GAT GAT GAT GAA GAC TCA TAT GAG ATT TTT GAA CCT CCA GAA 2176

Ile Pro Asp Asp Asp Glu Asp Ser Tyr Glu Ile Phe Glu Pro Pro Glu

685 690 695 700

TCT ACA GTC ATG GCT ACA CGG AAA ATG CAT GAT CGT TTA GAA CCT GAA 2224

Ser Thr Val Met Ala Thr Arg Lys Met His Asp Arg Leu Glu Pro Glu

705 710 715

GAT GAA GAG AGT GAT GCT GAC TAT GAT TAC CAG AAC AGA CTG GCT GCA 2272

Asp Glu Glu Ser Asp Ala Asp Tyr Asp Tyr Gln Asn Arg Leu Ala Ala

720 725 730

GCA TTA GGA ATT AGG TCA TTC CGA AAC TCA TCA TTG AAC CAG GAA GAA 2320

Ala Leu Gly Ile Arg Ser Phe Arg Asn Ser Ser Leu Asn Gln Glu Glu

735 740 745

GAA GAG TTC AAT CTT ACT GCC CTA GCT CTG GAG AAT GGC ACT GAA TTC 2368

Glu Glu Phe Asn Leu Thr Ala Leu Ala Leu Glu Asn Gly Thr Glu Phe

750 755 760

GTT TCT TCG AAC ACA GAT ATA ATT GTT GGT TCA AAT TAT TCT TCC CCA 2416

Val Ser Ser Asn Thr Asp Ile Ile Val Gly Ser Asn Tyr Ser Ser Pro

765 770 775 780

AGT AAT ATT AGT AAG TTC ACT GTC AAT AAC CTT GCA GAA CCT CAG AAA 2464

Ser Asn Ile Ser Lys Phe Thr Val Asn Asn Leu Ala Glu Pro Gln Lys

785 790 795

GCC CCT TCT CAC CAA CAA GCC ACC ACA GCT GGT TCC CCA CTG AGA CAC 2512

Ala Pro Ser His Gln Gln Ala Thr Thr Ala Gly Ser Pro Leu Arg His

800 805 810

CTC ATT GGC AAG AAC TCA GTT CTC AAT TCT TCC ACA GCA GAG CAT TCC 2560

Leu Ile Gly Lys Asn Ser Val Leu Asn Ser Ser Thr Ala Glu His Ser

815 820 825

AGC CCA TAT TCT GAA GAC CCT ATA GAG GAT CCT CTA CAG CCA GAT GTC 2608

Ser Pro Tyr Ser Glu Asp Pro Ile Glu Asp Pro Leu Gln Pro Asp Val

830 835 840

ACA GGG ATA CGT CTA CTT TCA CTT GGT GCT GGA GAA TTC AGA AGT CAA 2656

Thr Gly Ile Arg Leu Leu Ser Leu Gly Ala Gly Glu Phe Arg Ser Gln

845 850 855 860

GAA CAT GCT AAG CGT AAG GGA CCC AAG GTA GAA AGA GAT CAA GCA GCA 2704

Glu His Ala Lys Arg Lys Gly Pro Lys Val Glu Arg Asp Gln Ala Ala

865 870 875

AAG CAC AGG TTC TCC TGG ATG AAA TTA CTA GCA CAT AAA GTT GGG AGA 2752

Lys His Arg Phe Ser Trp Met Lys Leu Leu Ala His Lys Val Gly Arg

880 885 890

CAC CTA AGC CAA GAC ACT GGT TCT CCT TCC GGA ATG AGG CCC TGG GAG 2800

His Leu Ser Gln Asp Thr Gly Ser Pro Ser Gly Met Arg Pro Trp Glu

895 900 905

GAC CTT CCT AGC CAA GAC ACT GGT TCT CCT TCC AGA ATG AGG CCC TGG 2848

Asp Leu Pro Ser Gln Asp Thr Gly Ser Pro Ser Arg Met Arg Pro Trp

910 915 920

GAG GAC CCT CCT AGT GAT CTG TTA CTC TTA AAA CAA AGT AAC TCA TCT 2896

Glu Asp Pro Pro Ser Asp Leu Leu Leu Leu Lys Gln Ser Asn Ser Ser

925 930 935 940

AAG ATT TTG GTT GGG AGA TGG CAT TTG GCT TCT GAG AAA GGT AGC TAT 2944

Lys Ile Leu Val Gly Arg Trp His Leu Ala Ser Glu Lys Gly Ser Tyr

945 950 955

GAA ATA ATC CAA GAT ACT GAT GAA GAC ACA GCT GTT AAC AAT TGG CTG 2992

Glu Ile Ile Gln Asp Thr Asp Glu Asp Thr Ala Val Asn Asn Trp Leu

960 965 970

ATC AGC CCC CAG AAT GCC TCA CGT GCT TGG GGA GAA AGC ACC CCT CTT 3040

Ile Ser Pro Gln Asn Ala Ser Arg Ala Trp Gly Glu Ser Thr Pro Leu

975 980 985

GCC AAC AAG CCT GGA AAG CAG AGT GGC CAC CCA AAG TTT CCT AGA GTT 3088

Ala Asn Lys Pro Gly Lys Gln Ser Gly His Pro Lys Phe Pro Arg Val

990 995 1000

AGA CAT AAA TCT CTA CAA GTA AGA CAG GAT GGA GGA AAG AGT AGA CTG 3136

Arg His Lys Ser Leu Gln Val Arg Gln Asp Gly Gly Lys Ser Arg Leu

1005 1010 1015 1020

AAG AAA AGC CAG TTT CTC ATT AAG ACA CGA AAA AAG AAA AAA GAG AAG 3184

Lys Lys Ser Gln Phe Leu Ile Lys Thr Arg Lys Lys Lys Lys Glu Lys

1025 1030 1035

CAC ACA CAC CAT GCT CCT TTA TCT CCG AGG ACC TTT CAC CCT CTA AGA 3232

His Thr His His Ala Pro Leu Ser Pro Arg Thr Phe His Pro Leu Arg

1040 1045 1050

AGT GAA GCC TAC AAC ACA TTT TCA GAA AGA AGA CTT AAG CAT TCG TTG 3280

Ser Glu Ala Tyr Asn Thr Phe Ser Glu Arg Arg Leu Lys His Ser Leu

1055 1060 1065

GTG CTT CAT AAA TCC AAT GAA ACA TCT CTT CCC ACA GAC CTC AAT CAG 3328

Val Leu His Lys Ser Asn Glu Thr Ser Leu Pro Thr Asp Leu Asn Gln

1070 1075 1080

ACA TTG CCC TCT ATG GAT TTT GGC TGG ATA GCC TCA CTT CCT GAC CAT 3376

Thr Leu Pro Ser Met Asp Phe Gly Trp Ile Ala Ser Leu Pro Asp His

1085 1090 1095 1100

AAT CAG AAT TCC TCA AAT GAC ACT GGT CAG GCA AGC TGT CCT CCA GGT 3424

Asn Gln Asn Ser Ser Asn Asp Thr Gly Gln Ala Ser Cys Pro Pro Gly

1105 1110 1115

CTT TAT CAG ACA GTG CCC CCA GAG GAA CAC TAT CAA ACA TTC CCC ATT 3472

Leu Tyr Gln Thr Val Pro Pro Glu Glu His Tyr Gln Thr Phe Pro Ile

1120 1125 1130

CAA GAC CCT GAT CAA ATG CAC TCT ACT TCA GAC CCC AGT CAC AGA TCC 3520

Gln Asp Pro Asp Gln Met His Ser Thr Ser Asp Pro Ser His Arg Ser

1135 1140 1145

TCT TCT CCA GAG CTC AGT GAA ATG CTT GAG TAT GAC CGA AGT CAC AAG 3568

Ser Ser Pro Glu Leu Ser Glu Met Leu Glu Tyr Asp Arg Ser His Lys

1150 1155 1160

TCC TTC CCC ACA GAT ATA AGT CAA ATG TCC CCT TCC TCA GAA CAT GAA 3616

Ser Phe Pro Thr Asp Ile Ser Gln Met Ser Pro Ser Ser Glu His Glu

1165 1170 1175 1180

GTC TGG CAG ACA GTC ATC TCT CCA GAC CTC AGC CAG GTG ACC CTC TCT 3664

Val Trp Gln Thr Val Ile Ser Pro Asp Leu Ser Gln Val Thr Leu Ser

1185 1190 1195

CCA GAA CTC AGC CAG ACA AAC CTC TCT CCA GAC CTC AGC CAC ACG ACT 3712

Pro Glu Leu Ser Gln Thr Asn Leu Ser Pro Asp Leu Ser His Thr Thr

1200 1205 1210

CTC TCT CCA GAA CTC ATT CAG AGA AAC CTT TCC CCA GCC CTC GGT CAG 3760

Leu Ser Pro Glu Leu Ile Gln Arg Asn Leu Ser Pro Ala Leu Gly Gln

1215 1220 1225

ATG CCC ATT TCT CCA GAC CTC AGC CAT ACA ACC CTT TCT CCA GAC CTC 3808

Met Pro Ile Ser Pro Asp Leu Ser His Thr Thr Leu Ser Pro Asp Leu

1230 1235 1240

AGC CAT ACA ACC CTT TCT TTA GAC CTC AGC CAG ACA AAC CTC TCT CCA 3856

Ser His Thr Thr Leu Ser Leu Asp Leu Ser Gln Thr Asn Leu Ser Pro

1245 1250 1255 1260

GAA CTC AGT CAG ACA AAC CTT TCT CCA GCC CTC GGT CAG ATG CCC CTT 3904

Glu Leu Ser Gln Thr Asn Leu Ser Pro Ala Leu Gly Gln Met Pro Leu

1265 1270 1275

TCT CCA GAC CTC AGC CAT ACA ACC ATT TCT CTA GAC TTC AGC CAG ACA 3952

Ser Pro Asp Leu Ser His Thr Thr Ile Ser Leu Asp Phe Ser Gln Thr

1280 1285 1290

AAC CTC TCT CCA GAA CTC AGC CAT ATG ACT CTC TCT CCA GAA CTC AGT 4000

Asn Leu Ser Pro Glu Leu Ser His Met Thr Leu Ser Pro Glu Leu Ser

1295 1300 1305

CAG ACA AAC CTT TCC CCA GCC CTC GGT CAG ATG CCC ATT TCT CCA GAC 4048

Gln Thr Asn Leu Ser Pro Ala Leu Gly Gln Met Pro Ile Ser Pro Asp

1310 1315 1320

CTC AGC CAT ACA ACC CTT TCT CTA GAC TTC AGC CAG ACA AAC CTC TCT 4096

Leu Ser His Thr Thr Leu Ser Leu Asp Phe Ser Gln Thr Asn Leu Ser

›(D) OTHER INFORMATION · 3 of 4

1325 1330 1335 1340

CCA GAA CTC AGT CAA ACA AAC CTT TCC CCA GCC CTC GGT CAG ATG CCC 4144

Pro Glu Leu Ser Gln Thr Asn Leu Ser Pro Ala Leu Gly Gln Met Pro

1345 1350 1355

CTT TCT CCA GAC CCC AGC CAT ACA ACC CTT TCT CTA GAC CTC AGC CAG 4192

Leu Ser Pro Asp Pro Ser His Thr Thr Leu Ser Leu Asp Leu Ser Gln

1360 1365 1370

ACA AAC CTC TCT CCA GAA CTC AGT CAG ACA AAC CTT TCC CCA GAC CTC 4240

Thr Asn Leu Ser Pro Glu Leu Ser Gln Thr Asn Leu Ser Pro Asp Leu

1375 1380 1385

AGT GAG ATG CCC CTC TTT GCA GAT CTC AGT CAA ATT CCC CTT ACC CCA 4288

Ser Glu Met Pro Leu Phe Ala Asp Leu Ser Gln Ile Pro Leu Thr Pro

1390 1395 1400

GAC CTC GAC CAG ATG ACA CTT TCT CCA GAC CTT GGT GAG ACA GAT CTT 4336

Asp Leu Asp Gln Met Thr Leu Ser Pro Asp Leu Gly Glu Thr Asp Leu

1405 1410 1415 1420

TCC CCA AAC TTT GGT CAG ATG TCC CTT TCC CCA GAC CTC AGC CAG GTG 4384

Ser Pro Asn Phe Gly Gln Met Ser Leu Ser Pro Asp Leu Ser Gln Val

1425 1430 1435

ACT CTC TCT CCA GAC ATC AGT GAC ACC ACC CTT CTC CCG GAT CTC AGC 4432

Thr Leu Ser Pro Asp Ile Ser Asp Thr Thr Leu Leu Pro Asp Leu Ser

1440 1445 1450

CAG ATA TCA CCT CCT CCA GAC CTT GAT CAG ATA TTC TAC CCT TCT GAA 4480

Gln Ile Ser Pro Pro Pro Asp Leu Asp Gln Ile Phe Tyr Pro Ser Glu

1455 1460 1465

TCT AGT CAG TCA TTG CTT CTT CAA GAA TTT AAT GAG TCT TTT CCT TAT 4528

Ser Ser Gln Ser Leu Leu Leu Gln Glu Phe Asn Glu Ser Phe Pro Tyr

1470 1475 1480

CCA GAC CTT GGT CAG ATG CCA TCT CCT TCA TCT CCT ACT CTC AAT GAT 4576

Pro Asp Leu Gly Gln Met Pro Ser Pro Ser Ser Pro Thr Leu Asn Asp

1485 1490 1495 1500

ACT TTT CTA TCA AAG GAA TTT AAT CCA CTG GTT ATA GTG GGC CTC AGT 4624

Thr Phe Leu Ser Lys Glu Phe Asn Pro Leu Val Ile Val Gly Leu Ser

1505 1510 1515

AAA GAT GGT ACA GAT TAC ATT GAG ATC ATT CCA AAG GAA GAG GTC CAG 4672

Lys Asp Gly Thr Asp Tyr Ile Glu Ile Ile Pro Lys Glu Glu Val Gln

1520 1525 1530

AGC AGT GAA GAT GAC TAT GCT GAA ATT GAT TAT GTG CCC TAT GAT GAC 4720

Ser Ser Glu Asp Asp Tyr Ala Glu Ile Asp Tyr Val Pro Tyr Asp Asp

1535 1540 1545

CCC TAC AAA ACT GAT GTT AGG ACA AAC ATC AAC TCC TCC AGA GAT CCT 4768

Pro Tyr Lys Thr Asp Val Arg Thr Asn Ile Asn Ser Ser Arg Asp Pro

1550 1555 1560

GAC AAC ATT GCA GCA TGG TAC CTC CGC AGC AAC AAT GGA AAC AGA AGA 4816

Asp Asn Ile Ala Ala Trp Tyr Leu Arg Ser Asn Asn Gly Asn Arg Arg

1565 1570 1575 1580

AAT TAT TAC ATT GCT GCT GAA GAA ATA TCC TGG GAT TAT TCA GAA TTT 4864

Asn Tyr Tyr Ile Ala Ala Glu Glu Ile Ser Trp Asp Tyr Ser Glu Phe

1585 1590 1595

GTA CAA AGG GAA ACA GAT ATT GAA GAC TCT GAT GAT ATT CCA GAA GAT 4912

Val Gln Arg Glu Thr Asp Ile Glu Asp Ser Asp Asp Ile Pro Glu Asp

1600 1605 1610

ACC ACA TAT AAG AAA GTA GTT TTT CGA AAG TAC CTC GAC AGC ACT TTT 4960

Thr Thr Tyr Lys Lys Val Val Phe Arg Lys Tyr Leu Asp Ser Thr Phe

1615 1620 1625

ACC AAA CGT GAT CCT CGA GGG GAG TAT GAA GAG CAT CTC GGA ATT CTT 5008

Thr Lys Arg Asp Pro Arg Gly Glu Tyr Glu Glu His Leu Gly Ile Leu

1630 1635 1640

GGT CCT ATT ATC AGA GCT GAA GTG GAT GAT GTT ATC CAA GTT CGT TTT 5056

Gly Pro Ile Ile Arg Ala Glu Val Asp Asp Val Ile Gln Val Arg Phe

1645 1650 1655 1660

AAA AAT TTA GCA TCC AGA CCG TAT TCT CTA CAT GCC CAT GGA CTT TCC 5104

Lys Asn Leu Ala Ser Arg Pro Tyr Ser Leu His Ala His Gly Leu Ser

1665 1670 1675

TAT GAA AAA TCA TCA GAG GGA AAG ACT TAT GAA GAT GAC TCT CCT GAA 5152

Tyr Glu Lys Ser Ser Glu Gly Lys Thr Tyr Glu Asp Asp Ser Pro Glu

1680 1685 1690

TGG TTT AAG GAA GAT AAT GCT GTT CAG CCA AAT AGC AGT TAT ACC TAC 5200

Trp Phe Lys Glu Asp Asn Ala Val Gln Pro Asn Ser Ser Tyr Thr Tyr

1695 1700 1705

GTA TGG CAT GCC ACT GAG CGA TCA GGG CCA GAA AGT CCT GGC TCT GCC 5248

Val Trp His Ala Thr Glu Arg Ser Gly Pro Glu Ser Pro Gly Ser Ala

1710 1715 1720

TGT CGG GCT TGG GCC TAC TAC TCA GCT GTG AAC CCA GAA AAA GAT ATT 5296

Cys Arg Ala Trp Ala Tyr Tyr Ser Ala Val Asn Pro Glu Lys Asp Ile

1725 1730 1735 1740

CAC TCA GGC TTG ATA GGT CCC CTC CTA ATC TGC CAA AAA GGA ATA CTA 5344

His Ser Gly Leu Ile Gly Pro Leu Leu Ile Cys Gln Lys Gly Ile Leu

1745 1750 1755

CAT AAG GAC AGC AAC ATG CCT GTG GAC ATG AGA GAA TTT GTC TTA CTA 5392

His Lys Asp Ser Asn Met Pro Val Asp Met Arg Glu Phe Val Leu Leu

1760 1765 1770

TTT ATG ACC TTT GAT GAA AAG AAG AGC TGG TAC TAT GAA AAG AAG TCC 5440

Phe Met Thr Phe Asp Glu Lys Lys Ser Trp Tyr Tyr Glu Lys Lys Ser

1775 1780 1785

CGA AGT TCT TGG AGA CTC ACA TCC TCA GAA ATG AAA AAA TCC CAT GAG 5488

Arg Ser Ser Trp Arg Leu Thr Ser Ser Glu Met Lys Lys Ser His Glu

1790 1795 1800

TTT CAC GCC ATT AAT GGG ATG ATC TAC AGC TTG CCT GGC CTG AAA ATG 5536

Phe His Ala Ile Asn Gly Met Ile Tyr Ser Leu Pro Gly Leu Lys Met

1805 1810 1815 1820

TAT GAG CAA GAG TGG GTG AGG TTA CAC CTG CTG AAC ATA GGC GGC TCC 5584

Tyr Glu Gln Glu Trp Val Arg Leu His Leu Leu Asn Ile Gly Gly Ser

1825 1830 1835

CAA GAC ATT CAC GTG GTT CAC TTT CAC GGC CAG ACC TTG CTG GAA AAT 5632

Gln Asp Ile His Val Val His Phe His Gly Gln Thr Leu Leu Glu Asn

1840 1845 1850

GGC AAT AAA CAG CAC CAG TTA GGG GTC TGG CCC CTT CTG CCT GGT TCA 5680

Gly Asn Lys Gln His Gln Leu Gly Val Trp Pro Leu Leu Pro Gly Ser

1855 1860 1865

TTT AAA ACT CTT GAA ATG AAG GCA TCA AAA CCT GGC TGG TGG CTC CTA 5728

Phe Lys Thr Leu Glu Met Lys Ala Ser Lys Pro Gly Trp Trp Leu Leu

1870 1875 1880

AAC ACA GAG GTT GGA GAA AAC CAG AGA GCA GGG ATG CAA ACG CCA TTT 5776

Asn Thr Glu Val Gly Glu Asn Gln Arg Ala Gly Met Gln Thr Pro Phe

1885 1890 1895 1900

CTT ATC ATG GAC AGA GAC TGT AGG ATG CCA ATG GGA CTA AGC ACT GGT 5824

Leu Ile Met Asp Arg Asp Cys Arg Met Pro Met Gly Leu Ser Thr Gly

1905 1910 1915

ATC ATA TCT GAT TCA CAG ATC AAG GCT TCA GAG TTT CTG GGT TAC TGG 5872

Ile Ile Ser Asp Ser Gln Ile Lys Ala Ser Glu Phe Leu Gly Tyr Trp

1920 1925 1930

GAG CCC AGA TTA GCA AGA TTA AAC AAT GGT GGA TCT TAT AAT GCT TGG 5920

Glu Pro Arg Leu Ala Arg Leu Asn Asn Gly Gly Ser Tyr Asn Ala Trp

1935 1940 1945

AGT GTA GAA AAA CTT GCA GCA GAA TTT GCC TCT AAA CCT TGG ATC CAG 5968

Ser Val Glu Lys Leu Ala Ala Glu Phe Ala Ser Lys Pro Trp Ile Gln

1950 1955 1960

GTG GAC ATG CAA AAG GAA GTC ATA ATC ACA GGG ATC CAG ACC CAA GGT 6016

Val Asp Met Gln Lys Glu Val Ile Ile Thr Gly Ile Gln Thr Gln Gly

1965 1970 1975 1980

GCC AAA CAC TAC CTG AAG TCC TGC TAT ACC ACA GAG TTC TAT GTA GCT 6064

Ala Lys His Tyr Leu Lys Ser Cys Tyr Thr Thr Glu Phe Tyr Val Ala

1985 1990 1995

›(D) OTHER INFORMATION · 4 of 4

TAC AGT TCC AAC CAG ATC AAC TGG CAG ATC TTC AAA GGG AAC AGC ACA 6112

Tyr Ser Ser Asn Gln Ile Asn Trp Gln Ile Phe Lys Gly Asn Ser Thr

2000 2005 2010

AGG AAT GTG ATG TAT TTT AAT GGC AAT TCA GAT GCC TCT ACA ATA AAA 6160

Arg Asn Val Met Tyr Phe Asn Gly Asn Ser Asp Ala Ser Thr Ile Lys

2015 2020 2025

GAG AAT CAG TTT GAC CCA CCT ATT GTG GCT AGA TAT ATT AGG ATC TCT 6208

Glu Asn Gln Phe Asp Pro Pro Ile Val Ala Arg Tyr Ile Arg Ile Ser

2030 2035 2040

CCA ACT CGA GCC TAT AAC AGA CCT ACC CTT CGA TTG GAA CTG CAA GGT 6256

Pro Thr Arg Ala Tyr Asn Arg Pro Thr Leu Arg Leu Glu Leu Gln Gly

2045 2050 2055 2060

TGT GAG GTA AAT GGA TGT TCC ACA CCC CTG GGT ATG GAA AAT GGA AAG 6304

Cys Glu Val Asn Gly Cys Ser Thr Pro Leu Gly Met Glu Asn Gly Lys

2065 2070 2075

ATA GAA AAC AAG CAA ATC ACA GCT TCT TCG TTT AAG AAA TCT TGG TGG 6352

Ile Glu Asn Lys Gln Ile Thr Ala Ser Ser Phe Lys Lys Ser Trp Trp

2080 2085 2090

GGA GAT TAC TGG GAA CCC TTC CGT GCC CGT CTG AAT GCC CAG GGA CGT 6400

Gly Asp Tyr Trp Glu Pro Phe Arg Ala Arg Leu Asn Ala Gln Gly Arg

2095 2100 2105

GTG AAT GCC TGG CAA GCC AAG GCA AAC AAC AAT AAG CAG TGG CTA GAA 6448

Val Asn Ala Trp Gln Ala Lys Ala Asn Asn Asn Lys Gln Trp Leu Glu

2110 2115 2120

ATT GAT CTA CTC AAG ATC AAG AAG ATA ACG GCA ATT ATA ACA CAG GGC 6496

Ile Asp Leu Leu Lys Ile Lys Lys Ile Thr Ala Ile Ile Thr Gln Gly

2125 2130 2135 2140

TGC AAG TCT CTG TCC TCT GAA ATG TAT GTA AAG AGC TAT ACC ATC CAC 6544

Cys Lys Ser Leu Ser Ser Glu Met Tyr Val Lys Ser Tyr Thr Ile His

2145 2150 2155

TAC AGT GAG CAG GGA GTG GAA TGG AAA CCA TAC AGG CTG AAA TCC TCC 6592

Tyr Ser Glu Gln Gly Val Glu Trp Lys Pro Tyr Arg Leu Lys Ser Ser

2160 2165 2170

ATG GTG GAC AAG ATT TTT GAA GGA AAT ACT AAT ACC AAA GGA CAT GTG 6640

Met Val Asp Lys Ile Phe Glu Gly Asn Thr Asn Thr Lys Gly His Val

2175 2180 2185

AAG AAC TTT TTC AAC CCC CCA ATC ATT TCC AGG TTT ATC CGT GTC ATT 6688

Lys Asn Phe Phe Asn Pro Pro Ile Ile Ser Arg Phe Ile Arg Val Ile

2190 2195 2200

CCT AAA ACA TGG AAT CAA AGT ATT GCA CTT CGC CTG GAA CTC TTT GGC 6736

Pro Lys Thr Trp Asn Gln Ser Ile Ala Leu Arg Leu Glu Leu Phe Gly

2205 2210 2215 2220

TGT GAT ATT TAC TAGAATTGAA CATTCAAAAA CCCCTGGAAG AGACTCTTTA 6788

Cys Asp Ile Tyr

2

AGACCTCAAA CCATTTAGAA TGGGCAATGT ATTTTACGCT GTGTTAAATG TTAACAGTTT 6848

TCCACTATTT CTCTTTCTTT TCTATTAGTG AATAAAATTT TATAC 6893

(2) INFORMATION FOR SEQ ID NO:38:

›(i) SEQUENCE CHARACTERISTICS · 1 of 2

(A) LENGTH: 2224 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:38:

Met Phe Pro Gly Cys Pro Arg Leu Trp Val Leu Val Val Leu Gly Thr

1 5 10 15

Ser Trp Val Gly Trp Gly Ser Gln Gly Thr Glu Ala Ala Gln Leu Arg

20 25 30

Gln Phe Tyr Val Ala Ala Gln Gly Ile Ser Trp Ser Tyr Arg Pro Glu

35 40 45

Pro Thr Asn Ser Ser Leu Asn Leu Ser Val Thr Ser Phe Lys Lys Ile

50 55 60

Val Tyr Arg Glu Tyr Glu Pro Tyr Phe Lys Lys Glu Lys Pro Gln Ser

65 70 75 80

Thr Ile Ser Gly Leu Leu Gly Pro Thr Leu Tyr Ala Glu Val Gly Asp

85 90 95

Ile Ile Lys Val His Phe Lys Asn Lys Ala Asp Lys Pro Leu Ser Ile

100 105 110

His Pro Gln Gly Ile Arg Tyr Ser Lys Leu Ser Glu Gly Ala Ser Tyr

115 120 125

Leu Asp His Thr Phe Pro Ala Glu Lys Met Asp Asp Ala Val Ala Pro

130 135 140

Gly Arg Glu Tyr Thr Tyr Glu Trp Ser Ile Ser Glu Asp Ser Gly Pro

145 150 155 160

Thr His Asp Asp Pro Pro Cys Leu Thr His Ile Tyr Tyr Ser His Glu

165 170 175

Asn Leu Ile Glu Asp Phe Asn Ser Gly Leu Ile Gly Pro Leu Leu Ile

180 185 190

Cys Lys Lys Gly Thr Leu Thr Glu Gly Gly Thr Gln Lys Thr Phe Asp

195 200 205

Lys Gln Ile Val Leu Leu Phe Ala Val Phe Asp Glu Ser Lys Ser Trp

210 215 220

Ser Gln Ser Ser Ser Leu Met Tyr Thr Val Asn Gly Tyr Val Asn Gly

225 230 235 240

Thr Met Pro Asp Ile Thr Val Cys Ala His Asp His Ile Ser Trp His

245 250 255

Leu Leu Gly Met Ser Ser Gly Pro Glu Leu Phe Ser Ile His Phe Asn

260 265 270

Gly Gln Val Leu Glu Gln Asn His His Lys Val Ser Ala Ile Thr Leu

275 280 285

Val Ser Ala Thr Ser Thr Thr Ala Asn Met Thr Val Gly Pro Glu Gly

290 295 300

Lys Trp Ile Ile Ser Ser Leu Thr Pro Lys His Leu Gln Ala Gly Met

305 310 315 320

Gln Ala Tyr Ile Asp Ile Lys Asn Cys Pro Lys Lys Thr Arg Asn Leu

325 330 335

Lys Lys Ile Thr Arg Glu Gln Arg Arg His Met Lys Arg Trp Glu Tyr

340 345 350

Phe Ile Ala Ala Glu Glu Val Ile Trp Asp Tyr Ala Pro Val Ile Pro

355 360 365

Ala Asn Met Asp Lys Lys Tyr Arg Ser Gln His Leu Asp Asn Phe Ser

370 375 380

Asn Gln Ile Gly Lys His Tyr Lys Lys Val Met Tyr Thr Gln Tyr Glu

385 390 395 400

Asp Glu Ser Phe Thr Lys His Thr Val Asn Pro Asn Met Lys Glu Asp

405 410 415

Gly Ile Leu Gly Pro Ile Ile Arg Ala Gln Val Arg Asp Thr Leu Lys

420 425 430

Ile Val Phe Lys Asn Met Ala Ser Arg Pro Tyr Ser Ile Tyr Pro His

435 440 445

Gly Val Thr Phe Ser Pro Tyr Glu Asp Glu Val Asn Ser Ser Phe Thr

450 455 460

Ser Gly Arg Asn Asn Thr Met Ile Arg Ala Val Gln Pro Gly Glu Thr

465 470 475 480

Tyr Thr Tyr Lys Trp Asn Ile Leu Glu Phe Asp Glu Pro Thr Glu Asn

485 490 495

Asp Ala Gln Cys Leu Thr Arg Pro Tyr Tyr Ser Asp Val Asp Ile Met

500 505 510

Arg Asp Ile Ala Ser Gly Leu Ile Gly Leu Leu Leu Ile Cys Lys Ser

515 520 525

Arg Ser Leu Asp Arg Arg Gly Ile Gln Arg Ala Ala Asp Ile Glu Gln

530 535 540

Gln Ala Val Phe Ala Val Phe Asp Glu Asn Lys Ser Trp Tyr Leu Glu

545 550 555 560

Asp Asn Ile Asn Lys Phe Cys Glu Asn Pro Asp Glu Val Lys Arg Asp

565 570 575

Asp Pro Lys Phe Tyr Glu Ser Asn Ile Met Ser Thr Ile Asn Gly Tyr

580 585 590

Val Pro Glu Ser Ile Thr Thr Leu Gly Phe Cys Phe Asp Asp Thr Val

595 600 605

Gln Trp His Phe Cys Ser Val Gly Thr Gln Asn Glu Ile Leu Thr Ile

610 615 620

His Phe Thr Gly His Ser Phe Ile Tyr Gly Lys Arg His Glu Asp Thr

625 630 635 640

Leu Thr Leu Phe Pro Met Arg Gly Glu Ser Val Thr Val Thr Met Asp

645 650 655

Asn Val Gly Thr Trp Met Leu Thr Ser Met Asn Ser Ser Pro Arg Ser

660 665 670

Lys Lys Leu Arg Leu Lys Phe Arg Asp Val Lys Cys Ile Pro Asp Asp

675 680 685

Asp Glu Asp Ser Tyr Glu Ile Phe Glu Pro Pro Glu Ser Thr Val Met

690 695 700

Ala Thr Arg Lys Met His Asp Arg Leu Glu Pro Glu Asp Glu Glu Ser

705 710 715 720

Asp Ala Asp Tyr Asp Tyr Gln Asn Arg Leu Ala Ala Ala Leu Gly Ile

725 730 735

Arg Ser Phe Arg Asn Ser Ser Leu Asn Gln Glu Glu Glu Glu Phe Asn

740 745 750

Leu Thr Ala Leu Ala Leu Glu Asn Gly Thr Glu Phe Val Ser Ser Asn

755 760 765

Thr Asp Ile Ile Val Gly Ser Asn Tyr Ser Ser Pro Ser Asn Ile Ser

770 775 780

Lys Phe Thr Val Asn Asn Leu Ala Glu Pro Gln Lys Ala Pro Ser His

785 790 795 800

Gln Gln Ala Thr Thr Ala Gly Ser Pro Leu Arg His Leu Ile Gly Lys

805 810 815

Asn Ser Val Leu Asn Ser Ser Thr Ala Glu His Ser Ser Pro Tyr Ser

820 825 830

Glu Asp Pro Ile Glu Asp Pro Leu Gln Pro Asp Val Thr Gly Ile Arg

835 840 845

Leu Leu Ser Leu Gly Ala Gly Glu Phe Arg Ser Gln Glu His Ala Lys

850 855 860

Arg Lys Gly Pro Lys Val Glu Arg Asp Gln Ala Ala Lys His Arg Phe

865 870 875 880

Ser Trp Met Lys Leu Leu Ala His Lys Val Gly Arg His Leu Ser Gln

885 890 895

Asp Thr Gly Ser Pro Ser Gly Met Arg Pro Trp Glu Asp Leu Pro Ser

900 905 910

Gln Asp Thr Gly Ser Pro Ser Arg Met Arg Pro Trp Glu Asp Pro Pro

915 920 925

Ser Asp Leu Leu Leu Leu Lys Gln Ser Asn Ser Ser Lys Ile Leu Val

930 935 940

Gly Arg Trp His Leu Ala Ser Glu Lys Gly Ser Tyr Glu Ile Ile Gln

945 950 955 960

Asp Thr Asp Glu Asp Thr Ala Val Asn Asn Trp Leu Ile Ser Pro Gln

965 970 975

Asn Ala Ser Arg Ala Trp Gly Glu Ser Thr Pro Leu Ala Asn Lys Pro

980 985 990

Gly Lys Gln Ser Gly His Pro Lys Phe Pro Arg Val Arg His Lys Ser

995 1000 1005

Leu Gln Val Arg Gln Asp Gly Gly Lys Ser Arg Leu Lys Lys Ser Gln

1010 1015 1020

Phe Leu Ile Lys Thr Arg Lys Lys Lys Lys Glu Lys His Thr His His

1025 1030 1035 104

Ala Pro Leu Ser Pro Arg Thr Phe His Pro Leu Arg Ser Glu Ala Tyr

1045 1050 1055

Asn Thr Phe Ser Glu Arg Arg Leu Lys His Ser Leu Val Leu His Lys

1060 1065 1070

Ser Asn Glu Thr Ser Leu Pro Thr Asp Leu Asn Gln Thr Leu Pro Ser

1075 1080 1085

Met Asp Phe Gly Trp Ile Ala Ser Leu Pro Asp His Asn Gln Asn Ser

1090 1095 1100

Ser Asn Asp Thr Gly Gln Ala Ser Cys Pro Pro Gly Leu Tyr Gln Thr

1105 1110 1115 112

Val Pro Pro Glu Glu His Tyr Gln Thr Phe Pro Ile Gln Asp Pro Asp

1125 1130 1135

Gln Met His Ser Thr Ser Asp Pro Ser His Arg Ser Ser Ser Pro Glu

1140 1145 1150

Leu Ser Glu Met Leu Glu Tyr Asp Arg Ser His Lys Ser Phe Pro Thr

1155 1160 1165

Asp Ile Ser Gln Met Ser Pro Ser Ser Glu His Glu Val Trp Gln Thr

1170 1175 1180

Val Ile Ser Pro Asp Leu Ser Gln Val Thr Leu Ser Pro Glu Leu Ser

1185 1190 1195 120

Gln Thr Asn Leu Ser Pro Asp Leu Ser His Thr Thr Leu Ser Pro Glu

1205 1210 1215

Leu Ile Gln Arg Asn Leu Ser Pro Ala Leu Gly Gln Met Pro Ile Ser

1220 1225 1230

Pro Asp Leu Ser His Thr Thr Leu Ser Pro Asp Leu Ser His Thr Thr

›(i) SEQUENCE CHARACTERISTICS · 2 of 2

1235 1240 1245

Leu Ser Leu Asp Leu Ser Gln Thr Asn Leu Ser Pro Glu Leu Ser Gln

1250 1255 1260

Thr Asn Leu Ser Pro Ala Leu Gly Gln Met Pro Leu Ser Pro Asp Leu

1265 1270 1275 128

Ser His Thr Thr Ile Ser Leu Asp Phe Ser Gln Thr Asn Leu Ser Pro

1285 1290 1295

Glu Leu Ser His Met Thr Leu Ser Pro Glu Leu Ser Gln Thr Asn Leu

1300 1305 1310

Ser Pro Ala Leu Gly Gln Met Pro Ile Ser Pro Asp Leu Ser His Thr

1315 1320 1325

Thr Leu Ser Leu Asp Phe Ser Gln Thr Asn Leu Ser Pro Glu Leu Ser

1330 1335 1340

Gln Thr Asn Leu Ser Pro Ala Leu Gly Gln Met Pro Leu Ser Pro Asp

1345 1350 1355 136

Pro Ser His Thr Thr Leu Ser Leu Asp Leu Ser Gln Thr Asn Leu Ser

1365 1370 1375

Pro Glu Leu Ser Gln Thr Asn Leu Ser Pro Asp Leu Ser Glu Met Pro

1380 1385 1390

Leu Phe Ala Asp Leu Ser Gln Ile Pro Leu Thr Pro Asp Leu Asp Gln

1395 1400 1405

Met Thr Leu Ser Pro Asp Leu Gly Glu Thr Asp Leu Ser Pro Asn Phe

1410 1415 1420

Gly Gln Met Ser Leu Ser Pro Asp Leu Ser Gln Val Thr Leu Ser Pro

1425 1430 1435 144

Asp Ile Ser Asp Thr Thr Leu Leu Pro Asp Leu Ser Gln Ile Ser Pro

1445 1450 1455

Pro Pro Asp Leu Asp Gln Ile Phe Tyr Pro Ser Glu Ser Ser Gln Ser

1460 1465 1470

Leu Leu Leu Gln Glu Phe Asn Glu Ser Phe Pro Tyr Pro Asp Leu Gly

1475 1480 1485

Gln Met Pro Ser Pro Ser Ser Pro Thr Leu Asn Asp Thr Phe Leu Ser

1490 1495 1500

Lys Glu Phe Asn Pro Leu Val Ile Val Gly Leu Ser Lys Asp Gly Thr

1505 1510 1515 152

Asp Tyr Ile Glu Ile Ile Pro Lys Glu Glu Val Gln Ser Ser Glu Asp

1525 1530 1535

Asp Tyr Ala Glu Ile Asp Tyr Val Pro Tyr Asp Asp Pro Tyr Lys Thr

1540 1545 1550

Asp Val Arg Thr Asn Ile Asn Ser Ser Arg Asp Pro Asp Asn Ile Ala

1555 1560 1565

Ala Trp Tyr Leu Arg Ser Asn Asn Gly Asn Arg Arg Asn Tyr Tyr Ile

1570 1575 1580

Ala Ala Glu Glu Ile Ser Trp Asp Tyr Ser Glu Phe Val Gln Arg Glu

1585 1590 1595 160

Thr Asp Ile Glu Asp Ser Asp Asp Ile Pro Glu Asp Thr Thr Tyr Lys

1605 1610 1615

Lys Val Val Phe Arg Lys Tyr Leu Asp Ser Thr Phe Thr Lys Arg Asp

1620 1625 1630

Pro Arg Gly Glu Tyr Glu Glu His Leu Gly Ile Leu Gly Pro Ile Ile

1635 1640 1645

Arg Ala Glu Val Asp Asp Val Ile Gln Val Arg Phe Lys Asn Leu Ala

1650 1655 1660

Ser Arg Pro Tyr Ser Leu His Ala His Gly Leu Ser Tyr Glu Lys Ser

1665 1670 1675 168

Ser Glu Gly Lys Thr Tyr Glu Asp Asp Ser Pro Glu Trp Phe Lys Glu

1685 1690 1695

Asp Asn Ala Val Gln Pro Asn Ser Ser Tyr Thr Tyr Val Trp His Ala

1700 1705 1710

Thr Glu Arg Ser Gly Pro Glu Ser Pro Gly Ser Ala Cys Arg Ala Trp

1715 1720 1725

Ala Tyr Tyr Ser Ala Val Asn Pro Glu Lys Asp Ile His Ser Gly Leu

1730 1735 1740

Ile Gly Pro Leu Leu Ile Cys Gln Lys Gly Ile Leu His Lys Asp Ser

1745 1750 1755 176

Asn Met Pro Val Asp Met Arg Glu Phe Val Leu Leu Phe Met Thr Phe

1765 1770 1775

Asp Glu Lys Lys Ser Trp Tyr Tyr Glu Lys Lys Ser Arg Ser Ser Trp

1780 1785 1790

Arg Leu Thr Ser Ser Glu Met Lys Lys Ser His Glu Phe His Ala Ile

1795 1800 1805

Asn Gly Met Ile Tyr Ser Leu Pro Gly Leu Lys Met Tyr Glu Gln Glu

1810 1815 1820

Trp Val Arg Leu His Leu Leu Asn Ile Gly Gly Ser Gln Asp Ile His

1825 1830 1835 184

Val Val His Phe His Gly Gln Thr Leu Leu Glu Asn Gly Asn Lys Gln

1845 1850 1855

His Gln Leu Gly Val Trp Pro Leu Leu Pro Gly Ser Phe Lys Thr Leu

1860 1865 1870

Glu Met Lys Ala Ser Lys Pro Gly Trp Trp Leu Leu Asn Thr Glu Val

1875 1880 1885

Gly Glu Asn Gln Arg Ala Gly Met Gln Thr Pro Phe Leu Ile Met Asp

1890 1895 1900

Arg Asp Cys Arg Met Pro Met Gly Leu Ser Thr Gly Ile Ile Ser Asp

1905 1910 1915 192

Ser Gln Ile Lys Ala Ser Glu Phe Leu Gly Tyr Trp Glu Pro Arg Leu

1925 1930 1935

Ala Arg Leu Asn Asn Gly Gly Ser Tyr Asn Ala Trp Ser Val Glu Lys

1940 1945 1950

Leu Ala Ala Glu Phe Ala Ser Lys Pro Trp Ile Gln Val Asp Met Gln

1955 1960 1965

Lys Glu Val Ile Ile Thr Gly Ile Gln Thr Gln Gly Ala Lys His Tyr

1970 1975 1980

Leu Lys Ser Cys Tyr Thr Thr Glu Phe Tyr Val Ala Tyr Ser Ser Asn

1985 1990 1995 200

Gln Ile Asn Trp Gln Ile Phe Lys Gly Asn Ser Thr Arg Asn Val Met

2005 2010 2015

Tyr Phe Asn Gly Asn Ser Asp Ala Ser Thr Ile Lys Glu Asn Gln Phe

2020 2025 2030

Asp Pro Pro Ile Val Ala Arg Tyr Ile Arg Ile Ser Pro Thr Arg Ala

2035 2040 2045

Tyr Asn Arg Pro Thr Leu Arg Leu Glu Leu Gln Gly Cys Glu Val Asn

2050 2055 2060

Gly Cys Ser Thr Pro Leu Gly Met Glu Asn Gly Lys Ile Glu Asn Lys

2065 2070 2075 208

Gln Ile Thr Ala Ser Ser Phe Lys Lys Ser Trp Trp Gly Asp Tyr Trp

2085 2090 2095

Glu Pro Phe Arg Ala Arg Leu Asn Ala Gln Gly Arg Val Asn Ala Trp

2100 2105 2110

Gln Ala Lys Ala Asn Asn Asn Lys Gln Trp Leu Glu Ile Asp Leu Leu

2115 2120 2125

Lys Ile Lys Lys Ile Thr Ala Ile Ile Thr Gln Gly Cys Lys Ser Leu

2130 2135 2140

Ser Ser Glu Met Tyr Val Lys Ser Tyr Thr Ile His Tyr Ser Glu Gln

2145 2150 2155 216

Gly Val Glu Trp Lys Pro Tyr Arg Leu Lys Ser Ser Met Val Asp Lys

2165 2170 2175

Ile Phe Glu Gly Asn Thr Asn Thr Lys Gly His Val Lys Asn Phe Phe

2180 2185 2190

Asn Pro Pro Ile Ile Ser Arg Phe Ile Arg Val Ile Pro Lys Thr Trp

2195 2200 2205

Asn Gln Ser Ile Ala Leu Arg Leu Glu Leu Phe Gly Cys Asp Ile Tyr

2210 2215 2220

(2) INFORMATION FOR SEQ ID NO:39:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 3549 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 175...1599

›(D) OTHER INFORMATION · 1 of 2

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:39:

CCCCTCTTCC TCCTCCTCAA GGGAAAGCTG CCCACTTCTA GCTGCCCTGC CATCCCCTTT 60

AAAGGGCGAC TTGCTCAGCG CCAAACCGCG GCTCCAGCCC TCTCCAGCCT CCGGCTCAGC 120

CGGCTCATCA GTCGGTCCGC GCCTTGCAGC TCCTCCAGAG GGACGCGCCC CGAG ATG 177

Met

1

GAG AGC AAA GCC CTG CTC GTG CTG ACT CTG GCC GTG TGG CTC CAG AGT 225

Glu Ser Lys Ala Leu Leu Val Leu Thr Leu Ala Val Trp Leu Gln Ser

5 10 15

CTG ACC GCC TCC CGC GGA GGG GTG GCC GCC GCC GAC CAA AGA AGA GAT 273

Leu Thr Ala Ser Arg Gly Gly Val Ala Ala Ala Asp Gln Arg Arg Asp

20 25 30

TTT ATC GAC ATC GAA AGT AAA TTT GCC CTA AGG ACC CCT GAA GAC ACA 321

Phe Ile Asp Ile Glu Ser Lys Phe Ala Leu Arg Thr Pro Glu Asp Thr

35 40 45

GCT GAG GAC ACT TGC CAC CTC ATT CCC GGA GTA GCA GAG TCC GTG GCT 369

Ala Glu Asp Thr Cys His Leu Ile Pro Gly Val Ala Glu Ser Val Ala

50 55 60 65

ACC TGT CAT TTC AAT CAC AGC AGC AAA ACC TTC ATG GTG ATC CAT GGC 417

Thr Cys His Phe Asn His Ser Ser Lys Thr Phe Met Val Ile His Gly

70 75 80

TGG ACG GTA ACA GGA ATG TAT GAG AGT TGG GTG CCA AAA CTT GTG GCC 465

Trp Thr Val Thr Gly Met Tyr Glu Ser Trp Val Pro Lys Leu Val Ala

85 90 95

GCC CTG TAC AAG AGA GAA CCA GAC TCC AAT GTC ATT GTG GTG GAC TGG 513

Ala Leu Tyr Lys Arg Glu Pro Asp Ser Asn Val Ile Val Val Asp Trp

100 105 110

CTG TCA CGG GCT CAG GAG CAT TAC CCA GTG TCC GCG GGC TAC ACC AAA 561

Leu Ser Arg Ala Gln Glu His Tyr Pro Val Ser Ala Gly Tyr Thr Lys

115 120 125

CTG GTG GGA CAG GAT GTG GCC CGG TTT ATC AAC TGG ATG GAG GAG GAG 609

Leu Val Gly Gln Asp Val Ala Arg Phe Ile Asn Trp Met Glu Glu Glu

130 135 140 145

TTT AAC TAC CCT CTG GAC AAT GTC CAT CTC TTG GGA TAC AGC CTT GGA 657

Phe Asn Tyr Pro Leu Asp Asn Val His Leu Leu Gly Tyr Ser Leu Gly

150 155 160

GCC CAT GCT GCT GGC ATT GCA GGA AGT CTG ACC AAT AAG AAA GTC AAC 705

Ala His Ala Ala Gly Ile Ala Gly Ser Leu Thr Asn Lys Lys Val Asn

165 170 175

AGA ATT ACT GGC CTC GAT CCA GCT GGA CCT AAC TTT GAG TAT GCA GAA 753

Arg Ile Thr Gly Leu Asp Pro Ala Gly Pro Asn Phe Glu Tyr Ala Glu

180 185 190

GCC CCG AGT CGT CTT TCT CCT GAT GAT GCA GAT TTT GTA GAC GTC TTA 801

Ala Pro Ser Arg Leu Ser Pro Asp Asp Ala Asp Phe Val Asp Val Leu

195 200 205

CAC ACA TTC ACC AGA GGG TCC CCT GGT CGA AGC ATT GGA ATC CAG AAA 849

His Thr Phe Thr Arg Gly Ser Pro Gly Arg Ser Ile Gly Ile Gln Lys

210 215 220 225

CCA GTT GGG CAT GTT GAC ATT TAC CCG AAT GGA GGT ACT TTT CAG CCA 897

Pro Val Gly His Val Asp Ile Tyr Pro Asn Gly Gly Thr Phe Gln Pro

230 235 240

GGA TGT AAC ATT GGA GAA GCT ATC CGC GTG ATT GCA GAG AGA GGA CTT 945

Gly Cys Asn Ile Gly Glu Ala Ile Arg Val Ile Ala Glu Arg Gly Leu

245 250 255

GGA GAT GTG GAC CAG CTA GTG AAG TGC TCC CAC GAG CGC TCC ATT CAT 993

Gly Asp Val Asp Gln Leu Val Lys Cys Ser His Glu Arg Ser Ile His

260 265 270

CTC TTC ATC GAC TCT CTG TTG AAT GAA GAA AAT CCA AGT AAG GCC TAC 1041

Leu Phe Ile Asp Ser Leu Leu Asn Glu Glu Asn Pro Ser Lys Ala Tyr

275 280 285

AGG TGC AGT TCC AAG GAA GCC TTT GAG AAA GGG CTC TGC TTG AGT TGT 1089

Arg Cys Ser Ser Lys Glu Ala Phe Glu Lys Gly Leu Cys Leu Ser Cys

290 295 300 305

AGA AAG AAC CGC TGC AAC AAT CTG GGC TAT GAG ATC AAT AAA GTC AGA 1137

Arg Lys Asn Arg Cys Asn Asn Leu Gly Tyr Glu Ile Asn Lys Val Arg

310 315 320

GCC AAA AGA AGC AGC AAA ATG TAC CTG AAG ACT CGT TCT CAG ATG CCC 1185

Ala Lys Arg Ser Ser Lys Met Tyr Leu Lys Thr Arg Ser Gln Met Pro

325 330 335

TAC AAA GTC TTC CAT TAC CAA GTA AAG ATT CAT TTT TCT GGG ACT GAG 1233

Tyr Lys Val Phe His Tyr Gln Val Lys Ile His Phe Ser Gly Thr Glu

340 345 350

AGT GAA ACC CAT ACC AAT CAG GCC TTT GAG ATT TCT CTG TAT GGC ACC 1281

Ser Glu Thr His Thr Asn Gln Ala Phe Glu Ile Ser Leu Tyr Gly Thr

355 360 365

GTG GCC GAG AGT GAG AAC ATC CCA TTC ACT CTG CCT GAA GTT TCC ACA 1329

Val Ala Glu Ser Glu Asn Ile Pro Phe Thr Leu Pro Glu Val Ser Thr

370 375 380 385

AAT AAG ACC TAC TCC TTC CTA ATT TAC ACA GAG GTA GAT ATT GGA GAA 1377

Asn Lys Thr Tyr Ser Phe Leu Ile Tyr Thr Glu Val Asp Ile Gly Glu

390 395 400

CTA CTC ATG TTG AAG CTC AAA TGG AAG AGT GAT TCA TAC TTT AGC TGG 1425

Leu Leu Met Leu Lys Leu Lys Trp Lys Ser Asp Ser Tyr Phe Ser Trp

405 410 415

TCA GAC TGG TGG AGC AGT CCC GGC TTC GCC ATT CAG AAG ATC AGA GTA 1473

Ser Asp Trp Trp Ser Ser Pro Gly Phe Ala Ile Gln Lys Ile Arg Val

420 425 430

AAA GCA GGA GAG ACT CAG AAA AAG GTG ATC TTC TGT TCT AGG GAG AAA 1521

Lys Ala Gly Glu Thr Gln Lys Lys Val Ile Phe Cys Ser Arg Glu Lys

435 440 445

GTG TCT CAT TTG CAG AAA GGA AAG GCA CCT GCG GTA TTT GTG AAA TGC 1569

Val Ser His Leu Gln Lys Gly Lys Ala Pro Ala Val Phe Val Lys Cys

450 455 460 465

CAT GAC AAG TCT CTG AAT AAG AAG TCA GGC TGAAACTGGG CGAATCTACA 1619

His Asp Lys Ser Leu Asn Lys Lys Ser Gly

470 475

GAACAAAGAA CGGCATGTGA ATTCTGTGAA GAATGAAGTG GAGGAAGTAA CTTTTACAAA 1679

ACATACCCAG TGTTTGGGGT GTTTCAAAAG TGGATTTTCC TGAATATTAA TCCCAGCCCT 1739

ACCCTTGTTA GTTATTTTAG GAGACAGTCT CAAGCACTAA AAAGTGGCTA ATTCAATTTA 1799

TGGGGTATAG TGGCCAAATA GCACATCCTC CAACGTTAAA AGACAGTGGA TCATGAAAAG 1859

TGCTGTTTTG TCCTTTGAGA AAGAAATAAT TGTTTGAGCG CAGAGTAAAA TAAGGCTCCT 1919

TCATGTGGCG TATTGGGCCA TAGCCTATAA TTGGTTAGAA CCTCCTATTT TAATTGGAAT 1979

TCTGGATCTT TCGGACTGAG GCCTTCTCAA ACTTTACTCT AAGTCTCCAA GAATACAGAA 2039

AATGCTTTTC CGCGGCACGA ATCAGACTCA TCTACACAGC AGTATGAATG ATGTTTTAGA 2099

ATGATTCCCT CTTGCTATTG GAATGTGGTC CAGACGTCAA CCAGGAACAT GTAACTTGGA 2159

GAGGGACGAA GAAAGGGTCT GATAAACACA GAGGTTTTAA ACAGTCCCTA CCATTGGCCT 2219

GCATCATGAC AAAGTTACAA ATTCAAGGAG ATATAAAATC TAGATCAATT AATTCTTAAT 2279

AGGCTTTATC GTTTATTGCT TAATCCCTCT CTCCCCCTTC TTTTTTGTCT CAAGATTATA 2339

TTATAATAAT GTTCTCTGGG TAGGTGTTGA AAATGAGCCT GTAATCCTCA GCTGACACAT 2399

AATTTGAATG GTGCAGAAAA AAAAAAGATA CCGTAATTTT ATTATTAGAT TCTCCAAATG 2459

ATTTTCATCA ATTTAAAATC ATTCAATATC TGACAGTTAC TCTTCAGTTT TAGGCTTACC 2519

TTGGTCATGC TTCAGTTGTA CTTCCAGTGC GTCTCTTTTG TTCCTGGCTT TGACATGAAA 2579

AGATAGGTTT GAGTTCAAAT TTTGCATTGT GTGAGCTTCT ACAGATTTTA GACAAGGACC 2639

GTTTTTACTA AGTAAAAGGG TGGAGAGGTT CCTGGGGTGG ATTCCTAAGC AGTGCTTGTA 2699

AACCATCGCG TGCAATGAGC CAGATGGAGT ACCATGAGGG TTGTTATTTG TTGTTTTTAA 2759

CAACTAATCA AGAGTGAGTG AACAACTATT TATAAACTAG ATCTCCTATT TTTCAGAATG 2819

CTCTTCTACG TATAAATATG AAATGATAAA GATGTCAAAT ATCTCAGAGG CTATAGCTGG 2879

GAACCCGACT GTGAAAGTAT GTGATATCTG AACACATACT AGAAAGCTCT GCATGTGTGT 2939

›(D) OTHER INFORMATION · 2 of 2

TGTCCTTCAG CATAATTCGG AAGGGAAAAC AGTCGATCAA GGGATGTATT GGAACATGTC 2999

GGAGTAGAAA TTGTTCCTGA TGTGCCAGAA CTTCGACCCT TTCTCTGAGA GAGATGATCG 3059

TGCCTATAAA TAGTAGGACC AATGTTGTGA TTAACATCAT CAGGCTTGGA ATGAATTCTC 3119

TCTAAAAATA AAATGATGTA TGATTTGTTG TTGGCATCCC CTTTATTAAT TCATTAAATT 3179

TCTGGATTTG GGTTGTGACC CAGGGTGCAT TAACTTAAAA GATTCACTAA AGCAGCACAT 3239

AGCACTGGGA ACTCTGGCTC CGAAAAACTT TGTTATATAT ATCAAGGATG TTCTGGCTTT 3299

ACATTTTATT TATTAGCTGT AAATACATGT GTGGATGTGT AAATGGAGCT TGTACATATT 3359

GGAAAGGTCA TTGTGGCTAT CTGCATTTAT AAATGTGTGG TGCTAACTGT ATGTGTCTTT 3419

ATCAGTGATG GTCTCACAGA GCCAACTCAC TCTTATGAAA TGGGCTTTAA CAAAACAAGA 3479

AAGAAACGTA CTTAACTGTG TGAAGAAATG GAATCAGCTT TTAATAAAAT TGACAACATT 3539

TTATTACCAC 3549

(2) INFORMATION FOR SEQ ID NO:40:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 475 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:40:

Met Glu Ser Lys Ala Leu Leu Val Leu Thr Leu Ala Val Trp Leu Gln

1 5 10 15

Ser Leu Thr Ala Ser Arg Gly Gly Val Ala Ala Ala Asp Gln Arg Arg

20 25 30

Asp Phe Ile Asp Ile Glu Ser Lys Phe Ala Leu Arg Thr Pro Glu Asp

35 40 45

Thr Ala Glu Asp Thr Cys His Leu Ile Pro Gly Val Ala Glu Ser Val

50 55 60

Ala Thr Cys His Phe Asn His Ser Ser Lys Thr Phe Met Val Ile His

65 70 75 80

Gly Trp Thr Val Thr Gly Met Tyr Glu Ser Trp Val Pro Lys Leu Val

85 90 95

Ala Ala Leu Tyr Lys Arg Glu Pro Asp Ser Asn Val Ile Val Val Asp

100 105 110

Trp Leu Ser Arg Ala Gln Glu His Tyr Pro Val Ser Ala Gly Tyr Thr

115 120 125

Lys Leu Val Gly Gln Asp Val Ala Arg Phe Ile Asn Trp Met Glu Glu

130 135 140

Glu Phe Asn Tyr Pro Leu Asp Asn Val His Leu Leu Gly Tyr Ser Leu

145 150 155 160

Gly Ala His Ala Ala Gly Ile Ala Gly Ser Leu Thr Asn Lys Lys Val

165 170 175

Asn Arg Ile Thr Gly Leu Asp Pro Ala Gly Pro Asn Phe Glu Tyr Ala

180 185 190

Glu Ala Pro Ser Arg Leu Ser Pro Asp Asp Ala Asp Phe Val Asp Val

195 200 205

Leu His Thr Phe Thr Arg Gly Ser Pro Gly Arg Ser Ile Gly Ile Gln

210 215 220

Lys Pro Val Gly His Val Asp Ile Tyr Pro Asn Gly Gly Thr Phe Gln

225 230 235 240

Pro Gly Cys Asn Ile Gly Glu Ala Ile Arg Val Ile Ala Glu Arg Gly

245 250 255

Leu Gly Asp Val Asp Gln Leu Val Lys Cys Ser His Glu Arg Ser Ile

260 265 270

His Leu Phe Ile Asp Ser Leu Leu Asn Glu Glu Asn Pro Ser Lys Ala

275 280 285

Tyr Arg Cys Ser Ser Lys Glu Ala Phe Glu Lys Gly Leu Cys Leu Ser

290 295 300

Cys Arg Lys Asn Arg Cys Asn Asn Leu Gly Tyr Glu Ile Asn Lys Val

305 310 315 320

Arg Ala Lys Arg Ser Ser Lys Met Tyr Leu Lys Thr Arg Ser Gln Met

325 330 335

Pro Tyr Lys Val Phe His Tyr Gln Val Lys Ile His Phe Ser Gly Thr

340 345 350

Glu Ser Glu Thr His Thr Asn Gln Ala Phe Glu Ile Ser Leu Tyr Gly

355 360 365

Thr Val Ala Glu Ser Glu Asn Ile Pro Phe Thr Leu Pro Glu Val Ser

370 375 380

Thr Asn Lys Thr Tyr Ser Phe Leu Ile Tyr Thr Glu Val Asp Ile Gly

385 390 395 400

Glu Leu Leu Met Leu Lys Leu Lys Trp Lys Ser Asp Ser Tyr Phe Ser

405 410 415

Trp Ser Asp Trp Trp Ser Ser Pro Gly Phe Ala Ile Gln Lys Ile Arg

420 425 430

Val Lys Ala Gly Glu Thr Gln Lys Lys Val Ile Phe Cys Ser Arg Glu

435 440 445

Lys Val Ser His Leu Gln Lys Gly Lys Ala Pro Ala Val Phe Val Lys

450 455 460

Cys His Asp Lys Ser Leu Asn Lys Lys Ser Gly

465 470 475

(2) INFORMATION FOR SEQ ID NO:41:

›(i) SEQUENCE CHARACTERISTICS · 1 of 6

(A) LENGTH: 26928 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:41:

GCGTGAGCCA CTGCGCCCTG ACCACATATA ATTTTTATTA ATTATAATGT TGAAAGTCCC 60

TTTATTCCAC ACCTCTCCTC TCATTCACTC CTGGTAGGTC ATTTTTAATG ATTTGATGTA 120

TATACTGAAT TTGGATGCTT CTTGCTACAG GGCAAAGACG CTAATAAGAT TTTGCTGGAG 180

CCTTTTCACA GATGCAAGTC AATCCAGGCA GTGTCTATAG CTGCTGAACC CAAAATCAGA 240

AAGCGAGGGC TATCAAAGCT CTTCTGTCCT GATTTGCAAC TTTAGTAGTG CAAGAAAAAA 300

AATCTTAGAA TAAAAAATGG GTACCGTTCA GAGACCTTTA GAGATTGCAA GGCATCACAG 360

ATGATAAAAA GCTCCATCTC TAGACGTGTT CAGGAGTGGG TTGGGGCTTT GACCTTGACT 420

AGCTGCATCA ACTTGGACAA GTCACTTCGC TTCCCTGTGC CTCAGTTTCC TCATCCATAA 480

AATGGGGATA AGTATAGTAC CTACCTCATA AGTCCTGCCT ACCTAGCACA TGGTGAGCAA 540

TTACTAAATT GTAGGCCTAG TCCCTATAAT CCCAGCACTT TTGGAGAACA AGGTAGGGGA 600

ATCGCTTGAA GCCAGGAGTT CCAGACCAGC CTGGCCAACA TAGTGAGACT GTGTTTCTAT 660

AAAATAAAAA AAAAAAATAC CCAAGCTTGG TGGTGCAGGC CTGTAGTCCC GGCTACTTGG 720

GAGTCTGAGT CAGGAGGATT GCTTGAGCCC AGGAGTTCAA GGTTGTAGTA AGCTATGATT 780

GCACCACTGC ACTCCAGCCT GGCGACAGAG CATGACCCTG TCTCTAAAAA TATAAAATTA 840

GGCCAGGCAC AGTGGTTCAT GCCTGTAATT CCAACATTTT GGGAGGCCAA GGCAGGTGGA 900

TCACTGTGAG CTCAGCAGTT CGAGACCAGC CTGGGCAACA AGGCAAAATC CTGTCTCTAC 960

TAAAATTACA AAAATTAGCC AGGAGAGGTG GTACACGCCT GTAATCCCAG TTACTGGGGA 1020

AGCTGAAGCA GGAGAATTGC TTGAACCCGG GAGGCGAAGG TTGCAGTGAG CCAAGATCGT 1080

GCCATTGCAC TGCAGCCTAG GAGACAGAGC GAGACTCGAT CTCAATAAAT AAATAAATTA 1140

ATTAATTAAT AAAAAAATAA GTTGGGCATG GTGGCACCTG CCTGTAGTCC AAGCTACTCA 1200

GGAGGCTAGA GGTGGGAGGA TCACTTGAGC CAGGAGTTCT AGGCTGCAGT GAGCTATTAT 1260

CACGCCACCA TACTCCAGCC TGCTGTATGT ACTCCAGCCT GGGCAACAGA GTGACACCCT 1320

GTCTCAAAGT AAAGTAAAAT AAAAATTAAA AAACAAATTA CTAAATTGTA CTTAACAGTA 1380

TTGTCATCAG TCTTCCTAAA TAGGAGGACA GGCAAAATTA AGGGACTTAA CATGTGCCCT 1440

CAGGTATAGT AGTTTGGGGC AGGCCAGCAT CACCCGCACA GTAGTTCTGT ACTGTAGGTG 1500

CGTGTTCTCT GGGTCAACTT TATGGCCCAG TGAGGCCGTA CTCTACCAGA ATGTCAGGGG 1560

ACAAGGGTTG GGAGAGGCAA AAGTGCTGGT CTGAAGCAGG AGTCTGGGTT TCCATCCTAG 1620

CTCTACCACC AATTCTGTAT GACCGTGCCC CCTCCATTTC CTCCATGACC ACATAGAGAC 1680

ATGGGGCAGT TGGATGAAAT CAATGATTCC CAGTCTTGGC TCTATCATGG AACCATTTGC 1740

TAACTTCTTT TTTTCTCTTA TGGATCCCAT ATTTTTAAAG ATTTTTACTA AATAGAAATT 1800

GACTTATACT TTTCCAAGCT GGAGTGTGGT GGCATGATTT CAGCTCACTG CAACCTCCGC 1860

CTCCCGGGTT CAAGTGATTC TCCTGCCTCA GCCTCCTGAG TAGCTGGGAT TATAGGTGCT 1920

CACCAGGCCC GGCTAATTTT TTTGTATTTT TAGTAGAGAC AGAATTTCAC CATGTTGGCC 1980

AGGCTGATTT CAAACTCCTG ACCTCAAGTG ATCTGCTCAC CTCAGCCTCC CAAAGTGCTG 2040

GGATTACAGG CGTGAGTCAC TATGCCCAGC CGCTTACTCA CATTTTCTAG TCAAAATAGA 2100

AAACTGCTTA AGTCACTGTC TGCAGAAGAG CAAAAAAAAA AAAAGAAATA AAAAATTGAA 2160

AACTGCTGAT CAGATTGAGA AAAACATAAG ATTATTCACC ACCTAAAGAG AAAAAATTTC 2220

AGTCGAAAGG GAAAAAAATT CATTTTTGTC TTAATAAGGC AAATTCACAA TTTTTGAGGT 2280

TTTAACAAAA TATATGCAGA AAGACAAGGC CACCCCGTAG AACGTGCACA CAGCCCTAGG 2340

CTTGGAAATG GCTGGATTTA ATAATATCTG GTCTTTCTTT GAGCCCTGAA ATTCTCTAAC 2400

ACTATGTCTT GGAACATAAT TTTACTGTTT TCAGTGGTTA TAGAGATTTG CTTTACAATT 2460

TAGCATTGGT CTTTACCCAT GATTTTGTTT GACGCCAACT TGTTGGCAGG AATGCACCCC 2520

CTGCCCCCCG CTTTGTTATG GCCTTGCTCC TATAGGGCAA GAATATCTGC TTTAAGGCCG 2580

GGTGTGGTGG CTCAGGCCTG TAATCCCAGC ACTTTGAGGG GCCAAGGCGG GCAGATCACC 2640

TGAGGTCAGG AGTTTGAGAC CAGCCTGGCC AGTATGGTGA AATCCTGTCT CTACTAAAAA 2700

TAACAAAAAT TAGCTGGGTG TGGTGGCACA CACCTGTAAT CCCAGCTATT TGGGAGGCCG 2760

AAACAAGAGA ACCACTTGAA CCCAGGAGGC GGAGGTTGCG GTGAGCCGAG ATTATGCCAC 2820

TGCACTCCAG CCTGGGAAAC AGAGCAAGAT TCCGTCTCAC ACACAAAAAA TATATATATG 2880

TCTGCTTTAA GTATGCAGGC CGTGTTTGTG CTGAACGGCA GGAATGCCAA ACTTGGCTGC 2940

ATGGTACCAA CTAGGGACCT CAGAGTTCCA AGGAGAACAA ACAGTTGGTT CCTGGAGGCT 3000

GGGGGCTTGT ATCAGACCCT GAAGACTAAG CATGTGCTGG GTCCATTGTT GTCCTGCACC 3060

CATGGTAGTG CACTAAACAC CTAACCTATA TTTAAGTGTT TTTGTTTGTC CAAAAAATGT 3120

CTTTTTTTTT TGGGAGTCAA GAGTCTTGCT CTGTTGCCCA GGCTGGAGTG CAGTGACACG 3180

ATCTCAGCTC ACTGCAGCCT CCGCCTCCCG GGTTCAAGCT ATTCTCCTGT CTCAGCCTCC 3240

CAAATAGCTG AGACTATAGG CACGCACATC CATGCCCAGC TAATTTTTTT ATTTTTAGTA 3300

GAGACGAGGT GTCTCCATGG TGGCCAGGTT GGTCTTGAAC TCCTGTCCTC AAGTGATCCA 3360

CCTGCCTCGG CCTCCCAAAG TGGTGGGATT GCAGGCATGA GACACCGCGC CCGGCCTGCC 3420

TTGTCCCTTC TTAAAATGAG TTGTCCATTT GTAAGCTGCT GATTTCTTTG GGACATTGTC 3480

TCCGTAAACT TTTCATAAAG CATCAGTGAT TTCACCATTC TTCCACCCAA GCTTCACCGT 3540

AAATTTGTTG TTTGTTCTTG CTTCAATTTC AGCAGAATTC ATTTAGCTCT GATAAGGGCT 3600

CGCTTCAAAC TGATGTCTTA TCCTTCTTAG TGCCTCAAAC TACATCCTGT TCACTCATGT 3660

TATAGCAAGT TAGTGTGAGT TTATTTTGGT GCACAAAAAT TTTTTTAAAT CCATGCAGTC 3720

TTTTTTCATA ATACGCATTT TCCATGAACT TTTCGAAGAC CCCTTGTAGA TGTCTGTTGT 3780

TTAAACCACC CAGTTTACAG TAATTTTTTT TTTTTTTTGA GATGAAGTCT TGCTCTGTCG 3840

CCCAGGCTGG AGTGCATTGG CACACTCTCG GCTCACTGCA ACCTCTGCCT CCTGGGTTCA 3900

AGCAATTTTT CTGTCTCAGT CTCCCGAGTA GCTGGGATTA CAGGTGTGTG CCACCATGCC 3960

TAGCTAATTT ATGTGTTTTT AGTAGAGACG GGGTTTCACT ATGTTGGCTA GGCTGGTCTC 4020

GAACTCCTCA CCTTGTGATC GGCCCGCCTC GGCCTCCCAA AGTATTGGGA TTACAGGCGT 4080

GAGACTCTTG CACTTGGCCT ACAGTAATTT TATAGCAGCC TAGGCTAAGA TAGCCATTTC 4140

TGGGTATAAG AATGTCATAT ACTGAACAGG CCTGCAACTG TGAGTAAAAG TCTGCAAAGA 4200

GGCCGGGCAG TGGCTCATAC CTGTAATCCC AGCACTTTGG GGGGCCGAGG CAGGTGGATC 4260

ACCTGAGGTC AGCAGTTCGA GACCAGCCTG ACCAACATGG TGAAACCCCA TCTCTACTAA 4320

AAATACAAAA TTAGCTGGGC GTGGTAGTGC ATGCTTGTAA TCCCTAGCAT GCACTTGGGA 4380

GCTACTTGGG AGGCTGAGGC AGGAGAATCA CTTGTACTCA GGAGGCCGAG GTTGCAGTGA 4440

GCTGAGATCA CGCCACTGCA CTCCTTTCTG GGTGACAGAG TGAGACTCCA TCTCAAAAAA 4500

ACAAAACAAA ACAAAACAAA AACAAACAAA AAAACCCAAC AGGTAGGTAG CAGTGGTTCA 4560

CGCCTGTAAT CCCCACTTTG GAGGCTAAAG TGGGCAGATC ACCTGAGGTC AGGAGTTCAC 4620

GTCCAGCCTG GGCAACATGG TGAAACTCTG TCTCTACAAA AATACAAAAA TTAGCCAGGC 4680

ATGATGGCGG GTGCTGTAGT TCCAGCTATT CGGGAGGCTG AGGCAGGAGA ATCGCTTGAA 4740

CCTAGGAGGT AGAGGTTGCA GTGAGCCGAG TTCACGCTAT TGCACTCCAG CCTCCATCTC 4800

AAAACAAACA ACAAAACCCA AAATATATAT TATAATTTTA TTTTATTTAT TCAATTTTAT 4860

TTTATTTTAT TTTATTTTTC TAGGAACAGG TCTCATTCAG GCCAGGCATG GTGCTCACGC 4920

CTGTAATCCC AGCACTTGGG AGGCCGAGGT GGAGGTGGGC GGATCACCTG AGGTCAGGAG 4980

TTCGAGCCAT CCTGGTCAAT GTGGCGAAAC CCCATCTCTA CTAAAAATAC AAAAATTAGC 5040

›(i) SEQUENCE CHARACTERISTICS · 2 of 6

CAGGTGTGGT GGCACACGCC TGTAATTCCA GCTACTTGGG ATACTGAGTC AGGAGAATCA 5100

CTTGAACAGG GAGATGGAAA TTGCAGTGAG CCGAGATTGT TCCACTGCAC TCCAGCCTGG 5160

GTGACAGGGC GAGACTCCGT CTCAAAAAAA AAAAAAAAAA AGAAAGAAAG AAAGAAAGAA 5220

AGAAACAGGA TCTTACTCTG TTACCCAGGC TGGAGTACAG TGGTGCAATC ATAGCTCACT 5280

GCAGGCATGC ACCACCATTC CCAGCTAATT TTTAATTTTT TTTGGTAGAG ATGAGGGTCT 5340

TGCTATGTTG CCCAGGCTGG TCTCAAACTC CTGGCCTCAA GCGATCCTGC CATGTCGGCC 5400

TCCCAAAGTG TTGGGATTAC AAGTGTGAGC CACTATGCCT GGCCTAAAAA TATATATATG 5460

AAAATATATA AGAAATGGGC CTCCCAGGAA TTAAGGTGTT TGCGGGAGTC CTGGTCCCCA 5520

GTTTTTCTGC CAACACTCCC TGTTCCCACA CATGACCTGG TCCAGACCCC AAACAGCCAG 5580

GCCCAAAGGA CAGGTGAGGC GAGGCGAGAA CTTGTGCCTC CCCGTGTTCC TGCTCTTTGT 5640

CCCTCTGTCC TACTTAGACT AATATTTGCC TTGGGTACTG CAAACAGGAA ATGGGGGAGG 5700

GACAGGAGTA GGGCGGAGGG TAGGGTAGGA CCAGAAGCCT CTCTAGGCCT GCCATGGGGC 5760

AGGCAGCCAG GGAGAAGGAG GGCCCCTCAG TGGAGACCCA GGGATTTCAG TAGCCCCTGT 5820

TCCGGGACAG GCGCAGGTCC TGGGAGGTGA CAGAAGATAG ACTAAAGGCC CAAGAGTCCC 5880

TGGACCTGAC TCCTCCCAGC AGCTGCCACA CACAAACACA CCTCCAGGCA CCCTGGACAG 5940

GAAGGAGGAG AAATGGGCCC CTCCTCCAGT GGCTGAGAAG CTGGGGCAAA TGTTGGCTGT 6000

TCCTATCCCT GGTGCATCCC ATGGCGAGGG GCAACTTCCA TCAGGCCACA CCTTTTATCT 6060

TTGTCTCTAT TTTTGATATC TGTGTATTAT GATTATACAA ACCCCCACAT TGGCCTATAT 6120

GTGCAGATCT GATTAAGAAC TTACGATATT CCATGGACAT TCCATTCCTA ATCTCCTTTA 6180

GTCCTCACAA CAAAGTATTA TTCCCATTGT ATAGATGAGG AAACTGAGGC ACACAGAGAT 6240

GACAAGCAAC CACCGCTATA TGTTAGGATT CGAAGGAGCT CCAGGAAAGT CTCATAGCCC 6300

CACTGGCCAG AATGGGCTAA ATCTCAGAGG GGGAGGGTGG GAGATGGGGG TGACAGTGAC 6360

CTTTTTTGTG ACTCCTCCTA GACCATCCAT CCCTGCTCCC AGGAGGACCT GTCCTCCCAG 6420

ATGGTGGAGA TGGACAGGAG GACTATCTAC CCACCCGTCC CCACGGCCCT GACCCTCTGA 6480

CCTCACCCTC TCCGCTGATT TCTTCATGTT AGTTCAACAT TACCCAGAGG GGTCAGGACA 6540

GACAATTCCT CAGTGACCCA GGAGCTGACA CACTATGGCG CACGTCCGAG GCTTGCAGCT 6600

GCCTGGCTGC CTGGCCCTGG CTGCCCTGTG TAGCCTTGTG CACAGCCAGC ATGGTAAGGG 6660

AGTGCTTGCA GGCTGGAACA GGCTGGAGGA CTGGGGTGTG GGCCCATGGG CTGGGGTCTC 6720

CTGGCTGGAC AGAGCACACA GAGCTGGCCC CTAAGTAGGT CTCAGCCCCA GGCGGCCAGC 6780

TTAGGGAAGA AGTCAGGAGC TCAGGGCTGG AAAGAGAATG GCTGCTTCTC TCTTCCAATA 6840

TAGGGAGCAG GCTGGGGGCA AGGGGCAGTG TAGGAGGGGC ACAGGGGGCC ACATTTAGCA 6900

GCCTTCCAGG CCTTCCACCA GCCCAGACTG CCTCTCTCAG AAGCCAGCAG GGGAGGGTGG 6960

GCTTGCTTCA TGCCCCCAGA TGGCCAAGAC TGCCTGTTCC TGAGGTCGCT GTTCCATGAC 7020

CCCCCCACCG CCTTTACAGT GTTCCTGGCT CCTCAGCAAG CACGGTCGCT GCTCCAGCGG 7080

GTCCGGCGAG CCAACACCTT CTTGGAGGAG GTGCGCAAGG GCAACCTAGA GCGAGAGTGC 7140

GTGGAGGAGA CGTGCAGCTA CGAGGAGGCC TTCGAGGCTC TGGAGTCCTC CACGGCTACG 7200

GTGAGCCTGG GCTGCTCGGA CGGTGCCGGG GCCTCAGACC GGGCCCAACT CTAGACACTT 7260

CCACAGAGAA GCAAGCGAGG AACGCCACAG CCCCTTCGCT GCTCACAGCC TCATTTCAAC 7320

TCTGAGCCCC TCCTCACAGG GCTGGCAAGA GGAGCGGCCT CAGCCTTTCC TGGGGGTCTC 7380

TGTGCCTGGA CTGTGTCCCT GTGCAGCTCC ATGACATGGG GAGGCCTCCA CAGTCTTCAG 7440

ACATCCACCT GCCTTGGAGC TCTGTGTCCA CATGGCCTCC TCAGCGGCAG ACTCCCACAC 7500

CACCCTTGAG GGGTGGGACT CTGGGGAGGC CACCACAAGC CCCCGGGCTC AAGACTCAGT 7560

GTTCCTGGAG CTCTGTGTCG CCTTTCCTGT CTGTAGGGAC TCTGCCAGGG ACCCACTGCC 7620

CCCTCTCCTC CCATCTCCCC CAGCCTCTTT CAGACTCGGT GTGTGTGTTG GAGGAACTCC 7680

CCTATCCTCA AATATTCTTC TCCTTTTGGA AACAAAAGTA GGAAACTCTG CCACAAACCT 7740

CCCCAGAGCC TGCCCCCTGC GTGACCAGGG TAAGGAAAGT GTGAGGAGGA GCATAACATT 7800

TACTAAAACA ACACAAAACA GGAGCTGCCG TAGCCTCACT CCCAGCCCTT GTTTTTCAGG 7860

ATGTGTTCTG GGCCAAGTAC ACAGGTGAGC ACCGGGAAGG ATTTGCCCCA GGAAGGGAGG 7920

CCTGGGGACC CCAGTGAGAG AATTCTACCC AGAGAATCTT CTGCTGCACC TAGCCATCCA 7980

CCCATCCACC CCTTCCCCAC TCCTTCCTTG GTCCCTCCCA TCTGTTCATC CATCTTTCTG 8040

TTTCTCACCA ACATCCCATC CACCCTGACT CCAGCTCATC CTGGCCATAC CCCAATCCCA 8100

AAGGTAAACA CCTGGGTCTT TTCCAGCTTG TGAGACAGCG AGGACGCCTC GAGATAAGCT 8160

TGCTGCATGT CTGGAAGGTG AGCAACTGAC ACGGGTTTGG GGAGCAGGAC ATGGAGGGGA 8220

GCTTGGGAGA AGAGCTCAGG GGTGGGTTTG GAGTGTGGCT GGTGGAGGCC GAGGCAGTCC 8280

CCAGCATCTG ACATTGCTCC CATTCCTGGG GTCAAGATGT CTCTTTGTAC CTGGCTCTGT 8340

GTCTGGCATG CGAACGAATG AATGAATGAA TGGACTAATG AATTAATGTT TTTTTTTTTG 8400

AGACAGAGTC TCGCTCTGTT GCCCAGGCTG GAGTGCAGTG GCACGATCTT GGCTCACTGT 8460

AAACTCCGCC TCCCGGATTC AAGCAATTCT CTGCCTCAAC CTCCCAAGTA GCTGGGATTA 8520

CAGGTGCTCG CCACCACGCC TAGCTAATTT TTGTATTTTT AGTAGAGACG GGGTTTCACC 8580

ATGTTGGCCA GGCTGGTCTT GAACTCCTGA CCTCGTGATC CACCCACCTC GGCCTCAAAG 8640

TGCTGGGATT ATAGAAGTGA GCCACCGCGC CTGGCCATGA ATTCATGTTT AAGGCTTCAT 8700

TCTCCTTTGC CTGACCCGAG TCTCTGCCCC CACCTAGTCA GAGCTTTGAT GATGTCACAT 8760

TCCCCTTCTA GCTTTAGGTG TCACTGAACC AAACAGGAAC CCAAACCCCC AGCTGCTCTG 8820

ACACCAAGGA CTTCCCTAAG CATGCCAAGG TGTTTCTAGC ACCTGGCCTT GCATATGTTG 8880

TCAATTTCCT CTGGAGCGAC CATCACATCT ACTGAACACT TTCCTATCCT TCAAGGACTG 8940

CTTCAAATGT CACCACTTTT GCTGAGACTT CAGGGAGCAC CCTCCCTCCT GCACTGTGTC 9000

TGAAGGCACC TTTAGCACGA CAAAAATGGA ACTCTTTGTT TATTTATAAG AGCAGGGTCT 9060

CCCTTTTTTG CCAGGCTGAT CTTGAACTCT TGGGCTCAGG CAATTCTCCC ATCTCAGTCT 9120

CCCAAAGGAG TGGATTATAA GTGTGAGCCA CCATGCCTGG CTGCCATACT TTCATTTTTT 9180

TTTTTTTTTT TTTGAGGTGG AGTCTCACTC TGTCGCCTAG GCTGGAGTGC AGTGGCGCGA 9240

TCTCGGCTCG CTGCAACCTC CGCCTGGCGG TTCAAGTGAT TCTCCTGCCT TAGCCTCCTG 9300

AGTAGCTGGG ATTACAGGCA CACACTACCA TGCCCAGCTA ATTTTTTGTA TTTTTTAGTA 9360

GAGACGGGGT TTCACCATGT TGGCCAGGCT GGTCACAAAC TCCTGACCTC AGGTGATCCA 9420

CCAGCCTCAG CCTCCCAGAG TGCTGGGATT ACAGGTGTAA TCCACTGCGC CCAGCCTCAT 9480

TTGTTAAATT ACGTACTCAA CAGACATTTT ACAAAGTTCC TGCTACGTGC CAGGCACTAT 9540

ATCAGGTGCT GGGGATTTTA AGAGAATCAA ATACAGTCTC TGCCTTCAAG GAATTCAAAA 9600

TCTCAAAAGA GAACAAAAAT ACAAAATATT AAAATGATTG CGGCCGGGTG TGGTGGCTCA 9660

AGCCTGTAAT CCTAGCACTT TGGGAGCTGA GGTGGGCGCC CAGGCCAGGG GTTTGAGACC 9720

ATCTTGGCCA ACATAGTGAA ACCCCCAACC TCTACTAAAA ATACAAAAAT TAGCTGGGGT 9780

GTGGTGGCAC GCGCCTGTAA TCCTAGCTAC TAGGGAGGCT GATGGGGAGA ATTTCTTGAA 9840

TCTGGGAAGC GAAGGTTGCA GTGAGCTGAG ATCATGCCAC TGCACCTTCA GTCTCGGCAT 9900

CAGATCAAGA CTCATCTCAA ATACATAATA AATAATAATT CAATAAGTGA TTGCAAGAAA 9960

GTTCTGTTCA AGGCACCAAG AGACCACAGG AAAATGAGTG TCTGGTTTGC CAGAAAATGA 10020

GAGATGGCTT CCCAGGAGAG GCAGAGTTCT GCCTGGCCTA GTGGGATGCA TGGATGAACA 10080

AACAAGTGGG CATTCCAGTC AGAAGAAACA ATCCGTGGAA AGACCCAGAG GCATGAGAAG 10140

CTGAGCTAGC AGGGACAGGT AGACCAGGGC CAGTTGAAAA GGACCTTCAT CACTTTTTCA 10200

›(i) SEQUENCE CHARACTERISTICS · 3 of 6

TCCTGCTGGC CAAGAGAAGC CACAGAATGG AAGCTCCATG AGGGCAGGGC TGTGACTGTC 10260

CTATTGGTTG ATGTGTACTG AGCACCCGAC AGTGCCTGTC ATATGGTAGG CACTTAGCGA 10320

ATATTTGGAG GCCACTGTTG AGTGAATGGG AGAACTGCTG GTTGCAGAGG AAGAGGGGCT 10380

GGGTGAATGC AGGTTCAGGA TTGTGGACCT GCATGAGCTG GGAGGTGGGG GATAGACAAC 10440

TTTGCAGGGA GAGAGGAAAT AAGTCCCCAG GCTCCAAGGC TGACCGGGGT GGGGTCTCCG 10500

CAGGTAACTG TGCTGAGGGT CTGGGTACGA ACTACCGAGG GCATGTGAAC ATCACCCGGT 10560

CAGGCATTGA GTGCCAGCTA TGGAGGAGTC GCTACCCACA TAAGCCTGAG TGAGTGAGGG 10620

GTCGGCCTTC CCACCATGGG CTGAGAACAG GGAGCAAGCG TACCTCAAGT TCAACAGCCT 10680

CCTGTTGGGC AATTTCCTCT TCCAGAATCA ACTCCACTAC CCATCCTGGG GCCGACCTAC 10740

AGGAGAATTT CTGCCGCAAC CCCGACAGCA GCACCACGGG ACCCTGGTGC TACACTACAG 10800

ACCCCACCGT GAGGAGGCAG GAATGCAGCA TCCCTGTCTG TGGTAGGCTG GGGGCAGTGG 10860

GGCGACCCAT GACCAAGCCC GGGGGCTTCA TGGGGCCTGG CAGCCTGGGA TGGGAACCAA 10920

GAATACTGGC TACCCAGGCA CAGTGGCTCA TGCCCGTAAT CCCAGCACTT TGGGAGGCTG 10980

AGGCAGGCAG ATCACCTGAG GTCAGGGGTT TGAGACCAGC TGGGCCAACA TGGCAAAACC 11040

CCGTCTCTAC TAAAAATACA AAAATTGCCA GGCGTGGTGG TGGGCGCCTG TAATCCCAAC 11100

TACTCTGGAG GCTGAGGCAC GAGAATCGCT TGAACCCGGG AGGCGGAGTT TGCAGTGAGC 11160

TGAGATCCTG CCACTGTACT TCAGCCTAGG CGACAAGAGC AAAACTCTGT CTCAAAGAAA 11220

AAAAAAAGAT GCTGGCCACC TTCAGAGCTG GCGTCAGTCA TTCAGATCAT ATCTGTGCCT 11280

ATTGCTCAGT AAAGTCAGGG AATCAGGGGA TCTGAGTGGG GGGATCTGCC AGCCTCCTCC 11340

TCCCCCTCCC CACTCTTGAC TTCCTTATGG TCTAGGCTGT GGCTCATTCC AAACATGCCT 11400

CCTTTCTGAT CAAGGCACTC CTCCCTCCGG GAAGCCCTCC CTAGCCATTT CAGTCCACAC 11460

ACCCTGTTCT GAGTATCACA GAGCAAGCCT TGTGCAGTTT GGCCCGCGGG ATTCTGTCAT 11520

TATTATTTCC TTGGTGTGTT AAGTAGCTAT AGCCACCCCT TCCCTGAGGC AGACCACAAT 11580

AAGCATTTCT TTTTCCCATG AGGGTTGGCA GGTGTGGCTG CACTCGCTAA TGCGTCTGTA 11640

GGGTCAACTG ACGGAGGTTG GCCCTGGCTG GGTGGCTCTG ATTCAAATAA TGGGTCCAGC 11700

TGAGTCTGGC TCCTCGTTGA GGGTTGGGCC TAGATCTGCT CCACGTGCGT TCATGCTGGG 11760

GCTGAGGCTG AAAGAAGGTA CCTGGGAAAA CTCTTCTTAT GCTGATGACA GACACAGAAA 11820

ACAATGAACA GAAAAGCGTC TTCTGTCCTG AAGGCCTGGC TCAGAACAGG CACAGTCAGC 11880

CCTGCCCACG TTCCATTGGC CAGAGCAAGT ATATGTTCAA GGCCAGGGTC AAGAGGTAAA 11940

CTACACCTCA GCCTGTAAAA TCACAGAGCA AGGGATGTGG ATGCAGGCAG GGGTAAAGAA 12000

TTTGTGCCGA TTACCAGTCC ACAAACATGC GTTAGTGTTT GTTCTCTAGG CAACCCTGTC 12060

GGGCCCATTG CTCATTCCTG GGGTTGGTCT TTTTTTTTTT TCTTTCTAAG AAGGAGTCTC 12120

ACTCCCTTGC CCAGGCTGTT GGAGTGCAGT GGCCCTATCT CAGCTCACTG CAACCTCCGC 12180

CTCCTGGGTT CAAGCGATTC CCCTGCTTCA GCCTCCTGAG TAGCTAGGAT TACAGGCGTG 12240

TGCCACCACT CCTGGCTAAT TTTTTTTTAT GTTAGTAGAG ACGGGGTTTC ACCATGTTGG 12300

CCAGGCTGAT CTCAAACTCC TGACCTTGTG ATCCTCCCGC CTCGGCCTCC CAAACTGCTG 12360

AGATTACAGG GGTGAGGCAC TGCGCCCAGC CATTTTTTTT TTTTTTTTTT TTTGAGATGG 12420

AGTCTCACTC TCACCCAGGC TGGAGTGCAG TGGCATAATC TTGGCTCACT GCAACCTCCA 12480

CCTCCTGGGT TCAGGCGATT CTCTGCCTCA GCCTCTCATA TAGCTGGGAT TACAGGCACA 12540

CGCCACCACG CCTTGCTAAT TTTGTATTTT TAGTAGAGAC GGGGTTTCTT CATGTTGGCC 12600

TTGCCTGACT TGAACTCCTT GTTCCGGTGA TCTGCCCAGC TCGGCCTCCC AAAGTTCTGG 12660

GATTACAGGT GTAAGCCACT GCGCCTGGCC CCTGGTATTG GTCTTATAGC AAGTTTATCC 12720

CAACAAAAAC AGCTACTATT TACTCCCCAA CCCCCATACA CACGCACACA CATTGATGAT 12780

AAATAAGTTG CAGGCTTGCA GAAATTGGCC CATCCAGGTG AACAGCCTAG TGATCCGAGC 12840

AAGCGTCCTG CTGTGCAGCT ATAAAAACAT GACTCCTCCA GCAGCTCCAG GCAGCCACTA 12900

CCAGTTGGTT ACAGATGGCC TAGGAGGCCA AACCTGGTTA CTATCTCTGG TTTATTATGT 12960

GCCAGACACT TATGCTGTAT ATTTTGTTTA ATCCTCTCAA CAAACCTGCA AAAGTGGCAT 13020

TAGTAACCCC TTTAAAGGCA AACGGTCAGA AGCCCAGAGA GGTTAAGTAA CCTGAGGTCA 13080

CACAGGCAGA AAGCAGCAAG ACCGGGGTTC ACACCCCTGT CTGTTCCGGT CCATGTGTGG 13140

TCTCACTCAC TCTGCTGCCT CCTTGCCCCT CACCCACCAG GCCAGGATCA AGTCACTGTA 13200

GCGATGACTC CACGCTCCGA AGGCTCCAGT GTGAATCTGT CACCTCCATT GGAGCAGTGT 13260

GTCCCTGATC GGGGGCAGCA GTACCAGGGG CGCCTGGCGG TGACCACACA TGGGCTCCCC 13320

TGCCTGGCCT GGGCCAGCGC ACAGGCCAAG GCCCTGAGCA AGCACCAGGA CTTCAACTCA 13380

GCTGTGCAGC TGGTGGAGAA CTTCTGCCGC AACCCAGACG GGGATGAGGA GGGCGTGTGG 13440

TGCTATGTGG CCGGGAAGCC TGGCGACTTT GGGTACTGCG ACCTCAACTA TTGTGGTGAG 13500

CTGCCTGGGT AGGGGGCCTG AGTTGCAGGG ACAAATCCTA GTGGGAATAA CAACAGCCGC 13560

TTCTGCTTAT CGAACGCTTA CCTCATTGAG TGCGCTCATT ACAGCCTTAC AGTAACCAGG 13620

TGGGGGGTAA GGTCCTGTGC CCATTTCACA GATAAGTACA CTGAGGCCCC AGGAGGTTAT 13680

TGCCTAGTAG CCCAACTGTG CATGCACGCT TAACCTCTGC ACCAAATGGC CTCCAAGGCC 13740

CGTAGGGGAA CTGGGGGGAT CTAGGGGATG GGTGAGGAAT GGCCCAGCCC AGTCCCGGCC 13800

GGTGCCTGGG TCCCAACAGA GGAGGCCGTG GAGGAGGAGA CAGGAGATGG GCTGGATGAG 13860

GACTCAGACA GGGCCATCGA AGGGCGTACC GCCACCAGTG AGTACCAGAC TTTCTTCAAT 13920

CCGAGGACCT TTGGCTCGGG AGAGGCAGGT GAGGTAGTGG GCATCCGAGG GGATGCGGGG 13980

CTGCGGGGCT GGTGGCCAGG ACTTGCCCCT CACTGCTTGG CTTGCTCTGC AGACTGTGGG 14040

CTGCGACCTC TGTTCGAGAA GAAGTCGCTG GAGGACAAAA CCGAAAGAGA GCTCCTGGAA 14100

TCCTACATCG ACGGGCGCAT TGTGGAGGGC TCGGATGCAG AGATCGGCAT GTCACCTTGG 14160

TGTGTCCTGG AGCCCTGCGC TACCATTCAC TCCTGGGGGC AGGTGTGCTG CTGGACCCCC 14220

ACCCTCAGGC CCTGCCTGCA GGCCTGGGCT TTACAGATGA CAACAGCTGA GCATCCAGGA 14280

TCCCACCAAC TCCACACAGC AGCCACATGA GATGGGTTGT TTACTTCTTT TTTTTTTGTT 14340

TCTTAGATGG AGTCTTGCTC TGTCACCTAG GCTGGAGTGC AGTGCTGCAA TCTCGGCTCA 14400

CTACCTCGAT CTCAGCTCAC TGCAACTTCT GCCTTCCGGG TTCAAACGAT TCTCTTGCCT 14460

CAGCCTCCTG AGTAGCTGAA TTTACAGACA TGCGCCACCA CACCCGGCTA ATTTTTGTAT 14520

TTTAAGTAGA GACAGGGTTT CACCATGTTG GCCAGGCTGG TCTTGAACTC CTGACCTCAA 14580

GTGATCCACC TGCCTCAGCC TCCCAAAGTG CCGGGATTAC AGGCATGAGC CACCACACCC 14640

GGCCCATGGG TCCTTTACTT CTAAGCAGAT GGTAAAGCTG AGACTGACGG AGCTGGTGGC 14700

TCACCTCCGC GCACAGCTAA TGGGTTTGAA TCCAGTTCTT CTGATTCCAG AGCTGTGCTA 14760

CGCTATGTGA ACTCTGGACT GGAAGGACCT AGTTAGGGGG TGCAAAAAGC AGGAGGCAGG 14820

TCAGGTGCAG TGGCTCACCC CTGTAATCCC AGCACTTTGG GAGGCCAAGA CAGGAAGATC 14880

ACTTGAGGGC AGGAGTTCGA GGCCAGCTTG GGCAAAATGG TAAAACCCCG TCTCTACTAA 14940

AAATGCAAAA ATTAGCCAGG TGTAGCAGCA TGTCCCTGTA GTCCCAGCTA CTAAGGAGGC 15000

TGAGGCGGGA GGATCGCCTG AGCCCAAGAG GCTGAGGCTT CAGTAAGCTG TGACTGTACC 15060

ATTGCACTCC AGCCTGGGTG ACAAGAGTGA GACCCTGTCT CAAAAATAAA TAAATAAATA 15120

AATAAAAAGT GTGAGGCAGC CCCTCAGCAT CACACGGAGG CTCCAGCCCC AAAGGCGGCC 15180

AGCCCAAGCT TGGATCTGGG CCCCGGAGGC AGCTCTGCCC AGCTGGGTTC TTAGACCTGG 15240

GATTGTTACT TCTAGGGCTG GTGTAGAGGC AGCCCCCTCA TCCTCAGCTC CTAATGCTTC 15300

›(i) SEQUENCE CHARACTERISTICS · 4 of 6

CTGCTGCCCC TCCCAGGCAG GTGATGCTTT TCCGGAAGAG TCCCCAGGAG CTGCTGTGTG 15360

GGGCCAGCCT CATCAGTGAC CGCTGGGTCC TCACCGCCGC CCACTGCCTC CTGTACCCGC 15420

CCTGGGACAA GAACTTCACC GAGAATGACC TTCTGGTGCG CATTGGCAAG CACTCCCGCA 15480

CAAGGTACAG AACTGGTGGC CCGTGGGTGT CTGGCAGGGG TCTGAGTCCT CCAAAGCGAT 15540

CATGAGGGGC CTTGGTGGCT CCGGGACACA TAGGATGTTC TGTATACCCC CCAGAATATA 15600

ACATCCCAGC AGTCTCTGCT GGAAAGCCAT TTGGTCACGT CCTGACTGAG GCTTGGAGCG 15660

CGGGGAGAAT CCGTCTGTCT CTGGTCCCTC CAACACTAGG ATATAGCCCA TGTGGGAGTC 15720

TCTGAAAATA GAGTCTGTCT GGACTAGGGC GTGCAGCCTG TGCCCCTGTC CCCGTCCTCC 15780

AGGCTGTCTG ACTCCAAAGC CCTGCACGGC TTTAGGCCCA GGAAGAAACA CCCAGGGGGC 15840

TGCCATGGCA GGAACCAGCC CTATCCCCTC CCTGGTGGCC TGCAGGACAC ACTGTCTCCC 15900

AGAACCCCAA GGGCAGGCAG TTTCCTGCTC CTTGCTGGGT GAACCTGCAG CTTCTCCATT 15960

TCTTTCTTGG GGTCTCTGCA GGTACGAGCG AAACATTGAA AAGATATCCA TGTTGGAAAA 16020

GATCTACATC CACCCCAGGT ACAACTGGCG GGAGAACCTG GACCGGGACA TTGCCCTGAT 16080

GAAGCTGAAG AAGCCTGTTG CCTTCAGTGA CTACATTCAC CCTGTGTGTC TGCCCGACAG 16140

GGAGACGGCA GCCAGGTGGG CCACCAGATG CTTGTTAGCT GAGGGGCAGA AGCCAAGTTC 16200

TGGGCCTGGC TCTGATACCA AGTAGCCTTG CAAGAGCCCC TTTCCCTTTT CCAGGCCTCG 16260

GTTTCTTGGA GTGAACCCAA AAGTTCTTTT CAGTACTGGC GTTTTATTTT TTATTTATAT 16320

TTATTTATTT ACTGACGGAG TTCCACTCTT GTCTCCCAGG CTGGAGTGTA GTTGTGCGAT 16380

CTTGGCTCAC TGCAACCCCA CCTCCTGGGT TCAAGCGACT CTCCTGCCTC AGTCTCCTGA 16440

GTAGCTGGGA TTACAGGCTA ATTTTTGTAT TTTTAGTAGA GACTGGTGGG TTTCACCGTG 16500

TCGGCCAGGT TGGTCTCGAA CCCCTGACCT CAAGTGATTC ACCCGCCTCG GCCTCCCAAA 16560

GTGCCGAGAC CACAGGCGTG AACGTCTGTG CCCAGCCAGC TCTGGCGTTT TAGATTCTGG 16620

TCTCTAAGAA ATGGCGTTGG GGCCAGGCGG CTCCTGTGGG GGTTGGCTCT CACTAGGCCC 16680

TTCTTCCTTC CCCAAAGCTT GCTCCAGGCT GGATACAAGG GGCGGGTGAC AGGCTGGGGC 16740

AACCTGAAGG AGACGTGGAC AGCCAACGTT GGTAAGGGGC AGCCCAGTGT CCTGCAGGTG 16800

GTGAACCTGC CCATTGTGGA GCGGCCGGTC TGCAAGGACT CCACCCGGAT CCGCATCACT 16860

GACAACATGT TCTGTGCTGG CAAGTCTGTG CAGGGCGGGC TGAGGGAACA GTGGGGCCCA 16920

AGCTGGGAGA ACTGAGTTGT GCCTGGGTTC AAGCCATGTG ACTTTGAGCA AGTTGCCTAA 16980

CCTCTTGGTG GCTCAGTTTC TTCCTCTGTA AAATGGAGGT AAAAGTCTCT ATCCCATAAG 17040

GTTATGGGAG GGTTAAATGA AGTAGTATAT ATTAATGTAC TTGGCATAGT ATCAGTCACC 17100

AGTGAGCTCA GATAGCAGCA AGAGGCTGCG GGTAGGGAAA TGCCATTCAT TCAGTCACTC 17160

AGCAAATATT TATTGAGCGC CTATCACGTT CCAGGCAGCG TTCTAGGGTA TACAGCAGGG 17220

ACCCAGACGG ACAATGTCTG TGCCCTCAGA GAGCTTCCTT CCTAGGAGGG CACATCCATA 17280

AACAGATCTA AAACAGCAAT CCCTGACCAG TGCTGTGAAG AAAAATGAAG CACAGGGAGA 17340

GAGAACGGCT GATGAAGTGG GCTTCTAAAT AGGGTGGCCA GACAAGGTGG GCAGATCACT 17400

TGAGGTCAGG AGTTCAAGAC CAGCCTGGCC AACATGGTGA AACCCCGTCT CTACTAAAAA 17460

TACAAAAATT AGCTGGTCAT GGTGACGCAT GCCTGTAGTC GCAGCTACTC AGGAGGCTGA 17520

GGCAGGAGAA TTGCTTGAGC CAGGGAGGCG GAGGTTGCAG TGAGCTGAGA TCGGGCATCA 17580

TTGCACTCCA GCTGGGCAAC ACAGCAAGAC TCCATTGATC GATCGATCAA TCAATCAATC 17640

AGGTGGCCAG AGAAGGTTGG AGAAGGCCTC CCTGAGAAGG TGATGTCTGG GCAGGGACTG 17700

GAAGAGGGGA AGGAAGGAGT GAGCAGGCAT ATCTAGGGGA GGAGCACCGC AGGCTGGGGG 17760

CATGGCAGGC ACTAAGGCCC TGAGGTGGGA GCACTCTTGG CTTGTCTGGG GAGCAGTAGG 17820

GAGGCCTGGG GGGCTGAGGA GGGGCAGCAG TGGGTGAGGG GAGAGAGGGG GGCAGGCAGA 17880

GGACAGCCAC TTCCTTTAGG GCCTGGAAGG ACTTTATTGA GTGAGATGGG AAGTTATTGA 17940

GGGGCTTGAG GCAGGTTAAG AAATGATGTG ACTGACTTTA AAAGTAAAAA ATAAAAAAAT 18000

TTAGTGTAAT TTCAGACTCA CAGAAAAGTT GTAAAAATAA TACAAAGATT TCCTGTATAC 18060

TGTCATCCAG ATTGTCCTCC ATTCTGTGGA TGTGTGGGAA TTTTTATATA TATATATGCA 18120

TAGTTTGAGA GCAAATCATG AATATGGTTT CTTTTTACCC ATAAATACTT GAGTATTTCC 18180

AAAAAAAAAA AAAATACCCA AGGATGTTCT CTTATGCAAC CACAATACAA ATATTAAAAC 18240

CCGGAAATTT TTTTTTGACA TAGCTTCGCG TCACCCAGGC TTGAGTGCAG TGGCACAATC 18300

TCGGCTCACT GCAACCTCCT GCTCCCAGGT TCAAGTGATT CTCCTGCCTC AGCCTCCTGA 18360

GTAGCTGGAA TCACAGGCAT GTACTACCAT GCCTAGCTAA TTTTTGTATT TGTAGTAGAG 18420

ACAGGGTTTC ACCATGTTGG CCAGGTCGGT CTTGAACTCC GACCTCAGGT GATTCACCTG 18480

CCTCGGCCTC CCAAAGTGCT GGGATTACAG GCGTGAACCA CTGTACTCGG CCAAAACCAG 18540

GAAATTTTTT TTTTTTTTTG AGATGGAATC TTGCTCTGTT GCCCAGGCTA GAGTGCAGTG 18600

GCATGGTCTC GGCTTACTTG GAATTACAGG TGCCTGCCAC CACGCCCGGC TAACTTTTTG 18660

TATTTTTAGT ATTTTTAGTA GTGATGGGGT TTCACCATGT TGGCCAGGCT GGTCTTGAAC 18720

TCCTGACCTC GGGTAATCCA CCCACCTCGG CTTCCCAAAG TGCTGGGATT ACAGGCGTGA 18780

GCACCAGCAC CTGGCCCAAA ACCAGGAAAT TAATGATGAT ACAATATTAT TGTCTAATCT 18840

ATAGACCTTA TTCAAATTTT TGTTAGTCTT GCTAATGTCT TTTATAGGGA AAAAAAAAAA 18900

AAAAAGCGTG TTTCTCACCC AGGATTCAAT GAAGGATCTT TCTTTGTCTT CTATGACCTT 18960

GACATGTCTG ATGAGTGCAG TCTGGTTATT TTGTACACTG GCCCTGAATC CGGGTTTGTC 19020

TAAGGTTTCC TCACGGTCAG GTTCGGGCTC AGTGGTGCCA TGTCCTTCTT GGTGCATCCT 19080

GTTAACTGGC ACATGAGAAC AATTTGTCTC ATATGTGGTG AGTCTAACTC TGACCTCTTG 19140

AGGAAGGCAA TGTCTGCCAA GTTTCTTGCT GTAACTTCTG TTTTTCCCTT TGTAATTAAT 19200

AAGAATCTGG TAAAGAGACA CTTTGATGTT TTTTTTTTTT TTTTTTTTTG TGATGGAGTC 19260

TCCCTCTATC ACCCGGGCTG GAGTGTGTGG TGCGATCTCG GCTCACTGCA ACCTCCATCC 19320

CCCAGGTTCA AGTGATTCTC CTGCCTCAGC CTCCCAAGTA GCAGGGATTA CAGGCATGTG 19380

CCACCACACC CAGCTAATTT TTGTATTTTT AGTAGAGATG GGGTTTCACC ATGTTGGCCA 19440

GGATGGTCTC GAACTCCTGA CCTTGTGATC CGTCTGCCTC AGCCTCCCAA AGTGCTGGGA 19500

TTACAGGTGT GAGCCAATAC GCCTGGCCTA CTTTGATATT TTGTATTCTG TTTGCATCAA 19560

AACCTTCTCC CAACTAGGGT GACTACCAAA TGGCACTTAT CTAATTCTGT CATTCCTTCT 19620

ACATTTGTTA GTTACTTTAT TGCTTTCCTT CCTTTCATTC TATCAGTGTG GACTTAAGGA 19680

TCCTTACTTT ATTCTAAGGG TTCACCTTTT TTTTCTTTTT TTTTGAGATG GAGTTTCGCC 19740

CATGTTGCCC AGGCTGGATG GAGTGCAATG GCGTGATCTC GGCTCACTGC AACGTCCTCC 19800

TCCCAGGTTC AAGCAATTCT CCTGCCTCAG CCTCCTGAGT AGCTGGGATT ACAGGCATGT 19860

GCCACCACGC CTGGCTAATT TTTTGTATTT TTAGTAGAGA CAGGGTTTCA CCATGTTGGC 19920

CAGGCTGGTC TCGAACTCCT GACCTCAGGT GATCCGCCCG CCTCAGCCTT CCAAGGTTCT 19980

GGGATTATAA GCGTGAGCTC TACCGTGCCA GGCCATACTT TGTTACTACT GTTATTTTTT 20040

CTGATGCTCA GATGATCCCA AGTTTGGCCT GTGGAAGTCC CTTCAAGCTG GCTTCTGTGA 20100

CTTGGGGAGA TGTTCTGTCA TTCTTTGAGT ACTTTCTTTC TTTCTGGCAC AGCAAAATGA 20160

TTCAGGTTAA TCCTACTTTC CTTACTGTAG TGTTGGAACC AGCCATTTCT CCAGGGAACC 20220

CTTGTAGTCA AGAGTGGAAT TTAGAACTGA GATCTGGGTG CTGGCGTGTG CACATTGCTA 20280

GTGGGATGTC ATTACTTCTA GGCTCTCTTA GTGGACAGAA CCAGAAAAAA ATTATATGAT 20340

GCATATACCA ATATCTCTAT CATCTATATA AAAAACCATG AGTTCCTACT GAAACCTCCA 20400

›(i) SEQUENCE CHARACTERISTICS · 5 of 6

ATTCCATTCT AACACCACAG GATTAATTTT AGCTTTTCCT TTTCCATATT TGTAACTCTC 20460

TCTGTTGACA GTGAGAAACC TGACCCTCAT TATCTGTAAT GCATTTGCCT ATTTGAACAA 20520

TACTAGAATA TAGTTTCAAA ATCCTCCATC CATAACACTA TTAAAACCAA TCCTATGGCT 20580

GGGCTCAGCC CACTGCAACC TCTGCCTCCT GGACTCAAGC CAGCCTCCCA CTTTAGCCTC 20640

CCGAGTAGCC AGGGCTACAG GCACACACCA CCATGCCCAG CTAATTTTTG TATTTTTTGT 20700

AGAGACTGGG TCTCACTGTG TTGCCCAGAC AGGTCTTGAA CTCTGAGCTC AAGTGATCCA 20760

TCCAACTCAG CCTCCCAAAG TGCTAGGATT ACAGGTGTGA GTCACCATGC CTGGCCTCTC 20820

CTAGTAAATT TTTAGAAGTG GTGTTGTTAG GTCAAAAGGC AAACATGTAT GTCATTTTTT 20880

AGAGATTTTT AAATTTCTTT CCATAAGGGT TGTACCAGTT TGCATTTCCA TCACAGTGTA 20940

TGAGAATGCC TGTTTCCCCA CAACCTTGCC AAAAGAATGT CACAGTTTAA ATTTTACCAA 21000

TCTGAGAGGT GAGAAATAGT ACCTGAAATT GTTTAACGGA CATCTTCAAA TTGAAATTGA 21060

GGTTGACAAC GAATCATAGT TAGGACCTTT TTTTTTTTTT TTTTTGAGTG GGTCTCCTCG 21120

TCACCAAGCT GAGTGCATGG CACGATTTGC TCACTGCAAC TTCCGCCTTC TGGGTTCAAG 21180

CGATTCTCCT GCTTCAGCCT CCCAAGCAGC TGGGACTCCA GGCGCGAGTC ACCATGCCCG 21240

CTAATTTTTG TATTTTTAGT AGAGACAGGG TTTTACCAGA TTGGCCAGGC TGGTCTCGAA 21300

CTCCTTACCT TGTGATCCTC CCGCCTCGGC CTCCCAAAGT GCTGAGATTA CAGGCATGAG 21360

CCACCACGCC TGGCCTAAGG ACCATTTTTA TATAATTTTT TTTTTGAGAC AGAGTCTTGC 21420

TTTGTCACCC AGGCTGGAGT GCAATGGTGC AATCTTGGCT CACTGCAGCC TCCACTTCCC 21480

TGGTTCAAGT GATTCTCCTG CCTCAGCCTC CCGAGTAGCT GGTTCCACAG GTGCGTGCCT 21540

GGCTAGTATT TGTATTATAT AATTTTTTTG TGAATTGTCT CTTCATGGTT TTTTGCCCAT 21600

TTTTTGGTCC CTTTCTTATC AATTTTTGTG AGTTCTTCGT ATTTATATTA GGCCTTTATT 21660

TGTGATATAC ATTGCAAATG TTTTCTCCTA GTTTGTCAGT TTTTTTAACC TCATGTATAA 21720

TTTTTCTGGC CATGCAGTTT AAAAAATTAC TAGGTAGTCA AATTTATCAA TCATTATTTA 21780

TAAATCTGGT TTGAACAGAG ATAAACTTTC CTGGCCAAGT GTGGTGTTTA CACCTGTAAT 21840

CCCAGCACTC TGAGAGGCTG AGGTGGGGAT CACCTGAGGT CAGAAGTTCA AGACCAGCCT 21900

GGCCAACATG GTGAAACCCT GTCTCTACTA AAAATACAAA AATTAGCTGG GCGTGGTGGC 21960

TGATGCCTGT AGTCCCAGCT ACTCAGGAGA CTGAGGCTGG AGAATTGCTT GAACCTGGGA 22020

GGCGGAGGTT GCAGTGAGCA GAGATCGTGC CGCTGCACTC CAGCCTGGGT GACAGAGCAA 22080

GACTCTGTCT CAAAAACAAA ACGACAAAAA ACAACAACAG AAAAGCCTTT CCTGATAGCT 22140

AGGTCATTGA GGAATTCACT CATGTTTTCT TCTAGTACCT GATTTCATTT TTCTGCACTT 22200

AGATTCCTGA CTCATATGGA GTTTATTTTT GTATCTGATG TGAGGCATAG ATCTAATTTA 22260

TTATTTTCCA AATGGCTAAC TAGCTGTCTC TAAACCCTTT ATTAAAAATT ATTGGCCAAG 22320

TGCGGTAGCC ACACCTGTAA TCCCAGCAGT TTGGAAGGCT GAGGCAGGAT TGCTTGAGGC 22380

CAGGAATTCA AAACCAGCCC AGACAACATA GCAAGACCCT GTCTCTACAA GAAAATATTG 22440

GTCAGGTGTG GTGGCTCACG CCTATAATCC CAGCACTTTG GGAGGCTGAG GCAGGTGGAT 22500

CATGAGGTCA GGAGATAGAG ACCATCCTGG CCAACATGGT GAAACCCTCG TCTCTACTAA 22560

AATACAAAAA ATTAGCTGGG TGTGGTGGCG CATGCCTGTA GTACCAGCTA CTCAGGAGGC 22620

TGAGGCAGGG GAATCATTTG AACCCAGGAG GTGGAGGTTG CAGTGAGCTG AGATCACGCC 22680

ATTGAACTCC AGCCTGGCGA CAGAGCAAGA CTCCATCTCA AAAAAAAAAG GAAAAAGAAA 22740

ATATTTTAAA AATTAGCTGG GCATGGTGGC ATGTGCCTTG TAGTCTCAGC TACTTGAGAG 22800

GCTGAGTTAG GAGGATTGCT TGAGCCTAGG AGTTCAATAC TGCAGTGAGC TATGACCGCA 22860

CCATTGCACT CCAGCCTGGG CAACAGAGTG AGACCCTGTT TCTATTAAAA AAAAAAAATC 22920

GGCTGGGCGC GGTGGCTCAC GCCTGTAATC CTAGCACTTT GGGAGGCCGA GGCGAGCGGA 22980

TCACCTGAGG TCAGGAGTTC AAGACCAGCC TGACCAACAT GGAAAAACCC TGTCTCTGCT 23040

AAAAATACAA AATTAGCCAG ACATGGAGGC ACATGTCTGT AATCCCAGCT ACTCGGGAGG 23100

CTGAGGCAGG AGAATCGCTT GAACCTGGGA GACGGAGGTT GCAGTGAGCT GAGATCCCTC 23160

CATTGCACTC CAGCCTGGGC AACAAGAGTA AAAACTCCGT TTCGCCAGGT GCGGTGACTC 23220

ACACCTGTAA TCCCAGCACT TTGGGAGGCC GAGGTGGGTG AATCACAAGG TCAGGAGTTT 23280

GAGACAAGCC TGGCCGACAT GGTGAAACCC CATCTCTACT AAAATACAAA AAATTAGCCT 23340

GGCATGGTGG TGTGCGCCTG TAATCCCAGC TACTTGGGAG GCTGAGGCAG GGGAATCACT 23400

TGAACCTGGG AGGAGGAGGT TGCAGTGAGC CGAGATGGTG CCACTGCACT CCAGCCTGGC 23460

AACAGAGCGA GACTCTATCT CAAAATCAAT CAATCAATCA ATCAATCTTT GAACTAGTGA 23520

TTTGAGATTT CACCTTTATC ACATTCTAGA TTGTATCTTA TTTTCATTTA TTTATTTGAA 23580

ATATAGACAA GTCTCCCTGT GCTGCCCAGG CTGATTTCAA ACTCCTGGCT GGGCTCGAGC 23640

AAGTCTCCCG CCTTGGCCTC CCAAACTGCT GGGATTACAG ACGTGAGCCA CCATACCTGA 23700

CCCAGGTTTT ATTTTTTAGT TTTATTTTTT CCTGCATCCA GCTAATTTGA TTTGATTTGT 23760

AGAGACGGGG TCTTGCTATG TTACCTAGGC TGGTCTCGAA CTCTTGGGCT CAAGTGATCC 23820

TCCTACCTTG GCCTCCCAAA GTGTTGGGAT TACCAGCATG AGCCACGGTG CCCAGCCCCA 23880

CGTTCTAGAT TTCTATGGAT AGAGTATGCT TAAGGATGAG TATGTTTCTG GATGTTCGAC 23940

TCGGCTTTCC TGGTCTGTTG TCTGTCTGTG TACAGCGTCA CATTGTTTTA ATGATAGAGG 24000

CTTTAGCGTA CATAGCTGGG AAGGCTAATG TTCTCTTTTA GTTTTTCTTT CCAGTGGTTT 24060

CCTGGCAATT CTTGCATGTT TGTTTTTCCA TATGAACTTT AGTGTCAACA TGCCTAGGTC 24120

TATAAAAAAG CTTGGTGGTA ATTTTATTGG GATTATGACA CTTCAACAAA TTAACTGGGA 24180

GAATGAACAT ATTTTTGATG TTGAGTCATT TTATCCAAGG ATAAGAAACG TTTTCCTATT 24240

TGCTCAAGTC TATTATTGTA TCTTTCTTGA CTGCTGCAAT GTATTCTCTT ATAATTTTTT 24300

CTATTGGTAT CTTATTTTAT GTATTTGTAA TATCTTATTT TTCTTGAGTA AATTAGTTAA 24360

TGGCTTGCCG GTTTTCTCAA AACAAATATC TAGGGATTTG ATTTATGAAA TTATTAGGCC 24420

TATTATTTTT CTTTTTTTTG AGATGGAGTC TCACTCTGTC GCCCAGGCTG GAGTGCAGTG 24480

GCGTGATCTC AGCTCACTGC AACCTCCACC TCCTGGGTTC AAGTGATTCT CCTGCCTCAG 24540

CCTCCCCAGT AGCTGGGGTT ACAGGTGCAC GCCACCATGC CCGGCTAATT TTTTTATATT 24600

TTTAGTAGAG ACGGGGTTTC ACCATGTTAG CCAGGCTGGT CTCGAACTCC TGACCTCATG 24660

ATCCGACTGC CTCAGCCTCC CAAAGTGCTG GGATTACAGG TGTGAGCCAC CGTGCCTGGC 24720

CTTTTTTTTT TTTTTTTGAG ACAGAGTCTT GCTCTGTCAC CCAGGCTGGA GTGCAGTGGT 24780

GCGATCTCGG CTCACTGAAA GCTCCACCTC CCGGGTTCAC GCCATCCTCC TGCCTCAGCC 24840

TCCCGAGTAG CTGGGACTAC AGGTGTACAC TGCCACGCCC AGCTAATTTT TTGTATTTAG 24900

TAGAGACAGG GTTTCACCGC GTTCGCCAGG ATGGTCTCGA TCTCCTGACC TTGTGATCCG 24960

CCTGCCTCAG CCTCCCAAAG TGCTGGTATT ACGGGCGTGA GCCACTGCGC CCGGCCAGGC 25020

CTATTATTTT TCTATTGTGG TTCATTAATT TCTGCTTTTT TCTCTTAAAA AGTTTGCTTA 25080

CGTTTTTGTC TGGTTTACTT TGCTGTTCTC TTGCTAGCTT TTTTTTTTTT CAGATAGGGT 25140

CTTGCTCTGT TGCCCAGGCT GGAGTGCAGT GGCACAGTCA TAGCTCACTG CAGCCTTGAA 25200

CTCCTGGGCT CAAGCAATCC TCTTCTTGCT TCAGCCTCCC ACGTAGCTAG GATCAGAGGT 25260

ACATGCCACC ATGTTCGGCT AATTTTTTTT TTTCGAGACA GAGTCTTGTT CTGTCGCTCA 25320

GGCGGTAGTG CAGTGGTGCA ATCCCGGCTC ACTGCAACCT CCACCTCCAC CTCCCAGGTT 25380

CAAGCAATTC TACCTCAGTC TCCTGAGTAG CTGGGATTAT AGGCGCACAC CAACATGTCT 25440

GGCTAATTTT TGTATTTTTA GTAGAGACAG GGTTTCACCA CGTTGGCTAG GCTGGTCTTA 25500

›(i) SEQUENCE CHARACTERISTICS · 6 of 6

AACTCCTGAC TTCATGATCC GCCCGCCTTG GCCTCCCAAA GTGCTGAGAT TACAGGTGTG 25560

AGCCACAGCA CCTAGTGAAA GTGTGGTTTT TTTGTGTAGG TTTTACTGTT GTTAGTGTTG 25620

TTCTGTATTG TTTGTAGAGG ATACGTGGGG AGATTTGGAT AAAAGCAACT ATCATTATTA 25680

TCCTCATCAG ACTTGTAGGT CTAACTTTTT AATTTTTTAA TTTTTAATTT AAATTTTTTT 25740

CTTGGTCTTT TATCATTAAT TAATTTTTTC GAGACAGGGT CTCACTCTGT TGCCCAGGCT 25800

GGAGTGTGGT GACATGATCA CGGCTCACTG CAGCCTTAAC CTCCCAGGTG CAAGTGATCC 25860

TCCTCTCTTA GCCTCCCGAG TAGCTGGGAC TCCAGGCATG TGCCACCATG CCCAGCTAAT 25920

TTTTTGTAGA GAGAGGGTTT TGCCATATTG CCCAGGCTGG TCTTGAACTG CTGAGCTCAA 25980

GTGATCCACC CGGCTTGGGC ATGAGCCACC TCCCCTGGTC TGGTCCAACT TTTTAAAAGC 26040

ATTATTCTGC CTGTTGGGTG GAGAATAGAC TGTAGGTGGG CAAAGAATGA AGGAAACTAG 26100

TGGGTTCAGG AGCTCGAGCT AGAAGTGGTG AGAAGGGTTT GGATTTGGGG TCTATGCTGA 26160

AGGTAGAGCC GACAAGATTT GCTAGGATTG GATGTGTAGG GTGAGGAAGT GGGGACAGCA 26220

AGAATGACTG GAGGGGTAAG TGGACTCTCA CCAGCTGTGT CTCGTGAAGG GGCGTGGCTG 26280

GGCTATGAGC TATGCTCCTG AGCACAGACG GCTGTTCTCT TTCAAGGTTA CAAGCCTGAT 26340

GAAGGGAAAC GAGGGGATGC CTGTGAAGGT GACAGTGGGG GACCCTTTGT CATGAAGGTA 26400

AGCTTCTCTA AAGCCCAGGG CCTGGTGAAC ACATCTTCTG GGGGTGGGGA GAAACTCTAG 26460

TATCTAGAAA CAGTTGCCTG GCAGAGGAAT ACTGATGTGA CCTTGAACTT GACTCTATTG 26520

GAAACCTCAT CTTTCTTCTT CAGAGCCCCT TTAACAACCG CTGGTATCAA ATGGGCATCG 26580

TCTCATGGGG TGAAGGCTGT GACCGGGATG GGAAATATGG CTTCTACACA CATGTGTTCC 26640

GCCTGAAGAA GTGGATACAG AAGGTCATTG ATCAGTTTGG AGAGTAGGGG GCCACTCATA 26700

TTCTGGGCTC CTGGAACCAA TCCCGTGAAA GAATTATTTT TGTGTTTCTA AAACTATGGT 26760

TCCCAATAAA AGTGACTCTC AGCGAGCCTC AATGCTCCCA GTGCTATTCA TGGGCAGCTC 26820

TCTGGGCTCA GGAAGAGCCA GTAATACTAC TGGATAAAGA AGACTTAAGA ATCCACCACC 26880

TGGTGCACGC TGGTAGTCCG AGCACTCGGG AGGCTGAGGT GGGAGGAT 26928

(2) INFORMATION FOR SEQ ID NO:42:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 622 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:42:

Met Ala His Val Arg Gly Leu Gln Leu Pro Gly Cys Leu Ala Leu Ala

1 5 10 15

Ala Leu Cys Ser Leu Val His Ser Gln His Val Phe Leu Ala Pro Gln

20 25 30

Gln Ala Arg Ser Leu Leu Gln Arg Val Arg Arg Ala Asn Thr Phe Leu

35 40 45

Glu Glu Val Arg Lys Gly Asn Leu Glu Arg Glu Cys Val Glu Glu Thr

50 55 60

Cys Ser Tyr Glu Glu Ala Phe Glu Ala Leu Glu Ser Ser Thr Ala Thr

65 70 75 80

Asp Val Phe Trp Ala Lys Tyr Thr Ala Cys Glu Thr Ala Arg Thr Pro

85 90 95

Arg Asp Lys Leu Ala Ala Cys Leu Glu Gly Asn Cys Ala Glu Gly Leu

100 105 110

Gly Thr Asn Tyr Arg Gly His Val Asn Ile Thr Arg Ser Gly Ile Glu

115 120 125

Cys Gln Leu Trp Arg Ser Arg Tyr Pro His Lys Pro Glu Ile Asn Ser

130 135 140

Thr Thr His Pro Gly Ala Asp Leu Gln Glu Asn Phe Cys Arg Asn Pro

145 150 155 160

Asp Ser Ser Thr Thr Gly Pro Trp Cys Tyr Thr Thr Asp Pro Thr Val

165 170 175

Arg Arg Gln Glu Cys Ser Ile Pro Val Cys Gly Gln Asp Gln Val Thr

180 185 190

Val Ala Met Thr Pro Arg Ser Glu Gly Ser Ser Val Asn Leu Ser Pro

195 200 205

Pro Leu Glu Gln Cys Val Pro Asp Arg Gly Gln Gln Tyr Gln Gly Arg

210 215 220

Leu Ala Val Thr Thr His Gly Leu Pro Cys Leu Ala Trp Ala Ser Ala

225 230 235 240

Gln Ala Lys Ala Leu Ser Lys His Gln Asp Phe Asn Ser Ala Val Gln

245 250 255

Leu Val Glu Asn Phe Cys Arg Asn Pro Asp Gly Asp Glu Glu Gly Val

260 265 270

Trp Cys Tyr Val Ala Gly Lys Pro Gly Asp Phe Gly Tyr Cys Asp Leu

275 280 285

Asn Tyr Cys Glu Glu Ala Val Glu Glu Glu Thr Gly Asp Gly Leu Asp

290 295 300

Glu Asp Ser Asp Arg Ala Ile Glu Gly Arg Thr Ala Thr Ser Glu Tyr

305 310 315 320

Gln Thr Phe Phe Asn Pro Arg Thr Phe Gly Ser Gly Glu Ala Asp Cys

325 330 335

Gly Leu Arg Pro Leu Phe Glu Lys Lys Ser Leu Glu Asp Lys Thr Glu

340 345 350

Arg Glu Leu Leu Glu Ser Tyr Ile Asp Gly Arg Ile Val Glu Gly Ser

355 360 365

Asp Ala Glu Ile Gly Met Ser Pro Trp Gln Val Met Leu Phe Arg Lys

370 375 380

Ser Pro Gln Glu Leu Leu Cys Gly Ala Ser Leu Ile Ser Asp Arg Trp

385 390 395 400

Val Leu Thr Ala Ala His Cys Leu Leu Tyr Pro Pro Trp Asp Lys Asn

405 410 415

Phe Thr Glu Asn Asp Leu Leu Val Arg Ile Gly Lys His Ser Arg Thr

420 425 430

Arg Tyr Glu Arg Asn Ile Glu Lys Ile Ser Met Leu Glu Lys Ile Tyr

435 440 445

Ile His Pro Arg Tyr Asn Trp Arg Glu Asn Leu Asp Arg Asp Ile Ala

450 455 460

Leu Met Lys Leu Lys Lys Pro Val Ala Phe Ser Asp Tyr Ile His Pro

465 470 475 480

Val Cys Leu Pro Asp Arg Glu Thr Ala Ala Ser Leu Leu Gln Ala Gly

485 490 495

Tyr Lys Gly Arg Val Thr Gly Trp Gly Asn Leu Lys Glu Thr Trp Thr

500 505 510

Ala Asn Val Gly Lys Gly Gln Pro Ser Val Leu Gln Val Val Asn Leu

515 520 525

Pro Ile Val Glu Arg Pro Val Cys Lys Asp Ser Thr Arg Ile Arg Ile

530 535 540

Thr Asp Asn Met Phe Cys Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg

545 550 555 560

Gly Asp Ala Cys Glu Gly Asp Ser Gly Gly Pro Phe Val Met Lys Ser

565 570 575

Pro Phe Asn Asn Arg Trp Tyr Gln Met Gly Ile Val Ser Trp Gly Glu

580 585 590

Gly Cys Asp Arg Asp Gly Lys Tyr Gly Phe Tyr Thr His Val Phe Arg

595 600 605

Leu Lys Lys Trp Ile Gln Lys Val Ile Asp Gln Phe Gly Glu

610 615 620

(2) INFORMATION FOR SEQ ID NO:43:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 3997 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 17...2380

›(D) OTHER INFORMATION · 1 of 2

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:43:

GCGGGAGGCG GACGAG ATG CGA GCG CGG CCG CGG CCC CGG CCG CTC TGG GCG 52

Met Arg Ala Arg Pro Arg Pro Arg Pro Leu Trp Ala

1 5 10

ACT GTG CTG GCG CTG GGG GCG CTG GCG GGC GTT GGC GTA GGA GGG CCC 100

Thr Val Leu Ala Leu Gly Ala Leu Ala Gly Val Gly Val Gly Gly Pro

15 20 25

AAC ATC TGT ACC ACG CGA GGT GTG AGC TCC TGC CAG CAG TGC CTG GCT 148

Asn Ile Cys Thr Thr Arg Gly Val Ser Ser Cys Gln Gln Cys Leu Ala

30 35 40

GTG AGC CCC ATG TGT GCC TGG TGC TCT GAT GAG GCC CTG CCT CTG GGC 196

Val Ser Pro Met Cys Ala Trp Cys Ser Asp Glu Ala Leu Pro Leu Gly

45 50 55 60

TCA CCT CGC TGT GAC CTG AAG GAG AAT CTG CTG AAG GAT AAC TGT GCC 244

Ser Pro Arg Cys Asp Leu Lys Glu Asn Leu Leu Lys Asp Asn Cys Ala

65 70 75

CCA GAA TCC ATC GAG TTC CCA GTG AGT GAG GCC CGA GTA CTA GAG GAC 292

Pro Glu Ser Ile Glu Phe Pro Val Ser Glu Ala Arg Val Leu Glu Asp

80 85 90

AGG CCC CTC AGC GAC AAG GGC TCT GGA GAC AGC TCC CAG GTC ACT CAA 340

Arg Pro Leu Ser Asp Lys Gly Ser Gly Asp Ser Ser Gln Val Thr Gln

95 100 105

GTC AGT CCC CAG AGG ATT GCA CTC CGG CTC CGG CCA GAT GAT TCG AAG 388

Val Ser Pro Gln Arg Ile Ala Leu Arg Leu Arg Pro Asp Asp Ser Lys

110 115 120

AAT TTC TCC ATC CAA GTG CGG CAG GTG GAG GAT TAC CCT GTG GAC ATC 436

Asn Phe Ser Ile Gln Val Arg Gln Val Glu Asp Tyr Pro Val Asp Ile

125 130 135 140

TAC TAC TTG ATG GAC CTG TCT TAC TCC ATG AAG GAT GAT CTG TGG AGC 484

Tyr Tyr Leu Met Asp Leu Ser Tyr Ser Met Lys Asp Asp Leu Trp Ser

145 150 155

ATC CAG AAC CTG GGT ACC AAG CTG GCC ACC CAG ATG CGA AAG CTC ACC 532

Ile Gln Asn Leu Gly Thr Lys Leu Ala Thr Gln Met Arg Lys Leu Thr

160 165 170

AGT AAC CTG CGG ATT GGC TTC GGG GCA TTT GTG GAC AAG CCT GTG TCA 580

Ser Asn Leu Arg Ile Gly Phe Gly Ala Phe Val Asp Lys Pro Val Ser

175 180 185

CCA TAC ATG TAT ATC TCC CCA CCA GAG GCC CTC GAA AAC CCC TGC TAT 628

Pro Tyr Met Tyr Ile Ser Pro Pro Glu Ala Leu Glu Asn Pro Cys Tyr

190 195 200

GAT ATG AAG ACC ACC TGC TTG CCC ATG TTT GGC TAC AAA CAC GTG CTG 676

Asp Met Lys Thr Thr Cys Leu Pro Met Phe Gly Tyr Lys His Val Leu

205 210 215 220

ACG CTA ACT GAC CAG GTG ACC CGC TTC AAT GAG GAA GTG AAG AAG CAG 724

Thr Leu Thr Asp Gln Val Thr Arg Phe Asn Glu Glu Val Lys Lys Gln

225 230 235

AGT GTG TCA CGG AAC CGA GAT GCC CCA GAG GGT GGC TTT GAT GCC ATC 772

Ser Val Ser Arg Asn Arg Asp Ala Pro Glu Gly Gly Phe Asp Ala Ile

240 245 250

ATG CAG GCT ACA GTC TGT GAT GAA AAG ATT GGC TGG AGG AAT GAT GCA 820

Met Gln Ala Thr Val Cys Asp Glu Lys Ile Gly Trp Arg Asn Asp Ala

255 260 265

TCC CAC TTG CTG GTG TTT ACC ACT GAT GCC AAG ACT CAT ATA GCA TTG 868

Ser His Leu Leu Val Phe Thr Thr Asp Ala Lys Thr His Ile Ala Leu

270 275 280

GAC GGA AGG CTG GCA GGC ATT GTC CAG CCT AAT GAC GGG CAG TGT CAT 916

Asp Gly Arg Leu Ala Gly Ile Val Gln Pro Asn Asp Gly Gln Cys His

285 290 295 300

GTT GGT AGT GAC AAT CAT TAC TCT GCC TCC ACT ACC ATG GAT TAT CCC 964

Val Gly Ser Asp Asn His Tyr Ser Ala Ser Thr Thr Met Asp Tyr Pro

305 310 315

TCT TTG GGG CTG ATG ACT GAG AAG CTA TCC CAG AAA AAC ATC AAT TTG 1012

Ser Leu Gly Leu Met Thr Glu Lys Leu Ser Gln Lys Asn Ile Asn Leu

320 325 330

ATC TTT GCA GTG ACT GAA AAT GTA GTC AAT CTC TAT CAG AAC TAT AGT 1060

Ile Phe Ala Val Thr Glu Asn Val Val Asn Leu Tyr Gln Asn Tyr Ser

335 340 345

GAG CTC ATC CCA GGG ACC ACA GTT GGG GTT CTG TCC ATG GAT TCC AGC 1108

Glu Leu Ile Pro Gly Thr Thr Val Gly Val Leu Ser Met Asp Ser Ser

350 355 360

AAT GTC CTC CAG CTC ATT GTT GAT GCT TAT GGG AAA ATC CGT TCT AAA 1156

Asn Val Leu Gln Leu Ile Val Asp Ala Tyr Gly Lys Ile Arg Ser Lys

365 370 375 380

GTA GAG CTG GAA GTG CGT GAC CTC CCT GAA GAG TTG TCT CTA TCC TTC 1204

Val Glu Leu Glu Val Arg Asp Leu Pro Glu Glu Leu Ser Leu Ser Phe

385 390 395

AAT GCC ACC TGC CTC AAC AAT GAG GTC ATC CCT GGC CTC AAG TCT TGT 1252

Asn Ala Thr Cys Leu Asn Asn Glu Val Ile Pro Gly Leu Lys Ser Cys

400 405 410

ATG GGA CTC AAG ATT GGA GAC ACG GTG AGC TTC AGC ATT GAG GCC AAG 1300

Met Gly Leu Lys Ile Gly Asp Thr Val Ser Phe Ser Ile Glu Ala Lys

415 420 425

GTG CGA GGC TGT CCC CAG GAG AAG GAG AAG TCC TTT ACC ATA AAG CCC 1348

Val Arg Gly Cys Pro Gln Glu Lys Glu Lys Ser Phe Thr Ile Lys Pro

430 435 440

GTG GGC TTC AAG GAC AGC CTG ATC GTC CAG GTC ACC TTT GAT TGT GAC 1396

Val Gly Phe Lys Asp Ser Leu Ile Val Gln Val Thr Phe Asp Cys Asp

445 450 455 460

TGT GCC TGC CAG GCC CAA GCT GAA CCT AAT AGC CAT CGC TGC AAC AAT 1444

Cys Ala Cys Gln Ala Gln Ala Glu Pro Asn Ser His Arg Cys Asn Asn

465 470 475

GGC AAT GGG ACC TTT GAG TGT GGG GTA TGC CGT TGT GGG CCT GGC TGG 1492

Gly Asn Gly Thr Phe Glu Cys Gly Val Cys Arg Cys Gly Pro Gly Trp

480 485 490

CTG GGA TCC CAG TGT GAG TGC TCA GAG GAG GAC TAT CGC CCT TCC CAG 1540

Leu Gly Ser Gln Cys Glu Cys Ser Glu Glu Asp Tyr Arg Pro Ser Gln

495 500 505

CAG GAC GAA TGC AGC CCC CGG GAG GGT CAG CCC GTC TGC AGC CAG CGG 1588

Gln Asp Glu Cys Ser Pro Arg Glu Gly Gln Pro Val Cys Ser Gln Arg

510 515 520

GGC GAG TGC CTC TGT GGT CAA TGT GTC TGC CAC AGC AGT GAC TTT GGC 1636

Gly Glu Cys Leu Cys Gly Gln Cys Val Cys His Ser Ser Asp Phe Gly

525 530 535 540

AAG ATC ACG GGC AAG TAC TGC GAG TGT GAC GAC TTC TCC TGT GTC CGC 1684

Lys Ile Thr Gly Lys Tyr Cys Glu Cys Asp Asp Phe Ser Cys Val Arg

545 550 555

TAC AAG GGG GAG ATG TGC TCA GGC CAT GGC CAG TGC AGC TGT GGG GAC 1732

Tyr Lys Gly Glu Met Cys Ser Gly His Gly Gln Cys Ser Cys Gly Asp

560 565 570

TGC CTG TGT GAC TCC GAC TGG ACC GGC TAC TAC TGC AAC TGT ACC ACG 1780

Cys Leu Cys Asp Ser Asp Trp Thr Gly Tyr Tyr Cys Asn Cys Thr Thr

575 580 585

CGT ACT GAC ACC TGC ATG TCC AGC AAT GGG CTG CTG TGC AGC GGC CGC 1828

Arg Thr Asp Thr Cys Met Ser Ser Asn Gly Leu Leu Cys Ser Gly Arg

590 595 600

GGC AAG TGT GAA TGT GGC AGC TGT GTC TGT ATC CAG CCG GGC TCC TAT 1876

Gly Lys Cys Glu Cys Gly Ser Cys Val Cys Ile Gln Pro Gly Ser Tyr

605 610 615 620

GGG GAC ACC TGT GAG AAG TGC CCC ACC TGC CCA GAT GCC TGC ACC TTT 1924

Gly Asp Thr Cys Glu Lys Cys Pro Thr Cys Pro Asp Ala Cys Thr Phe

625 630 635

AAG AAA GAA TGT GTG GAG TGT AAG AAG TTT GAC CGG GAG CCC TAC ATG 1972

Lys Lys Glu Cys Val Glu Cys Lys Lys Phe Asp Arg Glu Pro Tyr Met

640 645 650

ACC GAA AAT ACC TGC AAC CGT TAC TGC CGT GAC GAG ATT GAG TCA GTG 2020

Thr Glu Asn Thr Cys Asn Arg Tyr Cys Arg Asp Glu Ile Glu Ser Val

655 660 665

AAA GAG CTT AAG GAC ACT GGC AAG GAT GCA GTG AAT TGT ACC TAT AAG 2068

›(D) OTHER INFORMATION · 2 of 2

Lys Glu Leu Lys Asp Thr Gly Lys Asp Ala Val Asn Cys Thr Tyr Lys

670 675 680

AAT GAG GAT GAC TGT GTC GTC AGA TTC CAG TAC TAT GAA GAT TCT AGT 2116

Asn Glu Asp Asp Cys Val Val Arg Phe Gln Tyr Tyr Glu Asp Ser Ser

685 690 695 700

GGA AAG TCC ATC CTG TAT GTG GTA GAA GAG CCA GAG TGT CCC AAG GGC 2164

Gly Lys Ser Ile Leu Tyr Val Val Glu Glu Pro Glu Cys Pro Lys Gly

705 710 715

CCT GAC ATC CTG GTG GTC CTG CTC TCA GTG ATG GGG GCC ATT CTG CTC 2212

Pro Asp Ile Leu Val Val Leu Leu Ser Val Met Gly Ala Ile Leu Leu

720 725 730

ATT GGC CTT GCC GCC CTG CTC ATC TGG AAA CTC CTC ATC ACC ATC CAC 2260

Ile Gly Leu Ala Ala Leu Leu Ile Trp Lys Leu Leu Ile Thr Ile His

735 740 745

GAC CGA AAA GAA TTC GCT AAA TTT GAG GAA GAA CGC GCC AGA GCA AAA 2308

Asp Arg Lys Glu Phe Ala Lys Phe Glu Glu Glu Arg Ala Arg Ala Lys

750 755 760

TGG GAC ACA GCC AAC AAC CCA CTG TAT AAA GAG GCC ACG TCT ACC TTC 2356

Trp Asp Thr Ala Asn Asn Pro Leu Tyr Lys Glu Ala Thr Ser Thr Phe

765 770 775 780

ACC AAT ATC ACG TAC CGG GGC ACT TAATGATAAG CAGTCATCCT CAGATCATTA 2410

Thr Asn Ile Thr Tyr Arg Gly Thr

785

TCAGCCTGTG CCACGATTGC AGGAGTCCCT GCCATCATGT TTACAGAGGA CAGTATTTGT 2470

GGGGAGGGAT TTGGGGCTCA GAGTGGGGTA GGTTGGGAGA ATGTCAGTAT GTGGAAGTGT 2530

GGGTCTGTGT GTGTGTATGT GGGGGTCTGT GTGTTTATGT GTGTGTGTTG TGTGTGGGAG 2590

TGTGTAATTT AAAATTGTGA TGTGTCCTGA TAAGCTGAGC TCCTTAGCCT TTGTCCCAGA 2650

ATGCCTCCTG CAGGGATTCT TCCTGCTTAG CTTGAGGGTG ACTATGGAGC TGAGCAGGTG 2710

TTCTTCATTA CCTCAGTGAG AAGCCAGCTT TCCTCATCAG GCCATTGTCC CTGAAGAGAA 2770

GGGCAGGGCT GAGGCCTCTC ATTCCAGAGG AAGGGACACC AAGCCTTGGC TCTACCCTGA 2830

GTTCATAAAT TTATGGTTCT CAGGCCTGAC TCTCAGCAGC TATGGTAGGA ACTGCTGGGC 2890

TTGGCAGCCC GGGTCATCTG TACCTCTGCC TCCTTTCCCC TCCCTCAGGC CGAAGGAGGA 2950

GTCAGGGAGA GCTGAACTAT TAGAGCTGCC TGTGCCTTTT GCCATCCCCT CAACCCAGCT 3010

ATGGTTCTCT CGCAAGGGAA GTCCTTGCAA GCTAATTCTT TGACCTGTTG GGAGTGAGGA 3070

TGTCTGGGCC ACTCAGGGGT CATTCATGGC CTGGGGGATG TACCAGCATC TCCCAGTTCA 3130

TAATCACAAC CCTTCAGATT TGCCTTATTG GCAGCTCTAC TCTGGAGGTT TGTTTAGAAG 3190

AAGTGTGTCA CCCTTAGGCC AGCACCATCT CTTTACCTCC TAATTCCACA CCCTCACTGC 3250

TGTAGACATT TGCTATGAGC TGGGGATGTC TCTCATGACC AAATGCTTTT CCTCAAAGGG 3310

AGAGAGTGCT ATTGTAGAGC CAGAGGTCTG GCCCTATGCT TCCGGCCTCC TGTCCCTCAT 3370

CCATAGCACC TCCACATACC TGGCCCTGAG CCTTGGTGTG CTGTATCCAT CCATGGGGCT 3430

GATTGTATTT ACCTTCTACC TCTTGGCTGC CTTGTGAAGG AATTATTCCC ATGAGTTGGC 3490

TGGGAATAAG TGCCAGGATG GAATGATGGG TCAGTTGTAT CAGCACGTGT GGCCTGTTCT 3550

TCTATGGGTT GGACAACCTC ATTTTAACTC AGTCTTTAAT CTGAGAGGCC ACAGTGCAAT 3610

TTTATTTTAT TTTTCTCATG ATGAGGTTTT CTTAACTTAA AAGAACATGT ATATAAACAT 3670

GCTTGCATTA TATTTGTAAA TTTATGTGTA TGGCAAAGAA GGAGAGCATA GGAAACCACA 3730

CAGACTTGGG CAGGGTACAG ACACTCCCAC TTGGCATCAT TCACAGCAAG TCACTGGCCA 3790

GTGGCTGGAT CTGTGAGGGG CTCTCTCATG ATAGAAGGCT ATGGGGATAG ATGTGTGGAC 3850

ACATTGGACC TTTCCTGAGG AAGAGGGACT GTTCTTTTGT CCCAGAAAAG CAGTGGCTCC 3910

ATTGGTGTTG ACATACATCC AACATTAAAA GCCACCCCCA AATGCCCAAG AAAAAAAGAA 3970

AGACTTATCA ACATTTGTTC CATGAGG 3997

(2) INFORMATION FOR SEQ ID NO:44:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 788 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:44:

Met Arg Ala Arg Pro Arg Pro Arg Pro Leu Trp Ala Thr Val Leu Ala

1 5 10 15

Leu Gly Ala Leu Ala Gly Val Gly Val Gly Gly Pro Asn Ile Cys Thr

20 25 30

Thr Arg Gly Val Ser Ser Cys Gln Gln Cys Leu Ala Val Ser Pro Met

35 40 45

Cys Ala Trp Cys Ser Asp Glu Ala Leu Pro Leu Gly Ser Pro Arg Cys

50 55 60

Asp Leu Lys Glu Asn Leu Leu Lys Asp Asn Cys Ala Pro Glu Ser Ile

65 70 75 80

Glu Phe Pro Val Ser Glu Ala Arg Val Leu Glu Asp Arg Pro Leu Ser

85 90 95

Asp Lys Gly Ser Gly Asp Ser Ser Gln Val Thr Gln Val Ser Pro Gln

100 105 110

Arg Ile Ala Leu Arg Leu Arg Pro Asp Asp Ser Lys Asn Phe Ser Ile

115 120 125

Gln Val Arg Gln Val Glu Asp Tyr Pro Val Asp Ile Tyr Tyr Leu Met

130 135 140

Asp Leu Ser Tyr Ser Met Lys Asp Asp Leu Trp Ser Ile Gln Asn Leu

145 150 155 160

Gly Thr Lys Leu Ala Thr Gln Met Arg Lys Leu Thr Ser Asn Leu Arg

165 170 175

Ile Gly Phe Gly Ala Phe Val Asp Lys Pro Val Ser Pro Tyr Met Tyr

180 185 190

Ile Ser Pro Pro Glu Ala Leu Glu Asn Pro Cys Tyr Asp Met Lys Thr

195 200 205

Thr Cys Leu Pro Met Phe Gly Tyr Lys His Val Leu Thr Leu Thr Asp

210 215 220

Gln Val Thr Arg Phe Asn Glu Glu Val Lys Lys Gln Ser Val Ser Arg

225 230 235 240

Asn Arg Asp Ala Pro Glu Gly Gly Phe Asp Ala Ile Met Gln Ala Thr

245 250 255

Val Cys Asp Glu Lys Ile Gly Trp Arg Asn Asp Ala Ser His Leu Leu

260 265 270

Val Phe Thr Thr Asp Ala Lys Thr His Ile Ala Leu Asp Gly Arg Leu

275 280 285

Ala Gly Ile Val Gln Pro Asn Asp Gly Gln Cys His Val Gly Ser Asp

290 295 300

Asn His Tyr Ser Ala Ser Thr Thr Met Asp Tyr Pro Ser Leu Gly Leu

305 310 315 320

Met Thr Glu Lys Leu Ser Gln Lys Asn Ile Asn Leu Ile Phe Ala Val

325 330 335

Thr Glu Asn Val Val Asn Leu Tyr Gln Asn Tyr Ser Glu Leu Ile Pro

340 345 350

Gly Thr Thr Val Gly Val Leu Ser Met Asp Ser Ser Asn Val Leu Gln

355 360 365

Leu Ile Val Asp Ala Tyr Gly Lys Ile Arg Ser Lys Val Glu Leu Glu

370 375 380

Val Arg Asp Leu Pro Glu Glu Leu Ser Leu Ser Phe Asn Ala Thr Cys

385 390 395 400

Leu Asn Asn Glu Val Ile Pro Gly Leu Lys Ser Cys Met Gly Leu Lys

405 410 415

Ile Gly Asp Thr Val Ser Phe Ser Ile Glu Ala Lys Val Arg Gly Cys

420 425 430

Pro Gln Glu Lys Glu Lys Ser Phe Thr Ile Lys Pro Val Gly Phe Lys

435 440 445

Asp Ser Leu Ile Val Gln Val Thr Phe Asp Cys Asp Cys Ala Cys Gln

450 455 460

Ala Gln Ala Glu Pro Asn Ser His Arg Cys Asn Asn Gly Asn Gly Thr

465 470 475 480

Phe Glu Cys Gly Val Cys Arg Cys Gly Pro Gly Trp Leu Gly Ser Gln

485 490 495

Cys Glu Cys Ser Glu Glu Asp Tyr Arg Pro Ser Gln Gln Asp Glu Cys

500 505 510

Ser Pro Arg Glu Gly Gln Pro Val Cys Ser Gln Arg Gly Glu Cys Leu

515 520 525

Cys Gly Gln Cys Val Cys His Ser Ser Asp Phe Gly Lys Ile Thr Gly

530 535 540

Lys Tyr Cys Glu Cys Asp Asp Phe Ser Cys Val Arg Tyr Lys Gly Glu

545 550 555 560

Met Cys Ser Gly His Gly Gln Cys Ser Cys Gly Asp Cys Leu Cys Asp

565 570 575

Ser Asp Trp Thr Gly Tyr Tyr Cys Asn Cys Thr Thr Arg Thr Asp Thr

580 585 590

Cys Met Ser Ser Asn Gly Leu Leu Cys Ser Gly Arg Gly Lys Cys Glu

595 600 605

Cys Gly Ser Cys Val Cys Ile Gln Pro Gly Ser Tyr Gly Asp Thr Cys

610 615 620

Glu Lys Cys Pro Thr Cys Pro Asp Ala Cys Thr Phe Lys Lys Glu Cys

625 630 635 640

Val Glu Cys Lys Lys Phe Asp Arg Glu Pro Tyr Met Thr Glu Asn Thr

645 650 655

Cys Asn Arg Tyr Cys Arg Asp Glu Ile Glu Ser Val Lys Glu Leu Lys

660 665 670

Asp Thr Gly Lys Asp Ala Val Asn Cys Thr Tyr Lys Asn Glu Asp Asp

675 680 685

Cys Val Val Arg Phe Gln Tyr Tyr Glu Asp Ser Ser Gly Lys Ser Ile

690 695 700

Leu Tyr Val Val Glu Glu Pro Glu Cys Pro Lys Gly Pro Asp Ile Leu

705 710 715 720

Val Val Leu Leu Ser Val Met Gly Ala Ile Leu Leu Ile Gly Leu Ala

725 730 735

Ala Leu Leu Ile Trp Lys Leu Leu Ile Thr Ile His Asp Arg Lys Glu

740 745 750

Phe Ala Lys Phe Glu Glu Glu Arg Ala Arg Ala Lys Trp Asp Thr Ala

755 760 765

Asn Asn Pro Leu Tyr Lys Glu Ala Thr Ser Thr Phe Thr Asn Ile Thr

770 775 780

Tyr Arg Gly Thr

785

(2) INFORMATION FOR SEQ ID NO:45:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 238 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:45:

CTGCAGGTAA ATGAAGAAGG CAGTGAAGCA GCTGCAAGTA CCGCTGTTGT GATTGCTGGC 60

CGTTCGCTAA ACCCCAACAG GGTGACTTTC AAGGCCAACA GGCCTTTCCT GGTTTTTATA 120

AGAGAAGTTC CTCTGAACAC TATTATCTTC ATGGGCAGAG TAGCCAACCC TTGTGTTAAG 180

TAAAATGTTC TTATTCTTTG CACCTCTTCC TATTTTTGGT TTGTGAACAG AAGTAAAA 238

(2) INFORMATION FOR SEQ ID NO:46:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 623 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:46:

AAAACTCAGG AAGAAACAAA CCCACCAATC GTTCCAGGCA TATCTCAAAT GCAAAAGGCA 60

TCCATTGTGA GTACAGTGGG CTTTCATGTT CTGCGCTGGT CCAGGGAGGT GCTCATAGCT 120

ACTTCCTCAC ATGTGCTCTG GGGCCAGCAA ATCATCTGTA TACCCTGACC TTGGCCCCCG 180

TGTACCCCCA GGTCGGCTTC TTCAAGCGGA ACCGGCACAC CCTGGAAGAA GATGATGAAG 240

AGGGGGAGTG ATGGTGCAGC CTACACTATT CTAGCAGGAG GGTTGGGCGT GCTACCTGCA 300

CCGCCCCTTC TCCAACAAGT TGCCTCCAAG CTTTGGGTTG GAGCTGTTCC ATTGGGTCCT 360

CTTGGTGTCG TTTCCCTCCC AACAGAGCTG GGCTACCCCC CCTCCTGCTG CCTAATAAAG 420

AGACTGAGCC CTGATGCTGA GCATGCTGCC TCCTTTTGGG GCCAGAGAAG AGAGTACCGA 480

AGAATGTTTT GGACGGGGAC CTAGGGCTGG TGGAAGTATG AACGAGAGAG TCACTGCCAG 540

GGCGAAGTTT GCAAATCACT GTCTTTGGGG AGTGTCAGGG AGTACAGAGT TGGGGTGGTA 600

GGTGTAACAG AAGACGGAGA GCC 623

(2) INFORMATION FOR SEQ ID NO:47:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 1787 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 131...1609

›(D) OTHER INFORMATION

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:47:

GTGAATCTCT GGGGCCAGGA AGACCCTGCT GCCCGGAAGA GCCTCATGTT CCGTGGGGGC 60

TGGGCGGACA TACATATACG GGCTCCAGGC TGAACGGCTC GGGCCACTTA CACACCACTG 120

CCTGATAACC ATG CTG GCT GCC ACA GTC CTG ACC CTG GCC CTG CTG GGC 169

Met Leu Ala Ala Thr Val Leu Thr Leu Ala Leu Leu Gly

1 5 10

AAT GCC CAT GCC TGC TCC AAA GGC ACC TCG CAC GAG GCA GGC ATC GTG 217

Asn Ala His Ala Cys Ser Lys Gly Thr Ser His Glu Ala Gly Ile Val

15 20 25

TGC CGC ATC ACC AAG CCT GCC CTC CTG GTG TTG AAC CAC GAG ACT GCC 265

Cys Arg Ile Thr Lys Pro Ala Leu Leu Val Leu Asn His Glu Thr Ala

30 35 40 45

AAG GTG ATC CAG ACC GCC TTC CAG CGA GCC AGC TAC CCA GAT ATC ACG 313

Lys Val Ile Gln Thr Ala Phe Gln Arg Ala Ser Tyr Pro Asp Ile Thr

50 55 60

GGC GAG AAG GCC ATG ATG CTC CTT GGC CAA GTC AAG TAT GGG TTG CAC 361

Gly Glu Lys Ala Met Met Leu Leu Gly Gln Val Lys Tyr Gly Leu His

65 70 75

AAC ATC CAG ATC AGC CAC TTG TCC ATC GCC AGC AGC CAG GTG GAG CTG 409

Asn Ile Gln Ile Ser His Leu Ser Ile Ala Ser Ser Gln Val Glu Leu

80 85 90

GTG GAA GCC AAG TCC ATT GAT GTC TCC ATT CAG AAC GTG TCT GTG GTC 457

Val Glu Ala Lys Ser Ile Asp Val Ser Ile Gln Asn Val Ser Val Val

95 100 105

TTC AAG GGG ACC CTG AAG TAT GGC TAC ACC ACT GCC TGG TGG CTG GGT 505

Phe Lys Gly Thr Leu Lys Tyr Gly Tyr Thr Thr Ala Trp Trp Leu Gly

110 115 120 125

ATT GAT CAG TCC ATT GAC TTC GAG ATC GAC TCT GCC ATT GAC CTC CAG 553

Ile Asp Gln Ser Ile Asp Phe Glu Ile Asp Ser Ala Ile Asp Leu Gln

130 135 140

ATC AAC ACA CAG CTG ACC TGT GAC TCT GGT AGA GTG CGG ACC GAT GCC 601

Ile Asn Thr Gln Leu Thr Cys Asp Ser Gly Arg Val Arg Thr Asp Ala

145 150 155

CCT GAC TGC TAC CTG TCT TTC CAT AAG CTG CTC CTG CAT CTC CAA GGG 649

Pro Asp Cys Tyr Leu Ser Phe His Lys Leu Leu Leu His Leu Gln Gly

160 165 170

GAG CGA GAG CCT GGG TGG ATC AAG CAG CTG TTC ACA AAT TTC ATC TCC 697

Glu Arg Glu Pro Gly Trp Ile Lys Gln Leu Phe Thr Asn Phe Ile Ser

175 180 185

TTC ACC CTG AAG CTG GTC CTG AAG GGA CAG ATC TGC AAA GAG ATC AAC 745

Phe Thr Leu Lys Leu Val Leu Lys Gly Gln Ile Cys Lys Glu Ile Asn

190 195 200 205

GTC ATC TCT AAC ATC ATG GCC GAT TTT GTC CAG ACA AGG GCT GCC AGC 793

Val Ile Ser Asn Ile Met Ala Asp Phe Val Gln Thr Arg Ala Ala Ser

210 215 220

ATC CTT TCA GAT GGA GAC ATT GGG GTG GAC ATT TCC CTG ACA GGT GAT 841

Ile Leu Ser Asp Gly Asp Ile Gly Val Asp Ile Ser Leu Thr Gly Asp

225 230 235

CCC GTC ATC ACA GCC TCC TAC CTG GAG TCC CAT CAC AAG GGT CAT TTC 889

Pro Val Ile Thr Ala Ser Tyr Leu Glu Ser His His Lys Gly His Phe

240 245 250

ATC TAC AAG AAT GTC TCA GAG GAC CTC CCC CTC CCC ACC TTC TCG CCC 937

Ile Tyr Lys Asn Val Ser Glu Asp Leu Pro Leu Pro Thr Phe Ser Pro

255 260 265

ACA CTG CTG GGG GAC TCC CGC ATG CTG TAC TTC TGG TTC TCT GAG CGA 985

Thr Leu Leu Gly Asp Ser Arg Met Leu Tyr Phe Trp Phe Ser Glu Arg

270 275 280 285

GTC TTC CAC TCG CTG GCC AAG GTA GCT TTC CAG GAT GGC CGC CTC ATG 1033

Val Phe His Ser Leu Ala Lys Val Ala Phe Gln Asp Gly Arg Leu Met

290 295 300

CTC AGC CTG ATG GGA GAC GAG TTC AAG GCA GTG CTG GAG ACC TGG GGC 1081

Leu Ser Leu Met Gly Asp Glu Phe Lys Ala Val Leu Glu Thr Trp Gly

305 310 315

TTC AAC ACC AAC CAG GAA ATC TTC CAA GAG GTT GTC GGC GGC TTC CCC 1129

Phe Asn Thr Asn Gln Glu Ile Phe Gln Glu Val Val Gly Gly Phe Pro

320 325 330

AGC CAG GCC CAA GTC ACC GTC CAC TGC CTC AAG ATG CCC AAG ATC TCC 1177

Ser Gln Ala Gln Val Thr Val His Cys Leu Lys Met Pro Lys Ile Ser

335 340 345

TGC CAA AAC AAG GGA GTC GTG GTC AAT TCT TCA GTG ATG GTG AAA TTC 1225

Cys Gln Asn Lys Gly Val Val Val Asn Ser Ser Val Met Val Lys Phe

350 355 360 365

CTC TTT CCA CGC CCA GAC CAG CAA CAT TCT GTA GCT TAC ACA TTT GAA 1273

Leu Phe Pro Arg Pro Asp Gln Gln His Ser Val Ala Tyr Thr Phe Glu

370 375 380

GAG GAT ATC GTG ACT ACC GTC CAG GCC TCC TAT TCT AAG AAA AAG CTC 1321

Glu Asp Ile Val Thr Thr Val Gln Ala Ser Tyr Ser Lys Lys Lys Leu

385 390 395

TTC TTA AGC CTC TTG GAT TTC CAG ATT ACA CCA AAG ACT GTT TCC AAC 1369

Phe Leu Ser Leu Leu Asp Phe Gln Ile Thr Pro Lys Thr Val Ser Asn

400 405 410

TTG ACT GAG AGC AGC TCC GAG TCC ATC CAG AGC TTC CTG CAG TCA ATG 1417

Leu Thr Glu Ser Ser Ser Glu Ser Ile Gln Ser Phe Leu Gln Ser Met

415 420 425

ATC ACC GCT GTG GGC ATC CCT GAG GTC ATG TCT CGG CTC GAG GTA GTG 1465

Ile Thr Ala Val Gly Ile Pro Glu Val Met Ser Arg Leu Glu Val Val

430 435 440 445

TTT ACA GCC CTC ATG AAC AGC AAA GGC GTG AGC CTC TTC GAC ATC ATC 1513

Phe Thr Ala Leu Met Asn Ser Lys Gly Val Ser Leu Phe Asp Ile Ile

450 455 460

AAC CCT GAG ATT ATC ACT CGA GAT GGC TTC CTG CTG CTG CAG ATG GAC 1561

Asn Pro Glu Ile Ile Thr Arg Asp Gly Phe Leu Leu Leu Gln Met Asp

465 470 475

TTT GGC TTC CCT GAG CAC CTG CTG GTG GAT TTC CTC CAG AGC TTG AGC 1609

Phe Gly Phe Pro Glu His Leu Leu Val Asp Phe Leu Gln Ser Leu Ser

480 485 490

TAGAAGTCTC CAAGGAGGTC GGGATGGGGC TTGTAGCAGA AGGCAAGCAC CAGGCTCACA 1669

GCTGGAACCC TGGTGTCTCC TCCAGCGTGG TGGAAGTTGG GTTAGGAGTA CGGAGATGGA 1729

GATTGGCTCC CAACTCCTCC CTATCCTAAA GGCCCACTGG CATTAAAGTG CTGTATCC 1787

(2) INFORMATION FOR SEQ ID NO:48:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 493 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:48:

Met Leu Ala Ala Thr Val Leu Thr Leu Ala Leu Leu Gly Asn Ala His

1 5 10 15

Ala Cys Ser Lys Gly Thr Ser His Glu Ala Gly Ile Val Cys Arg Ile

20 25 30

Thr Lys Pro Ala Leu Leu Val Leu Asn His Glu Thr Ala Lys Val Ile

35 40 45

Gln Thr Ala Phe Gln Arg Ala Ser Tyr Pro Asp Ile Thr Gly Glu Lys

50 55 60

Ala Met Met Leu Leu Gly Gln Val Lys Tyr Gly Leu His Asn Ile Gln

65 70 75 80

Ile Ser His Leu Ser Ile Ala Ser Ser Gln Val Glu Leu Val Glu Ala

85 90 95

Lys Ser Ile Asp Val Ser Ile Gln Asn Val Ser Val Val Phe Lys Gly

100 105 110

Thr Leu Lys Tyr Gly Tyr Thr Thr Ala Trp Trp Leu Gly Ile Asp Gln

115 120 125

Ser Ile Asp Phe Glu Ile Asp Ser Ala Ile Asp Leu Gln Ile Asn Thr

130 135 140

Gln Leu Thr Cys Asp Ser Gly Arg Val Arg Thr Asp Ala Pro Asp Cys

145 150 155 160

Tyr Leu Ser Phe His Lys Leu Leu Leu His Leu Gln Gly Glu Arg Glu

165 170 175

Pro Gly Trp Ile Lys Gln Leu Phe Thr Asn Phe Ile Ser Phe Thr Leu

180 185 190

Lys Leu Val Leu Lys Gly Gln Ile Cys Lys Glu Ile Asn Val Ile Ser

195 200 205

Asn Ile Met Ala Asp Phe Val Gln Thr Arg Ala Ala Ser Ile Leu Ser

210 215 220

Asp Gly Asp Ile Gly Val Asp Ile Ser Leu Thr Gly Asp Pro Val Ile

225 230 235 240

Thr Ala Ser Tyr Leu Glu Ser His His Lys Gly His Phe Ile Tyr Lys

245 250 255

Asn Val Ser Glu Asp Leu Pro Leu Pro Thr Phe Ser Pro Thr Leu Leu

260 265 270

Gly Asp Ser Arg Met Leu Tyr Phe Trp Phe Ser Glu Arg Val Phe His

275 280 285

Ser Leu Ala Lys Val Ala Phe Gln Asp Gly Arg Leu Met Leu Ser Leu

290 295 300

Met Gly Asp Glu Phe Lys Ala Val Leu Glu Thr Trp Gly Phe Asn Thr

305 310 315 320

Asn Gln Glu Ile Phe Gln Glu Val Val Gly Gly Phe Pro Ser Gln Ala

325 330 335

Gln Val Thr Val His Cys Leu Lys Met Pro Lys Ile Ser Cys Gln Asn

340 345 350

Lys Gly Val Val Val Asn Ser Ser Val Met Val Lys Phe Leu Phe Pro

355 360 365

Arg Pro Asp Gln Gln His Ser Val Ala Tyr Thr Phe Glu Glu Asp Ile

370 375 380

Val Thr Thr Val Gln Ala Ser Tyr Ser Lys Lys Lys Leu Phe Leu Ser

385 390 395 400

Leu Leu Asp Phe Gln Ile Thr Pro Lys Thr Val Ser Asn Leu Thr Glu

405 410 415

Ser Ser Ser Glu Ser Ile Gln Ser Phe Leu Gln Ser Met Ile Thr Ala

420 425 430

Val Gly Ile Pro Glu Val Met Ser Arg Leu Glu Val Val Phe Thr Ala

435 440 445

Leu Met Asn Ser Lys Gly Val Ser Leu Phe Asp Ile Ile Asn Pro Glu

450 455 460

Ile Ile Thr Arg Asp Gly Phe Leu Leu Leu Gln Met Asp Phe Gly Phe

465 470 475 480

Pro Glu His Leu Leu Val Asp Phe Leu Gln Ser Leu Ser

485 490

(2) INFORMATION FOR SEQ ID NO:49:

›(i) SEQUENCE CHARACTERISTICS · 1 of 3

(A) LENGTH: 13204 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:49:

CTGCAGGTCA ACGGATCTGC TAGGGTCCTC CTATCAGCAC ACACACTCCA GCCCCACTTT 60

AGAGGTACCC GCTACCTTCC CTCATTAAAA CCAGCTCTCA AGAGGGGATC TGGTAACAGT 120

CTAGGCAGGC ATTCCAGGGA GCATGTGAAC CGCTGGTTCT TGTTGCGGGT GGAGGATGGA 180

GGTGTTGTAC AGAGTTTAGG TCTTTTTCAG CAAAGATCTC CAAACCCCGG GTGTTCAAAA 240

TCAAACCAAA GGGGATTATA GTCCCAGCTC TACTCACAAC TCACTGGTTA CTTTAGCCAC 300

GAGATTGCCC TCGCTGAGAG TCGGTTTCAC TGTCCATAAG ATGAAGAAGT ACATCACGGT 360

GGTCTGTGAG GTGTCATTGA GGAAAGATGG TCCAGTGCCC CCATGCCACA TGGCCTTCGG 420

GCAGTGCTCC CAGCGCCGGC GCCAGGGCCT GGGATACGCT GGAATCTGCG CGGCGCTCAC 480

CCAGCTTTCC TATGCAGAGT GGCCATCGTG GTGGGCGCCC CGCGGACCCT GGGCCCCAGC 540

CAGGAGGAGA CGGGCGGCGT GTTCCTGTGC CCCTGGAGGG CCGAGGGCGG CCAGTGCCCC 600

TCGCTGCTCT TTGACCTCCG TGAGTCCCAG GCAAGGAGAG CAAGGTTGGG GTCAGAGGGA 660

CGTGGACTGC CCGGGCTTCA GCGCCCCACC CCTTCTTGTG CCTTCCAGGT GATGAGACCC 720

GAAATGTAGG CTCCCAAACT TTACAAACCT TCAAGGCCCG CCAAGGACTG GGGGCGTCGG 780

TCGTCAGCTG GAGCGACGTC ATTGTGGTGG GCCCCGCGGT ACAGGGCACA GGGAACAATC 840

GGGGGCAGGG ACACTGGGGC CAGGAGGAGC CCAAGTCTCG CGCCCCGTCC CCATCTGTGG 900

CCCTTTCTCA GGCCTGCGCC CCCTGGCAGC ACTGGAACGT CCTAGAAAAG ACTGAGGAGG 960

CTGAGAAGAC GCCCGTAGGT AGCTGCTTTT TGGCTCAGCC AGAGAGCGGC CGCCGCGCCG 1020

AGTACTCCCC CTGTCGCGGG AACACCCTGA GCCGCATTTA CGTGGAAAAT GATTTTAGTA 1080

AGCGCCAGCT ACGACCTGGC CCCGCCCACT CGCGACGGCT TGGCCCCGCC CCCCATCGGA 1140

TCCCGCCCCC AGCGCCGCAG CCCTTGCTTT GGATCTGGCC TCGCCCCAGG GCCCCGCCGA 1200

CTCAAGGCCC CGCCCCTGTC CCCCAGCCCT CCTCCGGGCT CGCGCGCGCC TCCCTTCACC 1260

CCTGGGCTGA CCCCTCCTCC TTGTCTCCTC AGGCTGGGAC AAGCGTTACT GTGAAGCGGG 1320

CTTCAGCTCC GTGGTCACTC AGGCGAGTAG GGAGCAAAAG CGCAGTGGGG GCGGCTCCCA 1380

AACAGGGCCC CCTCTCACCC TCAGGACTTC CCTTCCAGGC CGGAGAGCTG GTGCTTGGGG 1440

CTCCTGGCGG CTATTATTTC TTAGGTACGT GCCCATCCGT ACACCTCCCT CCCTTCTCGC 1500

GGCCGAAGGA GACCGCTTTG GGCTTCACAC CCGCTGTCCC TCCCGCCCTA GGTCTCCTGG 1560

CCCAGGCTCC AGTTGCGGAT ATTTTCTCGA GTTACCGCCC AGGCATCCTT TTGTGGCACG 1620

TGTCCTCCCA GAGCCTCTCC TTTGACTCCA GCAACCCAGA GTACTTCGAC GGCTACTGGG 1680

GTAACACCGC CATTCCAGAC TTCCAGCACC CCGAGGGTCA CCGCCCACCG CAGACGGTCA 1740

GGTCCTGCCC CTGTGGGAGC CTCCATGGCC ACCCCTGCCG GCCAACCCAC CGCCTAAGCC 1800

GCTCCCGCCC TCCGCTCCTG CGCTTCCCCG CAGACCGCCC ACCTCCCATG CGCCCACCGC 1860

TCCCTTCCAC TGCGGACTCG TAGCGCAGCC TGGGGCAGGG CTTGGCCCCT CGAAGGCCTC 1920

CGTTTTTCCA TCTGCACAAT GCAGGGCTGG GGCTGAGTGG CCTTAATCTC CTCCTTCTTT 1980

GCCCTCCGTC CCCTCTGTGC TTCCTCCCCT GGAAAAGACT AATTTGCGCC CTTGTCCTCA 2040

GGGTACTCGG TGGCCGTGGG CGAGTTCGAC GGGGATCTCA ACACTACAGG CAAGAAATCC 2100

ACTTAGGGCG GGAGTTGGGT AGCCCAGCCC GGGGAGGAGC GCCTTCCTGA AATCTCCCCT 2160

ATGTAGCTGG GTGCAGAACG GGGAGCGGGA AGTGGGTAGG TTCTAAGGCT CTCATTCCCT 2220

GAGCCTGGCT CTCCCTATCG CCAGAATATG TCGTCGTGCC CCCCACTTGG AGCTGGACCC 2280

TGGGAGCGGT AAGTGCCCCC ACCACTGGGC CTCCCGAAGC CCCTTATCCC AGTTCTCAGG 2340

CTGACAACTC CTGAGCGCCC CCCACCCCCG CCCCGCCTCC ACCAAACCAC CCTTTCTCAC 2400

CTGGAGTGGG AGGTTGCTTT GGGTACAAGA ATGATGCTCT CGCCTGCGCT GTCCGTGCAG 2460

GTGGAAATTT TGGATTCCTA CTACCAGAGG CTGCATCGGC TGCGCGGAGA GCAGGTGGGG 2520

GCCAGGTCCC AGTGGGCGTG GCTGGGTGGA GGGGGAACTG AGACTTCAGA ATATTTCATG 2580

GGAGGTGAGG GCCCATTTCT TAAAGAGGAT GCTTGTCCAG CGGCGTGAAT GATGGTGCTC 2640

CTCATCTTGC AGATGGCGTC GTATTTTGGG CATTCAGTGG CTGTCACTGA CGTCAACGGG 2700

GATGGGTGAG GAGGGACATG CCCCCACCCC TACCCAGTTG GGTCCCAAAT TACCAGAGCT 2760

GCCCCTCTGT CTCCCTTTCC TAGCCCTAGT CTCACGTATC CACTGGAGGA ACAGGAGAGC 2820

AAGGGTCGAG GAGATTTGGC CCTAGCCCCA ATATACCCCT GGTCCAGTCC CATGTAACCA 2880

CTCATCTGGC CCACAGGAGG CATGATCTGC TGGTGGGCGC TCCACTGTAT ATGGAGAGCC 2940

GGGCAGACCG AAAACTGGCC GAAGTGGGGC GTGTGTATTT GTTCCTGCAG CCGCGAGGCC 3000

CCCACGCGCT GGGTGCCCCC AGCCTCCTGC TGACTGGCAC ACAGCTCTAT GGGCGATTCG 3060

GCTCTGCCAT CGCACCCCTG GGCGACCTCG ACCGGGATGG CTACAATGGT GAGGGAAGAG 3120

AGGAGCCCTA CTTGCTGCAG AGGGGTTAAC AGCCACTCAA AAAGCATGGA GTTGGCCTGA 3180

GGGCAGCCAG AACCAGGATG GGTTTTAAGC ATATAAGTAT GTGGCTTAGA CACATGGGGT 3240

GCTGAGTGGA GAGCAGATGG GAGAGTTGAA GACTAATTAG GAAGTGTTTG CCTTAATCCA 3300

AGCAAGAGAC AATGACCACC TGGATGTGGA TTTTGGCAGT GGAGTTAGAG ATGGGAGTGA 3360

CTTCACAGAT ATTTAGGACT CGGATTATTA GGACTTGGTG GGAGACTGGA TGTGGGGCCA 3420

GGGGAGAGGT TGGAGTTGGG TGCCTGTGAT GGCCTCCACT GCCTGGAACT CAGGCCGTGC 3480

AGCAGGTGCT GGGGAGAGGC GGGAGATCAG CAGTTCAGCT CTGGACCTGT TGAGCTTGAA 3540

GGGCTTGGGT GCTTTAGGCG GAAATATCCA AAGAACAGTT GGGAGTGGCT CTCCCCGCTT 3600

CCACAAGAGA GATCTGAATG GGAGACAGGG GTTTGGGGAA AGTGGATGAG GTCCCGGGAC 3660

CTGTGAAATA AGAGGCCCAG GATAGAGCCC TAGGGAGCAA AAGCATTTAG GTGACTCCTA 3720

CAGGAGGTAA GTCTGAGAAG GAGACAGAGG AGTGTCCAGA GAGGGAGGAG GGAACCCAGG 3780

GGGTCTGATG GCCCGGGACT CAAGGAAGAG CATGCGTTAA AGAGCATGCA CAGGAGGAAG 3840

TGGGCGCTGC AGCTCCTGCT GCTGCTGCAA GATACAATTA GGTGGGGCTG GAGAAATATT 3900

CATGGGCTTT AGCAAGAAGA GGGTGCCAGG CATGGTGGCT CATACCTGTA ATCCCAGCTA 3960

CTTGGGAAAT TGAAGCAGGA GAATCTCTTG AACCCGGGAA GTGGAGGTTG CACTGAGCTG 4020

AGCTTGCGCC ACTACTGCAC TCCAGCCTGG GTGACAGAGC AAGACTCCAT CTCAACAAAA 4080

TAAAAAAAAA AATAGAGAAA GAAAGGAAGA AAGAAAAAAG AAGGGGAGGT TATTGGTGAC 4140

AGTGACATAA ATTGATTCAG GCCAAGATAG GGTCAGAAGC CAGAATGCAA TGGGGTAAGG 4200

TATGAATGGA GATGAAAAAT TGGATGCAGC TAATGTAGAC AGCTCTTTCA ACAGGTTTGT 4260

GGTAAAAAGG AATTTGAGGA ATAGAAAGGA AAAAAAAAAA CATGTTTGAC TATAAGAGGA 4320

AAAAGAGAAA AGGTGATCAC AGAAAAGAGA TGAGGGTCAA GGGAAGATTA TTTCAATGTG 4380

GAAGAACATG TAGTAGGTTG AAAATGATGT TGTGGGGAAA TGGGGGGATG AGCCAGCAGA 4440

GAGTCCCTGT GATGCCTCAG GGGGTGGGAG GGTGACTGGC CCAGTGTCAG GGTGAAGGAA 4500

GGAAACCTCT TCCAGGGTCA AATGGGGAAA GGGAAAAAGA AAGTTGGTGT GGGATTATAG 4560

CATAACAGTG GGCTGCCTCT CTTCCTGAAG TAAGAGATTA CGTCACCTGC TGAAGGAAGT 4620

GTGGGGGGTC TGGGAGTTTG ATGGAATGGA GAAGGCTAGA AATAGATGCT AGATGGCCAG 4680

GCACGGTGGC TCACACCTGG AATCCCAGCA CTTTGGGAGG CCGAGGCAGG AGGATCACTG 4740

GAGCCTAGGA GTTTGACACC AGCCTGGCCA ACATAGGGAG ATCTCGTCTC CATAAAAATT 4800

TTTAAAAATT AGCTGGGCAT GGTGGCTATA GTCTCAACTG CTTGGGAAGC TGAGGTGGGA 4860

GGATTGCTTT AGTCCAGAAG GTTGAGGCTG CAGTAAGCCA TGGTTGCACC ACTGCACTTC 4920

AGCCTGAATG ACAAGTGCAA GACTGTCTTA AAATAAAAAA TTTAAAGGGC TTGGGCACGG 4980

TGGCTCACAC CTGTAATCCA GCACTTTGGG AGCCCAAGGT GGGCAGATCA CTTGAGGTCA 5040

›(i) SEQUENCE CHARACTERISTICS · 2 of 3

GGAGTTCGAG ATCAGCCTGG CCAATGTGGT GAAACCCCGT CTCTACTGAA AATACAAAAA 5100

TTAGCCGGGC ATGGTGGTAG GCGCCTGTAA TCCCAGCTAC TGAAGAGGCT GAGGCACAAG 5160

AATCACTTTA ACGGGGGAGG CAGAGGTTGC AGTGAGCCGA GATCGCACCA CTGCACTCCA 5220

GCCAGGACAA CAGAGCGAGA CTCCATCTCA AAAAAAAAAA AATTTAGAAA AGGGAATAAT 5280

GATGCTTAAT TTTCAGGATA TATTTTCCTC AATAGACAGT GAGAGTTGTC ACTGTTTTTA 5340

TAACAATCCT ACTTGGCAGG TCCCTCTCCC ACCTGATTGT TAACTCCTGG AGGGTAGGGC 5400

AGTGCCTCCT TCACCCACAC TTTGCACCCC TTTCCTAGTC TCCTGGGATG TTCCCAGAGA 5460

AGCTCAGGAA AGTTTTACAG TCATCTAGGG AGGCTGAATA ACAATCAGCC ACTTCCTTTC 5520

TGTTACTCCT TCCAGACATT GCAGTGGCTG CCCCCTACGG GGGTCCCAGT GGCCGGGGCC 5580

AAGTGCTGGT GTTCCTGGGT CAGAGTGAGG GGCTGAGGTC ACGTCCCTCC CAGGTCCTGG 5640

ACAGCCCCTT CCCCACAGGC TCTGCCTTTG GCTTCTCCCT TCGAGGTGCC GTAGACATCG 5700

ATGACAACGG ATACCCAGGT GCCCTGGACT GCCTCCAGCT AGAAATGCCC AAGAAAGGCC 5760

CTTGGACATT CGCTGGAAGT GCCAAGAGAC ACGGCCAGGG CTCATGCCTG GCCTGGTGTC 5820

CCACTATGGA CTGCCAGAGG GGCTGGGTGA AACCTCCAGT GGGGGAGGTG GTGTGGGGAA 5880

CCCCTGGGAA GATGAGATGA GGATCCCCAT ACCCTAATCG CCAATTCTGA CCCATTCCTC 5940

GATGTCTATA GACCTGATCG TGGGAGCTTA CGGGGCCAAC CAGGTGGCTG TGTACAGGTG 6000

AGCACTGGCT CCAGGGGCGG GATGGGGAAG GTCCTGTGCC ATCAAGAGGA GGCCAGGCCA 6060

GGAGGAGCCA CAATGGCAAG CCTCCCCATC ACCCTATCCC ATCAGAGCTC AGCCAGTGGT 6120

GAAGGCCTCT GTCCAGCTAC TGGTGCAAGA TTCACTGAAT CCTGCTGTGA AGAGCTGTGT 6180

CCTACCTCAG ACCAAGACAC CCGTGAGCTG GTGAGGAGGC AGAGGGCATG GGCCTTAAAG 6240

GATCTGGGAC CTCAGAAAGG CTCCAACCCC TGAGCCCCAC TTACGTCTTT GCAGCTTCAA 6300

CATCCAGATG TGTGTTGGAG CCACTGGGCA CAACATTCCT CAGAAGCTAT GTGAGTGGCA 6360

TGAAGGGGGC AGGAGGGAGG TGGGCTTGGA CTCCCCCGGA GGCTGGCCAG GGAGGTCCTG 6420

ACTCTTCTGC TTGCCCTGCC AGCCCTAAAT GCCGAGCTGC AGCTGGACCG GCAGAAGCCC 6480

CGCCAGGGCC GGCGGGTGCT GCTGCTGGGC TCTCAACAGG CAGGCACCAC CCTGAACCTG 6540

GATCTGGGCG GAAAGCACAG CCCCATCTGC CACACCACCA TGGCCTTCCT TCGAGTACGC 6600

CCAGGCAGGG GATTGGCAGG GCTGGGAGAG TAGAACTTAC CCACTGGACT TGTTCATCTA 6660

GCCCTGGGGC ACTGAGCTGG GTGCTGTGAG TCCGGGGGTG GTCAGGACAC AGGTGCCTAC 6720

TGGCCAGGAG AAGGTGGGAT GTGTATGGTA GCAAGATGGC CTGACTCTTG CCCCTGTCCT 6780

AGGATGAGGC AGACTTCCGG GACAAGCTGA GCCCCATTGT GCTCAGCCTC AATGTGTCCC 6840

TACCGCCCAC GGAGGCTGGA ATGGCCCCTG CTGTCGTGCT GCATGGAGAC ACCCATGTGC 6900

AGGAGCAGGT AGGGACAGGC AGGGACAGGC CAGGGAGGTG CAGGACCCCT GATAGCAAAT 6960

CAGGATTAGG GTTAGTGCCA AGTCACAATG TAACCCCAAA ACCTTGATGT CATTCCAAAC 7020

CCTAATGAAA ACCTCAAAAT CCAGCCAGTC ATGGTGGCTC ACACCTGTAA TCCCAGCACT 7080

TTGGGAGACC GAGGCAGGCA GATTGCCTGA GGTCAGGAGT TAGAGACCAA CCTGGCCAAC 7140

ATGGTGAAAA CCCATCTCTA CTAAAAATAC AAAAAAAATT AGCCGGGTGT GGTGACGCAT 7200

GCCTGTAATT CCAGCTACTC GGGAGGCTGA AGCAGGAGAA TCACTTGAAC CCAGGAGGCA 7260

GAGGTTGCAG TGAGCCAAGA GTGTGCCACA GCACTCCAGC CTGGGTGACA GAGCAAGACT 7320

CTGTCTCAAA AAAAAAAAAA AAAGCCAGGC GCAGTGGCCT CACGCCTGTA ATCCCAGCAC 7380

TTTGGGAGGC CAAGGCGGGT GGATCACGAG GTCAGGAGAT CAAGACCATC CTGGCTAACA 7440

CAGTGAAACC CCGTCTACTA AAAATACAAA AAAAAAAAAA AAATTAGCTG GGCGTGGTGG 7500

CGGGTACCTG TAGTCCCAGC TACTTGGGAG GCTGAGGCAG GAGAATGGCG TGAACCCCGG 7560

GGGCGGACGT TGCAGTGAGC CGAGATAGTG CCACTGCACT CCAGCCTGGA CGACAGAGCG 7620

AGACTCCGTC TCCAAAAATA AAAAAACACC TGAAAATCCC AGTATCCCCT AAGCTCTGAT 7680

GTAAATTGAC AAACCCTGAC ATTGTCCCAA ACCTCCAAAT ATAACCCGAG CCCCGATACC 7740

ATCTACAAAC TCCTTTTCGT CCTCAGATCT TCTTACTCCC TAAGCCCCTA TGTGAACCCC 7800

AAGCCCACTG TTTTCCTAAC CCTGATGTAA TCCCTAAACC TCACACATCC CCAACTTACC 7860

CGCACACCCC AATGTGCCCC TCTAGACACG AATCGTCCTG GACTGTGGGG AAGATGACGT 7920

ATGTGTGCCC CAGCTTCAGC TCACTGCCAG CGTGTGAGGA GGCCTCCCAT TCTGCCCGAC 7980

CCTGGCCCTT TCTGCCTATC ATACCTGCTC CACACCTTAG TCCCCTCTTT TCCCACATCC 8040

TGGGCCCAGA CCCAGGCTCC CTGGCTTCAC TCCTCTTTCC CCACAGGACG GGCTCCCCGC 8100

TCCTAGTTGG GGCAGATAAT GTCCTGGAGC TGCAGATGGA CGCAGCCAAC GAGGGCGAGG 8160

GGGCCTATGA AGCAGAGCTG GCCGTGCACC TGCCCCAGGG CGCCCACTAC ATGCGGGCCC 8220

TAAGCAATGT CGAGGTATGG CCCCCACCCT GGGAACAGTA CCCGGGACCT GGGAGGCACT 8280

GGAGCCTTGG CTCTCTCATC TCCCTCCCTG AGAGTCCCTC TTCTCTTCTG CTTTGCTGTC 8340

AAAGATGTAA TTTTTTTTTT AATTTGGAGG AGGATACTTG CTAATGGTCA GTCAGAATTC 8400

CAAAACTCTA TTACAAAAAC CAGAAAAACA AAAAAGGTTT AGGAACCAAA TGTTAACAGG 8460

AACCTCTGTT AACATTTGGT GGATTTCCTT CCAGTCTTTT TTTCAATATT GACTCACACT 8520

CACATAAGTA TATATTTATT TTTTATGTTG TTAATATAGT TTATAATAAT GGGGGTCATA 8580

CTCTAATGTT TTGTGTTTTT TATTTCCAAA ATGAAAATGC CTAAAAAGTA GTAGTGCTAC 8640

AGCAATACAC ACACTAGCAT GTGACAGTCC CTTGAGCGAC CCCACCCCAA GAAACCCCCC 8700

CCTCCCTACC TTGGCACACA AATCTTTCCA GACCTTCCAA GGGAGCTTAA ATATATATAT 8760

ATGATGCTCT GTAATTTCTT TCTTGGAACT GCCTTCCTGA AGGGCTTTGA GAGACTCATC 8820

TGTAATCAGA AGAAGGAGAA TGAGACCAGG GTGGTGCTGT GTGAGCTGGG CAACCCCATG 8880

AAGAAGAACG CCCAGGTGAG GCTGCTGGGT CGTGGTACCG GGTCTCCACC AGGGGCTCAT 8940

GAATAACCAG ATTTTAGGGG TGAGGTTTTA GAGCCACATA GTTCTGGGCC AGAATCTTGG 9000

TCCTCACACT CCCTTTGCCA ACATTGTCCT TGGGTGAGTG ACTTTCCCTC TCTGAGCCCC 9060

TTTACCAGTG GGCTTCCAGG TAAAATAGAA ATAATAATGG TGGCCTGGTG CGGTCGTCAC 9120

GCCTGTAATC CCAGCACTCT GGGAGGCCAG AGCGGGTGGA TCACGAGGTC AGGAGTTCAA 9180

GACCAGCCTG GCCAACATAG CAAAACCCCG TCTCTACTAA AAATACAAAA ATTACCCGGG 9240

CATGGTGGCG CACGCCTATA GTCAGAGCTA CTCGGGAGGT TGAGGCAGAA AAATCACTTG 9300

AACCTGGGAG GTGGAGGTTG CAGTGAGCCG AGATCATGCC ACTGCACTCC AGCCTGGGTG 9360

ACAGAGTGAG ACTCCGTCTC GGAAAAAAAA AAAAAGAAAA AGAATAGTGG TGATCTTGGA 9420

GGGTGAAGAC TGGAGGCCAC ATTCAGGGCA GGGCTGTCCT AAGTGGGGCA CTTGGGCAGT 9480

GACCTTGGCC CTCCTCATCT CCCAGATAGG AATCGCGATG TTGGTGAGCG TGGGGAATCT 9540

GGAAGAGGCT GGGGAGTCTG TGTCCTTCCA GCTGCAGATA CGGAGGTACT GACCTGGCGA 9600

GCGTGCCTAC CCACCACCCT TCCCCCGTCT GACCCCCGTG CAGAGCCCCT CAGGTCCCTT 9660

CCATACAGAA GGGTCTTTCG AGGCCAGGCG CAGTGGCTCA CACCTGTAAT CCCAGCACGT 9720

TGCGAGGCCA AGGCAGAAGG ATCACTGGAG GTCAGGAGTT GGAGACCAGC CTGGCCAACA 9780

TGGTGAAACC CCATCTCTAC TAAAATATAA AATTAGCTGG GCATGGTGGT GCGCACCTAC 9840

AATCCCAGCT ACTCGGGAGG CTGAGGCAGG AGAATAGCTT GAACCGAACC TGGGAGGTGG 9900

AGGTTGCAGT GAGCTGAGAT TGGGCCACTG CACTCCAGCC TTCCAGCCTG GGCGACAGTG 9960

CGAGATTCTA TCTCAAAAGA AAAAAAAAAA AAGGTCTTGA AGAAGCCTGG TTCCCTTTCT 10020

TCCTCAGAGA TTTAGCGAGT CTTGGAGCCC TAGAGGAAGT TCTTTCCCAG GTCTAACTTC 10080

AGTGTGGCAT GCTCTTTGTA TAATTAGCTC TCTCTGAACT CTCTAAAATT CTGGCCTCAC 10140

CCCCAGAAAG TCACTGGGCT GGTGTCCCTG GCCCTGTTTC TCCTCATCCC CTCCCCTCTA 10200

›(i) SEQUENCE CHARACTERISTICS · 3 of 3

GCAAGAACAG CCAGAATCCA AACAGCAAGA TTGTGCTGCT GGACGTGCCG GTCCGGGCAG 10260

AGGCCCAAGT GGAGCTGCGA GGGTGAGAGG CCAGGGGTGG AGAAGGGAGA TGGCATTCAG 10320

GGCTCTAAAC TCCAGGGGGC GCTGGGGAAA CCTCACAGGC CAATCAGGGC ATCACACTCT 10380

CTCTGGGGGT CTTGGGCACC TGCAGGAACT CCTTTCCAGC CTCCCTGGTG GTGGCAGCAG 10440

AAGAAGGTGA GAGGGAGCAG AACAGCTTGG ACAGCTGGGG ACCCAAAGTG GAGCACACCT 10500

ATGAGGTATT GGGGAGCCTC GCGTCCCTGG CTGGGGTGAG CGGGTCCTCA GAACTCCGGG 10560

TGAGGCGCTA AGCTCCCCAC ACCCTGCCAC CACCACCCCT TCAGCTCCAC AACAATGGCC 10620

CTGGGACTGT GAATGGTCTT CACCTCAGCA TCCACCTTCC GGGACAGTCC CAGCCCTCCG 10680

ACCTGCTCTA CATCCTGGAT ATACAGCCCC AGGGGGGCCT TCAGTGCTTC CCACAGCCTC 10740

CTGTCAACCC TCTCAAGGTA AGAGCTGGGT GGAAGAAAGA CCTGGGAAGG CGGCCCCAGA 10800

CCAACCACCG GGGCACCTCT GTGGGCTGGG GTTCGGGGGA GACCTGGGCC TGACCACTCC 10860

TTTGCCCCCC CAGGTGGACT GGGGGCTGCC CATCCCCAGC CCCTCCCCCA TTCACCCGGC 10920

CCATCACAAG CGGGATCGCA GACAGATCTT CCTGCCAGAG CCCGAGCAGC CCTCGAGGCT 10980

TCAGGATCCA GTTCTCGTAG TGAGCAGGCT CTCTGGTCTC GGGCCCGGCC TCCCCGGGAC 11040

CCACGGGGCA GAGGGGATGG GAGGAGGGAG AGGGGTCCGG GTGTGCTGTG GGCCTCTGTG 11100

GGCCACGCTT GGTCCCTGGG AGCACTTCAA GTGAACATGG AGGAGCATGC TGGCTTGTGT 11160

CTGGGGTGAG CTGAAAGACA CTTGCACTTT TTAAAAGCTT CCCAGTACGT TAAGGAGCAT 11220

AAAACAATGC CAAAGCAAGG TTATCATAGA TCTGAGCATT GTGCGCTGGG GGATGACCCT 11280

CCCTGCATCT CTGGGACTAT GTGAGCAAGC CCGTGGAAAG ACAGCATCCG AAGCTTGGAT 11340

CCAAGGCCCT TCCTGATGGG AAGGCCACCG CTTCCTGAAC CCCCGGCCCC TTCTGCGTTG 11400

GGTCCTGGGG GTAAGGGGGT GGGGGATGAT GGGGTGATGG GCCGGGACGG CTGGGGACTG 11460

ACGATGCTTC CCCTCAGAGC TGCGACTCGG CGCCCTGTAC TGTGGTGCAG TGTGACCTGC 11520

AGGAGATGGC GCGCGGGCAG CGGGCCATGG TCACGGTGCT GGCCTTCCTG TGGCTGCCCA 11580

GCCTCTACCA GGTGGGGTGG GCCGTGGTGG GGCGGGGCCG GGCCTTCTGG GCCGGGACCA 11640

CTTTGCTCTG GGAGGGGCGG GGTTTGGTGT GGGAGGGCAG GAAGAGAGGG AAGGCAAGGT 11700

TTACTTTGGG GGATTGCAGT GGGATTAGGT CAGAGGCAGG GCTTCCCCGC CGGGTGTGGG 11760

ACCTGGACTC CGTGCAACCA ATAGGCCTCT TGTGGGTGTA AACGGCTTTC AACCCCAACC 11820

TGTCCAGAGG CCTCTGGATC AGTTTGTGCT GCAGTCGCAC GCATGGTTCA ACGTGTCCTC 11880

CCTCCCCTAT GCGGTGGCCC CGCTCAGCCT GCCCCGAGGG GAAGCTCAGG TGAGTGTGGG 11940

GGGATGGAGC AGAGACCAGT CCTGCAGGAC CCATTGTCCC CCAGTCAGTG CCCAGCCAGA 12000

AAAGTCTGAG GGGTGGTACG GGTGGGTGGC ATGGCTGGAG GTCACCAGCC TGAGGTTTGA 12060

GTCTTTGTGA AAGGCAGGTG TCAAGGTGAC TGAGGAGACA CGTGGGTTTG CCCCAGGTGT 12120

GGACACAGCT GCTCCGGGCC TTGGAGGAGA GGGCCATTCC AATCTGGTGG GTGCTGGTGG 12180

GTGTGCTGGG TGGCCTGCTG CTGCTCACCA TCCTGGTCCT GGCCATGTGG AAGGTGAGGT 12240

GTGAAGGACG GTGGAGTCCC CAGCGGGGCA CAGGCTTGGC TCTGCCCTGC CTCACAGGGA 12300

GTCAAGGAGA GATGGTGGCC CACCCAAGTG GGTAATCCAG GGACCAGGGG TCTATGTCTC 12360

CACTATTAGA ATGTCATTCT CGTCCAGGGG GGTGGCTCAC ACCTGTAATC CCAGCACTTT 12420

GGCAGGCAAA GCGTTTAGAT CACCTGAGGT CAAGAGTTCG AGACCAGCCT GGCCAACATG 12480

GTGAAACCCC ATCTCTACTA AAAATACCAA ATTAGCCGGG CGTGTTGACA CATGCCTGTA 12540

ATCTCAGCTA CTCGGGAGGC TGAGGCAGTA GAATTGCATG AACCCAGGAG GCGGAGGTTG 12600

CAGTGAGCCG AGATCACACC ACTGCACTCC AGCTTGGGCA ACAGAGCGAG CCTCCATCTC 12660

AAAAAAAAAA CAAAAAAATA GAATGTCTTT CTCTAGTAGA GCAAAAGGCA AAACAAACAC 12720

AAAAATGTCA TTCTCCTGGG AACCCTTCCA GACACATACC ACTGGAAAGG ATAGCACCTG 12780

AAATTCTGAG GCCTTTAGAC ACCCCTGCCA CCAAAAAGAT TCAGAGGATA TAGAGGGTAT 12840

AGAGGGTGTA AGTCCTGCCT TCAGGAATTC CTGGCTGGTC TCAAGGACAA GATGCACTTC 12900

TTCCTAGCCC TGCCCTTCCC CTTGAGTGAG GAAGAGGCCA AGGATTGGTC TAGACCCTAT 12960

TCCATACCTT CCTATGTGGC CCTGGAGGGT CACTCGCTCC TCTGCACCTG GAGGAGTCTC 13020

AAGCACACTG AAGGGAAGAC ATGGTGCTTT TAGGGAAAAC CACGCACTAG ACCCACAATA 13080

ATCAAATACA TATCATCATA TGCTCGAGTC ATGCAGACAC AAACTTCAGT ATAAGAAAAA 13140

TTCCAGGCTG GGCGTTGGTG GCTCACACCG GTAAAATCCC AGCACTTTGG GAGGCCGAGG 13200

TGGG 13204

(2) INFORMATION FOR SEQ ID NO:50:

›(i) SEQUENCE CHARACTERISTICS · 1 of 4

(A) LENGTH: 15849 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:50:

GGGCTTTGCA TGTGTGAGAA CAAGACAGAG AATGAGGGAG GTGGGCCCCA CGAGGAGTGT 60

GGGCACAGAC AGCAGCCTCT GCCTGTGGTG CCACGCTGAA GACTCAGTAT TGTATGTGAC 120

AGATGAAGGC TCTAAGAAGA CAGCTCTGAC AAAAGCTAGA GTGCAAAATC AGACTCAGAC 180

ACAACCACCG GTCTGTGTCC TGAACACAAT GGACCTTTAC ACTCTGGAAT TTCTCAAACG 240

GAGCAATGCA CAGACACCCC CATGGGCCCC TTGCACACCC GCAGATTCTC CTAGGAGTCA 300

CATTCTCTCT TCAGATAGAC TCTGGGTGCC GACACTCCCA AACATGCTCT TGAGGAGCAG 360

TCTCTGTGAT AAGCTGATCT TCCAGACAAT CCAGAATATT CTTAAAACTT TTTAGATCAT 420

AAAATTTAAA ACACAAATTA AAAAACAAAT TATCATAAGG CCGGGCACAG TGACTCATGC 480

CTGTAATCCC AGCACTTTGC AAGGCTGAAG CAGGAGGATC ACTTGAGCCC AAGAGTTCAA 540

GACCAGCCTA GGCAACATAG TGAGACCCTG TCTCTACAAA AAAGTCAAAA GTTAGCTAGA 600

CATGGTGGTG TGCACCTGTA TTCCCAGCTA CTTGCAGGGC TGAGGTGAGG AGGATTGCTT 660

CAGCTCGGGA GGTTGAGGCT GCAGTGAGCC AAGATCACGC CACTGCACTC CAGCCTGGGT 720

AACAGAGTGA GACCCTGTCT CAAAAAACAC ATAGGGCCAG GCGTGGTGGC TCACGCATGT 780

AATCCCAGCA CTTTGGGAGG CCGAGACGGG AGGATCACTT CACTCCAGGA GTTCAACACC 840

AGCCTGGCCA ACATAGTGAA ACCCCGTCTC TACTAAAAAT ACAAAAAATT AGTTGGACAT 900

GGTGGTGTGC GCCTGTAATC TCAGCCACTC AGGAGGCTGA GGCAGGAGAA CGCTTGAACT 960

TGGGAGACAG AGGTTGCAGT GAGCTGAGAT CGCACCACTG CACTCCAGCA TGGGCAGCAG 1020

CGCGAAACTC TGTCTCAAAA CAAACAAACA AACAAACAAA CACCCATAAA CACAAAATGT 1080

ATCACAGCCT CAGAGATCCC CACGAATGCC TAAGTGGCCC TGAATTTGGG AGGCACTGCT 1140

CAGTAATAGT CCTATCTGTC CCACAACAGA CAGGAGTGCT GGGCTGCACC TACTGGCAAC 1200

AAACACAGCA ACCCTTGACT GAAGAAAGGT CCATGCCACA ATCCCCTTAT TCTGTAAGCC 1260

ACTAATTTTG TCCTCTCTCC TCCACCTTTC ACTGAGGAAC GAGCTCTTGG AAGGACAGGG 1320

ACACCCGCCT AGTAGCTGAG CCAGCCACAT CAGTCCTGGA GAGCAGGTGG AGGGCAGATG 1380

CTGTGATCAT CCCAGAAGAG AGGACACAGT TGGAGGCAGA TGCATGGTCT CTACTTTCAG 1440

CTACCCTCAA TGCAGCCTGG TCCCCAGAGG CCTGAAGAGC GCCTTGTTTA TGTGGTGACC 1500

TCAAGAGGGG CTGCTCCTGC ACCAAGGCTA TGTGTGCATG CTAACACAGT AACCGTCATA 1560

TACTCAAAGT GTCAGCTCTA AGAACTGGAG ATGAGGAGCT GCAAGCCACT CTACAGTTAT 1620

CAAAGGCACA GCTGAGGGGG TTTGTGCTGA CCAAGCTGGT TGCCTGGTGT TTGGATTGGG 1680

ACTTATTTAC TTTGGAAAAT ATGCAGCAAC AGCCCAGCAC CAAAGTTCAC ATCAAAATCC 1740

CACTGATGAC CTTGGCTGCT TTCATCTCTG AAGCGCCACT TCTCAGAAAC ACAGAGGTAA 1800

GTTGGGTTTC TAATGTTTCT GCTGATTATA AATTATTTTT GGTGTTTACG GATAGGCAAC 1860

TGGTTCATTT TTCTAGCAAA CTAAGAATTC AGAAGCTTTC TACACTGTTT TAGAAGTGGG 1920

AAATGGTTTC ATTTTTCAGT GTGCCTATTA TAAAATTGTG TCAGTTCCAT TGTTGGGAGA 1980

GTTGACAAAC TTAGAATAGG AGCTGTGGAA TAGATGAAAA TATTGTACTT ATATTAAATT 2040

AATCGAATTG GATAACTGTC CTGTGATTAT GTATGAGAAT ATCCTTGCTC TTGGGTATTT 2100

TCCCTGAAGT ATTAGTATTA AAGGTTAGAG GGGCCGGGTG CAGTGGCTCA CGCCTGTAAT 2160

CCCAACACTT TGGGAGGCCG AGGCGGGTGG ATCACGAGGT CAGGAGTTCA AGACCAGCCT 2220

GACCAACATG GTGAAGCCAA GTCTCTACTA AAAATACAAA AATTAGCTGG GCGTGGTGGC 2280

ACGCGCCTGT AATCCCAGCT ACTCAGGAGG CTGAGGCAGG AGAATCGCTT AAACCCGGGA 2340

GGCAGAGGTT GCAGTGAGCG GAGATCGTGC CACTGCACTC CAGCCTGGAC AACAGAGTTA 2400

GACTCCGTCA AAAAAAAAAA AAAAAAGAAG AAAAAAGAAA AAATGTTAGA GGAACAAGAT 2460

ATAGGAGACC TACTCTCAAA TGGTCTAGAA GAAAAAATGT GTATGTGCAT GCCTGTGAGA 2520

ACACACACGT ACGTACACAC ACACACAGAT AATGACAGGG CAAAGGTTCC AAAATTTTAA 2580

ACCTGGTAAA TCTCGGTACG GGTATACAGG AGTTGTTCTA CTACACTATT CTTTCAACAT 2640

TTTTGGAAGT TTGAACTTAC TTCAAAATAA AAAGTTTTCC AAACTTTAGG CAGTTACTTC 2700

TCTCCCATTC TGCCTGCTCT GTTGGGCCTG GAGACCATAC ACCAGGAGGG ATGACGGTTT 2760

ATCAAGTGTT ATGCTCTGAT GCGTGACTGA AAAGGCCAAC CCAGCTCTGG CAATTAGCAA 2820

GAAAGCACAA TATGAAGTTC CCAGGAAAAA AAAAAAGCAA AACAAACTTT TGAATGATTT 2880

ATCTTTAAAA TATATTGTTT CTCTTCAAAC AGTAATCTGG ATTTAATCAC AACCTAGTGA 2940

TAGTTTTTAA ACGTCTTCTA CAATGTTTGT TATACTAAAT AGCAAAACAT CAGGAAGATT 3000

TACCTTCAGA TCTTTAATTT CAATCCATAA AAGATATCAG AGATATTTTC TCCTTCCTCT 3060

GGTAAGGGAA TGACGAAAAC TATTTTTGGC TTTTTATCAG ATAATGTGGG AACAGGGTAT 3120

AAGAAGTTTC CAAATATAAC TTCTGAATAC CGGGATAAAA CATGCATGTC TTTACTCTGC 3180

CACTCTATCT GGCCTCAGAT ACGTTTTCCT GAATGCTTAT TTATTCAAGT TGGTTTTTGT 3240

TTTGTTCTTT AACCTTATTT TTATCTGAGA AGAAAACATT TTCCCCCTTT GTTCCTTCTT 3300

CTTTTGGCTT TCTTTTTTAA AATAGAGATG AGGTCTTGCT ATGTTGCTCC AGCTGGTCTT 3360

GAACTCCTGG GCTCAAGCGA TCCTCCTGCC TTGGCCTCCC AAGATGCTAA GATTACAGGT 3420

GTGAGCCCCT ATGCCTGGTC TTCTTCTTCT TGATCTTAGC CAAAAGGCCA AGAAGTGATA 3480

AGAGGAGGAC ACTTGAAGTG TAGTTGGGCA AGGAGCCTTC TACCAGCTGC TTACTTTCTT 3540

TGTTCCTGAC TTTTAAAAGT GTGTTGCTAT TGATACACAG TCTCCTGATA TGTAAAATGC 3600

TGGGAGGATG AAGCTAAGTT ACTCAAAGTG CCATTCAGAA ACTGGGCCCA GTTCTATTTG 3660

CAGCTACATA CATTAGAAAT CATTTCTAGA GGCTGAGCAT GGTAACTCAT ACCTGTAATT 3720

CCAGCACTTT GGGAGGCCAA GGCAGGAGAA TTGCCTGAGC TCAGGAGTTT GAGACCTGTC 3780

TGGGCAACAT GGTAAAACCC CATCTTTACC AAAAACACAA AAAATTAACT GGGTTTGGTG 3840

GCACACACCT GTGGTCCCAG CTACTTCAAA AGGCTGAGGT GGGAGGGTCT CTTGAGCCTG 3900

AGAGGAACAG GTGGCAGTGA ACCAATATTG TGCCACTGCA CTCCAGCCTG GGTGACAGAG 3960

TGAGACCCCG CCGTCTCAAA ATAAAAATAA AAAGAAATCG TTTCTAGAAA CTGTTTTCCC 4020

GTGTGTAAAC TAGTGGCACT GCAGCCTGAG GCAGGTGCTG AGATGGGGAC CTGGAAAAGG 4080

CAACAGGCAT TTTGAGTCAG AAACAATGTG ACTTTCCTGC TCCAAAATGT GCAATTCAAA 4140

AGTCTTTCTT AGTTGTGACT AAAACAAACT TTGAACTTAC TATTTCAACA GTATTATAAG 4200

GGGAAGACCC AAGGAATGGG ACTGGCACTG GGAAAACAGC TAGGAAGCTG CTCTGCACGG 4260

CCAGGGAGTC TGGAAGCATC CTGGTACTCC AGAGCGAACA AGGCTGAGCG CTTGATGTGG 4320

GGCTTAGAGG CTTAACCAAC TTGGTTCGAA TCTAGCCACT GCCACTTATT AGTGACAGTG 4380

ACGAAAGGCT CAGTCTCCTG ATATATAAAA TGTTGGGAGG ATGAAACTAA GTTACACGAA 4440

GTGCCTTATA CAGCGTGTCA GGCATCCAAC AGAGGCCATT ATCAACATTA ACCACACTGA 4500

CAGCATTTCA AGCAGAGTAT CCGAACAGTT ACCCCATCTT CAGGCCTACT GAGTTCAAAT 4560

ATTTGCTTAA CAAGAGCAGC CAGTAACTCT TACCTGGCCT CAACTGGCAG CAGATATTCT 4620

GGGCCTCAAA TATCTATCTA ATAGGAAATG GTCACAGACA CAAAATAAGC TTAACAAAAG 4680

GCAGTTTTTT TTTGTTTTTT TTTTGTTTTC TGTTTTTTGA GATAAGGACT CACTCTATCC 4740

CCCAGGTTGG AGTGCAGTAG TGGCGTGATC ACGGCTCACT GCAGACTCAA GTGATCCTCC 4800

TACTTCAGCC TCTCAAGTAG ATGGGACCAC AGGCGTGTGC CATCACACCA GGCTAATTAT 4860

TTTTCTTTTC TTTTTTTTTT TTTTGAGACG GAGTTTCGCT CTTTTTGCCC AGGCTGGAGT 4920

GCAATGGTGC GATCTTGGCT CACCACAACC TCTGCCTCCT GAATTCAAAC GAATCTCCTG 4980

CCTCAGCCTC CTAAGTATCT GGGATTACAG GCATGCGCCA CCACGCCGGC TAATTTTTTT 5040

›(i) SEQUENCE CHARACTERISTICS · 2 of 4

GTATTTTTTG TAGAGACAGG GTTTCTCCAT GTTGGCCAGG CTGGTCTCGA ACTCCCGACC 5100

TCAGATGATC CGCCCACCTC GGCCTCCCAA AGTGCTGGGA TTACTGACCT GAGCCACCGC 5160

ACCCAGCCTA TTTATTTAAT TTTTCACAGA GATGAGGTCT TGCTATGTTG CCCACACTGG 5220

TCTTGAGCTC CTGGGCTCAA GTGATCTTCC TGCCTTGGTC TCCCAGTGTT GGGATTATAG 5280

GCGTAAGCCA CAGCGCCTGG CCGGCAGTTC TTTCTGGGGT GATTAGAAGT TGGGACCATG 5340

TATTACCTGT CTGAGTCAGC ATTATAAACA CCTATGGTCA CTGTCCTGGC AAAACATGGA 5400

ATCATCAAAG CTCATCTAAC CAGAGTGCAG TTAATAACCA GGAAGTAAGC AAGAGAAAGA 5460

CAAAGGATTT GGCAGTCAAA ACAGATTTGA CAGGCCAAGT CAGATCCTCC TCTGAACGAG 5520

TCAGAGGAAC AAATAAAGAC AGGATTGCCA TAATGCCTCT GTGCTAAAAG CTTATCTTGT 5580

TTACTTAAAT AAAGGGAGTG CCCCTCAGGT CTTGAGTAAG AGCTTGCTGA CATCACCCTC 5640

ACACAGACTT TATCTCTTGT TTCTAACCCT GTGTTAGAAG CAGTAACACA GAAGATTTAG 5700

TTGCTCCTGA CAGCAGTGGG AGCTATTGTC TAAGAGATAC AAAGGAGAAA AAAGTATACC 5760

TGCAGCAAGT GATATCACCT CTGGGGCTGC CACCACATCA CCTCACTACG CCCTGAGGGG 5820

GTCTCAGCAC TAGACAAGTT CCAAATCTTT TGCAAATTAA ACAACCCCAG GTCAGGCGTG 5880

GTGGCTTATG CCTGTAATCC CAGCACTTTG GGGGGCTGAG GTGGGTGGAT CACCTGAGGT 5940

CAGGAGTTTG AGACCAGCCT GGCCAACAGA GCAAAACCCC ATCTCTACTA AACAAAATAC 6000

AAAAATTAAC CAGGCGTAGT GGTGTGCACC TGTAGTCCCA GCTACTTGGG AGGCTGAGGC 6060

AAGAGAATTG CTTGAGTCCA GGAGGCCGAA GTTGCAGTAA GCCGAGATCG CGCCACTGCA 6120

CTCCAGCCTG GGTGACAGAG TGAGACTCCA TTTCAAAAAA TAAAAACAAC AAAAGCCAAT 6180

TACAACAACA ACAACAAAAA AACAACGAAT TAAACAACCC CAAAGATTGC ACAAATTTCA 6240

AGTATCTTTA GAATATGTTT TCAGAAAGCC TGGCCCATGG ACATTTTTCA ACAGCATCTC 6300

CATTGCAAAG GTGGAATGGT GTGAGTCACA CAGGCATGGC TGAGTCCCAC TAATGCACAT 6360

CCCTTCTAGG TACTCTCCAA TCACCAGCCC CAGGTGCCCA CTCAAGCCCA GCTCTTAGTG 6420

AGGTTTCCCT GACTCTCTGG GCACTTCCAC TCCTACCACA CAGGGTAGAG CCACACCCCT 6480

TTCCGTACCC CCATGTGCTC TGGCAGCATT ATTTTGAGAG CCTTCGCTTT ACTGCACGTC 6540

TGTCCCATCT GTCCCCTGAC TGGTCCATGA GCCCCTGGTG GGAACTTTGT CTCTGGTAAC 6600

TAAACACTGT CTGGAGGTGG TGGACAAGGT GTCTGGAGAA AAACAAACTC CTCCCTGGGA 6660

TGCCTGAGCT CCCAGGATTC TAGAAGGTTA GTTTTGCAAA CCTTTAAAGA AGGGATTTTC 6720

ATCAAGGGGC CCACAGATCC TTCATTGAGG TTTATGAGTC CCACATCAAA GGTTGGGTGT 6780

CTATCTACAT CAGATTCTCT TAAAGTCCAT GATCCTAAAA CAGTTAAGAA CTAATGCTGT 6840

GAGGGCCTCT TCCTGGGTCA AAGCCACAGG GAACCTGCCA TGTGGATGCT GCAGCGGGGT 6900

GTGGATCAGC CAGGCCGCCT TTCACTGTGT TCTGTTTTCC CTCCCAGCTT TAGCTCCGCC 6960

AAAATGAAAC ACTCATTAAA CGCACTTCTC ATTTTCCTCA TCATAACATC TGCGTGGGGT 7020

GGGAGCAAAG GCCCGCTGGA TCAGCTAGAG AAAGGAGGGG AAACTGCTCA GTCTGCAGAT 7080

CCCCAGTGGG AGCAGTTAAA TAACAAAAAC CTGAGCATGC CTCTTCTCCC TGCCGACTTC 7140

CACAAGGAAA ACACCGTCAC CAACGACTGG ATTCCAGAGG GGGAGGAGGA CGACGACTAT 7200

CTGGACCTGG AGAAGATATT CAGTGAAGAC GACGACTACA TCGACATCGT CGACAGTCTG 7260

TCAGTTTCCC CGACAGACTC TGATGTGAGT GCTGGGAACA TCCTCCAGCT TTTTCATGGC 7320

AAGAGCCGGA TCCAGCGTCT TAACATCCTC AACGCCAAGT TCGCTTTCAA CCTCTACCGA 7380

GTGCTGAAAG ACCAGGTCAA CACTTTCGAT AACATCTTCA TAGCACCCGT TGGCATTTCT 7440

ACTGCGATGG GTATGATTTC CTTAGGTCTG AAGGGAGAGA CCCATGAACA AGTGCACTCG 7500

ATTTTGCATT TTAAAGACTT TGTTAATGCC AGCAGCAAGT ATGAAATCAC GACCATTCAT 7560

AATCTCTTCC GTAAGCTGAC TCATCGCCTC TTCAGGAGGA ATTTTGGGTA CACACTGCGG 7620

TCAGTCAATG ACCTTTATAT CCAGAAGCAG TTTCCAATCC TGCTTGACTT CAAAACTAAA 7680

GTAAGAGAGT ATTACTTTGC TGAGGCCCAG ATAGCTGACT TCTCAGACCC TGCCTTCATA 7740

TCAAAAACCA ACAACCACAT CATGAAGCTC ACCAAGGGCC TCATAAAAGA TGCTCTGGAG 7800

AATATAGACC CTGCTACCCA GATGATGATT CTCAACTGCA TCTACTTCAA AGGTAAGAGG 7860

CACCTTTACA GTTCTCACAG CAAACCCACA ACATACTATT TTTGTATGTG GGTAGATTGA 7920

ATGCCAAGAA CTGTACTGTA GCTATAATTT ATCCAGGAAA ACTAGACACA AGATTGACTC 7980

TGGAACGGGG ACAGGGAAGG CCAAGCTGAA GTGACAGTAG CATCTGACAC TTACTGAGCC 8040

CTAACTCTGT GCTTTAACAC AGCCTTGTGA GGTCATCACT GTTATTAGCA TCCCCATTTT 8100

ACAGAGGAAG CCACCAACAC ATGAAGTAAA AGGATGGGCT GGGCGCGGTG GCTCACGCCT 8160

GTAATCCCAG CACTTTGGGA GGCCGAGGCA GGCAGATCAC TTGAGGTCAG GAGTTCGAGA 8220

TCAGCCTGAC CAACAGACCA ACATGGTGAA AACCTGGCTC TACTAAAAAT ACAAAAATTA 8280

GCTGGGCCTG GCGGTGGGTG CCTGTACTCC CAGCTACTTG GGAGGCTGAG GCAGGAGAAT 8340

CACTTGAACC TGGAAGGCAG AGATTGCAGT GAGCCGAGAC TGTGCCACTG CACTCTAGCC 8400

TGGACGACAG AGTGAGACTC CATCTCAAAA AAAAAAAAAA AAGAAGTAAA ACGATGCTCC 8460

AAGGGCACCC AGTTATTAAG GGGCAGAGCC AAAGCTGAAC CCAGGGAGGC CAACCCTAGC 8520

AATCTGTTAA ATTGGAAGAA ATAATACAAA AACTGTTTTA GCATTTGGCC AGCCTGGATT 8580

TGAGTTTTCT CTTTTCCTTT CCCAATTATC AATAAGCAGG AATATAGACA AAAGGCTAAA 8640

GAAATGCACC TGTGAACTAT TCAGCTTGAG CAGCTGACAT TGACACCTAC AAGTGCTTTT 8700

CAGGATACTT TTGAACTACT GGGCAGGTGG GATGGAGAAA TAAATTACTA TTTCCCCAGC 8760

AACTGTTCTG GGCTGAGCAC AAGGGCACTT TTTAAGGAGG TCACCCCACA CCCATCACAC 8820

ACACATAGGA CCCCTGGAAT CCTAGGAATA AATAAGCATG GATTTGTAAA ATCCAAACCT 8880

CTCTTTTCAA ATATCCTCAC CTGGACCAGA CCAGAAGAAA CCTCTACTTT ACTCTCTAAG 8940

CTGAGAGTGT GGAAGGGGAA ACACGAGGAA TGGTTCGGCT TCAGGACTAA TTGCGGTGAC 9000

ACACAACCAC TTCTCTTTGC CACCAAGGAC TACCAGGTAC CTGCAAAGGG CAGTACTTGG 9060

AGGCCAGTGC TTTCTGCTAG TTAGCTCCCG TGGTTTTATA GCAGCCCAGG CGAAGGAAGG 9120

AGACCCCCCC CAGCTCCTGG CTTCTGTTCA GGGAAAGGGG GCCAGAGCCC CTCCTGATCT 9180

GTCCACACAC CTGCTCTGTG CCTTGGCTGA GGCCCCTGCA GCTCTACAAG GCAGGCATTC 9240

TGCTGGATAG GCCAAGCAGG GTCACTCTGA CACCCAGGTT TCCACCCCAA GGCATGGCAC 9300

AATGCTGGCC TCCTGTGGGT GGAATCAAAG GCTGAGTTCT AACAGGCTTG CGGCAGACAC 9360

ACACACAGAG ACCACATGTA CATGATGAAC ACACATATCC TTTTCATTAC AGGTTATTAG 9420

TACAAGTTTT GGAATTGAGC AAACAAGAGT CTAAGCGCTG GTTTCACCAC TTCTCGTTTG 9480

TGTGACCTCA GACAAGTCAT TCAACATCTC TATGACTCAG TTTCCTTATC TTTATCACAG 9540

AGATGACACC CACTCTGACA GGGCCGAGGG AAGAACCATA AGCGATGGCA ATGCAACAGA 9600

GTGGCACATG ACAAGAGCTC AGCGAATTTG AGGGAATGAA ACTGTAGATT ACAATACTAG 9660

TACAATATGA TAAACATATG ATATTGTTAG TGACATTTAT TTTACTTCTA CTAGCAAATA 9720

ACCTATGTTT AGGACTGACT TTAGAACAGG CTGGCAGAAG CATTTTTGGC AGCATCAAAG 9780

TCCTCCAACC TACTGGTCTG TTGGAGCCCC CCAAGTACAC CAAAGAGCCT CTGCATTAGC 9840

CCTGGCTGAG GGTTCAGGGA CAGGCAGAGA AGTACAGCAG TGAGCCATCC CTGCCTGCAT 9900

GGAGGTGGAG AAATGATCAG GCATGGTCAG TTGACAATCT CCTAAACACA GTAACCCGTG 9960

TCATACCACA GTGTAAACAC ACGTGCAAAT GCTTCTGCTT CCTTTCCCCA TCATGAGAAT 10020

AGTCACTCAA TGCCGGGCAT CACAAGGGAT CAAATGCTAG GAGTACCCAA TCATTCATGG 10080

ATGCTTCTCA AAGGGGACGA GTGTCTAGAA GTGTAATTTT AATTTCACTT AATTTCATAT 10140

GGAATCATCT CCATTACTAA TTTTGTTCTA ATTTTAATGT GATAATCACT TTGTAAAGCA 10200

›(i) SEQUENCE CHARACTERISTICS · 3 of 4

CAATAAACAG AGGCAGGCTC TCATGAGGAA GTCAGAAGGA AAGAATCCCA AGAGACATGG 10260

GACAGCTCCA TCCAAACTGA AAGGGCCGTG ATTCCCAAAA GAGCAATTTT GTCCCCAAGG 10320

TCTGAAGACA CTTTTGGTTG TCACAACCTG GGGGGTTGGA GTAAGCATTA CTGGTATCTA 10380

GAAGGGGGAG GCTGGGGATG TTGCTAAACA CCCTACCATG CACAGGGCAG CCCACATTGC 10440

CACAAACTAT TATGTGGCCC AAATGTCAAA AATGCTGAGG TTGAGAAACC CTGGGTGAGG 10500

CAGACTCAGG GAGAAGGGAA TCGAGCTTCA CTCACAGGCA GGCAGGAGCT GTCTGGTACT 10560

TCAACCTCCA AGACACCTCC TGCTCATCTC ATCCTGGCTG CTCTACCCAC CAGCTAGAAA 10620

CCTTGAACAA GTTACTTCAC TTCTTTGTGC CTCTGTTTCC TCATATGTAA AAGAGGGATA 10680

ACAAAACGCA CACAACTTGC ATGTTGCTAG GAGCAGAAAT GAGATAATAC AGGAAAGGTG 10740

CTGAGAAGAA TGCCCGGCAC ATGGCCAGTT CTCAACTACT AGTCACCCAT TACTATTAGT 10800

TACTCACATC TTAGAGCTAA CATAGACATG GGCTTATTCC TGGATACACA GCACTGTCCC 10860

CATATCTACA GTGGTGATCC TAAGGGCAAC ATGGCATCAC CCAAATGTCT TGTTAGTCAC 10920

TACAGAATCA CAGTGTGAGG GATGAAGGCC ATCAAGACAG AGCTGAGGCT GGCAGGGTGG 10980

CTCATGCCTA TAATCCCAGT GCTTTGGAAG GCTGAGGCAG GAGGATTGCT TGAGGCCAAG 11040

GGTTTGAGAC CAGCCTAGGT AACATAGCAA GACCCCATCT ACAATTAAAA AAAAAAAAAA 11100

AAAGACAGAA AGAAAAAATA GCCAGGCGTG GCATGTGCTT GTAGTCCAAG CTACTGGGGA 11160

GGGAGGCTGA GGCAGGAGGA TTCCTTGAGC CTGGGAGTGT GAGGCTGCAG TGAGCTATGA 11220

TGGCATCGCC GCACTCCAGC CTGCATGACA CAGTGAGACC TGGTCTCAAA AACCAAATAA 11280

TAATAACAGT AATAAAAGCT GGAAAGAGCT CAAAGTTACT CATTTGACAG ATGTGACAGA 11340

TGAAGAAATA GAAGCGAGTT AGGTGCCTTA CCATGGTCAA ACAACTAGTT CGTATCAGAC 11400

CCTACTCCAG AAACTATTCC AGTCCGGGTA ACCTCTCGTT AACCTCTCTT GTTAGAAATG 11460

CAAATTTCTG CCCAAATCAG GCCTCAGGAA TCAAGAGACT GTGGGGTCGG CTCTGCAGGC 11520

TATCTGAATG AGGCCTCCAG GGAAATCAGA TTCACTCTCA AGGGTGAGAC GATTTCCCTA 11580

AAGGAACCTT CTCATAACAG CCTCTTCCTG TGGCCTTTAC AGGATCCTGG GTGAATAAAT 11640

TCCCAGTGGA AATGACACAC AACCACAACT TCCGGCTGAA TGAGAGAGAG GTAGTTAAGG 11700

TTTCCATGAT GCAGACCAAG GGGAACTTCC TCGCAGCAAA TGACCAGGAG CTGGACTGCG 11760

ACATCCTCCA GCTGGAATAC GTGGGGGGCA TCAGCATGCT AATTGTGGTC CCACACAAGA 11820

TGTCTGGGAT GAAGACCCTC GAAGCGCAAC TGACACCCCG GGTGGTGGAG AGATGGCAAA 11880

AAAGCATGAC AAACAGGTAT TTCACACTGT GTGTTTGTTC TTTTGAGCTC CCAGATGCTG 11940

GGGGTGTCTG GGAATACTGG AAAATGGATC ATTTTTTTAA AAAGGGAGAA TTATGTACAA 12000

GTACCCAAGA ACTTCCATAC AGGGCCACTC TGTTAATTCA GCCCCAATTT GTTGCTTGAG 12060

ATAAGAGATG ATTAGAGAGC ATTCATAAGG GACACATCTG CCCTCTAGGG GCCAGTTTCA 12120

GAAGTTAGAG GCAGATGACT TAGAGACAGC TTGGTGCTTG CTTTGTGGCT TCGAGTCCCA 12180

GCTTCATCAT CCCTAAAATG GGTATAATTC CATTACTTCC CCGGGTCACT TGAGAAAATA 12240

ACAGAATCAG CGATGCTGAG CGCCCCTCCC AGTACTTGGA ACCTAGGAGG CACTCAAAAA 12300

AAGATTGGCT CAACTCTTCC CTGCCCAGGA AATTCCAAGG TCCTCTTAGC CTACCGAGGA 12360

CACATCATTC ATGATTTCCT CTATTATTAT TCGTTACTTT GTAGTTAAAA CTGCAGGTGT 12420

TAAGTACTTA TTGAGATTAT TATTGGGTCA TGGCAGAAAG AATGGAGAGG TCTTATTTCT 12480

GTCTTACTGG ATACTGGCTA GGCCCATATG AAGAAGTGAT TCTGGTTTGA ACCTCCTTAT 12540

AGGACAAGAA TACAAACATA TGCAACCAAA CTGAGAAAAG TAGGCTCTCA GAGGAAGGTA 12600

TTTGCCCGGG TAGCCAGTCA TCATGCTCTG TGAATTTTTC CTTAACAACG TCCCTTCTGT 12660

ACCTGCCTCC TTCCATTCCT CCCTGCAGCC CGGCAGCTCT TGAGAAAGGG ACTGCATCTT 12720

TTTTTTTTTT TTTTTTTTGA GACAGGGTCT TGTTCTGTCA CCCAGGCTGG AGTGCAGTGG 12780

CATCATCATG GCTCACTGCA GCCTCAACCT CCTGAACTTA AGTGATCCTC TCACCTCAGC 12840

CTCCTGAATA GTTGAGACTA CAGGCGTGCA CCTTCATGCC CAGCTAATTA AACTTTTTTT 12900

GGTAGAGATG AGGTCTCGCT GTGTTGCCCA GGCTGGTCTT GAACTCCTGG CCTCAAGCAG 12960

TCCTCCTGCC TTGGCCTTCC AAAGTGCTGG GATTAACAGG CGTGAGCCGC TGTGCCTGGC 13020

CCATTTGACT TTTAATTGAG ATCTTACTTG GTGCAAGGTA TGAGCTAGGT AAAAGAGTGA 13080

AGAAGATCAA GCCTTCCTGC CCATCCAGCT GGGATTGCAC CTTAAATCTC TTTATCCCCT 13140

GCAAAGTGCC AGACTAACTC CACAGGCACT ACTGTTGCTA TCCGCCCCCT TAGGGATTGA 13200

GTAAGTTGAG GCAAAGATTG AGATATTCAG CATTGTCTAG TATATACAGG AAAGGTTCTT 13260

TTTAAAAGTA CACTACCAGA TATTCGACTC CTTAATTACA AAAAAAAAAC CAAATGCCTA 13320

AAATTGGGAA ACCAAACCAG AGAATTATTT TAGATGCCTT TTTAAACCAT AAACCAGGAA 13380

AAGTTCTGCT GCTAACCTTG AAGATAGGAA ACGAACCATA CAGTCTCAAG GAAATAATCA 13440

TGCAACAGAA AACACACCTC AGTTTTCAGT AGCGGAATTA CAAAGGAGTG TGCTTCCTAA 13500

AATCCTCAAC TGACAGTCCC GGAATATAAA TTTTAATAAG TGCTATATCA ATTCTGTGAT 13560

AAATATAACC CGTGGCCCTT TAAAGGGAAA ATCATGATTC TTTTGTAACT TGTGGTTCAA 13620

TAAAACTGGG CCCCCCTTTC CTTTTCTGTC TAGAACTCGA GAAGTGCTTC TGCCGAAATT 13680

CAAGCTGGAG AAGAACTACA ATCTAGTGGA GTCCCTGAAG TTGATGGGGA TCAGGATGCT 13740

GTTTGACAAA AATGGCAACA TGGCAGGCAT CTCAGACCAA AGGATCGCCA TCGACCTGGT 13800

AACCACTCCC TTGTCCACCC CCGACCCGTC CCCAGGGTCT GCCTCAGCAC AGCCCCACCT 13860

CCACTTGCCC TTCCTACCCA CCCCCCAATC TCATGTCCCA GCTTGGGGTG CTGAGTCTGC 13920

TCTTCGGCCT GGGTGGGATA CACAGAATGC CTAGTTTCAT GGATGCCAGC TGGAGAGCAC 13980

GGCACCTGGC AGACACTTAC TGGGCAGGGG GGATCCCAAG AGCAGCCATG GGGTGAGCCC 14040

CACTCCCGCT GACACCAGAG ACAGGGGAGA CATGTGCTGC GGTCTGGGAA ATAGCTACCC 14100

CCAGCCAAAT CATGAAAGAG CCATTAAACA CCGCACTATA CAACATACTT AACTTAAACC 14160

AATCGGGTCG CTCAGCAAAA GAGAGAGAAC ACCAGTCCAA ACAGTGCAGC AGACCCAGTT 14220

CCCCATCCCG GAGAAGTGCG CAGCAGTGTG GGGAGCTGGA GCTGGGGTGG CTGTCCTGCA 14280

CCAGCCCCCA CGACCCTCAG ACCACAGGCA CTGCCAAGAG GGAACATGAA CCTAGCCGGC 14340

CTCTAAGTGC AACGGCTGCC CCTGACAGGT GGTGACAGAT ATTTTCAAGA GTGACTCTGA 14400

CCAGCTGTGA TTTCCACCTT ACATGTTGTC TTTGGATCCT TTCCCTGAAT GATATGAGAT 14460

TGTGCTGGGA ACTCTAGCCC TCTGTGTGCT GACCTCCAGA ATCTGACAAC TTTCCTTTCC 14520

AAACAGTTCA AGCACCAAGG CACGATCACA GTGAACGAGG AAGGCACCCA AGCCACCACT 14580

GTGACCACGG TGGGGTTCAT GCCGCTGTCC ACCCAAGTCC GCTTCACTGT CGACCGCCCC 14640

TTTCTTTTCC TCATCTACGA GCATCGCACC AGCTGCCTGC TCTTCATGGG AAGAGTGGCC 14700

AACCCCAGCA GGTCCTAGAG GTGGAGGTCT AGGTGTCTGA AGTGCCTTGG GGGCACCCTC 14760

ATTTTGTTTC CATTCCAACA ACGAGAACAG AGATGTTCTG GCATCATTTA CGTAGTTTAC 14820

GCTACCAATC TGAATTCGAG GCCCATATGA GAGGAGCTTA GAAACGACCA AGAAGAGAGG 14880

CTTGTTGGAA TCAATTCTGC ACAATAGCCC ATGCTGTAAG CTCATAGAAG TCACTGTAAC 14940

TGTAGTGTGT CTGCTGTTAC CTAGAGGGTC TCACCTCCCC ACTCTTCACA GCAAACCTGA 15000

GCAGCGCGTC CTAAGCACCT CCCGCTCCGG TGACCCCATC CTTGCACACC TGACTCTGTC 15060

ACTCAAGCCT TTCTCCACCA GGCCCCTCAT CTGAATACCA AGCACAGAAA TGAGTGGTGT 15120

GACTAATTCC TTACCTCTCC CAAGGAGGGT ACACAACTAG CACCATTCTT GATGTCCAGG 15180

GAAGAAGCCA CCTCAAGACA TATGAGGGGT GCCCTGGGCT AATGTTAGGG CTTAATTTTC 15240

TCAAAGCCTG ACCTTTCAAA TCCATGATGA ATGCCATCAG TCCCTCCTGC TGTTGCCTCC 15300

›(i) SEQUENCE CHARACTERISTICS · 4 of 4

CTGTGACCTG GAGGACAGTG TGTGCCATGT CTCCCATACT AGAGATAAAT AAATGTAGCC 15360

ACATTTACTG TGTATCTGTT ATAATTCTCT ATTTTTTGAA GCTCAAATAT CAAAAGCCAA 15420

ATCCAAATTC CTGGATAACT CCAGGTATGA TAAAGGCTGA GAGGAAGTCA CTTGAGCACC 15480

ACAATGTGCC ACAGCAGGGC ATGTTCTCAG GACAGGACAG GTGTGTGCTG AATCCTGGGG 15540

AGGGTCTGTG CAGTACCCCA GAACTGTGGG GTGCTAAGTG GCACACAAGC CCCAGGGCTC 15600

CCACAGTCTA TGCCAGGCTG CTGCAGCTTT CATCCCTCAT ACCTGGTCCT GCAGTGGGTC 15660

TGGTTTGACA GAGCAGATGA CACCTGAGGA ATATGTTTCT GGATCCTTCA ATCCCTGGGT 15720

AAGACAAGTG AAATCCACAG AGGCTGTTCA GCACGCAAGA GTGCCAGTGC TCTTTCAGTG 15780

AGGGGATGAC TGACGGTCAC AGGTGCTGTG TGTGCAGGTG TCTAACTGTA ACCCCACAGC 15840

CTGGCAGAT 15849

(2) INFORMATION FOR SEQ ID NO:51:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 499 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:51:

Met Lys His Ser Leu Asn Ala Leu Leu Ile Phe Leu Ile Ile Thr Ser

1 5 10 15

Ala Trp Gly Gly Ser Lys Gly Pro Leu Asp Gln Leu Glu Lys Gly Gly

20 25 30

Glu Thr Ala Gln Ser Ala Asp Pro Gln Trp Glu Gln Leu Asn Asn Lys

35 40 45

Asn Leu Ser Met Pro Leu Leu Pro Ala Asp Phe His Lys Glu Asn Thr

50 55 60

Val Thr Asn Asp Trp Ile Pro Glu Gly Glu Glu Asp Asp Asp Tyr Leu

65 70 75 80

Asp Leu Glu Lys Ile Phe Ser Glu Asp Asp Asp Tyr Ile Asp Ile Val

85 90 95

Asp Ser Leu Ser Val Ser Pro Thr Asp Ser Asp Val Ser Ala Gly Asn

100 105 110

Ile Leu Gln Leu Phe His Gly Lys Ser Arg Ile Gln Arg Leu Asn Ile

115 120 125

Leu Asn Ala Lys Phe Ala Phe Asn Leu Tyr Arg Val Leu Lys Asp Gln

130 135 140

Val Asn Thr Phe Asp Asn Ile Phe Ile Ala Pro Val Gly Ile Ser Thr

145 150 155 160

Ala Met Gly Met Ile Ser Leu Gly Leu Lys Gly Glu Thr His Glu Gln

165 170 175

Val His Ser Ile Leu His Phe Lys Asp Phe Val Asn Ala Ser Ser Lys

180 185 190

Tyr Glu Ile Thr Thr Ile His Asn Leu Phe Arg Lys Leu Thr His Arg

195 200 205

Leu Phe Arg Arg Asn Phe Gly Tyr Thr Leu Arg Ser Val Asn Asp Leu

210 215 220

Tyr Ile Gln Lys Gln Phe Pro Ile Leu Leu Asp Phe Lys Thr Lys Val

225 230 235 240

Arg Glu Tyr Tyr Phe Ala Glu Ala Gln Ile Ala Asp Phe Ser Asp Pro

245 250 255

Ala Phe Ile Ser Lys Thr Asn Asn His Ile Met Lys Leu Thr Lys Gly

260 265 270

Leu Ile Lys Asp Ala Leu Glu Asn Ile Asp Pro Ala Thr Gln Met Met

275 280 285

Ile Leu Asn Cys Ile Tyr Phe Lys Gly Ser Trp Val Asn Lys Phe Pro

290 295 300

Val Glu Met Thr His Asn His Asn Phe Arg Leu Asn Glu Arg Glu Val

305 310 315 320

Val Lys Val Ser Met Met Gln Thr Lys Gly Asn Phe Leu Ala Ala Asn

325 330 335

Asp Gln Glu Leu Asp Cys Asp Ile Leu Gln Leu Glu Tyr Val Gly Gly

340 345 350

Ile Ser Met Leu Ile Val Val Pro His Lys Met Ser Gly Met Lys Thr

355 360 365

Leu Glu Ala Gln Leu Thr Pro Arg Val Val Glu Arg Trp Gln Lys Ser

370 375 380

Met Thr Asn Arg Thr Arg Glu Val Leu Leu Pro Lys Phe Lys Leu Glu

385 390 395 400

Lys Asn Tyr Asn Leu Val Glu Ser Leu Lys Leu Met Gly Ile Arg Met

405 410 415

Leu Phe Asp Lys Asn Gly Asn Met Ala Gly Ile Ser Asp Gln Arg Ile

420 425 430

Ala Ile Asp Leu Phe Lys His Gln Gly Thr Ile Thr Val Asn Glu Glu

435 440 445

Gly Thr Gln Ala Thr Thr Val Thr Thr Val Gly Phe Met Pro Leu Ser

450 455 460

Thr Gln Val Arg Phe Thr Val Asp Arg Pro Phe Leu Phe Leu Ile Tyr

465 470 475 480

Glu His Arg Thr Ser Cys Leu Leu Phe Met Gly Arg Val Ala Asn Pro

485 490 495

Ser Arg Ser

(2) INFORMATION FOR SEQ ID NO:52:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 3472 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 225...1499

›(D) OTHER INFORMATION · 1 of 2

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:52:

GCGCCCGCGC GACCGCGCGC CCCAGTCCCG CCCCGCCCCG CTAACCGCCC CAGACACAGC 60

GCTCGCCGAG GGTCGCTTGG ACCCTGATCT TACCCGTGGG CACCCTGCGC TCTGCCTGCC 120

GCGAAGACCG GCTCCCCGAC CCGCAGAAGT CAGGAGAGAG GGTGAAGCGG AGCAGCCCGA 180

GGCGGGGCAG CCTCCCGGAG CAGCGCCGCG CAGAGCCCGG GACA ATG GGG CCG CGG 236

Met Gly Pro Arg

1

CGG CTG CTG CTG GTG GCC GCC TGC TTC AGT CTG TGC GGC CCG CTG TTG 284

Arg Leu Leu Leu Val Ala Ala Cys Phe Ser Leu Cys Gly Pro Leu Leu

5 10 15 20

TCT GCC CGC ACC CGG GCC CGC AGG CCA GAA TCA AAA GCA ACA AAT GCC 332

Ser Ala Arg Thr Arg Ala Arg Arg Pro Glu Ser Lys Ala Thr Asn Ala

25 30 35

ACC TTA GAT CCC CGG TCA TTT CTT CTC AGG AAC CCC AAT GAT AAA TAT 380

Thr Leu Asp Pro Arg Ser Phe Leu Leu Arg Asn Pro Asn Asp Lys Tyr

40 45 50

GAA CCA TTT TGG GAG GAT GAG GAG AAA AAT GAA AGT GGG TTA ACT GAA 428

Glu Pro Phe Trp Glu Asp Glu Glu Lys Asn Glu Ser Gly Leu Thr Glu

55 60 65

TAC AGA TTA GTC TCC ATC AAT AAA AGC AGT CCT CTT CAA AAA CAA CTT 476

Tyr Arg Leu Val Ser Ile Asn Lys Ser Ser Pro Leu Gln Lys Gln Leu

70 75 80

CCT GCA TTC ATC TCA GAA GAT GCC TCC GGA TAT TTG ACC AGC TCC TGG 524

Pro Ala Phe Ile Ser Glu Asp Ala Ser Gly Tyr Leu Thr Ser Ser Trp

85 90 95 100

CTG ACA CTC TTT GTC CCA TCT GTG TAC ACC GGA GTG TTT GTA GTC AGC 572

Leu Thr Leu Phe Val Pro Ser Val Tyr Thr Gly Val Phe Val Val Ser

105 110 115

CTC CCA CTA AAC ATC ATG GCC ATC GTT GTG TTC ATC CTG AAA ATG AAG 620

Leu Pro Leu Asn Ile Met Ala Ile Val Val Phe Ile Leu Lys Met Lys

120 125 130

GTC AAG AAG CCG GCG GTG GTG TAC ATG CTG CAC CTG GCC ACG GCA GAT 668

Val Lys Lys Pro Ala Val Val Tyr Met Leu His Leu Ala Thr Ala Asp

135 140 145

GTG CTG TTT GTG TCT GTG CTC CCC TTT AAG ATC AGC TAT TAC TTT TCC 716

Val Leu Phe Val Ser Val Leu Pro Phe Lys Ile Ser Tyr Tyr Phe Ser

150 155 160

GGC AGT GAT TGG CAG TTT GGG TCT GAA TTG TGT CGC TTC GTC ACT GCA 764

Gly Ser Asp Trp Gln Phe Gly Ser Glu Leu Cys Arg Phe Val Thr Ala

165 170 175 180

GCA TTT TAC TGT AAC ATG TAC GCC TCT ATC TTG CTC ATG ACA GTC ATA 812

Ala Phe Tyr Cys Asn Met Tyr Ala Ser Ile Leu Leu Met Thr Val Ile

185 190 195

AGC ATT GAC CGG TTT CTG GCT GTG GTG TAT CCC ATG CAG TCC CTC TCC 860

Ser Ile Asp Arg Phe Leu Ala Val Val Tyr Pro Met Gln Ser Leu Ser

200 205 210

TGG CGT ACT CTG GGA AGG GCT TCC TTC ACT TGT CTG GCC ATC TGG GCT 908

Trp Arg Thr Leu Gly Arg Ala Ser Phe Thr Cys Leu Ala Ile Trp Ala

215 220 225

TTG GCC ATC GCA GGG GTA GTG CCT CTC GTC CTC AAG GAG CAA ACC ATC 956

Leu Ala Ile Ala Gly Val Val Pro Leu Val Leu Lys Glu Gln Thr Ile

230 235 240

CAG GTG CCC GGG CTC AAC ATC ACT ACC TGT CAT GAT GTG CTC AAT GAA 1004

Gln Val Pro Gly Leu Asn Ile Thr Thr Cys His Asp Val Leu Asn Glu

245 250 255 260

ACC CTG CTC GAA GGC TAC TAT GCC TAC TAC TTC TCA GCC TTC TCT GCT 1052

Thr Leu Leu Glu Gly Tyr Tyr Ala Tyr Tyr Phe Ser Ala Phe Ser Ala

265 270 275

GTC TTC TTT TTT GTG CCG CTG ATC ATT TCC ACG GTC TGT TAT GTG TCT 1100

Val Phe Phe Phe Val Pro Leu Ile Ile Ser Thr Val Cys Tyr Val Ser

280 285 290

ATC ATT CGA TGT CTT AGC TCT TCC GCA GTT GCC AAC CGC AGC AAG AAG 1148

Ile Ile Arg Cys Leu Ser Ser Ser Ala Val Ala Asn Arg Ser Lys Lys

295 300 305

TCC CGG GCT TTG TTC CTG TCA GCT GCT GTT TTC TGC ATC TTC ATC ATT 1196

Ser Arg Ala Leu Phe Leu Ser Ala Ala Val Phe Cys Ile Phe Ile Ile

310 315 320

TGC TTC GGA CCC ACA AAC GTC CTC CTG ATT GCG CAT TAC TCA TTC CTT 1244

Cys Phe Gly Pro Thr Asn Val Leu Leu Ile Ala His Tyr Ser Phe Leu

325 330 335 340

TCT CAC ACT TCC ACC ACA GAG GCT GCC TAC TTT GCC TAC CTC CTC TGT 1292

Ser His Thr Ser Thr Thr Glu Ala Ala Tyr Phe Ala Tyr Leu Leu Cys

345 350 355

GTC TGT GTC AGC AGC ATA AGC TCG TGC ATC GAC CCC CTA ATT TAC TAT 1340

Val Cys Val Ser Ser Ile Ser Ser Cys Ile Asp Pro Leu Ile Tyr Tyr

360 365 370

TAC GCT TCC TCT GAG TGC CAG AGG TAC GTC TAC AGT ATC TTA TGC TGC 1388

Tyr Ala Ser Ser Glu Cys Gln Arg Tyr Val Tyr Ser Ile Leu Cys Cys

375 380 385

AAA GAA AGT TCC GAT CCC AGC AGT TAT AAC AGC AGT GGG CAG TTG ATG 1436

Lys Glu Ser Ser Asp Pro Ser Ser Tyr Asn Ser Ser Gly Gln Leu Met

390 395 400

GCA AGT AAA ATG GAT ACC TGC TCT AGT AAC CTG AAT AAC AGC ATA TAC 1484

Ala Ser Lys Met Asp Thr Cys Ser Ser Asn Leu Asn Asn Ser Ile Tyr

405 410 415 420

AAA AAG CTG TTA ACT TAGGAAAAGG GACTGCTGGG AGGTTAAAAA GAAAAGTTTA 1539

Lys Lys Leu Leu Thr

425

TAAAAGTGAA TAACCTGAGG ATTCTATTAG TCCCCACCCA AACTTTATTG ATTCACCTCC 1599

TAAAACAACA GATGTACGAC TTGCATACCT GCTTTTTATG GGAGCTGTCA AGCATGTATT 1659

TTTGTCAATT ACCAGAAAGA TAACAGGACG AGATGACGGT GTTATTCCAA GGGAATATTG 1719

CCAATGCTAC AGTAATAAAT GAATGTCACT TCTGGATATA GCTAGGTGAC ATATACATAC 1779

TTACATGTGT GTATATGTAG ATGTATGCAC ACACATATAT TATTTGCAGT GCAGTATAGA 1839

ATAGGCACTT TAAAACACTC TTTCCCCGCA CCCCAGCAAT TATGAAAATA ATCTCTGATT 1899

CCCTGATTTA ATATGCAAAG TCTAGGTTGG TAGAGTTTAG CCCTGAACAT TTCATGGTGT 1959

TCATCAACAG TGAGAGACTC CATAGTTTGG GCTTGTACCA CTTTTGCAAA TAAGTGTATT 2019

TTGAAATTGT TTGACGGCAA GGTTTAAGTT ATTAAGAGGT AAGACTTAGT ACTATCTGTG 2079

CGTAGAAGTT CTAGTGTTTT CAATTTTAAA CATATCCAAG TTTGAATTCC TAAAATTATG 2139

GAAACAGATG AAAAGCCTCT GTTTTGATAT GGGTAGTATT TTTTACATTT TACACACTGT 2199

ACACATAAGC CAAAACTGAG CATAAGTCCT CTAGTGAATG TAGGCTGGCT TTCAGAGTAG 2259

GCTATTCCTG AGAGCTGCAT GTGTCCGCCC CCGATGGAGG ACTCCAGGCA GCAGACACAT 2319

GCCAGGGCCA TGTCAGACAC AGATTGGCCA GAAACCTTCC TGCTGAGCCT CACAGCAGTG 2379

AGACTGGGGC CACTACATTT GCTCCATCCT CCTGGGATTG GCTGTGAACT GATCATGTTT 2439

ATGAGAAACT GGCAAAGCAG AATGTGATAT CCTAGGAGGT AATGACCATG AAAGACTTCT 2499

CTACCCATCT TAAAAACAAC GAAAGAAGGC ATGGACTTCT GGATGCCCAT CCACTGGGTG 2559

TAAACACATC TAGTAGTTGT TCTGAAATGT CAGTTCTGAT ATGGAAGCAC CCATTATGCG 2619

CTGTGGCCAC TCCAATAGGT GCTGAGTGTA CAGAGTGGAA TAAGACAGAG ACCTGCCCTC 2679

AAGAGCAAAG TAGATCATGC ATAGAGTGTG ATGTATGTGT AATAAATATG TTTCACACAA 2739

ACAAGGCCTG TCAGCTAAAG AAGTTTGAAC ATTTGGGTTA CTATTTCTTG TGGTTATAAC 2799

TTAATGAAAA CAATGCAGTA CAGGACATAT ATTTTTTAAA ATAAGTCTGA TTTAATTGGG 2859

CACTATTTAT TTACAAATGT TTTGCTCAAT AGATTGCTCA AATCAGGTTT TCTTTTAAGA 2919

ATCAATCATG TCAGTCTGCT TAGAAATAAC AGAAGAAAAT AGAATTGACA TTGAAATCTA 2979

GGAAAATTAT TCTATAATTT CCATTTACTT AAGACTTAAT GAGACTTTAA AAGCATTTTT 3039

TAACCTCCTA AGTATCAAGT ATAGAAAATC TTCATGGAAT TCACAAAGTA ATTTGGAAAT 3099

TAGGTTGAAA CATATCTCTT ATCTTACGAA AAAATGGTAG CATTTTAAAC AAAATAGAAA 3159

GTTGCAAGGC AAATGTTTAT TTAAAAGAGC AGGCCAGGCG CGGTGGCTCA CGCCTGTAAT 3219

›(D) OTHER INFORMATION · 2 of 2

CCCAGCACTT TGGGAGGCTG AGGCGGGTGG ATCACGAGGT CAGGAGATCG AGACCATCCT 3279

GGCTAACACG GTGAAACCCG TCTCTACTAA AAATGCAAAA AAAATTAGCC GGGCGTGGTG 3339

GCAGGCACCT GTAGTCCCAG CTACTCGGGA GGCTGAGGCA GGAGACTGGC GTGAACCCAG 3399

GAGGCGGACC TTGTAGTGAG CCGAGATCGC GCCACTGTGC TCCAGCCTGG GCAACAGAGC 3459

AAGACTCCAT CTC 3472

(2) INFORMATION FOR SEQ ID NO:53:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 425 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:53:

Met Gly Pro Arg Arg Leu Leu Leu Val Ala Ala Cys Phe Ser Leu Cys

1 5 10 15

Gly Pro Leu Leu Ser Ala Arg Thr Arg Ala Arg Arg Pro Glu Ser Lys

20 25 30

Ala Thr Asn Ala Thr Leu Asp Pro Arg Ser Phe Leu Leu Arg Asn Pro

35 40 45

Asn Asp Lys Tyr Glu Pro Phe Trp Glu Asp Glu Glu Lys Asn Glu Ser

50 55 60

Gly Leu Thr Glu Tyr Arg Leu Val Ser Ile Asn Lys Ser Ser Pro Leu

65 70 75 80

Gln Lys Gln Leu Pro Ala Phe Ile Ser Glu Asp Ala Ser Gly Tyr Leu

85 90 95

Thr Ser Ser Trp Leu Thr Leu Phe Val Pro Ser Val Tyr Thr Gly Val

100 105 110

Phe Val Val Ser Leu Pro Leu Asn Ile Met Ala Ile Val Val Phe Ile

115 120 125

Leu Lys Met Lys Val Lys Lys Pro Ala Val Val Tyr Met Leu His Leu

130 135 140

Ala Thr Ala Asp Val Leu Phe Val Ser Val Leu Pro Phe Lys Ile Ser

145 150 155 160

Tyr Tyr Phe Ser Gly Ser Asp Trp Gln Phe Gly Ser Glu Leu Cys Arg

165 170 175

Phe Val Thr Ala Ala Phe Tyr Cys Asn Met Tyr Ala Ser Ile Leu Leu

180 185 190

Met Thr Val Ile Ser Ile Asp Arg Phe Leu Ala Val Val Tyr Pro Met

195 200 205

Gln Ser Leu Ser Trp Arg Thr Leu Gly Arg Ala Ser Phe Thr Cys Leu

210 215 220

Ala Ile Trp Ala Leu Ala Ile Ala Gly Val Val Pro Leu Val Leu Lys

225 230 235 240

Glu Gln Thr Ile Gln Val Pro Gly Leu Asn Ile Thr Thr Cys His Asp

245 250 255

Val Leu Asn Glu Thr Leu Leu Glu Gly Tyr Tyr Ala Tyr Tyr Phe Ser

260 265 270

Ala Phe Ser Ala Val Phe Phe Phe Val Pro Leu Ile Ile Ser Thr Val

275 280 285

Cys Tyr Val Ser Ile Ile Arg Cys Leu Ser Ser Ser Ala Val Ala Asn

290 295 300

Arg Ser Lys Lys Ser Arg Ala Leu Phe Leu Ser Ala Ala Val Phe Cys

305 310 315 320

Ile Phe Ile Ile Cys Phe Gly Pro Thr Asn Val Leu Leu Ile Ala His

325 330 335

Tyr Ser Phe Leu Ser His Thr Ser Thr Thr Glu Ala Ala Tyr Phe Ala

340 345 350

Tyr Leu Leu Cys Val Cys Val Ser Ser Ile Ser Ser Cys Ile Asp Pro

355 360 365

Leu Ile Tyr Tyr Tyr Ala Ser Ser Glu Cys Gln Arg Tyr Val Tyr Ser

370 375 380

Ile Leu Cys Cys Lys Glu Ser Ser Asp Pro Ser Ser Tyr Asn Ser Ser

385 390 395 400

Gly Gln Leu Met Ala Ser Lys Met Asp Thr Cys Ser Ser Asn Leu Asn

405 410 415

Asn Ser Ile Tyr Lys Lys Leu Leu Thr

420 425

(2) INFORMATION FOR SEQ ID NO:54:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 3877 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:54:

GAATTCAAGG TCTGCATTTT CTAGGTATGA ACACTGTGCA TGATGAAGTC TTTCCAAGCC 60

ACACCAGTGG TTCCATGTGT GTGCACTTCC GGTTTGAGTG CTAGTGAGAT ACTTCTGTGG 120

TTCTGAATTG CCTGACTATT TGGGGTTGTG ATATTTTCAT AAAGATTGAT CAACATGTTC 180

GAATTTCCTC CCCAACAGTC TTCCATTACC AAGTAAAGAT TCATTTTTCT GGGACTGAGA 240

GTGAAACCCA TACCAATCAG GCCTTTGAGA TTTCTCTGTA TGGCACCGTG GCCGAGAGTG 300

AGAACATCCC ATTCACTCTG TGAGTAGCAC AGGGGGGCGG TCATCATGGC ACCAGTCCCT 360

CTCCTGCCAT AACCCTTGGT CTGAGCAGCA GAAGCAGAGA GCGATGCCTA GAAAACAAGT 420

CTTTAGTTAA AAAAATCAGA ATTTCAAAAT TGAGGTCTTT CCTCTATTTG ATATTGAGAA 480

AAAAATGCTT CAAATTGGCC ATTTTATTTT CACTTACTAG TTATATTTTT TTATTTATCA 540

TCTTATATCT GTTTATTTCT TTTATAAAGC TGCTGTTAAA CAATATAATT AAACTATCTC 600

AAAAGGTTTG ACATTAAAGA AAATGAGCAA TGGTAACAGG AAACCACTCT ATAGATGTAC 660

ATATAATATG TACAGAAAAT ATAAGTAGTA AGAAGTCCAT GACAAAGTGT TAGCTCTTTT 720

TTTTTTTTTT TTTTTTTTTT TTTTTGAGAT GGAGTCTCTC TCTATTGCCC AGGCTGGAGT 780

GCAGTGATTC GATCTCAGCT CACTGCAACC TCTACCTCCC GAGTTCAAAC AATTCTTCTG 840

TCTCAGCCTC CCGAGTAGCT GGGGCTGCAG GTGCCCACCA CCATGCCCAG CTAATTTTTG 900

TATTTTTAGT AGCGACAGGG TCTCACCATG TTGGCCAAGC TGGTCTTGAA TTCCTGATCT 960

CAGGTGATCC ACCCGCCTCG GCCTCCCAAA GTGCTGGGAT TACAGGTGTG AGCCACCATG 1020

CCCAGCCTAC CCTTTACTAC TAATCAAAGA AATAAAAGTA AGGCAACTTG ATACTTTTAC 1080

AATTACTAGA TGAACAAATC TTTAAAAATA GCCAGTGCAG ACAAGGTGGT GAAGCAGAAC 1140

ATGCGAACCT ACCATGCATC ATTCACGGCT AGAACCCTCC AGGTGCGGAA GGTAGTATTT 1200

TAATAACTTT CCATAGCTAC AAAATATTAT TACATAGAAG GGAGTGATTT TTTTCTAATA 1260

TTTATCCTAA AGAAATAGTC AACAAACATT TTTAAAAACA TCAATTACAG TCGTACCTAT 1320

ACTAGCATAA ATTAGAAACC CAGTATCCAA CATTGAGGCA GTGGGTAAAT GAATCGTGGT 1380

TTATCAAGTC ATTAAAATCA ATCTAGCCTT TAAAAACTAT AATTGTAGGA AACCCAGGAA 1440

AACATAGTAA AAAATGGAAT ATAAAATCTG AAGAGAATAA AGAATAGAGA ATCGTATGTG 1500

TGCTATGATT GTAGCTAAAT AATGTTCAAG TATCAACACA AATTGAAAAG GAATACATGA 1560

AAATGAAAAT TATATTTCTG AATGATTGAC TTCAGGATTT TCTTTTAGAA TTGTATTAAA 1620

TAGTTCATGT CATTAGGATA AATGCTGGAA TGTGGATATA ATTTAAAATA TACTAAATGC 1680

CATCGACCTT CATTTTGAGT TCTTTGTTGG ACATTTTTGT GCATTTTTAA AATATCCCCT 1740

AAATAATAAA GCTATTTATA TTTGGAGAGG AGAAAAAAAA GTGGGGGGCA GGGAGAGCTG 1800

ATCTCTATAA CTAACCAAAT TTATTGCTTT TTTGTTTAGG CCTGAAGTTT CCACAAATAA 1860

GACCTACTCC TTCCTAATTT ACACAGAGGT AGATATTGGA GAACTACTCA TGTTGAAGCT 1920

CAAATGGAAG AGTGATTCAT ACTTTAGCTG GTCAGACTGG TGGAGCAGTC CCGGCTTCGC 1980

CATTCAGAAG ATCAGAGTAA AAGCAGGAGA GACTCAGAAA AAGTAATTAA ATGTATTTTT 2040

CTTCCTTCAC TTTAGACCCC CACCTGATGT CAGGACCTAG GGGCTGTATT TCAGGGGCCT 2100

TCACAATTCA GGGAGAGCTT TAGGAAACCT TGTATTTATT ACTGTATGAT GTAGATTTTC 2160

TTTAGGAGTC TTCTTTTATT TTCTTATTTT TGGGGGGCGG GGGGGGAAGT GACAGTATTT 2220

TTGTATTTCA TGTAAGGAAA ACATAAGCCC TGAATCGCTC ACAGTTATTC AGTGAGAGCT 2280

GGGATTAGAA GTCAGGAATC TCAGCTTCTC ATTTGGCACT GTTTCTTGTA AGTACAAAAT 2340

AGTTAGGGAA CAAACCTCCG AGATGCTACC TGGATAATCA AAGATTCAAA CCAACCTCTT 2400

CCAGAAGGGT GAGATTCCAA GATAATCTCA ACCTGTCTCC GCAGCCCCAC CCATGTGTAC 2460

CCATAAAATG AATTACACAG AGATCGCTAT AGGATTTAAA GCTTTTATAC TAAATGTGCT 2520

GGGATTTTGC AAACTATAGT GTGCTGTTAT TGTTAATTTA AAAAAACTCT AAGTTAGGAT 2580

TGACAAATTA TTTCTCTTTA GTCATTTGCT TGTATCACCA AAGAAGCAAA CAAACAAACA 2640

AAAAAAAAAA GAAAAAGATC TTGGGGATGG AAATGTTATA AAGAATCTTT TTTACACTAG 2700

CAATGTCTAG CTGAAGGCAG ATGCCCTAAT TCCTTAATGC AGATGCTAAG AGATGGCAGA 2760

GTTGATCTTT TATCATCTCT TGGTGAAAGC CCAGTAACAT AAGACTGCTC TAGGCTGTCT 2820

GCATGCCTGT CTATCTAAAT TAACTAGCTT GGTTGCTGAA CACCAGGTTA GGCTCTCAAA 2880

TTACCCTCTG ATTCTGATGT GGCCTGAGTG TGACAGTTAA TTATTGGGAA TATCAAAACA 2940

ATTACCCAGC ATGATCATGT ATTATTTAAA CAGTCCTGAC AGAACTGTAC CTTTGTGAAC 3000

AGTGCTTTTG ATTGTTCTAC ATGGCATATT CACATCCATT TTCTTCCACA GGGTGATCTT 3060

CTGTTCTAGG GAGAAAGTGT CTCATTTGCA GAAAGGAAAG GCACCTGCGG TATTTGTGAA 3120

ATGCCATGAC AAGTCTCTGA ATAAGAAGTC AGGCTGGTGA GCATTCTGGG CTAAAGCTGA 3180

CTGGGCATCC TGAGCTTGCA CCCTAAGGGA GGCAGCTTCA TGCATTCCTC TTCACCCCAT 3240

CACCAGCAGC TTGCCCTGAC TCATGTGATC AAAGCATTCA ATCAGTCTTT CTTAGTCCTT 3300

CTGCATATGT ATCAAATGGG TCTGTTGCTT TATGCAATAC TTCCTCTTTT TTTCTTTCTC 3360

CTCTTGTTTC TCCCAGCCCG GACCTTCAAC CCAGGCACAC ATTTTAGGTT TTATTTTACT 3420

CCTTGAACTA CCCCTGAATC TTCACTTCTC CTTTTTTCTC TACTGCGTCT CTGCTGACTT 3480

TGCAGATGCC ATCTGCAGAG CATGTAACAC AAGTTTAGTA GTTGCCGTTC TGGCTGTGGG 3540

TGCAGCTCTT CCCAGGATGT ATTCAGGGAA GTAAAAAGAT CTCACTGCAT CACCTGCAGC 3600

CACATAGTTC TTGATTCTCC AAGTGCCAGC ATACTCCGGG ACACACAGCC AACAGGGCTG 3660

CCCCAAGCAC CCATTCTCAA AACCCTCAAA GCTGCCAAGC AAACAGAATG AGAGTTATAG 3720

GAAACTGTTC TCTCTTCTAT CTCCAAACAA CTCTGTGCCT CTTTCCTACC TGACCTTTAG 3780

GGCTAATCCA TGTGGCAGCT GTTAGCTGCA TCTTTCCAGA GCGTCAGTAC TGAGAGGACA 3840

CTAAGCATGT GACCTTCACT ACTCCTGTTC TGAATTC 3877

(2) INFORMATION FOR SEQ ID NO:55:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 135 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:55:

Phe His Tyr Gln Val Lys Ile His Phe Ser Gly Thr Glu Ser Glu Thr

1 5 10 15

His Thr Asn Gln Ala Phe Glu Ile Ser Leu Tyr Gly Thr Val Ala Glu

20 25 30

Ser Glu Asn Ile Pro Phe Thr Leu Pro Glu Val Ser Thr Asn Lys Thr

35 40 45

Tyr Ser Phe Leu Ile Tyr Thr Glu Val Asp Ile Gly Glu Leu Leu Met

50 55 60

Leu Lys Leu Lys Trp Lys Ser Asp Ser Tyr Phe Ser Trp Ser Asp Trp

65 70 75 80

Trp Ser Ser Pro Gly Phe Ala Ile Gln Lys Ile Arg Val Lys Ala Gly

85 90 95

Glu Thr Gln Lys Lys Val Ile Phe Cys Ser Arg Glu Lys Val Ser His

100 105 110

Leu Gln Lys Gly Lys Ala Pro Ala Val Phe Val Lys Cys His Asp Lys

115 120 125

Ser Leu Asn Lys Lys Ser Gly

130 135

(2) INFORMATION FOR SEQ ID NO:56:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 182 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:56:

TCTCCTTATC CACTTGTGTG TCTAGATCTC CTCAGTGGCC GCCTCTACTG GGTTGACTCC 60

AAACTTCACT CCATCTCAAG CATCGATGTC AATGGGGGCA ACCGGAAGAC CATCTTGGAG 120

GATGAAAAGA GGCTGGCCCA CCCCTTCTCC TTGGCCGTCT TTGAGGTGTG GCTTACGTAC 180

GA 182

(2) INFORMATION FOR SEQ ID NO:57:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 46 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: None

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:57:

Leu Leu Ser Gly Arg Leu Tyr Trp Val Asp Ser Lys Leu His Ser Ile

1 5 10 15

Ser Ser Ile Asp Val Asn Gly Gly Asn Arg Lys Thr Ile Leu Glu Asp

20 25 30

Glu Lys Arg Leu Ala His Pro Phe Ser Leu Ala Val Phe Glu

35 40 45

(2) INFORMATION FOR SEQ ID NO:58:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 2566 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: Genomic DNA

(ix) FEATURE:

(A) NAME/KEY: Coding Sequence

(B) LOCATION: 70...1596

›(D) OTHER INFORMATION

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:58:

CGTCGCCGTC CCCGTCTCCT GCCAGGCGCG GAGCCCTGCG AGCCGCGGGT GGGCCCCAGG 60

CGCGCAGAC ATG GGC TGC TCC GCC AAA GCG CGC TGG GCT GCC GGG GCG CTG 111

Met Gly Cys Ser Ala Lys Ala Arg Trp Ala Ala Gly Ala Leu

1 5 10

GGC GTC GCG GGG CTA CTG TGC GCT GTG CTG GGC GCT GTC ATG ATC GTG 159

Gly Val Ala Gly Leu Leu Cys Ala Val Leu Gly Ala Val Met Ile Val

15 20 25 30

ATG GTG CCG TCG CTC ATC AAG CAG CAG GTC CTT AAG AAC GTG CGC ATC 207

Met Val Pro Ser Leu Ile Lys Gln Gln Val Leu Lys Asn Val Arg Ile

35 40 45

GAC CCC AGT AGC CTG TCC TTC AAC ATG TGG AAG GAG ATC CCT ATC CCC 255

Asp Pro Ser Ser Leu Ser Phe Asn Met Trp Lys Glu Ile Pro Ile Pro

50 55 60

TTC TAT CTC TCC GTC TAC TTC TTT GAC GTC ATG AAC CCC AGC GAG ATC 303

Phe Tyr Leu Ser Val Tyr Phe Phe Asp Val Met Asn Pro Ser Glu Ile

65 70 75

CTG AAG GGC GAG AAG CCG CAG GTG CGG GAG CGC GGG CCC TAC GTG TAC 351

Leu Lys Gly Glu Lys Pro Gln Val Arg Glu Arg Gly Pro Tyr Val Tyr

80 85 90

AGG GAG TCC AGG CAC AAA AGC AAC ATC ACC TTC AAC AAC AAC GAC ACC 399

Arg Glu Ser Arg His Lys Ser Asn Ile Thr Phe Asn Asn Asn Asp Thr

95 100 105 110

GTG TCC TTC CTC GAG TAC CGC ACC TTC CAG TTC CAG CCC TCC AAG TCC 447

Val Ser Phe Leu Glu Tyr Arg Thr Phe Gln Phe Gln Pro Ser Lys Ser

115 120 125

CAC GGC TCG GAG AGC GAC TAC ATC GTC ATG CCC AAC ATC CTG GTC TTG 495

His Gly Ser Glu Ser Asp Tyr Ile Val Met Pro Asn Ile Leu Val Leu

130 135 140

GGT GCG GCG GTG ATG ATG GAG AAT AAG CCC ATG ACC CTG AAG CTC ATC 543

Gly Ala Ala Val Met Met Glu Asn Lys Pro Met Thr Leu Lys Leu Ile

145 150 155

ATG ACC TTG GCA TTC ACC ACC CTC GGC GAA CGT GCC TTC ATG AAC CGC 591

Met Thr Leu Ala Phe Thr Thr Leu Gly Glu Arg Ala Phe Met Asn Arg

160 165 170

ACT GTG GGT GAG ATC ATG TGG GGC TAC AAG GAC CCC CTT GTG AAT CTC 639

Thr Val Gly Glu Ile Met Trp Gly Tyr Lys Asp Pro Leu Val Asn Leu

175 180 185 190

ATC AAC AAG TAC TTT CCA GGC ATG TTC CCC TTC AAG GAC AAG TTC GGA 687

Ile Asn Lys Tyr Phe Pro Gly Met Phe Pro Phe Lys Asp Lys Phe Gly

195 200 205

TTA TTT GCT GAG CTC AAC AAC TCC GAC TCT GGG CTC TTC ACG GTG TTC 735

Leu Phe Ala Glu Leu Asn Asn Ser Asp Ser Gly Leu Phe Thr Val Phe

210 215 220

ACG GGG GTC CAG AAC ATC AGC AGG ATC CAC CTC GTG GAC AAG TGG AAC 783

Thr Gly Val Gln Asn Ile Ser Arg Ile His Leu Val Asp Lys Trp Asn

225 230 235

GGG CTG AGC AAG GTT GAC TTC TGG CAT TCC GAT CAG TGC AAC ATG ATC 831

Gly Leu Ser Lys Val Asp Phe Trp His Ser Asp Gln Cys Asn Met Ile

240 245 250

AAT GGA ACT TCT GGG CAA ATG TGG CCG CCC TTC ATG ACT CCT GAG TCC 879

Asn Gly Thr Ser Gly Gln Met Trp Pro Pro Phe Met Thr Pro Glu Ser

255 260 265 270

TCG CTG GAG TTC TAC AGC CCG GAG GCC TGC CGA TCC ATG AAG CTA ATG 927

Ser Leu Glu Phe Tyr Ser Pro Glu Ala Cys Arg Ser Met Lys Leu Met

275 280 285

TAC AAG GAG TCA GGG GTG TTT GAA GGC ATC CCC ACC TAT CGC TTC GTG 975

Tyr Lys Glu Ser Gly Val Phe Glu Gly Ile Pro Thr Tyr Arg Phe Val

290 295 300

GCT CCC AAA ACC CTG TTT GCC AAC GGG TCC ATC TAC CCA CCC AAC GAA 1023

Ala Pro Lys Thr Leu Phe Ala Asn Gly Ser Ile Tyr Pro Pro Asn Glu

305 310 315

GGC TTC TGC CCG TGC CTG GAG TCT GGA ATT CAG AAC GTC AGC ACC TGC 1071

Gly Phe Cys Pro Cys Leu Glu Ser Gly Ile Gln Asn Val Ser Thr Cys

320 325 330

AGG TTC AGT GCC CCC TTG TTT CTC TCC CAT CCT CAC TTC CTC AAC GCC 1119

Arg Phe Ser Ala Pro Leu Phe Leu Ser His Pro His Phe Leu Asn Ala

335 340 345 350

GAC CCG GTT CTG GCA GAA GCG GTG ACT GGC CTG CAC CCT AAC CAG GAG 1167

Asp Pro Val Leu Ala Glu Ala Val Thr Gly Leu His Pro Asn Gln Glu

355 360 365

GCA CAC TCC TTG TTC CTG GAC ATC CAC CCG GTC ACG GGA ATC CCC ATG 1215

Ala His Ser Leu Phe Leu Asp Ile His Pro Val Thr Gly Ile Pro Met

370 375 380

AAC TGC TCT GTG AAA CTG CAG CTG AGC CTC TAC ATG AAA TCT GTC GCA 1263

Asn Cys Ser Val Lys Leu Gln Leu Ser Leu Tyr Met Lys Ser Val Ala

385 390 395

GGC ATT GGA CAA ACT GGG AAG ATT GAG CCT GTG GTC CTG CCG CTG CTC 1311

Gly Ile Gly Gln Thr Gly Lys Ile Glu Pro Val Val Leu Pro Leu Leu

400 405 410

TGG TTT GCA GAG AGC GGG GCC ATG GAG GGG GAG ACT CTT CAC ACA TTC 1359

Trp Phe Ala Glu Ser Gly Ala Met Glu Gly Glu Thr Leu His Thr Phe

415 420 425 430

TAC ACT CAG CTG GTG TTG ATG CCC AAG GTG ATG CAC TAT GCC CAG TAC 1407

Tyr Thr Gln Leu Val Leu Met Pro Lys Val Met His Tyr Ala Gln Tyr

435 440 445

GTC CTC CTG GCG CTG GGC TGC GTC CTG CTG CTG GTC CCT GTC ATC TGC 1455

Val Leu Leu Ala Leu Gly Cys Val Leu Leu Leu Val Pro Val Ile Cys

450 455 460

CAA ATC CGG AGC CAA GAG AAA TGC TAT TTA TTT TGG AGT AGT AGT AAA 1503

Gln Ile Arg Ser Gln Glu Lys Cys Tyr Leu Phe Trp Ser Ser Ser Lys

465 470 475

AAG GGC TCA AAG GAT AAG GAG GCC ATT CAG GCC TAT TCT GAA TCC CTG 1551

Lys Gly Ser Lys Asp Lys Glu Ala Ile Gln Ala Tyr Ser Glu Ser Leu

480 485 490

ATG ACA TCA GCT CCC AAG GGC TCT GTG CTG CAG GAA GCA AAA CTG 1596

Met Thr Ser Ala Pro Lys Gly Ser Val Leu Gln Glu Ala Lys Leu

495 500 505

TAGGGTCCTG AGGACACCGT GAGCCAGCCA GGCCTGGCCG CTGGGCCTGA CCGGCCCCCC 1656

AGCCCCTACA CCCCGCTTCT CCCGGACTCT CCCAGCAGAC AGCCCCCCAG CCCCACAGCC 1716

TGAGCCTCCC AGCTGCCATG TGCCTGTTGC ACACCTGCAC ACACGCCCTG GCACACATAC 1776

ACACATGCGT GCAGGCTTGT GCAGACACTC AGGGATGGAG CTGCTGCTGA AGGGACTTGT 1836

AGGGAGAGGC TCGTCAACAA GCACTGTTCT GGAACCTTCT CTCCACGTGG CCCACAGGCT 1896

GACCACAGGG GCTGTGGGTC CTGCGTCCCC TTCCTCGGGT GAGCCTGGCC TGTCCCGTTC 1956

AGCCGTTGGG CCAGGCTTCC TCCCCTCCAA GGTGAAACAC TGCAGTCCCG GTGTGGTGGC 2016

TCCCCATGCA GGACGGGCCA GGCTGGGAGT GCCGCCTTCC TGTGCCAAAT TCAGTGGGGA 2076

CTCAGTGCCC AGGCCCTGGC ACGAGCTTTG GCCTTGGTCT ACCTGCCAGG CCAGGCAAAG 2136

CGCCTTTACA CAGGCCTCGG AAAACAATGG AGTGAGCACA AGATGCCCTG TGCAGCTGCC 2196

CGAGGGTCTC CGCCCACCCC GGCCGGACTT TGATCCCCCC GAAGTCTTCA CAGGCACTGC 2256

ATCGGGTTGT CTGGCGCCCT TTTCCTCCAG CCTAAACTGA CATCATCCTA TGGACTGAGC 2316

CGGCCACTCT CTGGCCGAAG TGGCGCAGGC TGTGCCCCCG AGCTGCCCCC ACCCCCTCAC 2376

AGGGTCCCTC AGATTATAGG TGCCCAGGCT GAGGTGAAGA GGCCTGGGGG CCCTGCCTTC 2436

CGGGCGCTCC TGGACCCTGG GGCAAACCTG TGACCCTTTT CTACTGGAAT AGAAATGAGT 2496

TTTATCATCT TTGAAAAATA ATTCACTCTT GAAGTAATAA ACGTTTAAAA AAATGGAAAA 2556

AAAAAAAAAA 2566

(2) INFORMATION FOR SEQ ID NO:59:

›(i) SEQUENCE CHARACTERISTICS

(A) LENGTH: 509 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(v) FRAGMENT TYPE: internal

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:59:

Met Gly Cys Ser Ala Lys Ala Arg Trp Ala Ala Gly Ala Leu Gly Val

1 5 10 15

Ala Gly Leu Leu Cys Ala Val Leu Gly Ala Val Met Ile Val Met Val

20 25 30

Pro Ser Leu Ile Lys Gln Gln Val Leu Lys Asn Val Arg Ile Asp Pro

35 40 45

Ser Ser Leu Ser Phe Asn Met Trp Lys Glu Ile Pro Ile Pro Phe Tyr

50 55 60

Leu Ser Val Tyr Phe Phe Asp Val Met Asn Pro Ser Glu Ile Leu Lys

65 70 75 80

Gly Glu Lys Pro Gln Val Arg Glu Arg Gly Pro Tyr Val Tyr Arg Glu

85 90 95

Ser Arg His Lys Ser Asn Ile Thr Phe Asn Asn Asn Asp Thr Val Ser

100 105 110

Phe Leu Glu Tyr Arg Thr Phe Gln Phe Gln Pro Ser Lys Ser His Gly

115 120 125

Ser Glu Ser Asp Tyr Ile Val Met Pro Asn Ile Leu Val Leu Gly Ala

130 135 140

Ala Val Met Met Glu Asn Lys Pro Met Thr Leu Lys Leu Ile Met Thr

145 150 155 160

Leu Ala Phe Thr Thr Leu Gly Glu Arg Ala Phe Met Asn Arg Thr Val

165 170 175

Gly Glu Ile Met Trp Gly Tyr Lys Asp Pro Leu Val Asn Leu Ile Asn

180 185 190

Lys Tyr Phe Pro Gly Met Phe Pro Phe Lys Asp Lys Phe Gly Leu Phe

195 200 205

Ala Glu Leu Asn Asn Ser Asp Ser Gly Leu Phe Thr Val Phe Thr Gly

210 215 220

Val Gln Asn Ile Ser Arg Ile His Leu Val Asp Lys Trp Asn Gly Leu

225 230 235 240

Ser Lys Val Asp Phe Trp His Ser Asp Gln Cys Asn Met Ile Asn Gly

245 250 255

Thr Ser Gly Gln Met Trp Pro Pro Phe Met Thr Pro Glu Ser Ser Leu

260 265 270

Glu Phe Tyr Ser Pro Glu Ala Cys Arg Ser Met Lys Leu Met Tyr Lys

275 280 285

Glu Ser Gly Val Phe Glu Gly Ile Pro Thr Tyr Arg Phe Val Ala Pro

290 295 300

Lys Thr Leu Phe Ala Asn Gly Ser Ile Tyr Pro Pro Asn Glu Gly Phe

305 310 315 320

Cys Pro Cys Leu Glu Ser Gly Ile Gln Asn Val Ser Thr Cys Arg Phe

325 330 335

Ser Ala Pro Leu Phe Leu Ser His Pro His Phe Leu Asn Ala Asp Pro

340 345 350

Val Leu Ala Glu Ala Val Thr Gly Leu His Pro Asn Gln Glu Ala His

355 360 365

Ser Leu Phe Leu Asp Ile His Pro Val Thr Gly Ile Pro Met Asn Cys

370 375 380

Ser Val Lys Leu Gln Leu Ser Leu Tyr Met Lys Ser Val Ala Gly Ile

385 390 395 400

Gly Gln Thr Gly Lys Ile Glu Pro Val Val Leu Pro Leu Leu Trp Phe

405 410 415

Ala Glu Ser Gly Ala Met Glu Gly Glu Thr Leu His Thr Phe Tyr Thr

420 425 430

Gln Leu Val Leu Met Pro Lys Val Met His Tyr Ala Gln Tyr Val Leu

435 440 445

Leu Ala Leu Gly Cys Val Leu Leu Leu Val Pro Val Ile Cys Gln Ile

450 455 460

Arg Ser Gln Glu Lys Cys Tyr Leu Phe Trp Ser Ser Ser Lys Lys Gly

465 470 475 480

Ser Lys Asp Lys Glu Ala Ile Gln Ala Tyr Ser Glu Ser Leu Met Thr

485 490 495

Ser Ala Pro Lys Gly Ser Val Leu Gln Glu Ala Lys Leu

500 505

Claims as granted

12 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

6 codes
IPC · International Patent Classification
Section C — Chemistry; metallurgy
  • C12Q1/6827
  • C12Q1/6883
  • C12Q1/68
USPC · US Patent Classification
435/6536/23.5536/23.1

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoom1998199920002001200220032004USPTOApplicantRestriction requirementNon-final rejectionRestriction requirementNon-final rejectionNon-final rejectionNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
5.9 y
2,148 days filing → grant
Office actions
3
after a restriction
Responses
4
no RCE
Examiner
James Martinell
art unit 1633 · TC 1600
Citations: 17 back · 1 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

⤢ drag to zoom19982000200220042006200820102012201420162018Owner 1
Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock